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SUMMARY
SUMMARY
A new method has been validated and used for measuring 
breath carbon monoxide (CO) as an indicator of success of two 
health education programmes for the prevention of smoking in 
patients admitted to the coronary care unit (CCU) in the 
Western Infirmary in Glasgow. Healthy adults (Ruchill 
Hospital employees) and Glasgow High School children were 
used to standardise methods for measuring carbon monoxide and 
to establish reference ranges for smokers and non-smokers.
In 212 patients (155 males, and 57 females) admitted to 
a CCU, 15$ were non-smokers, 30* were ex-smokers and 55% were 
current smokers. Smokers (n=1l6) were divided (for practical 
purposes according to their addresses) into 2 groups which 
were similar in respect of age, sex, smoking habit, social 
class and the presence or absence of myocardial infarction. 
The non-intervention group was given routine health care and 
routine health education. The second (Health education group) 
was given the same care and, in addition, intensive 
(personalised) health education about giving up smoking from 
a health visitor.
Study of the total CCU patients showed no significant 
relationship between age and smoking habit. Males were less 
likely to have never smoked. There was no significant 
relationship between smoking habit and social class but there 
was the expected trend, with more smokers in the lower 
socioeconomic groups. There was no significant relationship 
between MI and the presence of stress in each group.
Evaluation of the anti-smoking intervention was carried 
out after one year. 41 $ of previous smokers in the non­
intervention group had given up smoking. In the health
education group 633 had given up and the overall comparison
z.
between the two groups was not significant (X =3.1; 1df; 
P=N.S). Those who remained smokers after follow up in the 
health education group showed a significant reduction in the 
average number of cigarettes reported to be smoked per day 
(p<0.001). In comparison the difference in the non­
intervention group was not significant. In each group there 
was no significant relationship between social class and 
patient's knowledge about coronary heart disease (CHD) risk 
factors. An intensive health education programme of limited 
duration carried out under the conditions of the study did 
not seem to provide a significantly increased stimulus for a 
long term change in smoking habit in patients admitted to 
CCU, although it did seem to reduce the average amount 
smoked.
The study also compared two methods used for measuring 
blood COHb. There was no significant relationship between 
blood carboxyhaemoglobin (COHb) and smoking habit or the 
number of cigarettes smoked per day. This finding disagrees 
with published data and the possible reasons are inaccuracy 
of the spectrophotometric method used (CO-oximeter 282 ) or 
oxygen inhalation during emergency treatment. Poor agreement 
was found between measurements obtained by the Gas- 
chromatography method and the spectrophotometric (CO-
17
oximeter) method. In addition, blood COHb was compared with 
breath CO. Blood COHb was mostly higher than breath CO, and 
the 95# confidence limits for the mean of differences between 
the two were 1.2 and 2.9. A higher coefficient of variation 
was present at low CO concentration and vice versa.
Breath CO is known to decrease over time. The calculated 
half life in this study was 182 minutes (SD = 15).
Study of breath CO changes and the smoking habit of 
Glasgow high school children (n=105) and Ruchill Hospital 
employees (n=143) showed that although 34# of the pupils were 
smokers, 72# of the smokers smoked only 1 to 4 cigarettes per 
day and they were mostly weekend smokers. In these children 
there was no significant relationship between smoking habit 
and breath CO but in contrast a highly significant 
relationship was found in the group of 143 Ruchill Hospital 
employees (p<0.001). When breath CO was used to detect 
smokers the minimum error rate (2.0 - specificity - 
sensitivity) was 0.37 at cut off points between £-12 ppm CO 
for the employees, and 0.83 at 7 ppm for pupils. In addition 
to low sensitivity and low specificity for measuring breath 
CO in children,this CO monitor showed also a cross reactivitjr 
between breath hydrogen and breath CO. Therefore the value of 
using the objective measurement test (GMI CO monitor) of 
smoking behaviour is doubtful in children with low and 
sporadic consumption of tobacco.
The poor agreement between the two methods used for 
measuring COHb favours the use of breath CO. Measuring breath 
CO by the GMI hand-held CO monitor is simple and easy. The 
instrument is not sensitive to CO^ or water vapour but is 
sensitive to hydrogen which puts some restrictions on its 
use, particularly in sugar malabsorption syndromes. This 
should be taken into account when interpreting breath CO 
measurements by this method.
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INTRODUCTION
CHAPTER ONE : INTRODUCTION
1.1 GEHERAL ASPECTS REGARDING TOEACCO CONSUMPTION M D
ITS RELATED HEALTH HAZARDS
Le Riche believes that preventive medicine, like 
charity, should begin at home but usually doesn't. "The 
consumer" he said, "isn't interested in doing anything for 
his health that requires discipline, like eating less or 
exercising more. He wants to do things that are passively 
convenient and expects government or some other agency to 
find the solutions to his problem"(®9). ge Riche believes 
also that we live in an era of self-induced disease, arising 
for example from the chemical manipulation of food, which has 
a far greater effect than people believe because we don't 
know what we are putting into food or what we're taking out 
'Of it.
Considering the problem of smoking, human beings are the 
only animals who deliberately take smoke into their bodies 
^3). This they have done for centuries, before the intro­
duction of tobacco into Europe. Hippocrates prescribed smoke 
inhalation for asthma and certain other ailments, but the 
smoke came from dried cow dung or herbs. The word 'tobacco' 
is derived from a Y-shaped pipe called a 'tobaco', used by 
the American Indians, who inhaled smoke by inserting its two 
forks into their nostrils. The physician Francisco Hernandes 
was the first person to bring the tobacco plant to Europe
20
from Mexico in the 15th century. The French ambassador to 
Portugal, Jean Micot sent seeds of the plant to the Queen 
Mother of France and it is from his name that the word nico­
tine is derived.
Over the centuries smoking habits have changed according 
to fashion, and also as a result of wars (63). Cigarettes 
began to be popular during World War I. Before that, tobacco 
consumption was mainly pipes, cigars, chewing tobacco and 
snuff (95) # jjie annual consumption of manufactured cigarettes 
in the USA between 1920-1 960 rose from 37 to 195 packs per 
adult. In 1968, the average medical practitioner found that 
51$ of his male patients and 33$ of his female patients were 
regular smokers. Over the past decade the number of women 
smokers has increased by 50$ and there has been a slight 
increase in smoking in males. Women are rapidly approaching 
men in terms of prevalence of cigarette smoking (120,150)^
Smoking is, however, an international problem which has 
already begun to involve the developing countries^130)# jn 
the absence of resolute action, it will become an un­
avoidable epidemic and the resulting ill-health will replace 
the problems of infections and nutritional disease that are 
currently and rightly seen as public health priorities. The 
smoking problem in developing countries should be recognized 
from the start to be linked to activities in developed 
countries. In many developed countries certain forms of 
tobacco advertising and promotion have been restricted and 
levels of tar, nicotine, and carbon monoxide have been
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reduced. Few such restraints apply in developing countries 
where cigarettes are promoted in disregard of their 
consequences for health^30)# Smoking is less prevalent among 
females than among males. In children the figure rose from 6$ 
to 21.8$ in 1961 at the age of 15 in Colombo, Sri lanka. 
Smoking was practised by 38$ of 18 year olds in Southern 
Brazil in 1981.
The main tobacco producers are China, USA, India, 
Brazil, USSR, Greece, Turkey, Japan, Bulgaria, Canada, Korea 
and Zimbabwe (130)#. tobacco corporations in the
developed world are encouraged by their governments to 
promote tobacco growing and sales in the third world.
In nearly all producing countries, tobacco is one of the 
most valuable crops grown and its contribution to total 
agricultural income is almost invariably significant (1^8). 
The value of world exports in 1 979-1 981 averaged US $ *1,000 
million of which about US $ 1,600 million accrued to develop- 
ing countries. The World Bank notes that tobacco consumption 
over the current decade is likely to increase at one percent 
a year in industrialised countries and nearly four percent in 
developing countries. America exports nearly half of the 
tobacco it produces. In 1981, nearly $ 600 million of mainly 
Virginia tobacco was sold overseas. The exports of tobacco 
leaf and tobacco products were worth over $ 2.7 billion. The 
new markets for it are now in the Third World.
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For nearly twenty five years the US Federal Government 
helped tobacco exports to Third World countries by including 
the crop in the "Food for Peace" programme O W .  xtiis prog­
ramme was to combat hunger but at the same time to develop 
new markets for US farm products, to dispose of surplus 
agricultural commodities and promote American foreign policy. 
Tobacco was excluded from, the list of commodities in 1977 by 
a vote in the House of Representatives.
As regards the health hazards due to smoking, it plays a 
fundamental role in the cause of lung cancer and makes a 
major contribution to Ischaemic Heart Disease (63). other 
diseases related to cigarette smoking are diseases of the 
digestive tract, chronic bronchitis, peptic ulcer and 
pulmonary tuberculosis (Doll and Hill 196*1, 1966)^95)^
Rates of spontaneous abortion, low birth weight, neonatal 
death, ana stillbirth are higher in mothers who are smokers. 
They also have a higher percentage of infants with congenital 
heart disease^^0).
In India, Africa and China reports have confirmed that 
smoking plays an important role in the development of cardio­
vascular disease and to a lesser extent cerebrovascular 
diseased30)# Although lung cancer is common among cigarette 
smokers in developing as in developed countries, cancer of 
the oesophagus is more common in developing countries than in 
the developed ones, and tobacco consumption plays an 
important role in its causation.
23
From 1955 to 1967, cigarette production has expanded by 
one half in the developing and 40$ in developed 
countries^®). There is no suggestion of a decrease in 
cigarette smoking in developing countries where tobacco con­
sumption has. yet to be influenced by health considerations. 
Therefore, measures are needed to stop the growth of the 
habit in developing countries to decrease premature deaths 
and disability^^30)# jn orcj[er to do that, specific recom­
mendations on advertising, reductions in tar yield, health 
warnings and education are necessary and if no action is 
taken the cost will be counted in many lives lost^30)# 
Iherefore in developing countries just as much as in devel­
oped countries the prevention of cigarette smoking is an 
essential part of any programme in preventive m e d i c i n e ^ 5 S ) #
Coronary Heart Disease (CHD) forms one of the major 
public health epidemics of the 20th century. It was
first described as a clinical entity in 1912, and it is 
recognized with increasing frequency as being a major health 
problem. By 1940 it was the leading cause of death in the 
United States and its frequency continued to rise through the 
1950s, reaching a peak in the middle of 1960. During the last 
20 years the mortality from CHD has decreased markedly in the 
United States and in several other countries such as Canada, 
-Australia, but the rates have remained constant in most V/est 
European countries and have increased dramatically in Eastern 
Europe and some countries of the Third World.
Therapeutic medicine at present can do very little to 
reduce mortality due to smoking (125). Nearly one third of 
all initial attacks of diagnosed myocardial infarction (MI) 
are fatal before the arrival of the physician and even in 
those who survive long enough to come under medical care, the 
myocardium has frequently suffered severe and irreversible 
damage. Therefore it is apparent that the only hope for 
control of this disease lies in discovering and applying 
effective preventive measures.
At 1979 prices, the cost in million pounds to the 
National Health Service (NHS) of hospital tratment in England 
and Wales for road accidents was £75 M, alcohol related 
diseases £50-69 M, accidents at home £87 M and the highest 
£115 M for smoking related diseases (136).
in USA it was estimated that the excess of working man-
days lost in the year -was 77 million, of days spent ill in
bed 88 .million^®). In Britain, the Royal College of
Physicians estimated that the smoking habit results in the
loss of 50 million working days every year and surveys have
shown that smokers of more than 20 cigarettes a day have
twice as much time off work due to illness as do non-smokers 
(136)
•
In USA cigarette sales had declined in 1964 by 11 
'billion dollars as the effect of antismoking public service 
advertising on radio and television began to be felt. In 
1964 52$ of men and 32$ of women 21 years of age and over
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smoked. By 1975 these figures had declined to 39% and 29% 
respectively (90)# Since 1974 the number of cigarettes sold 
in the U.K. has been decreasing steadily. Sales of other 
forms of tobacco have also decreased slightly, 1978 was the 
first year since 1973 when the weight of tobacco sold (113.1 
million Kgs.) increased from the previous year (104.5 million 
Kgs.) (136).' since 1 978 the weight of tobacco sold has been 
gradually decreasing.
There is a growing awareness of the dangers in cigarette 
smoking at work and of its redefinition as an environmental 
hazard; whether or not passive smoking is harmful to the 
recipient, it is increasingly perceived as harming the rights
of non-smokers(130)^
The effect of passive smoking on infants and children is 
evident from Greenberg et al’s study in North Carolina (5 9) 
Nicotine and cotinine in the saliva and urine were 
significantly higher in the exposed groups than in the non­
exposed group* There was a direct relation between Cotinine 
excretion by the infants and self-reported smoking behaviour 
_of the mothers during the previous 24 hours.
Russell (131) explored the realistic goal of safer 
smoking and he thought that total abstinence from smoking is 
unrealistic and doomed to fail. He argued that the carbon 
monoxide yield of cigarette brands should be added to the 
official tar and nicotine tables. The safer cigarette, he 
suggested, is likely to be the one with low tar and CO yields
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but a higher rather than low nicotine yield. However, the 
goal of acceptably safe smoking will probably require the 
elimination of cigarette smoking in favour of. non-inhaled 
smoking of pipes or cigars with the combined effects of 
health education coupled to selective taxation. For this more 
realistic goal, success is not only possible but probable.
RESEARCH HYPOTHESIS
The health hazards associated with tobacco smoking are 
too numerous to mention. Nowadays a substantial reduction in 
tobacco smoking has been achieved through health education. 
Indirect methods of measuring smoking prevalence in a popula­
tion are important for checking self-reported smoking habit. 
A simple and reliable breath carbon monoxide measuring device 
might provide an alternative method.
The success of focussed health education on a coronary 
heart disease high risk group also needs evaluation.
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1.2 AIMS AND OBJECTIVES
The principal aims of this project were to:
1. Test the reproducibility of carboxyhaemoglobin and breath 
carbon monoxide measurements due to lack of published data on 
the subject.
2. To study changes over time and to compare blood 
carboxyhaemoglobin and breath carbon monoxide as a critical 
measuring method and to set the range for smokers and non- 
smokers.
3. Compare the outcome of two short-term health education inter­
ventions to combat smoking by use of carbon monoxide measure­
ments. Group I (non-intervention ) received routine advice 
about smoking and health education, Group II (health 
education) received additional personalised intensive health 
education advice from a health visitor including follow-up 
interviews in their homes.
it. Compare the characteristics of the group of patients who 
succeeded in stopping smoking with the failures, with respect 
to factors such as age, sex* social class, physical and 
mental status.
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REVIEW OF LITERATURE
CHAPTER TWO : REVIEW OF LITERATURE
2.1 HISTORY OF CORONARY HEART DISEASES IK GENERAL AKD EGYPT 
lUMHCfiLAR.
Ancient Egyptians had described most of the blood 
circulation in the body and some related diseases and they 
were ahead of the Greeks who, 2,000 years later, never 
mentioned the pulse rate (57). Egyptian papyri tell us a lot 
more in this matter e.g. that the heart is located on the 
left side from which it is displaced only by disease. The 
heart pours into a receptacle (the aorta) from which vessels 
branch to all the organs.
Especially interesting is prescription 855e of the Ebers 
papyrus that explains weakness of the heart (57).- Peripheral 
circulatory insufficiency expressed by such expressions as 
"the heart is dumb in the limbs" for example this remarkable 
description of cardiac ischaemia "if you examine a man for 
illness in his cardia, and if he suffers from pain in his 
arms, in his breast and in one side of his cardia it is death 
threatening him " (Ebers 191). Such observations may be at 
the origin of the belief in a nervous connection between the 
heart and the ring finger. Theologians explained creation as 
being the making of the heart that conceives and of the 
tongue that commands. The heart came thus to be held 
responsible for man’s actions. In scenes of the final judge­
ment in the Book of the Dead, it was weighted against the
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feather of truth. The results were recorded by the scribe of 
the gods, standing behind the jackal-headed god of the dead, 
Anubis, who tested the tongue on the scales, in front of the 
monster Am am who stood ready to devour the damned.
After the golden age of papyri, nothing happened for 
over a thousand years (57). The main cause of these dark 
periods was the repeated havoc of wars and invasions. The 
House of Life, which more or less corresponded to our 
academies was rebuilt later on. After Alexanders death, the 
Ptolemies established a grand tradition and made their city 
(Alexandria) an international emporium of trade and ideas 
that attracted the finest scholars of the known world. Two of 
these showed exceptional brilliance. They were Herophilus and 
Erasistratos who separated arteries from veins, different­
iated arterial from venous blood and nearly discovered circu­
lation. It is difficult to tell how deeply these two 
scientists might have been inspired by stray copies of the 
Pharaonic "Beginning of the Physician’s Secret" or the other 
papyri kept in the libraries of Alexandria and Memphis for, 
according to Galen, Greek physicians still studied there in 
the second century A D, But some notions seem curiously 
common to the Alexandrian and Pharaonic physicians: the 
relationship of the heart to the pulse, the notion of the 
pulse rate and its importance in diagnosis, and the concept 
of healthy and morbid circulating matter of different kinds.
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2.2 1X)RTALTX FROM CORONARY HEART DISEASE
In the UK and the USA one third of all male deaths 
between 35 and 64 years of age are due to coronary heart 
disease (CHD) (**8). In the USA 25$ of the deaths caused by 
CHD each year are also thought to be smoking-related. 
Cigarette smoking also accounts for 1 in 5 cancer 
deaths W i 63).
Prospective surveys have indicated that among young men 
the coronary mortality risk is five to ten times higher in 
heavy smokers than non-smokers. (Hammond, 1966; Doll and 
Hill, 1964) (125). The risk ratio diminished with advancing 
age. At all ages it is substantially less than for lung 
cancer; but because heart disease is so much commoner it is 
found that cardiovascular disease rather than lung cancer 
accounts for most of the excess mortality of cigarette 
smokers.
The age adjusted mortality ratio for male cigarette 
smokers in the USA for all causes of death was found to be 
-70$ higher than that for non-smokers (63). For lung cancer, 
the death rate in smokers was nearly 10 times higher than for 
non-smokers. Many other diseases including cancer of the 
larynx and cancer of the oesophagus showed significantly 
higher mortality rates for smokers.
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The impression of many physicians that serious 
cardiovascular diseases are now more frequently seen in 
younger subjects has been confirmed by statistical reports 
from the Registrar Generalfs Office (18). The death rate from 
coronary heart disease in males aged 30 to 49 years has 
increased by 37$ between 1950 and 1974.
According to the Royal College of Physicians of London, 
the calculated deaths in Scotland in 1980 from coronary 
artery disease, lung cancer and chronic bronchitis were over 
9 ,000 deaths attributable to smoking compared to 740 from 
road accidents (134).
The recent slight decrease in mortality from lung 
cancer, bronchitis and CHD in both sexes in Scotland may 
hopefully indicate a trend which will continue (134). 
Certainly the steady decrease in lung cancer mortality in 
early middle aged males has been related to the decrease in 
male smoking, which is at least partly attributable to health 
education. The failure of female mortality to fall until 
1979 -8 0 is consistent with the failure of overall female 
smoking to fall significantly.
The Advisory Committee of the Surgeon-General reported a 
markedly lower mortality ratio for ex-smokers than for 
current cigarette smokers and half of the excess deaths 
associated with cigarette smoking were attributed to 
CHD (14,61).
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The relation between the number of cigarettes smoked 
daily and death rate is clear (48,63). Thus the death rate 
from all smoking related diseases was increased by 40/6 for 
smokers of 1-9 cigarettes per day, 70$ for 10-19 per day and 
90$ for 20-3 9 per day. Mortality also was greater for 
inhalers than for non-inhalers.
Middle-aged men smoking more than 20 cigarettes each day 
are about 20 times as likely to die from lung cancer, and 
about twice as likely to die from CHD as their non-smoking 
counterparts. Out.of 100 excess deaths from all causes 
observed among heavy smokers, about 16 may be due to lung 
cancer but 50 might result from heart disease (48,58,11 8) 
Sudden death was four times more frequent in smokers than 
non-smokers (95).
The time of death after myocardial infarction is 
important: in a study in Kuwait, 85$ of myocardial infarction 
deaths occurred in the first 48 hours (41). in a coronary 
care unit most deaths occured within the first 12 hours. In 
Scandinavia it has been reported that the case fatality rate 
within the first hour was 15.5 $ for males and 9.3$ for 
females and within a year was 44.2$ for females and 37.4$ 
for females (52).
In the USA the major reduction in smoking has been in 
men, while the prevalence of smoking among young women has 
increased. Yet, both had an equal decline in coronary
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mortality (158). Several factors probably explain this. The 
greatest decrease in smoking in the USA has been in men, 
particularly among middle-aged and older men who are at high 
risk of coronary disease and account for most coronary 
deaths. The increase in smoking occurred among young women, 
who are at extremely low risk of coronary disease and account 
for little of the overall coronary mortality.
The conclusions of the Maryland conference in 1978 ^*0 
on the decline in CHD mortality were (1) the decrease in 
coronary heart disease is real and not a result of artefacts 
or changes in death certificate coding;(2) both primary 
prevention through changes in risk factors and fundamental 
and clinical research leading to better medical care have 
probably contributed to, but not fully explained, the 
decline, and (3) a precise quantification of the causes 
requires further studies.
In the USA, one large prepaid health care plan found 
that the number of coronary heart disease patients discharged 
has decreased each year since 1971 while the case fatality 
rate has not changed (3*0. In contrast, within a community 
with a comprehensive medical record system, the incidence of 
new coronary events among those having no previous coronary 
disease has not changed over recent years, while the 
frequency of deaths among those with known coronary heart 
disease has decreased. These limited observations cannot be 
extrapolated to the whole country and the question of trends
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in heart attack incidence remains unanswered. Changes in 
coronary heart disease care have probably had an impact on 
the decline but the contribution is difficult to ascertain; 
the same applies for changes in risk factors for 
atherosclerosis. Mortality from hypertensive heart disease 
and stroke began to decline some years before effective 
medical therapy for hypertension was available and during a 
time when coronary heart disease mortality was increasing. 
Although there is general agreement that the decline in CHD 
is real, the probable cause or causes could not be precisely 
identified.
Ischemic heart disease mortality information reported to 
WHO shows downward trends that are similar but less marked 
than in USA for Canada , Australia, Finland, Belgium and 
possibly Britain between 196 8 and 1976. Upward trends are 
noted in two Scandinavian countries (Sweden and Denmark), 
France, Poland, three Balkan countries (Yugoslavia, Romania, 
Bulgaria) and possibly in the Federal Republic of Germany, 
Austria, and Italy. The possible causes were not mentioned in 
this paper although the increase may be due to social or 
environmental conditions (42). In eight other countries IHD 
rates appeared to show little change.
Data on international CHD mortality trends have not been 
reported on a comprehensive scale since data have not been 
analysed separately by sex. Cause-specific death rates have 
been used but these are subject to various possible errors 
and uncertainties. The reported mortality trends need more
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detailed analysis (42). A more definitive report about CHD 
mortality trends should take into account competing causes of 
death with attention to any differences between the rates for 
men and women. The social and environmental conditions that 
affect CHD risk factors are likely to show different time 
trends not only between, but also within countries. Future 
analysis should take also account of such variation if the 
necessary data are available, since they could throw light on 
the reasons underlying differential trends.
The influence of cigarette smoking on prognosis after a 
first myocardial infarction was studied by Sparrow and 
Dawber (1978) (144) in the Framingham study. Follow-up of 458 
subjects developing myocardial infarction in terms of 
recurrent myocardial infarction, mortality and cigarette 
smoking revealed that of 82.8? of patients who survived the 
initial attack 53.3? had been cigarette smokers and 45.9? 
non-smokers. There was a 62.0? reduction in mortality among 
patients who stopped smoking compared to those who continued, 
over a 6 year period. However no significant difference in 
recurrent myocardial infarction rates was observed between 
the two groups.
Coronary heart disease (CHD) and cerebrovascular disease 
form the first and third most important causes of death in 
Israel (43). A comparison of the international trends reveals 
that Israeli Jews lagged behind only American and Australians 
in the rate of decline of coronary deaths (53). They have a 
peculiar feature also which is the unusually low male :
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female mortality ratio and in 1970 -71 it declined from 1.8 
at ages 25 to 34 to 1.05 at more than 75 year. During the 
corresponding period, CHD mortality rates in Israeli Jewish 
women were among the highest in the world. The sex ratio of 
Israeli CHD mortality rates (averaged for ages 40-69 years) 
was the lowest reported in any country (1.92), while the 
highest was in Finland (4.74)* This could reflect a sex- 
genetic-environment interaction.
The importance of examination of changes in mortality 
from CHD by examining the male/female ratio rather than by 
using conventional methods was illustrated by Anderson (1973) 
in Toronto (5). The fluctuation in rates caused by changes in 
terminology or diagnostic methods have tended to affect both 
sexes to an equal extent and, therefore, largely cancel out 
when the ratio of the two rates is calculated and this 
approach simplifies the interpretation of male mortality 
trends over the years. The ratio for the age group 45-64 for 
all heart disease rose from 1.1 in 1920 to 3.3 in 1968. By 
1968i the rate for all-cause male deaths rose to more than 
double the female rate (ratio 2 :1) compared to only a 10 % 
male excess in 1920.
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2.3 SMOKING AND RISK FACTORS FOR CORONARY HEART DISEASE
AND THE CHANGING PATTERN AMONG SMOKERS
2.3.1 CORONARY HEART DISEASE RISK FACTORS.
It is accepted that smoking can cause a disease if 
^®^(1) a temporal relationship is present (2) there is a 
strong association between cause and effect (3) there is 
consistency of results from several studies (4) it is 
biologically plausible (5) the incidence of the disease is 
quantitatively related to increasing exposure to cigarette 
smoke; (6) the incidence decreases in those who stop smoking, 
and (7) the disease could be produced or exacerbated by 
cigarette smoking. The evidence is strengthened if the 
disease can be produced in animals by exposure to cigarette 
smoke.
Paul et al (107) in their 4 year prospective study of
coronary heart disease (CHD) carried out in an industrial
\
population found that approximately one per 100 men per year 
will develop CHD and there was an association with an early 
age of death of father, history of chest discomfort, history 
of chronic cough, history of shortness of breath, presence of 
increased skin fold thickness, elevated BP, elevated blood 
cholesterol, ST and T abnormalities in the electrocardiogram 
and use of cigarettes and coffee. No relation was 
encountered between body weight, mean blood sugar levels, 
lipoprotein lipase level or diet (other than coffee) and the 
development of CHD. Similarly there is no association with 
job type and no certain relation to physical activity off the job.
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In contrast to the Paul et al study, diabetes mellitus 
in a Kuwaiti myocardial infarction study was present in 51.0$ 
of the Kuwaiti patients and 31$ in non-Kuwaiti patients (41). 
The occurrence of the risk factors hypertension, smoking, 
family history and previous CHD was very similar in the 
diabetic and non-diabetic group. The prevalence of diabetes 
in the population was not mentioned in this paper.
Under present nutritional and behavioural conditions in 
the western world it is now apparent that lipid infiltration 
of coronary vessels may occur by the age of 20 years (7,67).
2.3.1.1 AGE, SEX, MARITAL STATUS AND SMOKING HABIT
Kannel et al(82) in 1 965 in the Framingham study
mentioned that in both sexes it is quite clear that
susceptibility to CHD increases with age. The male however 
is more susceptible than the female. Women develop MI with 
comparable frequency some 20 years later in life but overall 
more men than women develop CHD, and they are more 
susceptible to the lethal forms of CHD. Only angina pectoris 
has similar incidence in both sexes.
In the Kuwait study, most of the MI patients (61.3 $)
were under the age of 60 years and 3 8.7,$ were older (41).
There were nearly five times as many males (85.2$) as females 
(14.8$) among the MI patients. The prevalence rate of IHD 
correlated positively with age, marital status (divorce or 
widowhood).
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The New Zealand study of smoking among 4,000 children 
from nine schools showed that boys began smoking at about 11 
years and girls at 12 years (63). A comparison was made with 
a similar study of children in English secondary modern 
schools. New Zealand children appeared to have a higher 
proportion of smokers than English children.
Until recently boys smoked more than girls (136). 
Information from a number of countries now suggest strongly 
that smoking by girls under 16 is increasing and sometimes 
surpasses that by boys. Limited surveys in the UK suggest 
that the gap between girls and boys has largely disappeared. 
For example, there was little information on the smoking 
habits of school children in Scotland until the report 
"Smoking among secondary school children " was published in 
1983 (133). It was disturbing that 24? of the children under 
age 1 8 said they smoked, 15? regularly (smoking one or more 
cigarettes a week) and 9? occasionally. The proportion of 
regular smokers rose from 4? of first year children to 10? in 
the second year, 19? in the third year and 26? in the fourth 
year. The proportion of boys and girls smoking regularly was 
similar, 15? of boys and 14? of girls. About one-fifth of the 
regular cigarette smokers in the sample had already acquired 
a habit of smoking more than ten cigarettes per day. The 
proportion of children who had never smoked decreased from 
60? of the first year children to 40? in the second year, 31? 
in the third year and 26? in the fourth year.
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Study of age and myocardial infarction
In a study of the registered cases of acute MI and 
sudden death due to CHD in 1971 in two Swedish and two
Finnish cities during a o n e - y e a r  p e r i o d , (52) incidence
increased steeply with age. In all groups it was far higher 
in males than in females. The case fatality rate was 44.2$ 
for males and 37.4$ for females and the difference was 
evident in the first hour after the onset of the attack. In 
acute MI patients, a history of previous cardiovascular 
disease was much more common than in the general population; 
such a history was found more often in patients who died 
suddenly than in acute MI patients who did not die suddenly.
In India, Sharma et al (1976) (138) studied patients 
admitted to a CCU in Indore. They found that CHD was more 
common'among age group 41-60 years, among professional 
workers and in persons having a higher social economic status 
with sedentary habits. This finding which is related to 
smoking is opposite to the smoking pattern and social classes 
in Britain (25,103).
2.3.1.2 PHYSICAL ACTIVITY AND CORONARY HEART DISEASE
Physicians and other health professionals are actively 
promoting physical exercise as preventive and therapeutic 
measures for CHD, yet critically controlled studies are rare
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and short in defining the exact role of physical activity in 
coronary artery disease (50). consistent finding of many
studies included decreased heart rate at rest and increased 
during exercise allowing increased myocardial perfusion at 
any work load. An important question is whether or not these 
haemodynamic and functional changes increase the quality of 
life. Psychological improvement is often noted clinically 
but the effect on morbidity and mortality is unknown. In a 
case-control study the results showed that there was no 
marked difference in physical activity of the job between 
coronary and non-coronary groups (^3).
The relationship of smoking habits and customary levels 
of physical activity at the time of infarction to both CHD 
incidence and early mortality has been studied by Frank et al 
in New York, 1966 (^9). Age-adjusted incidence rates for 
smokers and non-smokers of differing physical activity levels 
showed that physically inactive men show higher incidence of 
first myocardial infarction than more active men, among both 
smokers and non-smokers. Smokers exhibit an incidence of 
first infarction which is almost twice that of non-smokers. 
No difference in incidence of initial infarction was found 
between the least active non-smokers and the relatively more 
active cigarette smokers. The highest incidence is in 
inactive smokers and the lowest by the relatively more active 
non-smokers, with nearly three-fold difference between these 
two groups. Smoking had no significant relation to the 
immediate prognosis for either the least active or relatively 
more active men. The age-adjusted death rate from first
myocardial infarction showed a higher rate 3.29 among the 
least active men in comparison with 0.89 for more active men. 
This reflects the combined influence of increased incidence 
and increased risk of death shortly after onset (49),
2.3.1.3 JOB STRESS AND CORONARY HEART DISEASE
The-relation between job stress and risk factors for CHD 
had been studied in 1972 by Shirom et al among five 
occupational categories in Israel (140) Host of the CHD 
morbidity rates, the average values of CHD risk factors and 
average score of job stress and strains did not significantly 
differ among managerial and professional workers, clerical 
workers, craftsmen, factory workers and agricultural workers. 
In order to investigate the patterns of association of job 
stresses and strains with CHD risk factors, smallest space 
analysis was performed on the data matrix of each of the four 
major occupational categories separately. White collar 
workers were most disposed to obesity as a possible risk 
factor. Agricultural workers were most likely to experience 
job stress and strains associated with increased CHD risk, 
this has not been found in U.K. or European contries, and it 
may be peculiar to Israel.
2.3.1.4 WEIGHT.
Nemery et al in their study about smoking, lung function 
and body weight reported that smokers (76.1 Kg) were found to 
weigh significantly less than non-smokers (81.6 Kg) d°5).
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The lower weight of smokers was attributable to a group with 
airflow obstruction (FEV-)/VC) <66$, who weighed less (by 4.8 
Kg; p<0.05) than smokers with normal FEV^/VC ratio. In 
smokers only body mass index and FEV^/VC ratio were closely 
related (r = 0.34; p<0.001). This association was
apparently not due to an effect of body weight on lung 
function.
2.3.1.5. GENETIC COMPONENT IN CORONARY HEART DISEASE.
Deaths due to CHD among relatives of coronary patients 
were studied on the basis of death certificates among equal 
numbers of matched controls. They were one and a half fold 
higher among first degree relatives (1^9). The average age 
at death to second degree relatives was lower. The age at 
onset of MI did not affect the risk to relatives whereas sex 
-related influence was significant. The risk increase was 
found to be the greatest to first degree male relatives of 
female propositi, or over 7-fold to fathers and brothers. 
Mothers and sisters of both male and female propositi had a 
4-5 fold risk increase over the expected value among 
coronary mortality relatives of controls which is close to 
that of the general population. These findings indicate a 
genetic component in the aetiology of CHD.
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2.3.1.6 CORONARY HEART DISEASE RISK FACTORS AMONG CHILDREN.
Paediatricians have done well in keeping children 
healthy as children but at the same time they have fallen far 
short of creating healthy adults (165), Williams and Wynder 
demonstrated that risk factors for chronic diseases can be 
identified among young children and are highly prevalent as 
well. Twenty-five per cent of New York high school students 
were smokers, 5-15 $ were overweight and 20$ or more of 
school children aged 5-15 years may be hypercholesterolaemic. 
In order to fill this blind spot the American Health 
Foundation in New York City developed the ” Know your body 
program ” to improve health-related behaviour in a school-age 
population. As with other educational endeavours health- 
related behaviour can most effectively be influenced by 
lessons learned early in life.
Risk factors for coronary heart disease (CHD), can be 
identified among children (166), was reported that 46$ of 
a sample of 8 to 12-year old boys in California had one risk 
factor and an additional 14$ had two or more risk factors. 
Preliminary data from a sample of 3000 11 to 14-year old 
public school children in the "Know Your Body" study indicate 
that about 40$ have one or more risk factor for CHD 
(overweight, elevated cholesterol, current cigarette smoker, 
poor physical fitness, hypertension and diabetes).
2.3.1,7 CORONARY HEART DISEASE RISK SCORE CALCULATION.
Rose and Hamilton (126) their randomised controlled 
trial on the effect on middle-aged men of advice to stop 
smoking selected the cigarette smokers from the Whitehall 
study of male civil servants in London with high 
cardiorespiratory risk as follows :-
A risk score was calculated for each man who smoked 5 or 
more cigarettes per day. This score was based on a 
modification of the multivariate linear discriminant function 
coefficients. The complete cardiorespiratory risk score was 
calculated thus:
0.07 X (age in years)
+0.01 X (plasma cholesterol in mg/100 ml)
+0.02 X (systolic blood pressure in mm Hg)
+0.01 X (blood sugar in mg/100 ml two hours after a 
50 gm glucose load)
+1.5 for history of angina
+0.5 for possible history of MI
+2 .0 for history of intermittent claudication
+3.0 for major ECG findings (Minnesota codes 1.1-2)
+1.0 for minor ECG findings
+1.5 for history of phlegm for 3 months each winter 
+0 .5 for history of exertional dyspnoea 
+2.0 for FEV1.0 <2.2
+1.0 for FEV1.0 >2.2<3.0
The cut-off point was determined (10.24) such that the score
of 10# of all men and 32# of smokers exceed this value ^ 26)^
After one year, 63$ of the intervention group reported that 
they were not smoking any cigarettes and 29$ in the normal 
care group, indicating a highly significant effect of giving 
advice about smoking cessation.
2.3.1, 8  RELATIONSHIP BETWEEN CORONARY HEART DISEASE RISK FACTORS.
In order to study the relationship between risk factors,
Kok et al tested the hypothesis that risk factors are inter­
related (86). They studied the simultaneous occurrence of 
smoking, inadequate nutrition, obesity and physical 
inactivity in a random sample (n=1951) of the Dutch adult 
population by comparing observed and expected rates for up to 
four risk factors. Kok et al found that 20 % of the studied 
population had no risk factors, 6 6$ had one or two, 10% had 
3, and all four risk factors were found in 1$. Almost equal 
proportions with one or two risk factors were found in the 
two sexes. Significant sex differences were observed for the 
presence of zero risk habits (men 14$, women 24$).
The effect of differing life styles was examined by using 
Fisher's linear discriminat function. The order in which 
important cardiovascular risk factors were reported was as 
follows:- stress (7 0 $), diet excessive in fat (46$), 
hypertension (40$), smoking and physical inactivity shared 
the fourth place with 35$, and hyperlipideraia (31$) was the 
least important. The independent demographic and 
socioeconomic determinants of "risky" life style were found 
to be sex (men), education (low), and occupation (low); 
marital status and familial social class were no longer 
discriminating between the two categories of life style, so
men with a low level of education and occupation constituted 
the target group in which three or four risk factors were 
aggregated. The results did not suggest systematic cluster­
ing. The assumption of independence of these risk factors 
also could not be maintained .
In the national cooperative pooling project, the 10 year 
rates for first major coronary event was 20 per 1,000 for men 
aged 3 0 - 5 9 at entry who had none of the three risk factors 
(hypertension, elevated cholesterol level, and smoking) as 
contrasted with a rate of 171/1,000 for those with all three 
factors (93). Similar findings were found in the prospective 
Framingham study. The removal of all three factors was 
expected to reduce the risk of a major coronary event by over 
80/5. This is what happened in the Veteran Administration 
study where there was a clear reduction in the occurence of 
MI, congestive heart failure, and sudden death. The findings 
in other intervention trials are generally similar.
2.3.1.9 SMOKING AND MYOCARDIAL INFARCTION.
The importance of the relationship between smoking and 
myocardial infarction has been studied by Uhl and Farrell 
(151). They found that smoking was the most common risk 
factor in two groups of MI patients. They compared the risk 
factors and clinical course of 165 patients under 40 years of 
age having MI (group I) compared to 100 patients over 40 
(group II). Six risk factors were analysed : smoking 20 pack- 
years, hyperlipidaemia, hypertension, family history of
ischaemic disease, diabetes mellitus and obesity. Patients 
under age 40 had more risk factors than those over 40 
although 61% of the younger patients were heavy smokers 
compared with 75 % of the older patients (51»64)# higher
prevalence of heavy smoking in group II was probably due to 
heavy sdloking defined as 20 or more pack years ^51)# ^he 
younger patients would have had to smoke two packs/day or 
more to be included in the heavy smoker category. Group I had 
hyperlipidaemia, obesity and family history more commonly 
than did group II, while hypertension was more frequent in 
the older patients, a prior history of angina was present in 
nearly half of group I and II but physical exertion just 
prior to MI was more common in group I than in group II. The 
complication rate was similar in both groups but mortality 
rate was lower in young MI patients. ; v
Unfavourable changes were observed in smokers only for 
serum triglycerides and there was a gradient within the 
smoking habit (44)# There was no consistent pattern of 
cholesterol change with smoking habits. Erikssen and Enger 
concluded that smoking can promote CHD development 
independently of the accepted CHD risk factors.
The characteristics of 200 MI patients as regards age, 
sex, smoking habits and country of origin, have been analysed 
by Eisenberg et al (1981) They found that patients over
65 years were characterised by an overall low-risk profile. 
Women with MI, especially under the age of 6 5 , were 
characterised by a high risk profile, although fewer smoked
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cigarettes and their high density lipoprotein cholesterol 
levels were higher than in men. In patientsvof, Asian-African 
origin, hyperlipoproteinaemia of the type II b variety was 
more prevalent and the plasma triglyceride levels were higher 
than in the other patients. The analysis has thus indicated 
several distinct risk patterns among the study population, in 
particular plasma and lipoprotein lipid levels were found to 
be an important predisposing factor for coronary artery 
disease in young patients, in women and in immigrants from 
Asian and African countries.
The combined experimental and epidemiological evidence 
in the past few years strengthens the view that cigarette- 
smoking is a major risk factor for both fatal and non-fatal 
MI Cigarette smoking acts both independently and
synergistically with other major risk factors such as hyper­
tension and elevated serum cholesterol. In most studies the 
risk increases in direct proportion to the number of 
cigarettes smoked, and there is accumulation of evidence that 
CO plays an important part in the mechanism whereby smoking 
increases CHD.
The association of cigarette smoking for most of adult 
life with' subsequent development of clinical coronary disease 
is significant and it was natural that there was a relation 
between the number of cigarettes smoked and the manifestat­
ions of coronary disease identified (107). Acute MI patients 
were almost six times as likely as controls to be smokers 95% 
confidence limits 2.8-12.3,p<0.0001) (3).
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Cigarette smokers have two to four times the risk for 
CHD compared to non-smokers and the risk is dose related 
In the presence, of high serum cholesterol and hypertension, 
'the risk is eight times higher. The associations are 
confirmed by smoking cessation, a substantial reduction in 
risk for CHD within a few years of quitting and, after 10 
years, the risk is almost equivalent to that of non-smokers
(MS).
2.3.1.10 CORONARY HEART DISEASE RISK FACTORS IN DIFFERENT 
POPULATIONS.
In a study done to compare the risk factors for CHD in 
Edinburgh and Stockholm men aged *40, Logan et al (1978) ^ 2) 
found that Edinburgh men were shorter and fatter, had higher 
systolic and diastolic BP, smoked more cigarettes, drank more 
alcohol, had more ECG abnormalities and lower exercise 
tolerance. Edinburgh men also had a higher level of total 
serum triglycerides but serum cholesterol and low density- 
lipoprotein cholesterol were similar in both cities. 
Cholesterol in very low density-lipoprotein ( VLDL) was 
higher and cholesterol in HDL was lower in Edinburgh men and 
these metabolic factors may provide new information on the 
CHD pathogenesis.
The study of the coronary risk factors in medical 
students in Jerusalem participating in a class excercise to 
determine their own risk factors , showed that systolic and
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diastolic blood pressure, body-mass index, and proportion of 
smokers were all lower in females and gave them a 
significantly lower estimated coronary heart disease risk 
function (1 3^). There was no sex difference for measures of 
serum cholesterol. Comparison of the Israeli for CHD data 
with those from three studies of American medical students 
revealed that Israelis smoke more than their American 
counterparts but otherwise appear to have similar risk 
profiles.
In order to determine whether MI'in different countries 
is associated with different risk factors, Dolder and Oliver 
studied the risk factors for MI in young men aged kO or less 
in nine countries (37). in seven centres in developed 
countries there was a high prevalence of risk factors, 
particularly of hyperlipidaemia and cigarette smoking. The 
prevalence of hypertension, obesity, hyperglycaemia and 
hyperuricaemia varied from centre to centre. Risk factors 
were less prevalent in Bombay and Singapore. The most common 
risks operating in Bombay seemed to be cigarette smoking and 
hyperglycaemia, while in Singapore cigarette smoking was the 
commonest. Serum cholesterol levels of 7.25 mmol/1 or more 
were present in 25$ of all patients and serum triglyceride 
levels of 2.26 mmol/1 or more in 35$. Eighty per cent of 
patients were smokers and 15$ were either treated for hyper­
tension before MI, or had a raised BP after MI. Obesity was 
found in 19$ of all patients and serum uric acid levels over 
0.5 mmol/1 in 17$. Ten per cent of all patients were either 
treated for diabetes mellitus before MI or showed an abnormal
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glucose tolerance after MI*
In Egypt (1976) Mahmoud et al (9*0 studied the effect of 
smoking on the prevalence of CHD in 2318 males from four 
social groups, urban, shifted, commuting and rural. In this 
paper the authors do not exactly define these groups. Higher 
prevalence ( W M  in urban, 7% in the rural) was seen among 
smokers than non-smokers C12.756 urban and 2.8$ in rural).
The rate and duration of smoking correlated positively with 
the prevalence of CHD. They concluded that smoking appears 
to be among the important factors responsible for an 
increased ischaemic heart disease with urbanisation in Egypt.
In Puerto Rico, Garcia et al (1978) (55)found that rural 
men had a lower average BP, serum cholesterol, blood sugar, 
heart rate and relative weight than urban men. The age- 
adjusted CHD incidence rate for urban men was 1.5 times that 
of rural men and among rural areas the most rural had the 
lowest incidence. He suggested also that geographical 
mobility may have a role.
2.3.1.11 SMOKING HABITS OF THE FAMILY AND ITS EFFECTS ON CHILDREN.
It is widely accepted that although there is a direct 
relationship between the cigarette smoking of parents and 
their teenage children the observed influence is only 
transitory and does not endure into adulthood (169). However, 
identification theory would predict the opposite, that a 
young adult's smoking behaviour should directly relate to his 
parents1 smoking behaviour.
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Wohlford,( 146) in his study, found that the results 
support the identification and interpretation of the fatherfs 
non-smoking pattern, as father-son smoking behaviour was 
directly related in intact families. The variable of family 
intactness was a highly relevant moderator of the parent-son 
smoking pattern.The mother and daughter smoking patterns 
remained enigmatic. Family involvement was necessary to 
affect smoking attitudes and behaviour. Peer influence and 
self esteem were also related to smoking knowledge, smoking 
attitudes, future smoking intention and the "purchase” of 
cigarettes.
Despite recognition of the deleterious effects of 
passive smoking, quantitative information on the intake of 
environmental tobacco smoke is still lacking. Matsukura et al 
(1984) (97) examined the relationship between urinary 
cotinine excretion in 472 non-smokers and the smokiness of 
their environment. The urinary cotinine levels of non- 
smokers who lived with smokers were higher than those' of non- 
smokers who did not, increasing with the combined daily 
cigarette consumption of smokers in the family. The presence 
of smokers in both the home and the workplace also increased 
the cotinine levels. Urban non-smokers had more cotinine in 
their urine than rural non-smokers. They concluded that the 
deleterious effects of passive smoking may occur in proport­
ion to the exposure of non-smokers to smokers in the home, 
the workplace and the community.
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2.3.2 CIGARETTE SMOKING IN UK
The tobacco industry is made up of some of the richest 
and most powerful multinational companies in the world (148). 
The political and economic iterests forms what is called the 
"Smoke Ring" (148) which has protected the tobacco industry 
for the past twenty years. Unfortunately governments are 
themselves part of the smoke ring. The economic interest lies 
for example in the income from cigarette advertising, tax 
collection (4 billion pounds) and the huge number of 
employees in. the tobacco industry e.g. 1 80,000 in EEC 
countries. These factors may persuade governments that the 
wealth provided through the tobacco industry could come 
before health of the nation.
The proportion of adults (over 16) in Britain who smoke 
cigarettes has been decreasing since the early 19 7 0s (1 36). 
Since 1976 smokers have been a minority in the population and 
the number of adult cigarette smokers is around 18 million.
Prevalence of 1972 1974 1976 1978 1980 1982 1 984
cigarettes smoking % % % % % % %
Men 53 51 46 45 42 38 36
Women 41 41 38 37 36 33 32
The prevalence of smoking in Scotland is consistently
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higher than in Great Britain as a whole. In Scotland the 
percentages of adult men and women who were current smokers 
were 45.655 and 42.0? respectively in 1980 (24);
The number of male smokers has been steadily falling 
since 1972 when the General Household Survey (GHS) showed it 
to be 5 2.7?, whereas the proportion of female smokers 
remained unchanged (2^, These trends narrow the gap between 
the smoking habits of both sexes in Scotland. The figures for 
England and Wales collected in the same way (GHS) show a 
decline similar to Scotland for men but at a lower level, the 
figure for 1980 was 42.1?.
Since 1948 the proportion of adult male cigarette 
smokers in Britain has fallen by about 20? (25), However 
over the same period the proportion of female cigarette 
smokers has shown relatively little change and now there is a 
little difference between the percentages for men and women. 
In recent years the downward trend for men has been clear and 
there is some evidence of a fall for women also. During the 
1960's this decline in prevalence was accompanied by the 
emergence of a marked social class gradient, particularly for 
men, with the lowest percentage of smokers in class I and the 
highest in class V. Only women in social class V showed a 
rise in the prevalence of smoking between 1961 and 1972 - 
though by 1976 the figure had fallen back to the level for 
1961.
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SOCIO-ECONOMIC STATUS AND SMOKING.
From many studies it is evident that smoking behavoiur 
is related to social class. The prevalence of smoking is 
higher in the--lower' income groups, moreover these smokers 
have been found to start smoking at an earlier age. 
Occupations normally associated with higher education tend to 
have fewer smokers (103). For example in Glasgow smoking was 
clearly related to social class, (III Manual, IV, V, 46 $ in 
contrast to 37 % amongst social classes I, II, III Non- 
manual) (75).
A sample from central Scotland and the Highlands and 
Islands, studied by Aitken et al, showed that the percentages 
of male and female smokers were slightly higher than in the 
General Household Survey (GHS) study (25). They were 54$ and 
45$. This study also demonstrated geographical variation 
within Scotland, particularly in Glasgow and Edinburgh. The 
percentage of smokers in Glasgow was marginally higher than 
in Edinburgh (2).
In Glasgow, 44$ were smokers and the habit was equally 
common amongst men (45$) and women (43$). There was 
considerable variation with age , the habit being most 
strongly established among 35-54 years olds. Cigarettes 
smokers were 37$ in age group 16-24, 46$ in age group 25-34, 
55$ in age group 35- 54, 47$ in age groups 55-64 and 24$ in 
age group over 65 (75).
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The Glasgow 2000 project is a new antismoking initiative 
which was launched in 1983 by the City of Glasgow District 
Council, the Greater Glasgow Health Board, Strathclyde 
Regional Council and the Scottish Health Education Group 
(85)# jkg main aim cf this project is to reduce the incidence 
of smoking related diseases in Glasgow and to move towards 
having a nonsmoking population by the year 2000. The baseline 
survey indicated that over 60? of smokers in Glasgow had 
tried to give up and failed. Glasgow 2000 provides self-help 
material and courses to train group leaders. Prevention of 
the uptake of smoking by children has been identified as a 
major target particularly in primary schools.
In the General Household Survey of 1 982, 38% of men in 
Britain, 45 ? of men in Scotland and 45? in Glasgow, and 33? 
of women in Britain, 39? of women in Scotland and 43? of 
Glasgow women were found to be cigarette smokers compared 
with 53? for men and 42? for w o m e n  in 1 9 7 2  in 
Britain (75,133). The decline in smoking has occured in every 
age and in every socioeconomic group while this represented a 
continuously declining trend in men the percentage of women 
smoking remained between 42? and 44? throughout the 1970s. It 
was hoped that the 1982 figure of 39? will be the begining of 
a downward trend amongst women comparable to that amongst 
men. The downward trend amongst each sex has been mostly in 
25-49 age group and has now shifted to the 50-59 age group. 
The difference in the prevalence of smoking between the two 
sexes overall has been almost entirely due to the large
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difference in the oldest (60+) age group. The prevalence of 
cigarette smoking amongst women aged over 60 is 20-25$ 
compared with that in men of 38—49%.
The average weekly number of cigarettes consumed per 
smoker amongst men rose from 130 in 1972 to 1M2 in 1975 but 
then decreased to 132 in 1982 (133,136). Amongst women , 
there was an increasing trend from 95 in 1972 to 116 in 1980 
followed by a drop to 111 in 1982. Male smokers in each group 
in each year between 1972 and 1982 have a higher average 
consumption than female smokers and the difference is 
decreasing because of the increase in consumption by women.
In Britain, since the early 1960s about 9 million people 
have given-up smoking, 65$ of them found it easy to do (136).
The general decline in prevalence is due to the greater 
effect of the increase in the rate of giving up smoking and a 
decrease in that of taking it up (25). Despite this general 
decline in prevalence, the total number of cigarettes sold in 
the UK rose fairly steadily from 19^8 to a peak in 1973. 
However, changing patterns in 1960fs, particularly the change 
from plain to filter cigarettes, resulted in a fall in the 
total weight of tobacco sold as cigarettes. Since 1973, 
total weight of tobacco sales have fallen each year, although 
cigarette consumption per smoker has increased substantially 
over the last quarter of a century, particularly for women, 
and more noticeably for the 16-3*1 age group than for older 
smokers.
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Wald (155) j[n -j 976 compared the changes in the type and 
quantity of cigarettes smoked in the UK from 1956 to 1971 
with changes in the death rates due to lung cancer and CHD 
from 1956 to 1973. Despite little change in the number of 
cigarettes smoked, the change to filter cigarettes was 
associated with a decrease in lung cancer mortality among men 
aged less than 60 years. In contrast CHD mortality has 
continued to increase in both sexes but to a greater extent 
in women. These changes are consistent with the hypothesis 
that in tobacco smoke, tar is the principal aetiological 
factor in lung cancer, whereas CO or other gaseous 
constituents are involved in the development of CHD.
The tar, nicotine and CO yields of most cigarette brands 
on sale in UK are regularly determined by the government 
chemist (^5)# They have declined progressively since the 
1960s but CO more slowly than tar or nicotine. The incidence 
of lung cancer, bronchitis, and heart diseases are strongly 
related to cigarette smoking. Evidence suggests that the 
recent decline in mortality rates from these diseases in men 
is related to the decline in total consumption and in the 
amounts yielded by cigarettes, 
f
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2,H prevention of coronary heart disease with special
REFERENCE JO HEALTH EDUCATION
2.4.1 PUBLIC KNOWLEDGE ABOUT CORONARY HEART DISEASE.
Until recently, public knowledge about the risks of life 
and health that smokers run has steadily increased through 
many channels of information, particularly through the media 
(130)^  gut much ignorance remains, eg. about 30$ of smokers 
deny that they risk harming their health by smoking and many 
who accept a possible risk consider it applies only to those 
who smoke more than they do.
Shekelle and Liu, .-^39) in their study in Chicago, 
clarified the widespread lack of information about major 
causes of heart attacks among persons younger than 60 years. 
Twenty eight per cent named cigarette smoking, 21$ named high 
BP, 13$ named cholesterol, 50$ did not name any of these risk 
factors and only 1$ named all three. Although 75$ believed 
that heart attacks are preventable, few named specific 
behaviours would effectively reduce risk factors other than 
smoking: the prevalence of these responses increased with 
level of educational attainment. Sustained community educa­
tion programmes about reducing coronary risk factors are 
clearly needed. A similar nationwide survey carried out in 
1973 showed that 37$ named emotional pressure or anxiety, 33$ 
overweight, 29$ smoking, 13$ high BP and 8$ fatty foods. The 
results were similar to those obtained in the Chicago survey
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and suggests that the Chicago findings may be broadly 
applicable.
In Egypt in a study about the teacher*s smoking 
behaviour and anti-smoking behaviour, the researcher found 
that the sources of informations related to the health 
hazards of smoking were, mass media in 91 .4$, health 
experience of self, family and friends 67.35®* scientific 
researches 45.1$, scholastic experience 8.0%, teaching 
experience 5.6$ and other sources 1.9$ (119)#
2.4.2 BEHAVIOURAL ASPECTS INVOLVED IN SMOKING.
In 1972 Hetzel defined the environment as both physical 
and social and he stressed the difficulty in monitoring the 
social environment in contrast to the physical environ­
ment (67). The social indicators include health and illness, 
social mobility, income and safety. The physical environment 
includes science, art, participation and alienation. He 
referred also to 4 different epidemic health poblems in the 
last 20 years in Australia: traffic accidents, lung cancer, 
CHD and suicidal behaviour. He emphasised the close 
connection between these epidemics and patterns of behaviour 
- alcoholism, smoking, diet and the use of sedative pills.
Children do, however, learn by imprinting, particularly 
from their parents (11°). if the parents live a life that we 
associate today with reduced risk of CHD, it can be expected
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that the children will follow the same pattern and probably 
will benefit more than the parents. The effects of environ­
ment on the smoking behaviour of children was evident from 
their beginning of smoking at an early age ( W .  However the 
characteristics that distinguish smokers from non-smokers 
were conformity to a family smoking pattern, patterns of low 
achievement and patterns of peer group influence. Children 
usually use cigarette smoking to heighten their emotional 
state or to decrease negative feelings. Therefore the quality 
of school programmes influencing smoking as a determinant to 
health is important, particularly as teaching by example can 
be more powerful than teaching by precept.
Normally by the age of 20 years, personal identity is 
reached as a result of a process of socialisation that dates 
from birth. ^ 7 ) # gy that age also a life style is adopted 
which includes drinking and smoking patterns and these 
patterns may be due to many factors including birthplace, 
cultural background and social class. Other characteristics 
and life patterns, e.g. cigarette smoking, hypertension, 
hyperlipidaemia, hyperglycaemia and lower level of physical 
activity, may also affect the pathological changes underlying 
CHD
The few relevant studies suggest that there are several 
different patterns of experimenting with, initiating regular 
smoking of, and habituating to cigarettes (^8)^ YJhether or 
not an adolescent smokes probably involves a complex matrix 
of his personal dispositions and social factors, including
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his attitudes towards his parents (conformity to, or devia­
tion from their expectations) and his attitudes towards his 
significant peer groups (conformity to, or deviation from 
their expectations). Cigarette smoking is significantly 
related to a wide variety and somewhat contradictory array of 
personal dispositions, including rebelliousness, extroversion 
and psychopathic behaviour. Although the relationship in 
adults between extroversion and smoking has been replicated 
most often, the relationships between rebelliousness and 
smoking is solidly supported in longitudinal data regarding 
the pre-smoking personal disposition.
It has been mentioned also that a number of factors may
influence a young person to begin to smoke and they are :- 
(136)
a) The example of parents, teachers and older brothers
and sisters.
b) Pressure from smoking friends.
c) Lack of interest in schools.
d) The general social acceptability of smoking.
The psychosocial forces that account for the initiation 
of the smoking habit differ from those that account for 
continuation and habituation, and that even smokers who have 
indulged equally long and who consume the same daily number 
of cigarettes may differ from one another in the social and 
psychological forces that influence their smoking 
behaviour (70). Among several reasons for taking up smoking, 
perhaps the most important related to the fact that smoking
6H
among adolescents represent both a symbolic striving for 
adult status and a rebellion against adult authority (58)^
An example of a possible reinforcer which demonstrates 
that the distinction between social and psychological 
reinforcers may not be complete is that of the reinforcement 
of a male adolescent smokers self-image afforded by smoking 
a cigarette (102). Psychological reinforcements in smokers 
are related to nicotine which stimulates, tranquillizes, 
sharpens concentration and may facilitate social 
communication.
The expectation of reward or punishment being a 
consequence of a particular behaviour may be sufficient to 
control the performance or otherwise of that behaviour (102)# 
The act of smoking a cigarette may represent a complex of 
consequences to the smoker, some of which may be pleasant and 
some not so pleasant. A smoker may perceive distant health 
benefits arising from a decison to stop smoking and an 
immediate increase in the ability to cope with social and 
personal tensions arising from a decision to continue 
smoking. The balance of these two positive outcomes may 
decide whether the smoker continues to smoke or not.
Some personal characteristics were found to be 
associated with an increased probability of smoking 
cessation (73*126)^ These are: smoking less than 20 
cigarettes a day, a report of non-inhaling, use of filter 
tips, previous attempts at stopping, marital status (other
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than married), professional or executive employment grade, 
and neuroticism. Lower recidivism rate has also been reported 
in light smokers (73).
Wallace and Wallace in Nev/castle (1977) (1 9^) tested the 
hypothesis that the patients who had had post-coronary 
education at Inpatients Advice Group (IAG) would have a 
better psychological adjustment to their post infarct state 
than those who had none, and that the reinforcing effect of 
the coronary education group (CEG) would be followed by a 
better psychological adjustment in most cases compared with 
patients who had had IAG alone. In fact the reverse 
happened, due to more anxiety in the CEG group*s education. 
In spite of this drawback the meetings were helpful, 
particularly in explanation of mechanism, management and 
prognosis in MI. The authors recommended a further study in 
this area and group education should be compared with bedside 
instructions both for efficacy and prognosis generally.
For prevention of acquisition of the smoking habit, 
three approaches were suggested by Wynder and Hoffmann (171). 
The approaches were youth anti-smoking programmes to prevent 
the acquisition of the smoking habit, smoking cessation 
programmes to help current smokers quit and a less harmful 
cigarette for those who cannot or will not quit smoking. 
However, since changes in attitudes, knowledge and beliefs 
about cigarette smoking do not necessarily precipitate 
corresponding changes in smoking behaviour, it seems to 
matter little whether the students are approached by teachers
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or peer groups.
Simple recognition of the hazards of smoking is not the 
total answer because in spite of the evidence of the gravity 
of cigarette smoking problems, the majority of habitual 
smokers may continue to do so even if they are patients with 
acute coronary insufficiency or survivors of MI (95)# There­
fore giving up cigarettes is the patient!s choice to become a 
non-smoker. The decision, however, to smoke or not to smoke, 
is an intellectual as well as an emotional process; you can 
lead a horse to water but you can’t make him dri n k ^ 2)#
A healthy lifestyle programme was introduced by Simons as 
a part of the Sydney Coronary Heart Disease Prevention prog­
ramme The aims were to influence health attitudes,
knowledge, behaviour and perhaps risk factors in three main 
areas (i) nutrition (ii) physical activity and fitness and 
(iii) alcohol, tobacco and drug use. The attitude and know­
ledge parameters in girls improved with age, which may be due 
to home science offered in secondary education. On the other 
hand, boys showed little improvement.
Prevention and treatment of illness is increasingly a 
matter of motivating and helping to alter lifestyle and 
behavioural patterns that place one at increased risk for 
poor health For example, cigarette smoking, obesity,
excessive drug or alcohol use, carelessness resulting in 
accidents, are better understood as regards health 
consequences than those of a diet high in saturated fats and
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cholesterol and sedentary or type A coronary prone, time- 
pressured, lifestyles. A meaningful change in lifestyle can 
be achieved by behavioural techniques based on social 
learning theory. Behavioural approaches use 3 strategies to 
alter the environmental factors that maintain health 
threatening lifestyles. The first strategy is reinforcement 
control which involves building skills and rewards for 
healthful alternatives. The second, stimulus control, 
involves rearranging social and physical environments and the 
third, self-control strategies, emphasise personal 
responsibility for lifestyle change.
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2.4.3 SMOKING CESSATION
In order to design a smoking cessation programme, 
several principles should be considered; (171) (1) scientific 
character (the method has been developed and evaluated on an 
experimental basis, using a statistical method of assessment;
(2) efficacy (the method has been demonstrated and compared 
with other therapies); (3) permanence (reliable data exists 
on recidivism and cure for at least one year); (4) economj.c- 
viabilitv (the cost is low relative to the results obtained, 
makes maximum use of non-professional staff and time); and
(5) broad range of application (can reach as many smokers as 
possible).
A lot of behaviour modification techniques or methods pof 
giving up smoking were published and they can be summarised 
as follows:
1) Behaviour changes.
2) Positive rewards for non-smoking behaviour.
3) Stimulus control.
4) Giving up activities associated with
the onset of cigarette smoking.
5) Identification of stress associated with the
onset of smoking and the use of relaxation to 
reduce or avoid it (73)#
Three kinds of aims can possibly be distinguished in a 
smoking controlled prevention trial (125)# Does normal modi­
fication of a suspected cause lead to a reduction in
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incidence? How large is the benefit and what are the risks 
and costs of the proposed regime? To what extent can smoking 
habits be changed and by what means? Rose^ ^ m e n t i o n e d  also 
the value of the use of a high risk group. First, the 
reduction in the size and cost of the trial. Secondly, the 
subjects selected will be receptive to health advice. 
Thirdly, concentrating efforts on those in special need.
Sivarajam et al found that fewer than half of the MI 
patients were smoking at the time of admission to hospital 
(142). TJie high rate of quitting and reducing the number of 
cigarettes smoked per day is similar to or better than those 
reported in other studies that provided no specific 
intervention. At three months, 45$ of the initial smokers 
had stopped with 7 8$ of those citing the recent myocardial 
infarction as the reason for giving up smoking. But some 
investigators suggest that behavioural techniques applied at 
the time of MI generally achieve good compliance as long as 
the subject receives supervision but compliance often 
regresses after the intervention stops.
In the Glasgow 2000 project, 33$ of smokers had succeeded 
in giving-up. Two thirds of the remaining smokers had tried 
to give-up, but failed. The main reasons for trying to stop 
were concerns over health (71 $) and cost ( 3 8 $)
The result of the multicomponent behavioural programme 
which uses a number of approaches simultaneously (social 
support, smoke aversion, non-smoking skill training and
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contingency contracting) are twice as favourable as results 
achieved with traditional medical and mental health 
approaches (71).
Most attempts to influence the smoking behaviour of the 
young have had little success (150\  A variety of studies 
have compared teaching methods and/or message themes but the 
studies themselves are often not comparable. Probably the 
most common message theme aimed at youth has been that 
smoking is unhealthy. Programmes testing the effectivenes of 
this theme have reported little success. On the contrary, 
quite promising results have been reported from a prospective 
study involving adolescent Swiss males. Matched controls 
were used and evaluation was conducted four years after the 
start of the programme. Inclusion of smoking education within 
a comprehensive health education programme was successful in 
preventing non-smokers from becoming smokers, although it did 
not persuade smokers to stop smoking. Generally, programmes 
for adult smoking education have shown mixed results. Anti­
smoking campaigns have had little reported effect on smoking 
behaviour. On the contrary, smoking withdrawal clinics and 
individual counselling have shown the most success, producing 
^abstinence rates of 20 - 35% one year after treatment. These 
would appear to be the most consistently effective techniques 
reported in the literature, but all usually undertaken as 
self-selected, highly motivated, populations.
Experimental studies which used treatment and control 
groups fell into two groups: those dealing with emotional
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role playing and those involving aversive conditioning. 
Results were equivocal (150). Roughly one-half of those 
studied in each group demonstrated a significant difference 
between the experimental and control group smoking habits. 
Once the programme was over the other half of each group 
showed no significant difference between experimental and 
control subjects.
Behaviour researches clarified that the process of 
giving up smoking begins with simple awareness of the dangers 
of smoking requiring decision making immediately to give up 
and a continued determination not to resume (48).
A community based programme to control cardiovascular 
diseases was started in North Karelia, Finland, in 1972 and 
10 years of a community intervention programme showed among 
the middle-aged male population, that there was 28£ reduction 
in smoking (p<0.001), 3% reduction in mean serum cholesterol 
concentration (p<0.001), 3% fall in mean systolic BP 
(p<0.001), and 1? fall in mean diastolic BP (p<0.05) (115).
The natural discontinuance of smoking or the cessation 
ratio is the ratio of ex-smokers to current smokers plus ex­
smokers, that is
Ex-smokers 
Current smokers + Ex-smokers
This relation is called the "cessation ratio" (102). In 
the present social climate in Britain, (1971) it is unlikely
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that more than 15? who smoke regularly undergo natural 
discontinuance to permanent ex-smoking status before the age 
of 60. Discontinuance tends to occur after the age of 30 and 
increases with age. The average daily consumption of 
cigarettes also tends to drop quite sharply afer the age of 
60. The natural discontinuance refers to a permanent change 
of smoking status whereas ^x-smokers1 status per se is not 
reliable. The shorter the period of cessation the higher the 
percentage of relapse, eg. 37$ relapse among ex-smokers of 
less than one year compared to 19? of those with 1 -2 years1 
'standing and 5? of those maintained for more than 2 years. 
Six reasons were mentioned also for discontinuance of 
smoking:
(7) Health: particularly minor ailments being more
important than dramatic illness.
(2) Expense is the second motive for adults and the 
prime for adolescents.
(3) Social influences in the form of pressure from other 
people.
(M) Example: non-smoking example set by parents, teachers, 
doctors.
(5) Mastery: giving up smoking as a test of willpower.
(6) Aesthetics: the belief that smoking is nasty and dirty.
Reasons *J,5 and 6 are of comparatively minor importance. 
These reasons for giving up smoking should be useful to anti­
smoking programmes of various kinds.
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Another survey was carried out by Hammond (61) in 1958 
to clarify the reasons which make people give up smoking. He 
found that 6 0$ of the respondents to the postal survey 
stopped because they suffered from physical complaints such 
as cough. Other 17$ mentioned "doctor’s orders" as a cuse of 
giving up smoking. Two years after enrolment in the 
prospective study, Hammond found a larger percentage had 
stopped cigarette smoking among those who had been 
hospitalised or had heart or circulatory disease than among 
those not hospitalised and those who had not had heart or 
circulatory disease. He observed also that the longer since 
giving up the habit the less likely the ex-smoker will be to 
resume the habit.
A dentist developed a smoking cessation method 
"Conditioned inhibition" which include writing at least 10 
reasons why he or she wants to stop smoking, five times per 
day (19). Smoking can be stopped in from 1 to 6 weeks and 
should continue for several weeks following cessation to 
reinforce the new behaviour.
Hall (6 0 ) used two techniques to produce smoking 
abstinence. The first was health motivation treatment - this 
included self-management skills, film model, verbal 
commitment and discussion of the costs and benefits of 
smoking and abstinence. The second was ’aversive smoking1 
which includes "normally paced aversive smoking", relaxation 
training, role playing, high risk situations and discussion 
of maladaptive thought patterns. He found that there was no
74
significant difference between the two techniques.
Study of the different approaches used by teachers to 
change smoking behaviour of school pupils have been done in 
Egypt as a part of study of the effect of teachers smoking 
behaviour and anti-smoking education in schools (119). It was 
found that 1.2/5 of the teachers used direct orders, 42.6$ 
impressed students with the hazards of smoking, 36.4$ were 
setting a good example by not smoking, 9.9$ provided or 
suggested educational materials and 8.0$ referred students to 
the appropriate resources and 1.9$ used other methods.
In California, a sample of physicians used the following 
methods to help patients stop smoking and the percentages of 
cessation were: direct orders 28$; impressing patients with 
hazards 85$; suggestion or persuasion 47$; tranquilisers 17$; 
educational materials 16$ and a number of other methods from 
2 to 14$ (Schwartz, 1969) (132). Schwartz mentioned also the 
standardized criteria for measuring success in smoking 
cessation programmes which are:-
a) percent reduction in amount smoked.
b) smoking category at the end of the study and 
follow-up, eg. occasional, one half pack and none.
However, each control study can be evaluated on 4 points;
(1) whether placebos on controls were used.
(2) whether the follow-up was based on at least 
three-fourths of the subjects.
(3) whether a follow-up was conducted after at
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least 6 months.
(4) whether reported results were based on all
subjects starting the test or just those available 
at follow up< 3^ 2)#
In a study carried out by Pozen et al in 1977 to
evaluate the effectiveness of a nurse rehabilitator on MI 
patients, they found that she was effective in increasing the 
return to work rate (p<0.05) and decreasing smoking (p<0.05) 
in a randomised trial of 102 patients with MI. She was also 
effective in increasing patients' knowledge of heart disease 
(p<0.01). There was also an increase in individual 
counselling.
Improving the effect of anti-smoking advice has been 
tested in Oxfordshire in which 35$ of 6052 adult patients in 
a general practice were smokers Smokers were allocated
to one of four study groups - a control group, a group that 
received verbal and written antismoking advice from the 
general practitioner, a group that received this advice and 
also a demonstration of exhaled CO, and a group that received 
this advice plus the offer of further help from a health 
visitor. Seventy two per cent of the smokers replied to 
questionnaires sent after one year. The percentages of those 
who stopped smoking were 11$ in the control, 15$ in the group 
that received advice alone, 17$ in the exhaled CO group and 
13$ in the health visitor group. Validation of these 
findings by analysis of urinary cotinine showed that between 
24$ and 40$ of subjects may have misreported their smoking
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habits but there was no indication that the rate of 
misreporting was higher in the intervention groups than in 
the control groups. Therefore anti-smoking advice has a 
useful effect, but using an objective measurement test may 
improve the results particularly in lower socioeconomic 
groups.
Does quitting help? Kuebler (88) agreed that cessation 
leads to significant improvement in an individuals risk 
status regarding lung cancer, heart disease and chronic 
obstructive lung disease. The attack rate was one half that 
of individuals who continued to smoke in the Framingham heart 
study. Other stressed that the problem was not how to get 
people to give up smoking but to get people to remain non- 
smokers once they had quit (73).
The central and most important obstacle to smoking 
cessation is the huge amount of money spent in cigarette 
advertising: in the U.K it is about 100 million pounds in 
comparison to the very little spent in health education 
against smoking (130).
2.4.H CORONARY HEART DISEASE PREVENTION TRIALS.
Louria et al (93)in their analysis on screening and 
health education concerning primary and secondary prevention, 
showed that only a small number of diseases were preventable 
by risk factor modification and, in the majority, the risk 
factors were alcohol and tobacco.
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Any programme directed at the identification of high 
risk populations or those with early forms of disease and 
attempting to reduce the number of serious diseases 
experienced by these groups requires four steps ^ 10).
1. The identification of the high risk population in 
a primary screening.
2. The successful referral of those found at this 
primary screening to a secondary screening for 
diagnostic evaluation.
3. The initiation of appropriate therapy.
The creation of a system whereby appropriate 
intervention is maintained and the situation 
evaluated periodically.
Considerable attention has focussed on intervention 
programmes which attempt to modify the relevant risk factors 
for heart disease. Cigarette smoking was associated only with 
increased incidence of infarction and not with a higher case 
fatality rate .(**9), In another study carried out by Doyle et 
al, they confirmed the observations from the Albany and 
Framingham experience of cardiovascular disease which 
indicated that men who habitually smoked 20 or more 
cigarettes daily experienced a risk of MI or death from all 
-causes three times greater than non-smokers or pipe and cigar 
smokers. On the contrary, there was no relationship between 
smoking habit and angina pectoris (39)#
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As a result of this analysis of risk factors a number of 
intervention trials have been carried out. For example the 
primary aim of the North Karelia project (Finland) was to 
reduce cardiovascular disease mortality and incidence rates 
among the population through a reduction of smoking rates, 
serum cholesterol levels and elevated B.P (114). In the North 
Karelia project for males a 10? reduction in smoking rate, 4? 
reduction in serum cholesterol levels, 4? in systolic B.P. 
and the respective net reduction of estimated CHD risk was 
17? for men and 12 ? for women.
The European Multifactorial Preventive Trial of CHD in 
Belgium, Italy, Poland, Spain and Britain conducted in 44 
pairs of factoriesd studied over 63,000 men aged 40 to 59 
(100). High risk (upper 15 to 20? men were individually 
advised on smoking cessation, cholesterol-lowering diet, 
regular exercise, weight reduction and drug control of hyper­
tension whereas mass education on these topics was given to 
non-high risk individuals. Changes in cigarette consumption 
after 4 years varied from -3.9? in Belgium to —15.6  ^ in 
Britain. The data showed a net reduction of 8.8? in 
cigarette consumption, 2.5? in serum cholesterol, 1.3% in 
systolic BP and 0.5% for body weight. The high risk group 
showed a net reduction of 15.2% for cigarette consumption, 
5.8? in serum cholesterol, 2.6? for systolic BP and 0.9? in 
body weight. Net reduction of coronary risk was estimated at 
12? in the random sample and 17? in the high risk subjects.
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In order to study the effect of advice to change eating 
habits and to stop smoking, Hjermann (69) in 1983 carried out 
an intervention study in 1,232 healthy coronary high risk 
middle-aged men at high risk of CHD, (the Oslo study) (6 9 ). 
The results showed a significant reduction in the incidence 
of first events of MI and sudden death. Eighty per cent of 
both intervention and control groups were smokers at the 
beginning of the randomised trial. The men had serum 
cholesterol levels between 7.5 mmol/L and 9.8 mmol/L, 
coronary risk score (based on cholesterol, smoking and BP) in 
the upper quartile of the distribution and SBP less than 150 
mm Hg. Cholesterol was lowered by 13? triglycerides by 20?, 
tobacco consumption by 45? in the intervention group compared 
with controls. At the end of the Oslo study, the incidence 
of MI and sudden death was 47? lower in the intervention 
groups than the controls.
The Veterans Administration Clinical Diet Study showed 
that subjects receiving a diet high in unsaturated fat had a 
24 ? lower incidence of myocardial infarction and sudden 
death and 41 % lower incidence of strokes (158). In another 
study cigarette smoking was found to be related to mortality 
from Coronary Heart Disease independently of all other risk 
factors (48).
The Multiple Risk Factor Intervention Trial (MRFIT) was 
a 6-year clinical trial to investigate the effect of reducing
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cardiovascular risk factors, elevated cholesterol, 
hypertension and cigarette smoking in a group of asymptomatic 
men at high risk (73). The programme provided maintenance 
for those who stopped smoking and an extended intervention 
for those unable to quit initially. At the end of the first 
four months which correspond to the end of smoking 
intervention phase of the study there was a forty-seven per 
cent rate. After 4 years the quit rates were strongly 
associated with the initial level of smoking with lighter 
smokers reporting a higher quit rate.
The example given in MRFIT indicates that attempts to 
change the risk factors of individuals involves great 
effort Rose (39) suggested a third preventive strategy
intermediate between primary and secondary prevention. It 
would start with population screening for signs of early 
myocardial ischaemia, mentioning that early ischaemia can be 
diagnosed by positive response to validated questionnaires on 
chest pain and by positive resting ECG (Q/QS,ST segment or T 
wave abnormalities or LBB block). He also clarified that a 
self-administered questionaire was almost as effective as an 
EGG in predicting risk of CHD death. One must also consider 
the problem of screening for ischaemia which arises when the 
criteria for a case are set wide enough to give warning of 
high numbers of future heart attacks. Only a minority of 
positive cases will actually face serious trouble in the 
following few years. Stricter criteria can reduce false 
alarms but bring reduced benefit to the community.
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Secondary prevention of CHD would consist of treatment 
of angina or coronary insufficiency in order to prevent MI or 
sudden death (93), Hypertension is associated with both* 
Increasing cholesterol concentration increases the incidence 
of angina and coronary insufficiency. Reduction in 
cholesterol in uncomplicated angina reduces the subsequent 
major coronary events. Smoking is less strongly associated 
with coronary insufficiency and is not associated with 
angina.
Epidemiological research has demonstrated a phenomenon 
known as "tracking” . It means that for a given variable
an individual tends to remain in the same part of a 
distribution curve, even if in time the entire distribution 
has moved in one or another direction. For example , children 
with relatively high blood pressure or high serum cholesterol 
levels will be likely to retain the status into adult life, 
while the actual values increase still further. On this 
basis, many children might be already manifesting the 
earliest precursors of CHD.
2.4.5 METHODS USED FOR CONTROL OF SMOKING AND PREVENTION
OF SMOKING-RELATED CORONARY HEART DISEASE.
The major diseases that are likely to be susceptible to 
primary prevention are those in which the risk factors are 
known, prospective studies have provided estimates of 
attributable risk* the data appears reasonably convincing and
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the evidence is strong enough (93).
Primary prevention of coronary heart disease is an 
essential and readily adaptable component of a comprehensive 
school health program By combining screening for
disease risk factors, giving children their results in a 
"Health Passport” and providing innovative learning 
activities in a health education curriculum, children can. be 
motivated to assume responsibility for their own future 
health and modify their lifestyles in a direction of reduced 
risk for disease. The initial phase of, "Know Your Body” 
programme has three main components :a) health screening, b) 
feedback of results, and c) health education. It has been 
demonstrated that this approach to primary prevention of 
chronic disease is welcomed by students, parents, and 
educators. Whether or not the strategy for behavioural 
modification of lifestyles will be successful enough to 
demonstrate reduced risk factor profiles attained and 
sustained through adolescence will constitute the focus of 
effort over the next few years.
The positive results of primary risk factor intervention 
trials of CHD and the partial explanation of declining trends 
of coronary mortality in some countries, represent the 
theoretical basis for justifying a nationwide preventive 
action against CHD, including a Mediterranean-type diet, 
directed to lower and to maintain low levels of serum 
cholesterol; the drug treatment of high blood pressure and 
the elimination of smoking, can warrant measurable reduction
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of incidence and mortality from coronary heart disease (101).
Watkin (160) in his study about the efficacy of primary 
prevention of CHD by multiple risk factor modification 
suggested that primary prevention may be more effective if 
efforts begin early in life before behavioural and 
physiological characteristics that may increase the risk 
become established.
In another study carried out by Rost (1982) it was 
stressed that smoking cessation should be used for the 
secondary prevention of MI due to the increased risk in post­
infarction patients who continue to smoke (51,129). The main 
objectives of secondary prevention are: (1) intervention to 
change some behavioural patterns (ie. diet, smoking, physical 
training, control of weight and stress); (2) medical 
treatment of internal risk factors (ie.hypercholesterolaemia, 
diabetes, hyperuricaemia; (3) medical treatment of CHD 
complications and (4) medical intervention on possible 
mechanisms of infarction (133). In order to reduce the health 
hazards and death that result from smoking a programme 
should have three main objectives:(48)
A. To encourage young people not to start smoking.
B. To reduce the number of current smokers.
C. To encourage the development of less hazardous cigarettes.
This can be achieved by different means, of which the most
important are (48):
1. The education of young people not to take up smoking.
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2. To obtain the cooperation of health workers in 
influencing the public.
3. To control cigarette smoking among adults by group 
approaches. v„
4 To control cigarette smoking among the public by 
mass approaches.
5. Restriction of advertising and promotion of cigarettes.
6. To find ways of making smoking less hazardous.
A programme accomplishing a little under each of these 
categories would probably be more effective than one 
accomplishing a great deal under one but neglecting the other 
methods (48)#
In the Annual Health Conference of the New York Academy 
of Medicine in 1974, Terris ^30) recommended legislative 
measures to control smoking, including the prohibition of 
cigarette advertising, a massive campaign of Health Education 
and taxation. The tax funds should go to educational and 
other programmes to prevent smoking. Another recommendation 
suggested that taxes raised on tobacco should be an 
indication of moral disapproval rather than a method of 
raising revenue (63). prohibition of smoking on trains, in 
TV interviews and hospitals is an important preventive 
measure. Taxation has failed to control the degree of 
smoking;; Anti-smoking clinics also in their long term-results 
are ineffective and disappointing.
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In June 1981, the Egyptian government passed an 
antismoking law, containing the following provisions: (1°9)
1) No cigarette or tobacco containing more than 20 mg tar 
to be imported, exported or produced.
'2) Tar and nicotine levels must be shown on cigarette 
packs.
3) Advertising to be banned in public places.
4) No smoking policy to be adopted for public transport.
5) Penalties to be introduced for those breaking the law
(109).
Many smoking cessation programmes have been done, 
however Cummings (35) noted that commercial cessation 
programmes offering multifactorial approaches often achieve 
higher success rates. However Pederson (111) found in his 
study that the commercial self-help manual was not an 
effective non-smoking cessation aid. The cessation rate in 
the treatment group was 16.7%, and in the control group 
25.6£.
Unfortunately, many anti-smoking programmes have not 
included evaluation components so that it is difficult to 
determine the relative effectiveness of the various 
approaches (171). However, the existing evidence clearly 
indicates that smoking programmes that merely provide 
information about the consequences of smoking are not able to 
decrease, the proportion of those who become smokers (63,171) 
On the other hand, approaches that take into account the 
underlying cause of the acquisition of the smoking habit and
teach smokers to cope with various social and psychological 
factors that promote smoking do seem to be capable of 
producing behavioural changes and thus seem to be the most 
promising.
The best place for preventive intervention would seem 
to be the primary health care system, which has almost 
complete access to a country!s population (^3>84)
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2.4.6 SMOKING AND RESPIRATORY SYSTEM.
A larger percentage of cigarette smokers reported cough 
and shortness of breath than men who had never smoked 
regularly (61,107). Both of these complaints were reported 
by a smaller percentage of ex-cigarette smokers than of non- 
smokers.
The above findings have been observed also in a 
randomised controlled trial of smoking cessation carried out 
by Rose and Hamilton (126). They found that 51$ of the inter­
vention group were not smoking after a one year follow-up 
compared to 10 % in the non-intervention group. Men in the 
intervention group showed a decline in the prevalence of 
sputum production and dyspnoea (172). Thus it is clear that 
this complaint diminishes quickly when a cigarette smoker 
gives up the habit and also shortness of breath diminished 
gradually with time after giving up.
It is evident that the lung parenchyma does not revert 
to normal after giving up smoking but thereafter it does not 
progress so rapidly to a more advanced distinctive stage (61). 
Also, ventilatory function did not improve after giving up 
smoking but its rate of decline was markedly slowed (126). 
Rose and Hamilton concluded that smoking cessation in middle- 
aged men improved the symptoms and progress of chronic 
bronchitis but that the reversibility of the effect of 
cigarettes to the smoker's life expectancy may have been 
over-estimated in observational studies (126).
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2.4.7 HEALTH EDUCATION AND SMOKING.
The scientific evidence concerning the health risks of 
smoking first began to achieve prominence in 1955 ^ 30)# 
Royal College of Physicians published its first report in 
1962 about the health effects of smoking. Publication of the 
first report was followed up by a 5% decrease in cigarette 
^ales. A slow recovery followed later at the rate of one per 
cent per year. The findings of the report were accepted by 
the government and this led to the start of publishing 
information about the harmful effects of smoking. The report 
also resulted in banning of direct cigarette advertising on 
television in 1965 and the setting up of the Health Education 
Council and Scottish Health Education Unit. The second 
report in 1971 was followed by the setting up of the 
organisation -Action on Smoking and Health (ASH).
The report issued by the Royal College of Physicians in 
1983, !t Health or Smoking ? " drew particular attention to 
opportunities for further initiatives in health 
education ^3).
The trends in the prevalence of smoking indicate that 
health education has already had considerable success in 
reducing smoking in Britain d33)# ^he decrease has been 
greatest among the better educated, also more among men than 
women. Many expert bodies, including The Royal College of 
Physicians of London, WHO Expert Committee and the Secretary
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. of State for Scotland, have emphasised the importance and the 
priorities of anti-smoking health education in prevention of 
disease.
The pessimistic view that the modification of behaviour 
is not possible in large groups whose members are not 
stimulated by personal illness does not appear to reflect the 
actual situation. In New York the prevalence of the major 
risk factors for coronary atherosclerosis in 197.4 among white 
males'is inversely related to social status and the 
percentage of cigarette smokers among blue-collar workers 
(45$) has decreased compared to five years before 
These differences reflect the effect of community educational 
programmes on cigarette smoking and dietary habits.
The Scottish Health Education Co-ordinating Committe 
produced a report in 1983 entitled, "Health education in the 
prevention of smoking related diseases", which also 
underlined the importance of health education as the most 
helpful approach in the control and prevention of smoking and 
its related diseases, (125,134) especially chronic 
bronchitis, the leading cause in Britain of sickness absence 
and of premature disablement (125)#
Cohen in 1979 ^0) stated that the possibilities for 
meaningfully influencing health through education and indivi 
dual decision making have been severely curtailed. He stated 
also that many of the major causes of disease would be 
unaffected by lifestyle changes, eg. workplace, stresses,
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socioeconomic forces and environmental pollutants.
Fletcher and Horn in 1 970 in their report,
recommended that an action is required by the health 
authorities in collaboration with the education authorities 
to clarify the health hazards of cigarette smoking; they 
specified that the tasks to be undertaken are;
1) Establishment of statutory upper limits for various 
constituents of cigarettes .
2) Reduction of advertisements with a view to its eventual 
elimination.
3) Health workers should set an example bynot 
smoking and discourage young people from starting 
to smoke.
i|) Health authorities should discourage cigarette
smoking in medical premises and establish anti-smoking 
counselling services in hospitals.
5) Health authorities shouid help in preparation of 
health education programmes for schools, teacher 
training institutions curricula and teaching 
materials dealing with the health hazards of 
smoking.
6) Research on effectiveness of health education 
designed to discourage cigarette smoking and better 
use of existing methods.
7) The hazards of smoking should be included as a 
specific part of occupational health programmes in 
places of employment.
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Many recommendations were published in the report of the 
working group on ’’Inequalities in Health" in respect to the 
problem of smoking in Britain O20)# They recommended that 
the government should sponsor an enlarged programme of anti­
smoking health education and it should be started in schools. 
This programme would be a joint responsibility of local 
education authorities and health authorities. They also 
recommended stronger measures to reduce cigarette smoking. 
These included:
a) Legislation to phase out advertising of tobacco products 
and banning of sponsorship of sport by tobacco companies.
b) A regular annual increase in duty on tobacco products.
c) Health warning to appear on all tobacco packets.
d) Provision of non-smoking areas in public places.
e) Anti-smoking counselling services to be made 
available in all health districts.
Since 1978 the anti-smoking strategy of the Scottish 
Health Education Group (SHEG) has moved from the previous 
negative message of the dangers of smoking to the positive 
promotion of non-smoking by emphasising its benefits (133V
Health education was the main recommendation of the 
workshop conference held at the University of Kent for 
preventing CHD The main recommendation concerning
health education was to establish a health education service 
in all district health authorities. Advice should include 
both health risk advice and ways of improving health. One
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member of the district health education team should be 
allocated to develop local community action. Schools are a 
powerful force for health promotion. The school health 
education officer should review school meals and staff 
smoking and teaching. Employers should provide exercise 
^facilities for staff and implement healthy eating policies in 
their canteens.
The most visible parts of the anti-smoking campaign 
carried out by HEC and SHEG are the mass media advertising 
and associated activities, eg the "Look After Yourself" 
campaign by HEC, the "Dying Scotsman" by 31 EG, the "Superman 
campaign" (1980-1983) by HEC and the "Go for Goals" 
campaign (130)# In addition to the National Health education 
agencies major contributions have been made by the BBC and 
the independent broadcasting companies. The number of smoking 
withdrawal clinics increased from 20 in 1962 to H9 in 1980 
but their direct contribution to cessation rates is small.
Sport and art sponsorship is an attractive form of 
promotion of tobacco (1^8)# In this way the tobacco companies 
associate cigarettes with a healthy life and create good-will 
among the public. Tobacco sponsorship is designed to change 
the public perception of cigarettes and companies who make 
them. Therefore the consumer is a crucial link in what has 
been described before as the " Smoke Ring". The activities 
of ASH, the only specialist organisation, have done much to 
counter the promotional activities of the tobacco companies.
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The greatest tribute to ASH's work has come from the tobacco 
industry ^3.0)#
Taking into our consideration the importance of 
childhood in combating smoking, VIetzler (1979) mentioned 
that the most effective primary prevention should begins in 
childhood because it is easier not to adopt a habit than to 
alter it after it has been established. YJetzler mentioned 
also that health education must not be restricted to 
lifestyle strategies and the core should concern itself with 
health and all its determinants.
Between a half million to one million children annually 
have been influenced by the school's council and health 
education council projects ^130)^  instructions regarding the 
health hazards of smoking are now provided in secondary 
schools as a component of general health education. The 
support of the Department of Education and Science in 1981 
for health education has given a marked impetus to the 
promotion of school health education. Examples of school 
health education projects include the "My Body” project in 
Sheffield, and the "Jimmy” project in Glasgow, both done for 
the 10 - 12 year age group. Evaluation of the "My Body" 
project has shown that its use leads to major gains in 
knowledge, favourable changes in attitudes and considerable 
influence on parents.
Health education programmes at local level are 
systematic attempts to change smoking behaviour within a
9*1
localised population However, Bradshaw, in a review of
smoking control had this to say about health education under­
taken to control smoking, " For the health educator the 
solution to the problem of control is as simple as it is 
obvious; disseminate the facts about the health hazards 
associated with cigarette smoking and the facts should speak 
for themselves. They do not always do so is evidenced by the 
negligible long-term effects of the considerable publicity 
given to medical opinion in the United Kingdom during the 
1 9 6 0 's"
In order to compare methods of health education against 
smoking, Louria et al ^3) mentioned that the impact of fear 
is often clearly superior to attempts at non-anxiety 
producing persuasion in reducing use of tobacco, automobile 
safety and immunisation programmes ( ^ 2). it has been 
mentioned that the techniques for changing risk factors are 
different from treatment in conventional medical practice. 
In order to increase the motivation of the participants, it 
is necessary to introduce the fact that something is wrong 
with the subject ^ * 0 .
Health education through mass media and counselling by 
physicians has been the chief tools in the medical care 
sector's response to lifestyle health-threats ^ 1)#
In health education, mass communication needs to be 
tempered with an appreciation of its strengths and 
weaknesses Mass communication reaches large numbers of
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people and an individual will act on it if he is directed by 
an experienced person. This is one reason for the importance 
of obtaining active support of health workers to reinforce 
mass media campaigns on the effect of smoking on health. 
Reducing the effectiveness of the promotion of cigarettes on 
television and radio is another approach. Printed 
advertising also is largely neglected and some control might 
be placed on its content. For those who will continue to 
smoke, establishment of limits to the amounts of various 
harmful substances permitted in cigarettes particularly tar 
and nicotine is a priority. As regards group approaches to 
combat smoking,few attempts to reach smokers have been 
carried out and they are limited to the presentation of 
posters, leaflets,lectures and films designed for anti­
smoking purposes.
While myocardial infarction patients are in hospital 
(and there by inhibited from smoking) the time may be ideal 
to inform them of the risk of smoking and to provide specific 
coping strategies to face the situations when they feel the 
urge to smoke or when they subsequently meet others who smoke 
(51). The particular effects of CO and nicotine on persons 
who have already had an MI can often be explained to help 
make them quit. The value of counselling while patients are 
in the hospital is demonstrated by a study in which 66^ of MI 
patients remained abstinent at M months.
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In another study it was reported also that a significant 
proportion of coronary patients can be persuaded to give up 
smoking while in hospital and to remain non-smokers for at 
least a year or more (22,64)^ Thus, nearly a third of the 
infarct patients gave up completely. Furthermore, the 
proportion of those smoking more than 20 cigarettes a day 
dropped from at least 37 to 6$. Perhaps the more dramatic 
illness of cardiac infarction induced a greater determination 
among the infarct patients to accept advice to stop smoking .
There are two main types of communications from doctors 
and other medical workers to patients (91), one kind is 
^designed to give the patient information about his condition, 
its treatment prognosis, etc., while the aim of the other 
types is to pepsupde the patient to follow a prescribed 
course of action such as taking medicine, dieting or looking 
after children in given ways. The criteria for judging the 
success of the first type are (1) has the message been under­
stood? (2) does the patient feel satisfied that he has been 
adequately informed? In the persuasive communication the main 
success criteria are (1) has the message been understood and 
(2) is the advice carried out? This problem of patients* 
satisfaction with communications has been investigated. The 
results show that the percentage of dissatisfied patients 
ranges from 11 to 65$. Dissatisfaction in a group of studies 
varies with year of survey, length of time between discharge, 
and follow-up.
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Evaluation of individual antismoking campaigns showed 
that none has ever produced more than a transient effect on 
smoking prevalence and consumption (130)# Their value lies 
more in drawing attention to the smoking problem.
In 1984, Jenkins et al studied patient’s evaluation of a 
teaching programme administered by nurses (8(0 , patients 
admitted to Coronary Care Unit (CCU) with confirmed MI were 
given a detailed information session by nurses, information 
included in detailed programme of exercise during 
convalescence and attitudes towards diet, smoking, sexual 
intercourse. Patients were asked to assess the value of 
these sessions using questionnaires administered during 
convalescence. Between 76$ and 91$ of patients considered 
the presentation necessary and there was a significant 
improvement in their understanding of what an infarction was. 
More than 80$ of patients found a booklet entitled 
"Recovering from your Heart Attack” particularly helpful. 
Most of the patients believed that more health education 
should be given at school and that members of the general 
public should be taught the techniques of cardiopulmonary 
resuscitation. The teaching programme appears to have 
reduced the admitted smoking habits of patients. On 
admission 56$ of patients were smokers. This fell to 7$ at 
the end of 3 weeks but had risen to 17$ at 6 months.
Communication frequently fails to produce the desired 
effects (9-D, Failure in understanding contributes to the 
failure of information-giving communications. Forgetting is
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inversely related to the amount presented and the relation­
ship between amount presented and amount forgotten is linear. 
Communications from doctors to patients frequently fail due 
both to failure to understand and failure to remember.
In contrast, Jamrozik (76) mentioned in his study that 
anti-smoking advice from a physician is useful and it can 
have an effect on smoking cessation rates. Demonstrating the 
immediate personal and harmful effects of smoking with 
measurements of exhaled CO may enhance this effect, 
particularly in lower socioeconomic groups. Anti-smoking 
advice from a physician is also expected to reduce the risk 
of post myocardial infarction mortality by 20* (28).
The British Royal College of Physicians is battling to 
curb smoking through education and legislation(88b). 
Information on the harmful effects of smoking is dissiminated 
by health education groups to the public through the mass 
media and to adolescents through classroom instruction. The 
two main areas where action could make a difference are 
taxation and advertising. The ban on television advertising 
of cigarettes, enacted in 1965, is still the only legislation 
on the issue; other forms of advertising are uncontrolled or 
are a matter of voluntary agreements.
In a study to assess the effect of television in 
reducing the habit, smokers were recruited from about 4,500 
persons exposed to stop smoking posters at worksites for 2 
weeks before the broadcast of a special series. Smokers who
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were willing to participate were given program titles, dates, 
and times of the broadcasts and a copy of the booklet 
associated with the series, and asked to complete a 
questionnaire on smoking habits. Only 3.4$ of smokers in the 
total group chose to participate. A follow-up of 62 heavy 
smokers for 12 months showed that the BBC television series 
"So You Want to Stop Smoking" helped 9 to quit, a cessation 
rate of 14.5$ jj. noted that the cessation rate is
similar to those reported for clinic and physician 
intervention programs.
Health care leaders should set an example and pay 
attention to discouraging smoking in the community. In this 
respect the deans of several schools of public health called 
for discouragement of cigarette smoking as one of the most 
cost effective health initiatives ^Oa)^ They suggested that 
a ban could be initiated in most health institutions provided 
that the officials involved actively discourage smoking. In 
this case if such a policy is adopted at just one institution 
it will encourage others to do the same. It will also show 
the public that heath care leaders oppose smoking.
The marked decline (26$) in cigarette consumption in the 
UK over the past 10 years is considered one of the success of 
preventive medicine On the individual level,
physicians can be very effective in smoking intervention by 
giving: advice to quit, a leaflet, and a request for a return 
visit for follow up. By these efforts from GPs about 25 
patients per practitioner become non-smokers each year. In
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each district, the health authority should have antismoking 
policies for all hospital wards, and a ban on cigarette sales 
in hospital shops (17a,6 0a).
The use of tobacco substitutes (nicotine chewing gum) as 
an aid for cessation of smoking has been shown in the 
specialized smoking withdrawal clinics (88a). Evaluation of 
different programmes to stop smoking shows that one year 
cessation rates for programmes that included psychological 
treatment were 3855 for nicotine gum vs. 1*155 for placebo gum. 
The rates for group therapy were 31? vs 14?. Nicotine gum 
programmes were more successful when it was prescribed by a 
physician along with advice to quit smoking (10? of 1,550 
patients were abstinent at 1 year). Nicotine chewing gum was 
used to allay nicotine withdrawal symptoms rather than to 
provide a pulse of nicotine-induced pleasure. Side effects 
were present in up to 55? of the users, and included bad 
taste, nausea, sore throat, flatulence and heartburn.
In another study in which nicotine chewing gum was used, 
55 smokers recieved individual counselling and Nicorette- a 
nicotine containing chewing gum (150a). After instruction,
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smokers adjusted the use of Nicorette personally, depending 
upon the craving for tobacco and abstinence symptoms. Smokers 
attended five control consultations over a three months 
period. After one week 51 (93?) had stopped smoking. After 3 
months, 33 (60?) remained abstinent, and after 6 months, 27 
(49?) were still not smoking. Cessation was checked by 
measuring breath CO content in expired air. Among 27
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untreated controls, 301/0 had stopped smoking after 6 
months. Nicorette was gradually withdrawn after 3 months, and 
after 6 months, all patients had stopped using the gum. The 
results showed that Nicorette was well tolerated and only a 
few mild side effects were observed. Young men with a higher 
carbon monoxide content in expired air, and higher nicotine 
dependency scores showed a significantly lower frequency of 
breaking the smoking habit.
A study for comparing the use of nicotine chewing gum 
and acupunture methods for giving up smoking was carried out 
in general practice. Six hundred out of 35,000 smokers 
contacted agreed to participate. They were separated into 
three groups 1) acupuncture 2) nicotine chewing gum, and 3 ) 
controls (29a). The self-reported abstinence rates after 1 
month were 19$, 22$ and 8$ respectively, but results on 270 
subjects at 12 months follow-up showed a decline in success 
rates to approximately 6$ for all groups.
The effect of a smoking cessation kit has been evaluated 
following a television programme on the health hazards of 
smoking. 4,492 subjects requested a postal smoking cessation 
kit (34a). A one third random sample was chosen as controls 
and did not recieve the kit. Among 2,117 (47$) who responded 
to a 1 year follow up questionnaire, the reported cessation 
rate for those who recieved the kit (16%) was higher than for 
the control group (11$, p<0.001). Verification with salivary 
cotinine measurements reduced the difference, but kit users 
still had a higher cessation rate than controls (9$ vs 7$,
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p<0.05). Further study of nonresponders indicated that the 
likely effect of the kit was to induce 2% of recipients to 
give up smoking for at least 1 year.
In addition to the previously mentioned smoking 
cessation methods, hypnotherapy has been used in 683 smokers. 
They recieved one session of hynotherapy (30 minute 
consultation followed by relaxation) during which patients 
may detach themselves and view their quitting with composure 
(131b). The hypnotherapy was to reduce the conflict and 
anxiety surrounding abstinence so that subjects will not 
smoke again. During the consultation, the damaging effects of 
passive smoking to children and spouse were mentioned, but to 
avoid further anxiety, none of the other effects of smoking 
were pointed out. During induction, patients were told they 
will be calmer about quitting and the decision to quit will 
be accepted and tolerated more readily. It was noted that 
hypnotherapy confers no side effects, and relapse was more 
often due to regression under duress rather that treatment 
failure. It was suggested that additional follow-up sessions 
would probably improve the success rates.
A "Group-dynamics" approach in which 10 members meet 
once/week for 5 weeks with an interdisciplinary group of 
consultants (administrators, cardiologists and respiratory 
disease specialists) was described in a study in France 
(19a). Before the first session, questionnaires about smoking 
habits were completed by patients in the clinic. Data were 
given to each consultant and discussed with patients at the
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first meeting. The group method allows for a progressive 
relationship to develop among patients and therapists, 
therefore each patient takes an active part in the therapy. 
Success depends on the smokers who must be made aware of 
their habit, their attitude towards smoking, and the risk 
factors involved in continuing. In addition, health 
prctitioners transmit their convictions to the patients.
The role of physicians in health education is essential 
and they have to be the primary health educators. Counselling 
for smoking cessation should be one of their most natural 
tasks in view of the deleterious health consequences of 
smoking (62a). By contrast in practice physicians appear to 
lack knowledge of effective smoking cessation techniques and 
have inadequate training in counselling skills. The use of a 
combination of different techniques when effectively designed 
and implemented by properly trained physicians seems to be 
efficient in reducing the number of smokers.
In general physicians can be influential in convincing 
patients who smoke to quit (^3a). Smoking behaviour and 
cessation techniques were discussed in terms of a third 
generation health decision model that combines health 
beliefs, decision analysis, and behavioural decision therapy. 
It was suggested that physicians trying to produce smoking 
cessation should emphasize factors such as health beliefs, 
self efficacy, social support, and reduction of stress. In 
absence of a clear-cut advantage for any particular smoking 
cessation technique, physicians were encourged to provide
advice about smoking cessation as a regular part of every 
patient visit.
The role of primary health care, and particularly the 
general practitoner, in health education has been 
acknowledged only recently ^^a). General practice provides a 
good basis for health education because family doctors are 
regarded as particularly reliable sources of information on 
health matters. Consultation with doctors frequently arise 
because of fear of disease and this may help to motivate 
behaviour changes. Most importantly, general practice has 
access to virtually the entire population. Communication is 
in the form of a one to one method of teaching which is 
widely recognised as the most successful, especially when 
communication is two way process.
One study showed that the intervention programme 
administered by general practitioners was effective in 
helping patients to stop smoking in this study two
hundred cigarette smokers who attend a general practice were 
allocated to either a treatment (n=100) or a non-intervention 
control (n=100). After the initial visit treatment 
constituted of an educational consultation and four follow up 
visits. The smoking status was assessed biochemically at six 
months and three years. 35 patients in the treatment group 
were abstinent at three years compared with eight in the 
control group (p<0.001). The success rate of the intensive 
treatment programme (36? at three year follow up) compares 
favourably with other programmes administered by general
practitioners in which success rate ranged from 3? to 23? at 
one year follow up.
In spite of the best endeavours of doctors in giving 
verbal advice many patients fail to remember much of what 
they are told (48b). Study patients were able to recall only 
50? of the information given. Failure of comprehension and 
memory may be remedied to some degree by supplementing the 
spoken word with written information. In general it seems 
that general practitioners were reluctant to distribute 
literature (7?), compared with the 40? of health visitors who 
did so.
The role of general practitioners in Australia has been 
demonstrated in a smoking intervention programme carried out 
in general practice. In Australia, approximately 7 million 
people between 16 and 65 years of age visit their general 
practitioner at least once a year. About 37? of men and 30? 
of women between 25 and 65 years of age were smokers (120a). 
Of 100 smokers in the intervention programme, 36 were 
abstinent at 5 weeks, 30 at 3 months and 33 at 6 months. 
Reported abstinence was checked by blood tests for cotinine, 
carboxyhaemoglobin, and thiocyanate. Explanation of the 
results of lung function and blood tests in relation to risks 
of cardiovascular and respiratory diseases constituted a 
strong incentive to stop smoking. In general it was estimated 
that if one quarter of general practitioners in Australia 
adopted smoking intervention in their practice, approximately
150,000 new abstainers could be expected each year. The
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corresponding figures in Britain, if all GPs adopted smoking 
intervention programmes, would be about half a million 
exsmokers a year (131a).
In Britain 2138 cigarette smokers attending the 
surgeries of 28 general practitioners (GPs) in five group 
practices in London were allocated to one of four groups 
(131a): group 1 comprised non-intervention controls; group 2 
comprised questionnaire only controls; group 3 were advised 
by their GP to stop smoking; and group 4 were advised to stop 
smoking and given a leaflet to help them, and warned that 
they would be followed-up. Adequate data were available for 
88$ of patients who were followed up at one month, and 73$ at 
one year. Of the people who stopped smoking most did so 
because of the advice. This was achieved by motivating more 
people to try to stop smoking. The effect was strongest 
during the first month but still evident over the next three 
months and was enhanced by the leaflet and warning about 
follow-up. The proportions who stopped smoking during the 
first month and were still not smoking one year later were 
0.3%, 1.6%, 3.3%, and 5.1$ in the four groups respectively
(pco.ooi).
The face-to-face cessation advice from physician may be 
persuasive, especially in the less well educated majority. 
During repeated examination for certification as medically 
unable to work, 500 claimants were asked about smoking habits 
and whether they had recieved advice from their doctors to 
quit (39a). Of those with smoking related illness, (72$) had
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been advised to quit, with complete or partial success in 
72$. Of patients whose illness was not related to cigarette 
use only 37? had been advised to quit, with some success in 
23?. Although advice to quit may be less successful in 
patients who do not have smoking-related illness, it is still 
worthwhile.
Increasing attention is being paid to health education 
as a health care strategy, and more emphasis is being placed 
on its practical application. But the question frequently 
asked is, "Does it work?11 Evaluation of health
education should ideally measure outcome, but, except in 
certain circumstances, it may be confined to process 
measurement of the extent to which relevant objectives are 
achieved. Fowler clarified also that the health education 
approach is more effective than group methods, and that the 
least effective strategy is one involving the relatively 
impersonal mass media. This is not to deny the importance of 
mass media in health education for setting an agenda and in 
' providing a fertile environment for the more individual 
approaches.
A variety of studies have investigated the 
effectiveness of general practice as a setting for health 
education using group and individual methods and of the 
general practice consultation as a medium for it 
Lecture-discussion was one of the earliest descriptions of 
health education in general practice but there was no formal 
evaluation. The most rigorous studies of health education
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have investigated its effectiveness as part of the normal 
consultation and have been concerned with smoking cessation. 
The educational effect of demonstrating to smokers the level 
of carbon monoxide in their breath appeared to be a valuable 
smoking cessation technique in patients of lower socio­
economic groups, those who are otherwise least likely to 
respond to educational intervention (48c).
In USA, the public health strategy is to facilitate and 
maintain smoking cessation, including those used in community 
trials, physician practices, worksites and selfhelp methods 
(106a). Community trials have demonstrated that the media are 
an efective tool for creating an atmosphere for change, but 
that sucessful change occurs only when (1) a large variety of 
approaches are available in a community on many different 
levels,(2) interpersonal and intensive approaches are 
included, and (3) members of the community are involved in 
the development and delivery of intervention programmes. 
Physician delivered intervention can potentially affect a 
large segment of smokers. Worksite programs have been 
supported by management to reduce health care costs. Self- 
help strategies may be the most cost-effective approach, but 
results from self-help intervention vary widely. It appears 
that face to face interpersonal interaction is an important 
programme element for many smoking cessation programmes. An 
integrated approach ( a variety of techniques in many 
different settings within the smoker’s natural environment) 
seems to hold the best promise for reducing the number of 
smokers in the USA.
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2,6 CARBON MONOXIDE ;• PHYSIOLOGICAL AND PATHOLOGICAL
CHARACTERISTICS IN MAN,
2.6.1 SOURCES OF CARBON MONOXIDE.
Aronow.^2) clarified that carbon monoxide is the most 
abundant air pollutant in our environment. It is produced in 
large amounts by incomplete combustion of carbonaceous 
materials used as fuel for transportation and heating. 
Tobacco smoking, industrial processing and refuse burning 
also can produce carbon monoxide (CO).
Carbon monoxide is present in concentrations of 1-5? in 
the gaseous phase of cigarette smoke and carboxyhaemoglobin 
(COHb) levels in smokers vary from 2-15? depending on the 
amount smoked, inhalation and time elapsed since the last 
cigarette was smoked ^^D..
In Los Angeles, Curphey et al found in their post mortem 
studies that the main source of CO is automobile traffic and 
CO patterns tend to be inversely related to seasonal mean 
temperature cycles (36)# ^he curve for ambient CO 
concentration level was more approximate in shape to the CO 
level of non-smokers but the smokers* level varied widely. 
They found also that the median value for male non-smokers 
was greater by a factor of two than for female non-smokers.
110
2.6.2 PHYSIOLOGICAL CHARACTERISTICS OF CARBON MONOXIDE.
Claude Bernard was the first to point out that CO 
produces hypoxia through its reversible combination with 
blood to form carboxyhaemoglobin (COHb) (122), Smoking is the 
commonest source of small amounts of carbon monoxide. The 
alveolar air of smokers is said to contain only a small 
amount in the morning before smoking and this concentration 
is reported to rise steadily with the smoking of each 
cigarette or cigar. Carbon monoxide is present also in non- 
smokers blood under conditions where CO is not present in 
the inspired air (-1 21,122), The explanation of this is that 
endogenous CO formation occurs in man and is increased in 
haemolytic conditions.
The proportion of CO combined with myoglobin in man is 
estimated to be only 5? of that combined with haemoglobin of 
the circulating red cells when the distribution of CO in the 
body has revealed complete equilibrium (95,122).
In order to study the direct effects of CO on cardiac 
function, Takano et al .(1^ 7) used a haemoglobin-free living 
rabbit treated with perfluorochemical blood substitutes. 
They administered gas mixtures of oxygen with 5?, 10? and 20? 
of CO or nitrogen via a respirator. They found that the CO 
and nitrogen effects were significantly different as regards 
changes in arterial pressure, pulse pressure, heart rate, 
product of heart rate and systolic arterial pressure, in 
spite of the same Oxygen tension in the inhaled gases.
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Therefore they concluded that CO has a direct effect on the 
heart not mediated by haemoglobin.
Carbon monoxide increases cardiac output by 16$ during 
severe chronic CO poisoning (51*122)^ j|. reported also 
that it produces cardiac lesions in dogs at COHb values which 
are considered safe for men d 22). in addition, nicotine 
increases its pumping action imposing a great burden on an 
already damaged and failing heart d 26).
It seems clear that during the early part of exposure to 
CO most of this gas reaching the alveoli combines rapidly 
with haemoglobin in the pulmonary circulation and 10$ to 20$ 
fails to diffuse into the blood because of the very low CO 
pressure (PCO) in the alveoli d 22). This fraction is exhaled 
together with the gas in the physiological dead space. At 
rest the concentration of CO in the expired air is about half 
that in the inspired air. During exercise the increased 
physiological dead space, and especially the reduced time 
allowed for diffusion, result in the expired air containing 
60$ of the amount of CO inspired. As the exposure continues 
and the blood CO content rises the PCO increases in the blood 
and alveoli. This decreases the CO gradient and diminishes 
the rate of uptake.
In a study done by Wald et al in Oxford (1981) (157) 
they used a COHb cut-off level of 2$. They found that 81$ of 
cigarette smokers, 35$ of cigar and pipe smokers and 1.0$ of 
non-smokers had raised COHb levels. They found CO concentra­
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tion in alveolar breath were highly correlated with COHb 
levels (r = 0.97) indicating that COHb levels can be 
estimated reliably by measuring the concentration of CO in 
alveolar breath.
Jones et al studied the relationship between alveolar 
and blood carbon monoxide concentrations during breath 
holding (81). They found that during voluntary apnoea after 
full inspiration the alveolar CO pressure (PCO) first rose 
abruptly, reached a short plateau between 20 and 30 seconds, 
and then declined with breath holding at functional residual 
capacity.
Carbon monoxide exerts ill effects in several ways. It 
interferes with oxygen delivery and causes a leftward shift 
of the oxyhaemoglobin dissociation curve (95). CO inhibits 
the electron transport chain and slows oxidation by binding 
directly with cytochrome oxidase. It combines with 
haemoglobin and reduces the ability of red blood corpuscles 
to carry oxygen to vital organs such as the heart (118). For 
this reason the hypoxic symptoms produced by CO poisoning 
surpass in severity those produced by anaemia, despite the 
same blood oxygen content.
2.6.3 RANGE OF CARBOXYHAEMOGLCBIN VALUES IN DIFFERENT
POPULATIONS
In the Scottish MONICA draft manual of operations, May
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1984, the normal range of breath CO was given as 2-8 ppm for 
non-smokers and 9-40 ppm for smokers (162).
Getler and Mattice in 1933 (56) described the normal CO 
content of blood in 1 8 non-smokers living in New York City 
under conditions of minimal exposure as about 1 - 1.5$ of the 
Hb combined with CO. The average in rural localities is less 
than 1$ COHb. In non-smoking street cleaners in New York it 
was found to be 3$ COHb but taxi cab drivers were found to 
have the highest saturation of 8 - 19$.
Hanson and Hastings in 1933 (62) found that normal 
individuals who do not use tobacco and who are not habitually 
exposed to automobile gases showed an average saturation of 
blood with CO of 1.5$. Analysis made on the blood of 
subjects after smoking from 10 to 15 cigarettes showed 
saturation of COHb from 3.1 to 4.3$. Environmental exposure 
to CO causes a rise in blood CO concentration from 0.5 to 1 $ 
(73).
2.6.4. CARBON MONOXIDE ELIMINATION.
Virtually all of the CO absorbed by man can be recovered 
in the expired air if this is collected over enough 
time (122). However only 60$ to 70$ of the CO lost from the 
blood during the first hour is found in the expired air. 
This means that CO is present in some extravascular 
compartment.
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There are differences between individuals as regards CO 
elimination. In one study it took 250 minutes for the COHb 
level to fall to half its original value in an individual 
breathing air at sea level (122). This fall depends on the 
pressure gradient between blood and air CO in alveoli. Put in 
another way the blood loses 15$ per hour of CO which was 
present at the beginning of that hour. This rate of 
elimination is lowered with increasing age of the subjects by 
1$ for each year over 40.
Particular individuals may vary by + or- 20$ in the 
relation of the percentage saturation of Hb with CO to the 
percentage of CO in the inspired air (122). The reasons for 
this are variations in the ratio of tidal air to the dead 
space and variations in the value of the diffusion constants 
of the lungs.
2.6.5 FACTORS AFFECTING CARBOXYHAEM)GLOBIN LEVEL.
The body CO stores are influenced by two principal 
processes, the production and excretion of endogenous CO and 
the respiratory exchange cf exogenous CO (30). The main 
physiological parameters are (1) rate of CO production; (2) 
alveolar ventilation; (3) diffusing capacity of the lung; (4) 
mean oxygen tension in the pulmonary capillaries and (5) 
concentration of CO in inspired air. They found that 
measured values of blood COHb compared closely with values 
calculated from their equations for normal patients and 
normal volunteers who breathed 100$ oxygen for 5 to 7 hours 
and were probably in a steady state. It was also shown that 
the blood carboxyhaemoglobin measurement is not a precise
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index of CO in vivo since it is markedly influenced by other 
parameters.
Ho-Yen et al found that smoking fewer cigarettes resulted 
in an increase in plasma nicotine concentration (p<0.01), but 
carboxyhaemoglobin concentration remained the same (72)* ^ ey 
also observed while the volunteers smoked half their usual 
number of cigarettes they changed their inhalation behaviour. 
These findings suggest that advice given to patients to smoke
fewer cigarettes should be accompanied by a warning against
increasing inhalation.
As regards smoking non-tobacco cigarettes, Hynes 
found that blood COHb levels for volunteers smoking non­
tobacco cigarette made from Cocoa bean achieved significantly 
higher levels of COHb than tobacco.
2.6.6 TOBACCO SMOKING AND COHb VARIATION.
Cigarette smoke contains more than 2,000 chemicals 
mostly in the particulate phase . Volatile and semi-
volatile compounds account for more than 90$ of the weight of 
the total main stream smoke, 70$ of that being nitrogen and 
oxygen.
In another study it was found that different cigarette 
preparations do not result in significant variation in a 
subjects COHb level (3 3 ). The author found also a 
significant difference in COHb between individual smokers.
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They suggest that these differences may be due to inhalation 
practice or factors such as pulmonary functions which are of 
importance in determining whether an individual achieves low, 
moderate, or high COHb levels while smoking.
Exposure to CO in smokers of middle and low tar 
cigarettes was studied by Stepney. He found that CO intake 
from a single cigarette (measured by the rise in expired air 
CO concentration) was significantly less in low tar 
smokers (ins). Longer term exposure, measured by pre-smoking 
CO levels, was also less in low tar smokers but not 
significantly so.
Wald et al (1977) studied blood carboxyhaemoglobin 
(COHb) levels in 3^3 healthy male cigarette smokers aged 35- 
64 (-J56)* They found that the mean COHb level was 30$ higher 
in those who smoked unventilated filter cigarettes than in 
-the men who smoked plain cigarettes, after adjusting for 
the number of cigarettes smoked (p<0.001). The medical 
implications of these results are uncertain. High COHb levels 
(3 - or more) can exacerbate angina pectoris and 
intermittent claudication, and it is therefore of concern 
that COHb levels are higher in smokers of filter cigarettes 
than in smokers of plain cigarettes.
The variations in carboxyhaemoglobin level in smokers 
have been studied by Castleden and Cole (27). They reported 
that in the individual smoker the COHb level does not 
increase gradually during the day but is kept within
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relatively narrow, limits. Moderately heavy smokers get up in 
the morning with substantially raised COHb level because the 
half life of COHb is significantly longer during sleep than 
^during the day. VIomen excrete their CO faster than men. It 
was found also that a random COHb estimation gives a good 
indication of the mean COHb level of an individual.
VIaid et al (151}) in Oxford (1975) described a method of 
using a single COHb measurement with a recent smoking history 
to estimate the average COHb (boost) produced by each 
cigarette , the total daily CO uptake from smoking and the 
mean COHb level throughout the day. The indices were 
reasonably reproducible within the same person and the 
differences between people were statistically highly signifi­
cant (p< 0.001). In smokers who smoked 15 to IJO cigarettes a 
day the mean daily COHb ranged from 0.7$ to 9.3$. These 
differences are large enough to distinguish possible 
differences in the risk of developing diseases such as IHD. 
These suggested indices depend less on the time of the blood 
test and on the daily smoking pattern than on COHb alone. 
The ratio of COHb boost to the CO yield for a cigarette may 
reflect the depth of inhalation more accurately than a 
smoker’s self-assessment,
Castleden and Cole ^26 ) found that COHb levels in a 
group of. 11 men who smoked cigars or a pipe but who had not 
previously smoked cigarettes were similar (mean 2 .3$) to 
those found in urban non-smokers. In another 39 men who had 
switched from cigarette to pipe or cigars, they had COHb
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level (mean 5»2%) comparable to those of cigarette smokers.
In situations where CO inhalation is a hazard, automatic 
alarming devices often cannot be used; calculation of degree 
of exposure is unreliable; and direct estimation of blood 
COHb is impracticable (g«j)» Simultaneous, blood COHb and 
alveolar partial pressure of CO (PCO) analyses in 9 normal 
subjects on 58 occasions showed an excellent correlation, but 
slightly alinear though very close relationship. Correlation 
between COHb saturation and CO meter reading was even closer. 
The principle of the CO meter reading method involves use of 
the lungs as aerotonometers until gas pressure of pulmonary 
blood and alveoli approach equilibrium. The COHb % 
saturation is theneOstimated indirectly by rapid physical 
analysis of the CO content of expired air with model 16 
Liston-Becker infra red analyzer.
2.0.7 EFFECTS OF CARBON MONOXIDE ON CARDIOVASCULAR SYSTEM
Aronow (-j0) reported in an editorial that many studies 
have documented a significant association between cigarette 
smoking and the incidence of myocardial infarction and death 
from coronary heart diseases independent of other risk 
factors especially in young and middle-aged men.
In a letter, Brown et al said that 11 It is almost 
impossible to prove that relatively high CO level in 
cigarettes will not lead to additional deaths from CHD since 
it is probable that various smoke constituents1 interactions
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affect death from this cause (23)* Similarly, a role for CO 
is not excluded by the observation that smokers of cigarettes 
with reduced tar and nicotine levels and smokers of filter 
cigarettes show a reduced risk of coronary heart disease. 
They suggest also that CO yield of individual brands of 
cigarettes should be published with tar and nicotine levels.
The results of the Framingham study indicate that 
smoking's greatest contribution to CHD is at the younger age - 
level^^. Other risk factors contribute more at the older 
ages. Atheroma formation is inevitable when blood fat is 
persistently elevated above some critical level (9 5)* 
Nicotine also is an agent in the production of ischaemia and 
other acute effects. Nicotine liberates nor-epinephrine, 
causing vasoconstriction. Nicotine, however, has not been 
shown to be responsible for atherosclerosis. The most 
acceptable hypothesis is that CO of cigarette smoking plays a 
primary role in the genesis of atherosclerosis. Until 
recently, CO had not been considered to have pathogenic 
significance. In patients with angina pectoris, a dose- 
related increase in resting heart rate, aortic blood pressure 
and arterial CO levels and decrease in the stroke volume 
response to excercise were noted after cigarette smoking.
Coronary heart disease studies have shown that smoking a 
cigarette has an effect similar to an injection of nicotine 
in that it produces an immediate increase in the blood 
pressure, the output of the heart, and it increases the risk 
of coronary thrombosis (-j *18)*
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Aronow (n) investigated the significant increase in 
sudden death from CHD in cigarette smokers and suggested it 
was due to CO interference with oxygen delivery to 
myocardium. As cigarette smoke exposes the pulmonary 
capillary blood to at least 400 p.p.m. of CO it is much 
higher than those resulting from atmospheric air pollution. 
The increase in sudden death from CHD is due to nicotine, 
which increases the myocardial oxygen demand but not the 
myocardial oxygen supply at times of myocardial ischaemia. 
Nicotine also increases thrombotic tendency by increasing 
platelet adhesiveness. During myocardial ischaemia, nicotine 
can lower the threshold to ventricular fibrillation.
The thrombogenic effects of smoking may be of multiple 
origin. Carboxyhaemoglobin in blood will increase erythro- 
poiesis which in turn increases blood viscosity and 
haematocrit levels (95)* Catecholamine release at adrenergic 
end-plates and circulating catecholamine are both increased 
leading to increase in peripheral resistance.
In another study done by Kaufman et al evaluate
whether nicotine and CO of cigarette smoke is related to the 
risk of non fatal first myocardial infarction in young men, 
502 cases were compared with 835 hospital controls between 
the ages of 30 and 54 years. The increased risk of MI with 
the number of cigarettes smoked was estimated. The relative 
risk for current smokers was 2.8 and did not vary according 
to the amount of nicotine or CO in cigarettes. They
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suggested that smokers who smoke the newer cigarettes with 
reduced amounts of nicotine and CO do not have a lower risk 
of MI than those who smoke cigarettes containing larger 
amounts of these substances.
The effects of hypoxia or increased carbon monoxide have 
been studied through several experiments which indicate that 
either increased CO or decreased blood oxygen accelerates the 
atherosclerotic process in experimental animals and that 
increasing the oxygen retards vascular lipid accumulation 
(14,16,51,118). It is proposed that local hypoxia of the 
arterial wall results in vessel injuries, oedema and 
congestion of the tissues as well as vessel wall degeneration 
and myocardium.
Carbon monoxide probably causes enzymatic disturbances 
in fluid transport across the arterial wall (14). Diffuse 
fibrous thickening of the arterial and arteriolar walls 
located in multiple organ systems occurs more frequently in 
smokers.
A similar effect can happen after prolonged hypoxia 
exposure for 8-10 weeks (14,51,118). Severe effects are seen 
as areas of necrosis in the myocardium, occurred after 2 
weeks exposure to 16-18$ CO. This indicates that CO is 
toxic, particularly in young smokers with MI and peripheral 
arterial insufficiency.
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Astrup (17) observed that CO promotes development of 
atheroma in cholesterol-fed rabbits; the cholesterol content 
in the aortic tissue of the experimental group was about 2.5 
times higher than the control group.
The effects of moderate CO exposure in man were studied 
by Astrup (15). He found that intermittent exposure to CO 
rather than nicotine due to tobacco smoking may be regarded 
as a real cause of the higher risk for smokers who develop 
arterial diseases compared with non-smokers. This demon­
strated toxicity of low concentrations of COHb and should be 
acknowledged when discussing air pollution and threshold 
limit value for CO.
Cigarette smoke with more than 2% CO can expose the 
pulmonary capillary blood to at least MOO ppm and angina can 
then be triggered by a demand for more Oxygen than the 
myocardial circulation can supply (58).
Another study was carried out by Cohen et al (32) to 
clarify the relationship between atmospheric CO air pollution 
and fatalities from IHD. They have studied case fatality 
rates for patients admitted with MI to 35 Los Angeles 
hospitals. The results indicate that there is ,an increased 
MI case fatality rate in ’'high” pollution areas and this 
difference is only evident during periods of relatively 
increased CO pollution.
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The effect of cigarette filters on cardiovascular 
diseases has been studied by Hammond et al (171). The results 
clarified that the risk of heart attack is reduced among 
filter cigarette smokers and Koch has reported also a 
reduction in peripheral vascular disease. He suggested that 
cardiovascular events are affected by components in the 
particulate matter, probably nicotine. Carbon monoxide which 
is a major component of the gaseous phase of smoke does not 
have a major role since CO was not markedly reduced in filter 
cigarettes until products with perforated filter tips were 
introduced.
The association between acute coronary events (ACE) and 
cigarette or cigar smoking has been studied by Matroos et al 
in Netherlands (96). Cigarette smoking was related more to 
rapidly fatal than to non-fatal acute coronary events, 
especially in the younger age categories. The association 
could be shown for cigar smoking with no marked difference 
between inhalers and non-inhalers. In a series of sudden 
deaths, the non-current smokers were present only in the 
older age categories (50 years and older), contradicting most 
previous reports which stated that cigar smoking should not 
be considered harmless.
The risk for MI and CHD varies according to the form of 
tobacco used (79). Jayant et al, found that the risk ratio 
for bidi smokers (3.8) in India was higher than for cigarette 
smokers (3.3) and there was no added risk for tobacco chewers.
1 2 4
They explained the lower risk ratio found among tobacco 
chewers by postulating that it is the CO produced by smoking 
tobacco that increases the risk of CHD. Substitution of non­
tobacco cigarette may be associated with more immediate 
health hazards ie (CO poisoning) than tobacco smoking (65).
Prue (113) in his study of 27 smokers in a 2 year 
gradual transfer to low tar and low nicotine brands (brand 
fading treatment) programme found that smokers showed a 
decreased rates of consumption and the majority had lower CO 
level after they changed to low-yield cigarettes at the end 
of treatment. Therefore low yield cigarettes would appear to 
be an alternative for risk reduction in individuals who 
cannot stop smoking.
Aronow (10) has mentioned that COHb level in tobacco 
smokers correlated better with the presence of CHD than the 
smoking history. He mentioned also that smokers of non­
nicotine cigarettes at a rate of one every 30 minutes and at 
their normal pace of activities, developed a mean increase in 
venous COHb level from 1.58 to 7.79$. This increased COHb was 
associated with a decrease in excercise time until the onset 
of angina.
Carbon monoxide and angina.
Anderson et al in North Carolina (1973) studied the 
effect of low level CO exposure on onset and duration of 
angina pectoris (6 ). Ten adult men with stable angina
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pectoris breathed air with 50 ppm CO or 100 ppm CO for four 
hours on 5 successive days. After each exposure a standard 
treadmill exercise ECG was recorded. Mean COHb level after 
air breathing was 1.3? rising to 2.9? after 50 ppm CO and to 
4.5? after 100 ppm CO. The mean duration of exercise before 
onset of pain was significantly shortened after both 50 and 
100 ppm CO in comparison with air. Duration of pain was 
significantly prolonged after 100 ppm compared with air but 
not after 50 ppm. ECG showed worsening of ST segment changes 
with earlier onset and longer duration of ST segment 
depression.
Aronow in 1980 also evaluated the effect of smoking 
five non-nicotine cigarettes and of breathing CO on exercise- 
induced angina (13). Smoking increased venous COHb from 1.7 
to 5.3? and decreased exercise duration (until angina is 
noted) by 45?, increased ischaemic ST segment depression at 
angina from 1.3 to 1.5mm and decreased systolic BP times 
heart rate at angina. He compared these results after CO 
breathing and after smoking. Finally he suggested that 
tobacco components other than nicotine or CO are responsible 
for a small decrease in exercise performance until angina.
Angina also was found to be 70? higher among cigarette 
smokers in a health insurance plan in New York City. Pipe or 
cigar smokers, taken as a whole, have little or no excess 
mortality compared with non-smokers (48).
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Aronow (197*0 showed that smoking high nicotine
cigarettes causes a significant increase in systolic and 
diastolic arterial pressure, a significant increase in heart 
rate and no significant reduction in aortic systolic ejection 
period - changes that increase myocardial oxygen demand. 
Nicotine causes these changes by increasing catecholamine 
discharge and stimulating sympathetic ganglion cells. In 
addition, nicotine affects a chemoreceptor in carotid and 
aortic bodies reflexly causing increases in arterial pressure 
and heart rate. The CO levels resulting from cigarette 
smoking (400 ppm) are much higher than those resulting from 
atmospheric air pollution and eight times greater than the 
permitted level in industry.
127
2.7 CARBON KOKOXIDE; METHODS OF MEASURING BLOOD COHb.
2.7.1 METHODS OF MEASUREMENT
Methods for determining carboxyhaemoglobin are well 
documented and innumerable satisfactory methods are available 
to scientists. Blackmore (1970) tested and described the 
various methods used. He divided these methods into three 
groups (20).
This method involves comparison of maximum and minimum 
absorbence spectra for mixtures of either COHb and 
Oxyhaemoglobin, COHb and reduced haemoglobin or a combination 
are numerous. Blackmore also mentioned that Machly has 
critically reviewed the methodology and clarified the 
problems of dilution error, sulphaemoglobin formation and 
• spectrophotometer inaccuracy (20)* suggests calculation 
based on readings of the minimum absorbence between alpha and 
beta haemoglobin bands (about 568 nm), the absorbence at 600 
nm for the blood diluted in borate buffer, and the absorbence 
difference at the peak near 557 nm and the trough near 575 nm 
for the buffered solution treated with sodium dithionite.
A wide discrepancy is present in the ratios of 
carboxyhaemoglobin standards diluted 1 in 100 with 0.4/5 
ammonia solution with the extinction ratios 576:560 nm and 
541:560 nm plotted against percentage saturation of carboxy-
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haemoglobin. This discrepancy indicates the presence of 
interfering pigments (2 0).
It was found also that large differences in carbon 
monoxide saturation resulted in small changes in the movement 
of alpha band (20). In addition to the normal 
spectrophotometric errors account must be taken of the errors 
involved by dilution of the sample.
An experienced operator can achieve an accuracy of 
+ 10? but for a random determination mode at infrequent 
intervals up to 25?, differences can occur between workers in 
the same laboratory, all of whom use the same spectros 
cope (20).
Most of the reported measurements of COHb have used 
venous blood and analysed spectrophotometrically on a CO 
Oximeter 182. Many workers have reported the unstability of 
CO Oximeter (Instrumentation Laboratory Inc.). The technique 
is generally simple and applicable to analysis of lage 
numbers of samples (33a).
2. DIFFERENTIAL PROTEIN PRECIPITATION
This is a method of assay in which oxyhaemoglobin is
o
precipitated by heating a buffered solution of blood at 55 C 
for 5 minutes at pH 5.05. Under these conditions the 
carboxyhaemoglobin remains in solution. The filtered 
solution can be measured spectrophotometrically and compared 
with a 100? carboxylated blood.
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Analysis with differential protein precipitation is 
complicated and needs:
a) Standard test tubes.
b) Accurate temperature of water bath, pH and 
vigorous mixing.
c) Open test tube racks so that tubes reach 
the same temperature at identical times.
d) Strict control of cooling after reaction.
e) Strict control of time between removal from 
bath, filtration and COHb measurement.
Therefore it is evident that this method needs considerable 
effort and time.
3. LIBERATION OF CO AND SUBSEQUENT MEASUREMENT.
This large group of methods relies on the treatment of 
whole blood with reagents to liberate the CO gas which is 
then measured by a chemical or physio-chemical method (20). 
The major limitation of this method lies in the problems 
involved in the 100$ carboxylation of the control haemolysate 
with which the test is compared. If blood is aged, 
contaminated or contains haemoglobin pigments other than 
oxyhaemoglobin, then treatment with a strong reducing agent 
before carboxylation is essential. The liberated CO is 
measured by gas-chromatography and plotted against the time 
of gassing with pure carbon monoxide. This method is 
sensitive also to changes in potassium ferricyanide concen­
tration, pH, detergents and time of mixing.
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Blackmore concluded that spectrophotometric and 
differential protein precipitations techniques have been 
found to be unsatisfactory ; in contrast the use of gas 
chromatography for determining the CO content of the specimen 
together with determining haemoglobin and iron to calculate 
the total COHb content will give reliable results (20).
H. OTHER METHODS USED FOR MEASURING CARBON MONOXIDE.
A) Infra red analysis of extracted CO (121).
Measuring Carbon Monoxide in man required a method of 
estimating blood COHb of greater sensitivity, specificity and 
technical simplicity. Coburn et al (31) developed a technique 
involving infra-red analysis of extracted CO. In the course 
of this method it became obvious that significant quantities 
of CO can be produced in the blood during treatment of the 
sample. The method uses CO dissociated from Hb by oxidizing 
haemoglobin to Met-haemoglobin with ferricyanide and measured 
as a gas in infra-red analyses. The method had a SD of ±
0.006 ml/ 100 ml in the range from 0.1 to 1.0 ml/ 100 ml.
Rees et al in 1980 (23a) in London have compared 
estimation of alveolar CO measured either as end expired CO 
(after a breath hold of 20 seconds) or mixed-expired CO 
tension in mixed expired gas and allowance was made for 
estimated dead space with 2 spectrophotometric estimations of 
venous blood COHb. Alveolar CO was estimated by the mixed- 
expired method using an infra red CO analyser (Analytical
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Development Company). They found that estimation of mixed- 
expired CO was more convenient than the end-expired method, 
and this estimation of CO exposure discriminated between non- 
smokers and smokers as well as measurements of COHb.
B) Mine Safety Appliance.
Breysse et al (21) had used two field methods for 
measuring COHb?S. The first method was the Mine Safety 
Appliance CO poisoning kit. The concentration of CO in the 
expired air was determined by a field device using the length 
of stain in indicator tubes as well as by gas chromatography.
C) CO poisoning kit.
The second method used by Breysse et al (21) measured CO 
concentration in the expired air and COHb % can be calculated 
from the following equation:
COHb % = 0.5 + (CO ppm/5)
Both methods proved reasonably reliable when the results were 
compared with COHb % determined from blood specimens.
D) Measurement of breath CO by Ecolyzer.
Since carbon monoxide in alveolar air after breath 
holding is in equilibrium with the concentration of 
carboxyhaemoglobin in the blood. Jarvis et al (77), in their 
study on the development of a simple breath test of tobacco 
smoke, found that the amount of CO in end-expired alveolar 
air provides a rapid and accurate non-invasive indirect 
measure of carboxyhaemoglobin. They used the carbon monoxide
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analyser, Ecolyzer Series 2000, which is portable and 
inexpensive. The method has a potentially wide application 
as an objective test of the amount smokers inhale and of 
their claims to have stopped. Impaired lung function cannot 
be an important factor in normal smokers. The closeness of 
the relationship between COHb and expired air CO suggests 
that there is little to be gained from analysing a sample of 
blood rather than expired air.
The relationship between percent saturation of Hb and CO
to the percent of CO in inspired air has been studied. In
order to calculate blood C0Hb?S at rest for an individual 
(ventilation 6 litres per minute, pulse 70 per minute), the 
concentration of carbon monoxide in the inspired air in 
percent (?C0) times the minutes of exposure (t) multiplied by 
3 ( 122).
% COHb = 3 x {%C0) x t.
If COHb measured during light activity 5 is used instead
of 3 and for heavy work 11 will be used in place of 3.
In the Multiple Risk Factor Intervention Trial in 
Alabama, breath carbon monoxide was measured by Ecolyzer to 
provide positive feedback for smoking changes (73). Breath CO 
tended to increase with the increase in number of cigarettes 
smoked, depth of inhalation and other smoking-related factors 
and to decrease after cessation.
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2.7.2 METHODS FOR DETECTING SMOKING USING OTHER METABOLITES OF 
TOBACCO.
It is well known that tobacco smoke is a mixture of 
gases and millions of minute particles from which some 300 
different components have been identified (63). Nicotine is 
one of them; it is rapidly degraded to non-toxic products and 
there is no evidence that chronic toxicity to this substance 
occurs in smokers.
Cotinine, which is a metabolic product of nicotine, has 
a longer half life (19 - 40 hours as compared with less than 
30 to 110 minutes for nicotine) (6 8). Therefore cotinine 
measurements provide advantages over those for nicotine. The 
former can be measured by sensitive radioimmunoassays and its 
presence is an indicator of chronic exposure to tobacco, 
whereas that of nicotine is an indicator of recent exposure.
Nicotine, cotinine and carboxyhaemoglobin levels in 
long-term (> 1 year) smokers of a given cigarette should be 
compared with the corresponding nicotine and CO levels in the 
smoke of that cigarette; only such long term studies can 
determine what adjustment, if any, is made in smoking 
patterns when smokers switch to low tar, low nicotine 
cigarettes (171).
In order to verify the smoking histories of MI patients 
by measuring both urine nicotine and cotinine, Wilcox et al 
(1 9 7 9 ) found that while in non-smokers detectable
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concentrations were always below the confidence limits set 
for the method (6.04 ±  0.73 mmol/L), smokers were always 
above these limits (163). Forty six to 53$ of previous 
smokers had actually stopped smoking compared with the 63$ 
who said that they had stopped. Therefore assays of urinary 
nicotine and cotinine at the same time may be a useful means 
of verifying patients* current smoking habits.
The study of the relationship between plasma cotinine 
and COHb by Hill et al clarified a higher significant 
correlation between both (r = 0.7 0: r= 0 .67 men:women) and 
with nicotine (r = 0.73: r = 0.74 men:women) than with 
thiocyanate (r =0.53: r = 0.59 men:women) (6 8). They found 
also when smokers were separated into those smoking 
cigarettes yielding more or less than 1mg nicotine per 
cigarette, COHb was the better indicator of daily exposure 
and absorption. With increasing consumption, COHb and plasma 
nicotine showed a comparable progressive increase in men and 
women in a linear relationship.
In addition to CO gas, other components in cigarette 
smoke are toxic (6 8). These include hydrogen cyanide, which 
is converted to thiocyanate. Thiocyanates accumulate in body 
fluids and inhibit cellular respiration.
A significant correlation has been found between 
carboxyhaemoglobin and plasma thiocyanate concentrations with 
self-reported daily cigarette consumption (152). The extent 
to which inhalation patterns affected the intake of cigarette
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smoke constituents was determined from the partial 
correlation between carboxyhaemoglobin and plasma thiocyanate 
concentrations after the number of cigarettes smoked per day 
had been allowed for. Thus, 23? of the variation in carboxy­
haemoglobin and thiocyanate concentrations was accounted for 
by the way a cigarette was smoked and a further 2 1? by the 
number smoked per day. Furthermore, the relation between 
COHb or plasma thiocyanate and daily cigarette consumption 
was not linear but reached an asymptote at consumption rates 
above 25 cigarettes a day.The remaining variability may be 
due to difficulties in CO or hydrogen cyanide yields of 
cigarettes, excretion, and environmental or nutritional 
factors.
Vogt et al (153) have studied the baseline carbon 
monoxide and serum thiocyanate levels as predictors of 
outcome. In a San Francisco clinic, 162 male smokers 
participated in a smoking cessation programme. They underwent 
analysis of expired air carbon monoxide and serum 
thiocyanates (SCN) at entry and one year later. They found 
that persons who failed to stop smoking (58?) had higher base 
line CO and SCN and smoked more cigarettes per day than those 
who succeeded in stopping. They also noticed that persons who 
failed to quit reduced the reported number of cigarettes 
smoked per day by one third. At the same time there was no 
corresponding reduction in CO and SCN, suggesting that self- 
reporting of a reduction in number of cigarettes smoked may 
not lead to corresponding decline in exposure measured 
independently.
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2.7.3 DETECTION OF TOBACCO METABOLITES IN PASSIVE SMOKERS.
In recent years there is an increasing concern as 
regards non-smokers chronically exposed to tobacco smoke in 
their daily lives who may suffer a significant risk to their 
health (78). Therefore in order to study the reliability of a 
non-invasive marker and validated questionnaire measures for 
assessing the degree of exposure in non-smokers, Jarvis et al 
(1984) examined the levels of COHb, saliva thiocyanate, 
plasma nicotine and cotinine. They studied also the relation 
between the levels of self reports by questionnaire in non- 
smokers exposed to tobacco smoke. The results clarified that 
cotinine level showed a significant variation with exposure. 
Thiocyanate and carbon monoxide levels were unrelated to 
exposure as was the concentration of nicotine in plasma, so 
cotinine can provide a sensitive guide to the extent of 
recent daily passive smoke exposure in stringently defined 
non-smokers. The concentration of nicotine in saliva was 
related to exposure, but only exposure on the day of testing. 
Therefore the non-invasive samples of urine and saliva are 
particularly suited to epidemiological investigation.
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MATERIALS AND METHODS
CHAPTER THREE: MATERIALS MID METHODS
3.1 DESCRIPTION OF POPULATION. DEFINITION OF TERMS AND HEALTH
EDUCATION METHODS
This project was based on a follow up study for the 
validation of a breath carbon monoxide test as an indicator 
of smoking cessation among patients admitted to a coronary 
care unit (CCU).
The populations studied were:-
1- A population of patients admitted in 1983 to the coronary 
care unit (n=212) at the Western Infirmary irrespective of 
the clinical diagnosis. It included all ages and both sexes 
and was used to evaluate two health education interventions. 
In addition random sub-samples of these patients were taken 
when required for detailed study of blood carboxyhaemoglobin 
(COHb) and breath carbon monoxide (CO).
2- Glasgow High School pupils (n=105) and Ruchill Hospital 
employees (n=l43) were also included in the study for 
evaluating the repeated use of a carbon monoxide (CO) breath 
measuring device in normal adults and children.
The admission rate of patients to the Coronary Care Unit 
at the Western Infirmary was about 60 cases on average every 
month. Patients were admitted from the Western Infirmary 
catchment area which extends from the city centre (Post code 
G1) to the Clydebank area (Post code G81). Clydebank 
patients constituted about 20$ of the total CCU admissions.
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A pilot study was done to investigate the difficulties 
which would be encountered in the study. Difficulties were 
found in following-up patients in their homes (other than 
Clydebank area) because they were scattered over a large 
catchment area. Searching for homes was time-consuming and 
sometimes a house had to be visited many times to see the 
patient. The cost of transport was another difficulty. It 
showed that Clydebank patients were comparable with the 
other patients with regards age, sex, social class 
distribution and smoking habit.
Sample size was estimated before the study began as 
follows (47) The successful follow-up of 80 patients in 
group I (non-intervention group) and 25 in group II (health 
education group) together with an expectation of a 3 0$ 
reduction in smokers in group I and 60$ in group II, was 
calculated to give an 80$ chance of detecting a significant 
difference (p <0.0 5).
Fresh venous blood samples for blood carboxyhaemoglobin 
analysis were collected immediately after admission. All CCU 
patients (n=212) included in the study filled in a question­
naire based on the previous Midspan Study in Renfrew and 
Paisley (Appendix A2) (103). This was done after a patientfs 
condition became stable. Such a self-administered 
questionnaire is reliable enough to allow confident 
estimation of the variables within groups and between 
different groups, eg. smokers and non-smokers.
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The questionnaire included standard demographic material 
and the standardized and validated questions on respiratory 
symptoms developed by the Medical Research Council Committee 
on the aetiology of chronic bronchitis (98,99). In addition 
to the standard questions on respiratory symptoms, chest 
illness and detailed smoking habits, a series of questions on 
occupation, family history of smoking, and chest pain were 
incorporated. These questions were developed at the London 
School of Hygiene and Tropical Medicine and approved by WHO 
for use in field studies (123,124). All questions were coded 
to facilitate analysis by a computer file (Appendix C).
Each questionnaire was checked immediately and standard 
investigations were carried out which included:
1. Measuring weight and height of subjects in indoor 
clothing (without shoes).
2. Measuring FEV 1.0 and FVC using a Garthur Vitalograph
with the subject sitting. The best expiration was 
recorded, the one second vital capacity determined with 
vitalography, and the results expressed as a percentage of 
the total vital capacity (66).
3. The social and laboratory data and results of
investigations were recorded from medical records eg.
ECG findings.
4. Blood pressure measurement was done at rest after 
admission, by a Mercury sphygmomanometer with a cuff width 
of 14 cm, on the right arm. Diastolic blood pressure was 
taken at the disappearance of the fifth Korotkoff sound.
5. Plasma levels of cholesterol, triglycerides, glucose
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and cardiac enzymes (CK, SGOT and LDH) were measured 
in a venous blood sample.
6 . The reported daily number of cigarettes, cigars and 
pipes smoked were summed and values were presented as 
mean tobacco consumption per person.
7. A chest X-ray was carried out for each patient.
8. Exhaled Carbon Monoxide was measured, the method for
which is described later in a separate section 
(Section 3.3).
The 212 cases studied were given the basic health 
education material (Appendix E1)( 108) and divided into two 
groups comprising 116 smokers and 96 ex and non-smokers. 
Smokers were followed up. The response rate was 9^  (81$) out 
of 116 patients who were smokers. The entry and follow-up 
data were collected by the research student.
Smokers from Clydebank were also given the Middlesex 
Hospital Questionnaire (MHQ Appendix A3), an Illness 
behaviour Questionnaire (IBQ Appendix A5) and a dietary 
questionnaire (Appendix A^) in the CCU to assess their 
psychological profile and feeding habits. Assessment was done 
by the CCU health visitor by scoring the answers given to 
each question.
This group was given also another booklet about health 
education and heart disease "Beating heart disease" (135) ( 
Appendix E2). It contains details about what heart disease 
is, why some people get it, how to help yourself to avoid it,
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what is meant by angina and a heart attack, who suffers from 
heart disease and what are its causes. Advice was given about 
smoking and heart disease, diet and what the patient can do 
for himself; and about high blood pressure - what is it, 
what the patient can do. A section is included on stress and 
the heart, and how to stay fit and healthy after a heart 
attack.
In the CCU these Clydebank patients were given intensive 
personalised health education by the trained health visitor 
about smoking and its hazards, the benefits to be gained from 
smoking cessation, and the important role of such risk 
factors as smoking, diet, obesity and hypertension in 
coronary heart disease according to the previously assessed 
psychological profile of the patient. It included also at 
least one home visit for follow-up after discharge from the 
hospital. Home visits lasted on average 45 minutes.
Visiting patients at home is an important part of inten­
sive health education because most patients live with their 
families and usually are affected by family feeding habits 
and psychological and social factors in the house. Therefore 
it might be useful to include the spouse in the health 
education process to manage the new circumstances properly.
The presence of a suitable clinic in the Clydebank 
Health Centre under supervision of Consultant Cardiologists 
from the Western Infirmary facilitated further follow-up of 
the patients. The health visitor who was providing health
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education for patients in the Western Infirmary also worked 
in the follow-up clinic in Clydebank health centre. He was an 
ex-smoker at the time of the study. Ease of access to 
patients in this area made follow-up and home visits more 
likely to be successful than following up patients living in 
other parts of the Western Infirmary's catchment area.
DETAILED METHODS OF HEALTH EDUCATION.
Basic health education material; This was standard for all 
CCU patients in the form of a booklet "Advice for those 
recovering from a heart attack" published by the Scottish 
Health Education Unit ( Appendix El) (10 8) and it included 
the following titles:
1. What is a heart attack?
2. Physical activity during the time of illness and 
after recovery.
3. Advice about returning back to work, the suitable 
time and type of activity at work.
4. Sleep and rest.
5. Advice concerning the diet and weight reduction if 
the patient is overweight.
6. Advice about giving up smoking.
7. Advice for women as regards household duties and
family planning methods.
Intensive health education was undertaken after every Clyde­
bank patient (smoker) filled in the MHQ, IBQ and a dietary 
questionnaire (Appendix A4) in the hospital, and was 
continued after dicharge. This was specifically tailored to
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their responses after scoring the answers and assessing the 
psychological profile and it included advice and health 
education with regard to:
1. Hazards of smoking and the best way to give up smoking.
2. Advice in tackling the psychological problems of 
the patient and also physical fitness training 
(Appendix A6 ).
3. Recommendations about dietary changes according to 
the patient's answers to the dietary questionnaire.
4. Advice about exercise according to the fitness of 
the patient.
All patients in this group were also given the detailed 
booklet 'Beating Heart Disease' (135 and Appendix E2). It was 
essential that the patient should trust our judgement and our 
concern for his wellbeing. The aim of the advice in general 
was to avoid raising major fears and to emphasise the 
positive merits of the health advice, that is mostly the 
gains from stopping smoking rather than the danger of 
continuing.
Follow-up
One year after discharge an invitation letter was sent 
to patients who were smokers (n=1 l6 ) at the time of 
admission. All smokers were invited to return to the Western 
Infirmary except for Clydebank patients who were asked to 
attend the Clydebank Health Centre. Non-respondents were 
invited twice to participate in the study by letter and
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phone-call (Appendix A7). A response rate of 81 % (94/116) was 
achieved. Of the 22 non-respondents, 2 patients refused to 
participate and 20 could not be traced. Of the 94 responses, 
7 patients (7.5$) were found to have died after discharge 
from the hospital within that year. The main purpose of the 
follow-up examination at one year was to compare the status 
of the two groups with regard to smoking habits and other 
risk factors and to evaluate the effectiveness of the health 
education procedures.
Awareness about cardiovascular risk factors was studied 
by having the subjects identify the correct risk factors from 
a list of questions and answers generally associated with 
coronary heart disease (Appendix A, page 2 9 7)(86). Their 
current smoking, dietary history, and their ability to recall 
the advice they had been given 1 year previously were 
measured. Smoking history was checked against both blood 
COHb and breath CO, allowing a further comparison of the two 
methods.
Confidentiality
Assurance was given to respondents that this informatiom 
was for the purpose of research only.
Data processing
The completed questionnaires were coded and the data were 
stored in a computer file. The Statistical Package for Social 
Science (SPSS) (106) and the Minitab Statistical Package 
(10*0 were used for analysis of the data.
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Definition of terms ^  Q3)
Age is counted from the date of birth to the date of hospital 
admission and thus involvement in the study.
Occupation and social class: according to Classification of 
Occupation (OPCS 1980) (29).
Stress index is obtained from the sum of all the positive 
answers to a series of related questions (103) (Appendix B). 
Smoker is any person who still smokes at the moment of the 
research or before admission and he or she can be: 
a) cigarette smoker, b) pipe smoker, c) cigar smoker.
In this study smokers were classified as light smokers who 
smoke less than 15 cigarettes per day, moderate who smoke 
between 15-25 cigarettes per day and heavy smokers who smoke 
more than 25 per day.
Non-smoker is any person who has never smoked a cigarete, 
pipe or cigar before.
Ex-smoker includes those who have smoked for some time but 
were not smokers at the time of the study.
Knowledge about cardiovascular risk factors was assessed from 
a list of questions. The maximum possible score is 16. 
(Appendix B)
Cardiorespiratory symptoms For reference see Appendix B.
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3.2 CROSS-REACTIVITY OF CO WITH BREATH HYDROGEN
A study was made of cross-reactivity between breath 
carbon monoxide and hydrogen in the 2 groups of healthy 
individuals- Ruchill Hospital employees and Glasgow High 
School pupils. Ruchill Hospital employees included in this 
study comprised both sexes, smokers and non-smokers. Every­
one was invited to take this breathing test through a notice 
circulated to all hospital departments. One hundred and 
forty three personnel responded to take the test. About 10 
personnel, mainly cleaners refused; all were smokers. The 
employees were asked to take the test in the Coffee Lounge on 
the specified dates; each one was asked to answer a few 
questions, particularly about their smoking habit. Each 
person was asked to take a breath hydrogen test at the same 
time as the breath carbon monoxide test.
Because nearly all hospital employees were over 18 years 
of age and had a different smoking pattern from younger age 
groups (<1 8 years), I arranged to do the same procedure on 
Glasgow High School children for the purpose of comparison.
One hundred and five pupils from Glasgow High School 
carried out breathing tests in confidence - that is without 
personal identification. It included breath carbon monoxide 
measured by a GMI (Gas Measurement Instruments Ltd) portable 
carbon monoxide monitor and breath hydrogen measured by a GMI 
breath hydrogen monitor (Appendix D2). Each test was done 
twice at the same time for each pupil. Each pupil was asked a 
few questions regarding his smoking habits, age, family
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smoking habits and, for those who smoked, the time since 
their last cigarette.
3.3 TECHNIQUES OF CAHBON MONOXIDE MEASUREMENT: COMPARISON 
BETWEEN METHODS. CHANGES IN CO OVER TIME. AMD ACCURACY
Blood COHb was measured for each patient at entry and at 
follow-up as well. For detailed study of blood COHb sub­
samples from the total patient population were used. The 
relationship between blood COHb and breath CO was studied in 
a random sample of 42 patients. Changes in COHb over time was 
studied in 8 persons. Study of the effect of storage was done 
on 21 patients. In order to calculate the half life of breath 
CO, six healthy subjects carried out the breath test every 15 
minutes for 3 hours.
Blood COHb is measured by the CO-oximeter 282 as percentage 
saturation and for the purpose of comparison in some tables 
it is converted to ppm (1$ saturation is nearly equal 5 
ppm)(122). Normal levels were measured up to 1.9$ saturation 
(about 9 ppm)(62,161,162). Higher levels of blood COHb (>2$ 
saturation) were divided arbitrarily into moderately high (2- 
4$ ) and high levels ( >4$ saturation). In this study CO was 
measured by three different methods which were:
3.3.1 Spectrophotometrie method for measuring blood COHb
A 3cc fresh venous sample was collected in a 
heparinised (one drop of heparin 5,000 I.U.) airtight syringe 
immediately after admission, for immediate analysis. 
Carboxyhaemoglobin was measured by CO-oximeter 282
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(Instrumentation Laboratory Inc. Appendix D3) according to
the instruction manual (74). Five COHb measurements were
taken for each blood sample. The averages of each five
readings were recorded. A subsample was used for COHb
measurement by a second CO-oximeter 282 machine and the COHb
measurements were similar for both machines. The measurements
were in $COHb and in order to transfer $COHb to carbon
monoxide content the following equation was used.
1.39 x THB x $COHb = ml C0/100ml blood 
I00
(THB = the total amount of haemoglobin in the sample 
calculated also by CO-oximeter 282 at the same time).
Light absorption at certain wave length was the 
underlying theory of this CO-oximeter and of spectrophoto­
metry; the wave lengths used are 541 nm, 560 nm and 576 nm 
(74). Light absorption at 548 nm is related to changes in 
total haemoglobin concentration. Absorption at 568 nm to 548 
nm is related to carboxyhaemoglobin and 578 to 548 is related 
to oxyhaemoglobin. The range for readings is 0-100$ for 
carboxyhaemoglobin, 6-20gm/100ml for blood haemoglobin and 0 
to 100$ for oxyhaemoglobin. Reproducibility of this machine 
is reported tobe+1$ (74)*
3.3.2 Gas chromatography method for measuring carboxyhaemoglobin.
The principal of this method is liberation of bound carbon 
monoxide from haemoglobin and its subsequent measurement. 
Apparatus:Gas-chromatograph fitted with Katharometer 
detector, linear amplifier and gas sampling valve with 0.5ml
and 5.0ml loops (20)*
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Reagents: Distilled water, saponin and de-gassing reagent.
Procedure:
(1) Put lml whole blood + 3ml of distilled water + 10mg of 
white saponin then mix for 10 minutes and centrifuge 
for 15 minutes at 3000 rpm.
(2) Remove the supernatant liquid and pipette 1ml of it 
into a 5ml plastic syringe fitted with a short length 
of plastic tube. Into the syringe draw 1ml of air, 
into another syringe place 3ml of degassing reagent and 
attach this syringe into the other end of the plastic 
tube. Mix the two solutions by transferring the 
degassing agent to the syringe containing the haemoly- 
sate.
(3) Mix on a rotary mixer for 10 minutes and the air space 
containing the CO is then transferred to the empty 
syringe.
(H) Transfer the air space to a 5ml gas loop of the gas 
chromatograph.
(5) The recorder reading shows the separation of oxygen, 
nitrogen and carbon monoxide obtained from such an 
injection at the optimum sensitivity of the detector 
and Katharometer. The volume of carbon monoxide 
liberated from an aliquot of haemolysate is calculated, 
with allowances for difference in amplifier 
attenuation, as follows:
Volume of CO from test
Peak height of test x Attenuator setting for test X Volume of pure CO 
Peak height of CO Attenuator setting for CO
1 50
From the relationship 100mgHb = 0.34mg iron = 136 ul of CO, 
the total volume of CO that would represent 100? carboxylation 
of haemolysate can be calculated.
Per cent saturation is equal to the volume of CO liberated 
from 1ml of haemolysate devided by the volume of CO that 
would combine with 1ml of haemolysate as calculated from Hb 
and iron concentration.
3.3.3 Breath CO measurement by GMI portable CO-monitor.
Breath carbon monoxide was measured by a carbon monoxide 
monitor developed by Gas Measurement Instruments Ltd., (GMI).
It is based on an electrochemical cell which has recently 
become available (Appendix D1). This CO monitor is hand held 
and it works with a rechargeable battery for about 20 hours 
continuously. The monitor was calibrated by carbon monoxide 
gas 93 ppm. After switching on, but before using, it is 
allowed to settle to zero, otherwise the zeroing screw has to 
be readjusted. Everyone breathed into a sterile disposable 
mouthpiece connected to the GMI CO monitor from full 
inspiration to the end of expiration. Expiration was 
continued as long as possible and samples were taken at end - 
expiration in order to include a good sample of alveolar 
air. The test was repeated five times for every person with 
all measurements made at rest.
The mean, standard deviation and coefficient of 
variation for each group of 5 readings were obtained for both 
COHb and breath CO readings.
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Simple breath CO measurement is of importance as 
measuring CO in blood or measuring urinary cotinine is time 
consuming, expensive and requires considerable experience in 
laboratory work; on the other hand measuring breath CO is 
cheap, quick and simple using portable monitors. Because of 
this they can be used in field studies concerned with 
measuring breath CO.
3.4 STATISTICAL METHODS USED 
1 • TerminologvC 8).
Null Hypothesis (Ho) :states that there is no difference 
in the frequency of a risk factor or in the prevalence of a 
stated condition between two or more groups.
Significance level: this is the probability of rejecting Ho 
when it is true. Often the 5$, 1$ and 0.1$ (ie. 0.05, 0.01, 
0.001 respectively) levels are chosen as important.
Critical value: this is the value found in statistical tables 
which if exceeded by the test statistic will lead to the
rejection of HQ a .^ sorae significance level. The main 
statistical significance tests used for the tabulated data 
are:
2. Chi Square (8).
2
Chi-square (X^) test is used for making a conclusion
2
about the prevalence data. In its basic form the X test
compares the observed frequencies with those which would be
2expected under some theory or hypothesis. Thus X = the sum
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of the squared differences between the observed and expected 
values divided by the expected value ie.
If X is small, the implication is that the observed and 
expected frequencies do not differ markedly, and there is no 
strong evidence against the null hypothesis (ie. cannot 
reject null hypothesis). The larger the value of X , the 
greater the discrepancy between observed and expected 
frequencies and the less likely it is that the hypothesis is 
true (ie. reject null hypothesis). There is a critical value 
of X2" such that any value of X2 greater than this critical 
value implies disagreement between observed and expected
p
frequencies. This critical value can be found in X 
distribution tables and the value depends on the degrees of 
freedom of the problem under consideration. Fisherfs exact 
test was used for some 2 x 2  tables with small numbers and 
results are given under each table.
3-Use of Correlation Coefficient for comparison between two methods 
Comparison of a new measurement technique with an 
established one is often needed to see whether they agree 
sufficiently for the new to replace the old (20a). Such 
investigations are often analysed inappropriately, notably by 
using correlation coefficients. The use of the correlation 
coefficient is misleading because (1) it measures the 
strength of a relation between two variables, and not the 
agreement between them unless the points are on the line of 
equality with similar scales. (2) it is not affected by
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change in the scale of measurement which certainly affects 
agreement. (3) correlation depend on the range of the true 
quantity in the sample. (4) the test of significance may show 
that the two methods are related, but it would be very 
surprising if two methods designed to measure the same 
quantity produced values which were not related in some way. 
(5) data which seem to be in poor agreement can still produce 
quite high correlations.
However an alternative approach, based on graphical 
techniques and simple calculation is appropriate. Precision 
of the estimated limits of agreement can be obtained by 
using standard errors and confidence intervals to see how 
close the agreement is (20a).
4. Oneway Analysis of Variance (Oneway ANOVA) (8).
This test is used to compare the means of more than two 
populations, where it is inappropriate to analyse the data by 
performing multiple t-tests, ie. the more t-test that are 
performed, the greater the probability of establishing an 
apparently significant difference (in the absence of a real 
difference) purely by chance. Therefore, it is better to 
perform the analysis of variance on the data, and to examine 
it more closely by performing t-tests between pairs of groups 
only if the initial analysis of variance demonstrates a 
significant difference between groups (giving an indication 
that at least two groups differ from one another, but not 
indicating which groups they are). The test statistic is:
F = (between groups sum of square) / (no. of groups -1)
(within groups sum of square)/(no. of observations- no. of groups)
ie. BSSg / (k-1)
WSSq / (n-k)
when k = no. of groups and n = no. of observations.
The degrees of freedom are k-1, n-k. We reject the null 
hypothesis if F is larger than the critical value from F 
distribution tables.
5. Exponential decay model
COHb concentration in blood decreases gradually over 
time (provided the subject refrains from smoking) due to 
excretion through the lungs. The reported half life of COHb 
in publications is 4 hours (122).
It is useful to apply the exponential decay model to 
observed COHb measurements at time t hours after last 
cigarette to find out what the value was at time 0. The 
equations used are
1 j x t
- h a l f  l i fe
The concentration at time t = concen. at time 0 X 2  
therefore to calculate COHb concentration at time 0 is 
equal to:
Co= Ct / 2 H 
H = half life in hours.
6. Measurment of Reliability
Reliability of observations is different from their 
accuracy eg. findings of two physicians may agree (be
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reliable), and yet be wrong as compared to an independent 
standard of accuracy (87). Agreement of physicians is termed 
inter-observer agreement and agreement of a physician with 
himself regarding repeated observations is termed intra­
observer agreement. Overall agreement is the proportion of 
all patients about whom observers agree on the presence or 
absence of an abnormality. Specific agreement is the propor­
tion of patients about whom observers agree on the presence 
of an abnormality. Neither overall nor specific agreement 
rates take into account the varying contribution of chance 
agreement rates.
As regards the reliability of self-reported smoking 
behaviour, it is generally felt that confidential smoking 
questionnaires can give reliable results but this reliability 
may be improved by the use of a "visible” objective 
test (141).
Accuracy of many diagnostic procedures is subject to 
impairment from errors in technique of examination and inter­
pretation (55). Even experienced physicians are found to have 
a measurable degree of ’observer error1. Accuracy in 
diagnosis can be improved by independent examination either 
by the same observer on two different occasions or by two 
different observers. The observer error in different fields 
should provide a stimulus to greater care in examination, to 
increased use of consultation and, above all, to continued 
attempts at elucidation and correction of the factors 
involved.
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7-Sensitivitv and specificity
The most useful reliable investigation fulfils a 
discriminating function (128). The results are either 
positive or negative, normal or abnormal, diagnostic or non­
diagnostic. The reliability of tests in separating diseased 
from non-diseased subjects may be measured in terms of their 
sensitivity and specificity (Vecchio, 1966). Sensitivity is 
a measure of whether the test will identify the disease in 
question. Specificity is the ability of the test to separate 
subjects with the disease from those without it. The possible 
outcomes of using the test are:-
Disease
Positive Negative
Positive True positives False positives
Test result
Negative False negatives True negatives
To maximise the yield of true positives an operator must 
accept a degree of contamination by false negatives. The 
functions of individuals interpreting results may be 
calibrated on a *receiver operating characteristic* (ROC) 
curve. In any given investigation the distribution of 
criteria for diagnosis or exclusion will seldom permit 
complete separation from those with a disease from those 
without.
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8.Use of analysis of variance to estimate reliability of
measuremeftts (167).
For a person who has a magnitude of (7\)for a specified 
characteristic the observed score after using a measuring 
device will be (*+n) therefore, a measurement on person (i) 
with measuring device (j) will be
Xij =^i + nij 
where Xij = observed measurement
7^  i = true magnitude of characteristics 
nij = error °** measurement 
After the assumption that ^  i is constant upon repeated 
measurements and is assumed to vary, the mean of (k) 
repeated measurements will be
^,.x. -
» 11 -  p. - T V  "i 
k " '
and the variance within person (i) is due to error of 
measurement and the pooled within-person variance also 
estimate variance due to error of measurement.
The reliability of the mean of (k) measurements is the 
variance due to the true scores divided by the sum of the 
variance due to the true scores and variance due to error of 
measurement.
Reliability of the mean of a group of measurements =
MS within people 
rk = 1 —------------------------
MS between people
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The reliability of Xij which is a single measurement is
« - MS between people MS within people
rl =■ — — --------------------- ----- --------
MS between people + (K-1) MS within people
MS = mean squares.
rk also can be expressed in terms of the reliability of a 
single measurement as follows:
1 +(k-1 )r 1
The assumptions underlying the validity of this formula 
are those underlying the analysis of variance and they are
1 - The error of measurement is uncorrelated with the
true score.
2 - The sample of n subjects (or people) is a random sample.
3 - The sample of k measuring instruments is a random
sample from a population of comparable instruments.
4 - The within-subject variance may be pooled to provide
A
an estimate of o n  .
INTERPRETATION OF THE RESULTS
The term rk means that if the experiment is repeated 
with another random sample of judges but with the same 
subjects the correlation between the mean ratings obtained 
from the two sets of data for the same people would be the 
value of rk. This assumes that the variance due to
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differences between the means of judges is part of the error 
of measurement and does not represent a systematic source of 
variation. But if these represent a systematic source of 
variation then the source of variation due to differences 
between those means should not be considered part of the 
error of measurement. In order to adjust for the frame of 
reference the deviation of the means of a judge from the mean 
of all judges should be calculated. By the adjustment 
procedure the SSq between people is not affected. However, 
SSq w ithin people for the adjusted data differs from the 
corresponding sums of squares for the unadjusted data by SSq 
judges. So adjustment was made to eliminate the between- 
judge variation from the within-subject variation.
The mean square within people (MSW) for the adjusted data 
is numerically equal to the mean square residual (MS res) for 
the unadjusted data and the estimates of reliability are
rk = 1 - MS-residual
MS between people
r1 = MS between people - MS res
MS between people + (k-1) MS res
The reliability of a single rating (r1) for the adjusted 
data is Approximately equal to the average intercorrelation 
between ratings given by pairs of judges.
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RESULTS
CHAPTER FOUR: RESULTS
4.1 DESCRIPTION OF THE TOTAL PATIENT POPULATION
This part of the study was done to validate the carbon 
monoxide (CO) breath test as an indicator of giving-up 
smoking as a result of the Health Education intervention. All 
patients came from the Western Infirmary catchment area in 
Glasgow which extends from the Clydebank area (Post code 
G81) to the City centre (Post code G1). The total number of 
patients was 212. All patients had been admitted to the CCU 
in Western Infirmary and they were given standard medical 
care as well as basic health education. 55? out of whom were 
current smokers (see Table 1). The 116 current smokers were 
followed-up and 94 (81?) responded, drop-outs were invited to 
participate in the study twice by letters and a phone call to 
arrange a suitable appointment. Twenty two patients could not 
be traced because they had moved during that year. Patients 
from Clydebank (Post code 81) were in addition given the 
intensive personalised health education.
The social class distribution was as follow:
Social class I and II 12?, social class III non-manual 
11?, social class III manual 24?, social class IV , V 11?, 
retired 16? , unemployed 11? and housewives 15?.
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AGE AND SMOKING HABIT FOR ALL CASES.
In Table 1 most (50$) of the patients are in the age
group 55-65 years, and only 13/5 are less than 45 years.
Elderly patients of more than 65 years form 9$ out of the
total patients. 55$ were current smokers at the time of the
study, ex-smokers 3055 and non-smokers 15$. It is evident that
the majority (8555) of patients have smoked or were current
smokers at the time of the study. Smokers comprised different
percentages in each age group,being lower at the extremes,
50% in age group less than 45, 61$ in age group 45-55, 56% in
age group 55-65 years and 3755 of the elderly above 65 years. 
%■
Statistically (X ) there is no significant relationship 
between age and smoking habit.
SEX AND SMOKING HABIT FOR ALL CASES.
Table 2 shows the distribution of smokers by sex, 57$ of 
males and 47$ of females are current smokers. There is no 
significant relationship between smoking habit and sex (X 
=5.51; 2 df; N.S). However combining "smokers" and "ex­
smokers" to give one group resulted in a significant 
relationship and males are less likely to have never smoked. 
(X =4.5; 1 df; p<0.05). Ex-smokers are equally frequent in 
both sexes.
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AGE WHEN SMOKING BEGAN AND NUMER OF CIGARETTES SMOKED
PER DAY FOR SMOKERS.
In Table 3a about half of the male patients (48$) 
started smoking between age of 1 5 to 25 years, 31$ started 
smoking before age 15 years and 22$ of the patients started 
at age more than 25 years. There is a significant relation­
ship between age when smoking began and number of cigarette 
smoked per day at admission (p<0.05). Table 3b is for female 
smokers, collapsed to a 2X2 table due to small numbers. The 
relationship was also significant (p<0.05) as in males. This 
means that in each sex, the younger the age when smoking 
began the higher the number of cigarettes smoked per day 
later in life.
SMOKING HABIT AND CARBOXYHAEMOGLOBIN LEVEL FOR ALL CASES
In Table 4, there was no significant relationship 
between COHb and smoking habit at entry in the study. The 
mean COHb for smokers was 10.3 ppm and 10.2 ppm for non- 
smokers. This result was not expected when the study was 
initially planned which may be due to inaccuracy and 
instability of the spectrophotometric method used (20,33a). 
Inhaled oxygen during the emergency phase could be another 
factor.
Table 5 shows the relationship between the number of 
cigarettes smoked per day and COHb in smokers. Mild smokers 
(less than 15 cigarettes per day) comprised 40$, 32$ smoked 
between 15-25 cigarettes per day and 28$ smoked more than 25 
cigarettes per day. Mean COHb for mild smokers was 9.6 ppm,
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moderate 10.6 ppm and 10.5 ppm for heavy smokers. There was 
no significant relationship between the number of cigarettes 
smoked per day and COHb level.
THE PRESENCE OF ANGINA AND COHb LEVEL FOR ALL CASES.
From Table 6, 74$ of patients with angina (n=83), had 
COHb over 10. The mean COHb for patients with and patients 
without angina is 10.2 ppm, 10.5 ppm respectivley. There is 
no significant relationship between angina and COHb level 
(Chi-square= 3.7; 4df).
Table 7 shows the distribution of COHb levels in 
patients with (48$) or without (52$) myocardial infarction. 
70$ of patients with myocardial infarction have a COHb over 
10 ppm. 85$ of patients without MI have a COHb level over 
10 ppm. The table shows a significant inverse relationship 
between myocardial infarction and COHb with a tendency for 
patients with MI to have a within normal COHb. This 
relationship may not be more than a chance finding.
STRESS AND SMOKING HABIT IN ALL CASES.
Due to small frequencies in each group, the two group 
’no stress’ and 'mild stress’ were combined to form one 
group, and the other consisted of ’moderate’ and ’severe* 
stress. Table 8 shows that 23$ of the smokers, 13$ of ex­
smokers and 9$ of non-smokers had no stress or mild stress as 
estimated from the questionnaire. It is evident also from
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table 8 that 77$ of smokers, 88$ of ex-smokers and 91$ of
z
non-smokers suffered from moderate or severe stress. X shows 
no significant relationship between smoking habit and stress 
(X*=4.6, df=2).
MYOCARDIAL INFARCTION AND LIFE EVENTS IN THE YEAR BEFORE 
HOSPITAL ADMISSION.
In Table 9, more than half of the patients (56$) did not
suffer from any of the listed life events (job loss, family
member death, financial problems or residence change). Few
patients ( 1 W  suffered from more than one event. Death of
a family member forms the most frequent life event (11$),
followed by financial problems (9$). The percentage who had
had more than one life event and not had a myocardial
infarction was 19$ compared to 8$ had MI. There is no
significant relationship between the presence or absence of
2.life events and myocardial infarction (X =0.73; df=1).
Study of the presence of life events and smoking habit shows 
also no significant relationship between the two variables.
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ANALYSIS OF OTHER FACTORS INCLUDED IN THE STUDY FOR ALL CASES.
It was evident from a study of respiratory symptoms 
among patients that 6 8$ of those recording sputum were 
smokers compared to only 48% of those without sputum. 
Statistically there is no significant relationship between 
smoking habit and the presence of sputum for as much as three 
months in the winter each year. However recurrence of sputum 
lasting for 3 weeks or over for more than one period in the 
last three years before admission was much more common in 
smokers (46$) than in non-smokers (11$) (p< 0.01).
Further analysis of the other factors included in this
study showed no significant relationship between presence or
\
absence of acute myocardial infarction with any of the 
following variables: age, angina, indoors or outdoors work, 
tea , coffee or alcohol consumption, haemoglobin, blood sugar 
or blood triglycerides. The relationship between the presence 
of acute myocardial infarction and having a high cardiac 
enzymes (SGOT, CK, LDH) is highly significant (p<0.001) , 
reflecting the criteria used for the diagnosis of myocardial 
infarction. The relationship between the presence of acute 
myocardial infarction and having chest pain later on is 
significant (p<0.05). It is not surprising that patients 
suffering from MI are more likely to suffer from chest pain 
later on. The relationship between smoking habit and
respiratory function tests (FVC or FEV1 ) was a^so no  ^
significant.
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*1.2 COMPARISON BETWEEN BREATH CARBON MONOXIDE MID BLOOD
CARBOXYHAEMOGLOBIN
COMPARISON BETWEEN BLOOD COHb AND BREATH CO.
Table 10 and Fig 1 show a comparison between breath 
carbon monoxide in a randon subsample of *12 patients measured 
by GMI CO-monitor in ppm and blood COHb measured by C0- 
oxiraeter-2 82. In each case the mean of 5 readings was 
calculated. The mean for blood COHb is 7.98 ppm and for 
breath CO is 5.96 ppm. For comparison the differences between 
the value obtained by the two methods in each patient have 
calculated. The overall mean of the differences (d) is 2.02 
,variance 10.7 and SD is* 3.3. Statistically (paired t-test 
for comparison between two means) CO is apparently present in 
higher concentration in blood than in breath CO (p<0.001) as 
might be expected. A 95 % confidence limit for d is 1.2 and 
2.9. Figure 1 shows the differences between both methods 
used for each patient and it is evident that although the 
mean difference is small (2.02), some of the individual 
differences are quite large which may indicate poor agreement 
between the two methods.
Figures 2, 3 and table 10 show at different CO means for 
the *12 patients the relationship between blood COHb and its 
coefficient of variation (CV) and breath CO and its 
coefficient of variation. There is an inverted (J) shaped 
curve; this implies that the variability is proportionately 
higher in smaller CO concentrations.
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4*1 CARBON MONOXIDE MEASUREMENTS IH BLOOD AND EXPIRED AIR: 
CHANGES OVER TIME AND ACCURACY
Table 11 shows the reliability of blood COHb 
measurements analysed immediately after the sample was taken 
and also 24 hours later for 8 blood samples. Each sample was 
analysed five times. Reliability for the measurements for the 
whole group analysed immediately is 0.99 and for each 
measurement in this group is 0.99. Reliability of COHb 
analysed 24 hours after the samples were taken is slightly 
lower, 0.98 for the group and 0.94 for each single 
measurement. Comparison of the difference between the 2 
methods for the 8 patients shows that the overall mean 
difference is 0.05, SD ±  0.55 and variance is 0.3 .
Table 12 shows mean and coefficient of variation of COHb 
measurements for a further group of 21 patients. The 
samples were measured by CO-oximeter 282. Each sample was 
measured five times. The relationship between the mean COHb 
and coefficient of variation also again is an inverted J 
shaped curve which means that the variability is 
proportionately higher in smaller COHb concentration. By 
using the analysis of variance reliability test, reliability 
of each measurement is = 0.94. This high reliability value 
indicates that the average intercorrelation between ratings 
given by pairs of judges (the two methods) is high (167).
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Table 13 shows the effect of time and storage on further 
21 venous blood samples analysed immediately after the sample 
was taken and 24 hours after by C0-oximeter-282. The mean for 
the first half (immediate analysis) is 4.4$ saturation. The 
mean for the second half is higher (5.6$ saturation). The 
mean of differences between the two methods for each patient 
is = 1.2, SD ±2.0 and variance 4.0 . There is no evidence 
however of significant increase in COHb concentration with 
storage. (Paired t test = 1.6; df=20; N.S).
Table 14 compares two methods for COHb measurement ; 
gas-chromotography and spectrophotometry by C0-oximeter-282 
in 31 venous blood samples. The mean COHb measured by 
spectrophotometry methods is 6.1 ppm, SD ± 6.6 while the mean 
COHb measured by gas-chromatography is 5.6 ppm, SD ± 2.4. 
The mean of differences between the two methods for each 
patient is (d) =0.55, SD ±7.2 and variance is 52.1. A 95 % 
confidence limit for the mean of differences is -1.7 and 2.8 
which means that there is no evidence of bias between the two 
methods but many of the individual differences are very large 
(Fig. 4). It is evident that there are large disagreement 
between the measurements, but without a reference standard it 
cannot be deduced which is "better".
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RAPID CHANGES IN CO MEASUREMENTS IN BLOOD AND BREATH.
Table 15 shows the change in blood COHb level in 6 
random subjects measured every 30 minutes. 3 samples were 
taken from each subject 30 minutes apart and analysed by CO- 
oximeter 2 82. Reliability of the whole group is (rk) = 0.95 
and reliability of each single measurement (r 1) = 0.87.
In a second experiment the decay curve of breath CO was 
done in a group of 6 different subjects after smoking a 
single cigarette. The results are shown in Table 16 (raw 
values) and Figure 5 (values after logarithmic 
transformation). Breath CO was measured every 15 minutes by 
GMI portable CO monitor. The fitted regression lines (Fig.5) 
for values after smoking show a gradual decrease in breath CO 
over time. The "outlier” in Fig. 5 was excluded in the 
calculation of CO half life. The mean slope for breath CO 
regression is - 0.00*18 and the mean intercept is 3.7. 
Calculation of the half life for each subject showed that it 
was on average 182 minutes with SD + 15.3.
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4.4 BREATH CARBON MONOXIDE STUDY FOR GLASGOW HIGH SCHOOL
PUPILS AND RUCHILL HOSPITAL EMLOYEES
Age and smoking habit
Out of 105 total pupils included in the study 83$ were 
in age 15-1 8 years, 17$ were less than 15 years. Two-thirds 
of the pupils examined were non-smokers and nearly one third 
admitted to being smokers (34$). Out of the smokers, 72$ 
smoke only from 1 to 4 cigarettes per day, the other (28$) of 
smokers use between 5 and 10 cigarettes per day. In the 
sample males (61$) outnumbered females (39$).
Family smoking habit:
Fifty six per cent of the pupils’ families had no 
members who were a smoker. In 16$ of the families only the 
fathers were smokers and in 13$ of the families one or other 
parent was a smoker. In the remaining 15$ , either the 
brother or sister were the only smokers in the family.
SMOKING HABIT AND BREATH CO OF THE HIGH SCHOOL PUPILS
Table 17 shows that most of the pupils (85$) have a 
breath CO within normal range and 15$ have a high level (>10 
ppm). 25$ of the smokers (n=36 ) have a high breath CO.
Breath CO measurements were divided into two groups less 
than 10 ppm and more than 10 ppm(l6l), the sensitivity of 
breath carbon monoxide is 0.25, and specificity is 0.9. The
predictive value of a positive test is 56$ and for a negative 
test is 70$. Chi-square test shows a significant relationship 
between smoking habit and breath CO with a higher level of CO
t %in smokers. (X =4.04; 1 degree of freedom; p<0.05).
Table 1 8 shows the time between last smoking and breath 
carbon monoxide test for Glasgow High School pupils who smoke 
(n=36). It is evident that 81$ out of the smokers had not 
smoked within 12 hours of the test. 24$ (7/29) of the smokers 
had a high breath CO (10ppm and over) and they had not smoked 
for more than 12 hours. 29$ (2/7) of smokers had a high 
breath CO and smoked within 12 hours of breath test.
CROSS-REACTIVITY WITH BREATH HYDROGEN.
Table 19 shows no significant relationship between 
smoking and breath hydrogen among pupils (X3-* =0.06; 1df).
Breath hydrogen in the pupils was highly correlated with 
breath CO (r= 0.75) and it was highly significant (p<0.001). 
In hospital employees breath hydrogen was poorly correlated 
with breath CO (r = 0.1 9).
SMOKING HABITS AND BREATH CO FOR RUCHILL HOSPITAL EMPLOYEES 
Age characteristics: Out of the total of 143 employees 
seen in the study 42$ were aged between 20-30 years, 19$ were 
between 30 and 40 and 16$ were between 40 and 50 years. In 
the sample females (67$) outnumbered males. There was little 
sex difference as regards smoking. 38$ of males were smokers 
compared to 42$ of females.
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Smoking habit: Most of the employees (59$) were non- 
smokers and 41$ were smokers. 4$ of the employees were a pipe 
smokers. Only 15$ of smokers smoked less than 5 cigarettes 
per day, 16$ smoked 5-15 cigarettes, 47$ of the smokers 
smoked between 15-25 cigarettes and 19$ smoked more than 25 
cigarettes per day.
Table 20 shows the relationship between breath CO and 
smoking habit for Ruchill Hospital Employees. 74$ of smokers 
have more than 10 ppm CO, compared to 11$ of non-smokers. 
The sensitivity using this cut-off point is 0.74, and 
specificity 0.89. The predictive value of the positive test 
is 83 $ and for the negative test is also 83 $. There is a 
significant relationship between smoking habit and breath CO, 
with much higher levels in smokers in this population (X2 
=60.17; 1 df; p<0.001).
Table 21 shows time between the last cigarette smoked 
and breath CO for Ruchill Hospital employees. Sixty four per 
cent of the smokers finished their last cigarette less than 
one hour before the test, 72$ of them having a high breath 
CO (more than 10ppm). Comparison between an interval of less 
than one hour and more than one hour shows that there is a 
significant relationship between breath CO and time since 
•last cigarette the longer the time the lower the CO level 
(Chi-square= 16.7; 2df; p<0.001).
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Table 22 shows that breath hi^drogen was similar in 
smokers and non-smokers, the exact probability test being not 
significant at the 5% level (P=0.09). Breath hydrogen was 
poorly correlated with breath CO in the hospital employees 
(r=0.19, p<0.001). This result, which is in contrast to that 
found in school children, may be due to the differences in 
their smoking habit.
4.5 ACCURACY OF BREATH CO: SENSITIVITY AMD SPECIFICITY
Table 23 shows comparison between sensitivity and 
specificity for breath CO at different CO levels for Glasgow 
High School pupils and Ruchill Hospital employees. It is 
evident from these tables that as expected, increasing the 
cut-off level decreases sensitivity and specificity 
correspondingly increases. The same finding is found in the 
results from the pupils.
Figure 6 shows the Receiver Operating Characteristics 
Curve for breath CO in both Ruchill Hospital employees and 
Glasgow High School pupils. In this curve the X axis 
represents the False positive percentage which is equal to 
100- (specificity X 100). The Y axis represent the true 
positive percentage. The curve for the hospital employees is 
higher than that for the school pupils. Assuming what they 
said about their smoking habit was true, the minimum error 
rate for breath CO occurs at cut off points between 8 and 12 
ppm for the hospital employees , and at 7 ppm for the High 
School pupils.
4.6 GENERAL DESCRIPTION OF THE FOLLOWED-PP GROUPS AND 
COMPARISON BETWEEN THEM 
The psychological profile for the health education 
patients was assessed by the health visitor involved in the 
health education. The distribution of health and 
psychological problems was as follow:- 39$ had normal 
psychlogical profile defined as within 1 S.D of the published 
means (141a). Out of the rest who had high scores for at 
least one factor, 6 9$ of the patients had free floating 
anxiety, 50$ had phobic anxiety, 18$ had obsessive compulsive 
traits, 64$ had somatic symptoms, 11$ had depressive tendency 
and "hysterical trait" was noted in 10$ of males and 23$ of 
females.
4.6.1 CHANGES OF SMOKING HABITS FOR BOTH GROUPS OF PATIENTS
Table 24 shows that 33$ of patients in the non­
intervention group were aged 45-55 and 54$ were older than 55 
years. Males comprised 75$ and females 25$ of the non-inter­
vention cases. Table 25 shows that in the health education 
group 25$ of patients were younger than 45 and 54$ were older 
than 55 years. 67$ were males and 33$ were females. Fisher's 
exact probability test was used for comparison of the 
frequency of observations in a fourfold table when the 
numbers are too small for a Chi-square test. Within each 
group, the age distribution of each sex was similar. Further 
comparison of the age distribution between the two groups was 
not significant (Chi-square = 2.54; 2df) and for sex 
distribution was also not significant (Chi-square =0.55; 
1df).
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AGE DISTRIBUTION AND ACUTE MYOCARDIAL INFARCTION IN BOTH GROUPS 
4355 of the patients in the non intervention group and 
67% I n  the health education group suffered from acute MI. In 
each group and between both groups there is no significant 
relationship between age and presence of acute MI.
AGE WHEN SMOKING BEGAN AND NUMBER OF CIGARETTES SMOKED PER DAY 
AT THE TIME OF STUDY
In the non-intervention group, 37$ began smoking under 
the age of 15. 46$ began smoking between 15 and 25 years. In
comparison 15$ of the health education group began smoking 
under the age of 15, and 75$ began smoking aged between 15 
and 25. In each group the older the age of starting smoking 
the lower the number of cigarettes smoked now per day 
(p<0.001). Comparison of the age when smoking began in both 
groups shows no significant difference CX* =4.6; 4 df).
SMOKING HABIT OF THE PATIENT'S FAMILIES
Study of the smoking habit of the patient’s families 
showed that in the non-intervention group, 71$ of the smokers 
had at least one family member who was a smoker, 42$ of them 
had more than one. In comparison with the health education 
group 73$ of the smokers had at least one family-member who 
smoke, 64$ of them had more than one smoker. The difference 
was not significant.
SMOKING HABIT AND SOCIAL CLASS FOR BOTH GROUPS
In Table 26, the social class distribution of the non­
intervention group was as follows:- patients in social
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classes I and II 15$, III NM 7$, III M 35$ and in classes 
IV,V 14$. 29$ were unemployed or retired (X2=0.25; 1 df; 
N.S). In Table 27, the health education group social classes 
was distributed as follows:- I, II and III NM 25$ and 30$ in 
social classes III M, IV and V , unemployed and retired 
patients were 45$. Fisher’s exact probability test was used 
for collapsed table (social class I,II,IINM and the others) 
due to small expected frequencies (P=0.31; N.S). As expected 
most of the patients were in low social classes. In each 
group there is no significant relationship between social 
class and smoking habit. The distribution was similar in both 
groups.
SOCIAL CLASS AMD RESIDENCE AREA FOR MOST OF THE PATIENTS LIFE
Comparison between the two groups as regards the area of 
residence shows that in each group most of the patients were 
living in cities for most of their life. There is no 
significant difference between the two groups as regards 
their social class distribution and their area of residence 
for most of their lives.
RELATIONSHIP BETWEEN PATIENTS KN0V7LEDGE ABOUT CORONARY HEART 
DISEASE RISK FACTORS AND SOCIAL CLASS.
Awareness about CHD risk factors was assessed by having 
the subject identify the correct answers from a list of 
possible factors (see Appendix A1). The maximum possible 
score was 16. The mean score and SD for each social class 
group is shown in tables 28 and 29. Oneway AMOVA for non­
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intervention group F = 2.08; df= 2,60. F was 0.56; df= 2,21 
for the health education group; both were non-significant. In 
each group there was no significant relationship between 
social classes (I,II, IIINM) and the others and knowledge 
score.
MYOCARDIAL INFARCTION AND PATIENT'S KNOWLEDGE ABOUT CORONARY 
HEART DISEASE PROBLEM
In non-intervention group, 43? (n=26) had acute MI and 
73$ of them had a satisfactory amount of knowledge. In the 
health education group, 67? (n=l6) had a myocardial 
infarction 76 ? of them had good knowledge about CHD problem. 
In each group there is no significant relationship between 
patient’s knowledge about CHD and the presence or absence of 
myocardial infarction. There is no significant relationship 
also between both groups as regards patient’s knowledge about 
CHD problem and presence or absence of myocardial infarction.
LIFE EVENTS IN THE YEAR BEFORE HOSPITAL ADMISSION
Table 30 shows that in non-intervention group, 29? of 
patients (n= 18) suffered from at least one stressful life 
event in the year before hospital admission. Patients who had 
more than one event comprised about 15$. Chi-square =0.0; 1df 
between non and presence of any life events. Table 31 shows 
that in health education group 37? patients reported at least 
one stressful life event (Chi-square =0.0 8; 1 df; N.S). There 
is no significant relationship between those have and those 
not reported life events in the nast and the presence or 
absence of myocardial infarction.
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STRESS AND MYOCARDIAL INFARCTION
From Table 32, in the non-intervention group, 6 8?
suffered from moderate or severe stress, and 32? had mild or
no stress (Chi-square =0.48; 1df ; N.S). In the health
education group as evident from Table 33, 88? suffered from
moderate or severe stress and 12? had mild or no stress
(Fisher's exact probability test = 0.22; N.S). There is no
significance difference in each group between stress and the
presence or absence of MI. There is no significant
relationship also between the two groups as regards the
x
presence or absence of stress (X =3.26; 1df).
COMPARISON BETWEEN LABORATORY FINDINGS IN BOTH GROUPS
Study of laboratory findings for both groups in Table 34 
showed that there is no significant difference between the 
two groups as regards the presence of MI, presence of high 
triglycerides, cholesterol, Haemoglobin, blood sugar, high 
cardiac enzymes (CK > 160 U/L, LD enzymes >230 U/L) between 
both groups. In each group, high cardiac enzymes were 
significantly related to the presence of myocardial 
infarction as expected.
CARBOXHAEMOGLOBIN AND DAILY CONSUMPTION OF CIGARETTES
Tables 35 and 3 6 show that at entry to the study 44? of 
the non-intervention group, smoked less than 15 cigarettes 
per day and 30? smoked between 15-25 cigarettes per day. 90? 
have high blood COHb over 2? saturation. The mean COHb was 
3.0? saturation for patients smoking less than 15 cigarettes 
per day, 3.5? for those smoking between 15 to 25 and 3.4? for
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those smoking over 25 cigarettes per day. There is no 
significant relationship between COHb and the number of 
cigarettes smoked per day in the non-intervention group. 
(Oneway ANOVA done on raw values gives F=0.98; df= 2,60; 
P=NS). In the health education group 8355 have high blood COHb 
(over 2? saturation). The mean COHb for the group smoking 
less than 15 cigarettes per day is 2.5$ saturation and 2.9$ 
for those smoking more than 25? cigarettes per day. There is 
no significant relationship between COHb and the number of 
cigarettes smoked per day in the health education group. 
Oneway ANOVA done on raw values gives F=0.16, df=1,22; N.S.
FOLLOW-UP COHb LEVEL AND SMOKING HABIT
In Tables 37 and 38 patients having a high COHb (more 
than 2%) comprised 51? of the non-intervention and 46? of the 
health education group. In the non-intervention group, 41? 
are non-smokers, most of them (89?) having a normal COHb. 
The mean COHb for patients who had given up smoking, those 
smoking less than 15 cigarettes per day, 15-25 per day and 
more than 25 per day were 1.2, 2.2, 2.6 and 1.8 respectively. 
In the health education group 63? were non-smokers and most 
of them (73?) had a normal COHb. The mean COHb for patients 
who had given up smoking, those smoking <15 and 15-25 per day 
were 1.5, 2.2 and 2.4? saturation respectively. Oneway ANOVA 
was used for comparison between the means of COHb for more 
than 2 groups at the same time. Oneway ANOVA is significant 
in the non-intervention group (F=13.8; df= 3,59; p<0.001). In 
the health education group this relation is not significant 
(F=2.86; df= 2,21). Comparison between the groups as regards
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COHb distribution shows no significant difference in follow-
up COHb (normal, and high COHb levels) between the two groups 
, x '
(X = 0,17;1 df; N.S). The proportion of smokers with COHb of 
over 255 who stopped smoking was 11.5$ (3/26) in the non­
intervention group and 37$ (4/15) in the health education 
group. The difference was not significant (X =1.55; 1df;N.S).
COMPARISON BETWEEN BLOOD CARBOXYHAEMOGLOBIN MEASUREMENTS AT 
ENTRY AND FOLLOW-UP.
In Tables 39 and 40 the difference between entry COHb 
and follow up COHb were calculated. The mean of differences 
in the non-intervention group is 0.83$ saturation and - 1.16$ 
saturation in the health education group. There is no 
significant difference between COHb level in the non­
intervention group at entry and follow-up (Paired t test = 
1.85; 62 df;N.S). In the health education group there is also 
no significant difference between the COHb level at entry and 
follow-up (Paired t test =0.93; 23 df;N.S).
CARBOXYHAEMOGLOBIN AND TYPE OF HEATING IN THE HOUSE
In Tables 41 and 42, the type of heating in the house 
has been studied because persons may be exposed to other 
sources of CO other than smoking eg. open fire or gas in 
absence of sufficient ventilation can be a source of CO. It 
was found that 3 6 $ of the followed-up patients used 
electricity for heating and, 25$ use central heating 14$ use 
mixed types (more than one type). The mean percentage 
saturation of COHb for those use electricity as a source of 
heating is 0.05 $, 4.1 $ for those use open fire or gas, 2 $
for those using central heating and 1.0% for those using 
mixed types. About twenty five percent use gas or open fire 
heating. There is no significant relationship between the 
type of house heating and blood COHb (Oneway ANOVA =1.02; df=
2,81; N.S).
COMPARISON BETWEEN INITIAL NUMBER OF CIGARETTES SMOKED PER DAY 
FOR BOTH GROUPS.
Tables 43 and 44 show the differences between the number 
of cigarettes smoked per day at entry minus the number of 
cigarettes smoked at follow up. The mean of the differences 
in the non-intervention group is -1.03 and SD ±7.3 and in 
health education group is 8.2, SD ±9.1. There is no 
significant decrease in the number of cigarettes smoked in 
the non-intervention group (Paired t test = 1.12; df=62; N.S) 
compared to the highly significant decrease in the health 
education group (Paired t test=4.4; df=23; p<0.001).
CHANGES IN SMOKING HABIT BETWEEN INITIAL AND FOLLOW-UP EXAMINATIONS 
The follow up self-reported smoking habit in Table 45 
shows that in the non-intervention group, 41? of the patients 
who were originally smokers (n=63) had stopped smoking after 
the initial examination. In the health education group 63? 
had stopped smoking. All patients in non-intervention and 
health education group were originally smokers. Patients 
restarting smoking having originally been recorded as non- 
smokers were not assessed. Comparison of the changes in 
smoking habit of the two groups at the follow-up examination 
shows no significant difference between both groups (Chi-
square=3.l4; 1df; N.S).
Comparison between smoking habit of the two groups at
entry and follow up by use of breath CO monitor at a cut off
point of 9 ppm (Table 45a) shows that 8$ (5/63) of the
patients in the non-intervention group had misreported their
smoking habit in comparison to 17$ (4/24)in the health
education group. Statistical comparison between the two
Zgroups defined this way was also not significant (X =1.17; 
1 df; N.S).
SMOKING HABIT AND MYOCARDIAL INFARCTION
In the non-intervention group 38$ of MI patients were 
smokers and in the health education group 60$ of MI patients 
in this group were smokers.
FOLLOW-UP BREATH CARBON MONOXIDE AND SMOKING HABIT
From Tables 46 and 47 it was evident that at follow-up,
59$ of non-intervention group were smokers, 78$ of smokers 
had a high breath CO more than 10 ppm. Out of the ex-smokers 
19$ had a high breath CO (X =21.5; 2df; p<0.001). Table 47 
shows that in the health education group 3 8$ were smokers. 
Out of the smokers 89$ (n=8) had a high breath carbon 
monoxide. 27$ of ex-smokers (n=4) had a high breath CO (X 
= 8.7; 1 df; p<0.01 for collapsed table <10 and 10 ppm and 
more). In each group there is a significant relationship 
between smoking habit and breath CO with a higher level of 
CO among smokers than non-smokers as expected.
COMPARISON BETWEEN FOLLOW UP BLOOD COHb AND BREATH CO.
The opprtunity was taken to compare blood COHb and 
breath CO in the combined groups, (Table 48) as done earlier 
(Table 10). The mean of the differences between blood COHb 
minus breath CO was - 7.7 (SD* 7.1) and the paired t test 
=10.1; df=86; p<0.001. This highly significant difference 
between the two variables is seen in both the non­
intervention group (Paired t test= -9.8; df=62; p<0.001) as 
well as in the health education group (Paired t test = -3.8; 
df=23; p<0.001).
4.6.2 RESULTS OF FURTHER ANALYSIS OF OTHER FACTORS INCLUDED IN 
THE STUDY 
Respiratory symptoms
In the non-intervention group, 52$ had cough, 49$ 
suffered from morning sputum , all of them were smokers. 51$ 
suffered from chest wheezes, 74$ suffered from sputum for 3 
months and 50$ suffered from sputum for 3 weeks more than 
once in the last 3 years.
In health education group, 29$ had cough, 51$ suffered 
from morning sputum. Thirtythree per cent suffered fron chest 
wheezes, 6 9$ suffered from sputum for three months and 44$ 
suffered from phlegm for three weeks more than once in the 
last three years. There is no significant difference between 
both groups as regards the previously mentioned variables. 
There is no significant relationship between either FEV0L1 or 
FVC and the number of cigarettes smoked per day in each 
groups.
Electrocardiogram findings and myocardial infarction.
In both groups the incidence of T-inversion, presence of 
arrythmia, bundle branch block and left ventricular 
hypertrophy were similar. The realtionship between ST 
elevation or depression and MI is significant in the non- 
intervention group (p<0.001). The presence of Q wave and 
myocardial infarction also is significant in each group (p 
<0.001) indicating that there is a relationship between Q 
wave, ST changes and the diagnosis of acute myocardial 
infarction.
Mvocardial-infarction and recurrence of chest pain
In non-intervention group at follow-up patients 
reporting chest pain (64$) are nearly double those without 
chest pain (36$). In the health education group, the 
figures are 52$ with and 48$ without chest pain.
In the non-intervention group there is a significant 
relationship (p<0.05) which means that in this group patients 
initially suffering from acute myocardial infarction were 
more liable to suffer from chest pain later on. The results 
are not significant in the health education group.
Comparison between some other characteristics in the two groups
Table 49 shows no significant difference between the two 
groups as regards age, sex, weight, height,consumption of 
alcohol tea or coffee, systolic BP, diastolic BP and activity 
in work. Finally there was no significant relationship 
between carboxyhaemoglobin and intermittent claudication in
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each group.
4.6.3 CHARACTERISTICS OF THE GROUP GIVING UP SMOKING
Study of some of the characteristics of patients who
gave up smoking and those who continue to smoke showed that
there was no significant difference in the age distribution
of those gave up smoking between both groups (X =0.95; 2df).
There was also no significant relationship with sex (non-
%
intervention group X =1.13; 1 df; and health education group 
X2 =0.53; 1df; N.S). Of those who gave up smoking, 28$ of the 
non-intervention group were in upper social classes 
(I,II,IIINM) compared to 44$ in the health education group.
In each group there was no significant difference
between those who gave up smoking and those who continued to
smoke as regards either the presence or absence of chest
wheezes, angina, and amount of knowledge about CHD (in non­
-­intervention group X =0.24; 2df and in health education group
X2 =1.4; 2df )
Comparison between inhalation behaviour of both groups
at entry and at follow up showed that there was no
2.
significant difference between the two groups (X 1.14; 1df;
%
at entry and X =1.32 at follow up.)
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DISCUSSION
CHAPTER FIVE :DISCUSSION
5.1 CHARACTERISTICS OF THE STUDIED POPULATION AHD COEOKARY
HEART DISEASE RISK FACTORS
It is well known that coronary heart disease (CHD) is a 
major public health problem in terms of the number of 
patients who need treatment and in terras of the number of 
deaths. The adverse effect of cigarette smoking on non-fatal 
myocardial infarction (MI) is well recognised.
For CHD as for many other diseases, diagnosis, together 
with secondary and tertiary prevention, is not sufficient, 
and primary prevention is essential. For such an approach, 
whether at individual or community level, health education is 
a necessary part of health promotion.
It is recognised that although the public knows about 
CHD, few individuals are ready to apply what they know 
because they may think that the scientific evidence is still 
controversial. Alternatively, they may think that there are 
more important things to worry about than one’s own health in 
the distant future, or they may not care very much about 
longevity. Epidemiological studies have indicated that the 
risk of CHD increases with cigarette consumption. Two major 
constituents of tobacco smoke, nicotine and carbon monoxide 
(CO), are of prime importance in exacerbating cardiovascular 
events. A rapid reduction in the risk of myocardial 
infarction has been reported for ex-smokers (^,^9). The
stress of hospital admission with acute chest pain gives an 
invaluable opportunity for secondary prevention, for example 
by reducing cigarette smoking which even at this stage can 
reduce the risk of future MI (1^ 2).
5.1.1 HEALTH EDUCATION AND SMOKING HABIT
This study compared the effectiveness of two methods of 
health education in preventing smoking. The first method was 
the normal care and advice given to all patients admitted to 
the coronary care unit (CCU) and the second was intensive 
health education which was given to CCU patients who lived in 
Clydebank. The second method was for a health visitor to give 
tailored health advice, particularly about smoking, to 
patients in hospital, with follow-up visits in their home 
after discharge. Ereath and blood COHb were used to measure 
the success of anti-smoking health education in each group of 
patients.
Sometimes skilled physicians examining a patient may 
disagree regarding the findings. Such disagreements reflect 
the imperfect reliability of the clinical methods used. 
Today, consumers, insurers as well as physicians and their 
students must become aware of the imperfect reliability of 
the methods and data of clinical medicine. Reflecting this 
concern, this study was done to validate two of the methods 
commonly used for measuring carbon monoxide. The first method 
measured blood carboxyhaemoglobin (COHb) and the second 
measured breath carbon monoxide (CO). It also included the
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study of the relationship between breath CO and blood COHb. 
The repeatability and validity of each method was assessed. 
The results are discussed later.
Out of the total cases (n=212), 116 were smokers (55$). 
95$ confidence intervals are 52.8$ to 66.8$, and this group 
was followed-up one year after hospital admission. The 
response rate 81$ (94 cases) for the assessment of the two 
health education interventions was good. This could be 
explained by the use of a second letter and telephone call 
for non-responders. Successful follow-up of 80 patients in 
group I (non-intervention) and 25 in group II (health 
education group) and an expectation of a 30$ reduction in 
smokers in group I and 60$ in group II was calculated to give 
a 80$ chance of detecting a significant difference (p<0.05) 
(47). However due to difficulty reasons in ensuring complete 
follow up of all patients, the study ended with a power of 
about 70$ (47).
Mortality was 8$ (7 cases and 95$ confidence interval 
3.0$ to 14.7$) amongst the followed-up smokers (n=1l6). 
Survivors (n=87) were contacted successfully, 24 cases from 
the Clydebank area and 63 cases from the catchment area of 
the Western Infirmary. Smoking habit, social, medical, 
laboratory findings and other factors were compared in both 
groups. As regards reliability of self reported smoking 
behaviour,it was generally felt that confidential smoking
reliability was improved by the use of an objective test 
(1i|1)
About 55# of the total patients at the time of admission 
were current smokers, 50# of the total were in the age group 
55-65 (Table 1) and 28# were in age group 45-55 years. The 
higher percentages of smokers among the older age groups 
could be explained by the fact that older cohorts continued 
to smoke more than younger ones who did not start smoking or 
had given up smoking earlier. However out of the total 
number, 85# we re either smokers or ex-smokers (95# confidence 
interval 79.7# and 89.0#). This percentage is much higher 
than that reported in Scotland (136). In Scotland 38# of men 
and 33# of women were smokers in 1982 and it is reported from 
Glasgow that 45# of men and 43# of women were smokers (75). 
There is no relationship between age and smoking habit. The 
higher percentage of smokers in this study of patients with 
chest pain and myocardial infarction agrees with published 
results (3»4,51,64,107,1 51).
As regards sex and smoking habit more males (57#) 
included in the study were current smokers (Table 2) in 
comparison to females (47#). Combining” Smokers " and "Ex- 
smokers” in one group gives a significant relationship and 
males are less likely to have never smoked (X2 =5.4 ; idf; 
p<0.05). This finding is in agreement with published 
literature (136). The percentage in both sexes was higher 
than that in the general population (8). However Tables 3a 
and 3b show a significant relationship (p<0.05) between the
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age at which smoking began and the number of cigarettes 
‘smoked per-day at the time of hospital admission in each sex.
Out of the male smokers, 31$ began smoking under the age 
of 15 years and *18$ began between 15-25 years, which agrees 
with previous results (133). Out of the female smokers 36$ 
began smoking under the age of 1 5 years and 64$ began after 
age 15 which agrees with previous results (133). Hovzever 
there is a significant relationship between sex and the age 
of begining to smoke. This young age of starting smoking can 
be explained by the effect of peer group pressure. It may 
also be due to the presence of a smoker in the family, or due 
to lack of interest in school, or teachers who smoke and 
pressure from smoking friends (136). The psychological 
reinforcements of nicotine could be another factor, (102) or 
smoking may represent both a symbol for adult status and 
rebellion against adult authority (70).
5.1.2 RELATIONSHIP BETWEEN SMOKING AND CARBON MONOXIDE
Carbon monoxide can be produced both physiologically and 
pathologically, however cigarette smoking is a common and an 
important source of CO (132,1 57). The presence of CO in the 
blood of non-smokers can sometimes be explained by 
significant endogenous CO formation, particularly in 
haemolytic conditions. It is suggested also that CO is formed 
by the clearing of the porphyrin ring in choleglobin 
formation. Elimination of CO in expired air has been shown to 
be a physiological phenomenon. The strong affinity between 
CO and haemoglobin (Hb) plays a role in the excretion of this
product. Analysis of expired air CO as an indirect measure of 
COHb, which avoids the inconvenience of taking a blood 
sample, is now frequently used in population studies. The 
close correlation of breath CO with blood COHb was 
demonstrated in many studies done in Britain and the USA. It 
has been shown that breath CO is also associated with 
cigarette smoking as well as exposure to atmospheric 
pollution with CO. Therefore COHb levels can be estimated 
reliably by measuring the concentration of CO in breath.
Study of the relationship between smoking habit, number 
of cigarettes smoked per day and blood COHb at entry 
examination (Tables 4 and 5) shows no relationship (/= 2.0; 
4df). This result was not expected when the study was 
planned, which may be due to inaccuracy and instability of 
the spectrophotometry method used (CO-oximeter 282) (20,33a). 
Inhaled oxygen during the emergency phase could be another 
factor. Similar results were obtained by a second CO-oximeter 
machine in Western Infirmary. The short half life of CO 
(between 2-4 hours) mentioned in the literature could be 
another explanation. Furthermore all CO absorbed by man can 
be recovered in the expired air if this is collected over a 
sufficient period of time. On the average it takes 250 
minutes for CO to fall to half its original level (122), in 
this study it was 182 minutes.
5.1.3 SMOKING HABIT, ANGINA, MYOCARDIAL INFARCTION AND STRESS
There are indications in the literature that CO can 
cause earlier onset and longer duration of pain (6). Angina
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was found also to be 70$ higher among cigarette smokers in a
health insurance plan in New York city (48). Smoking also
increases the heart work load which increases oxygen demand 
(1 1 )• In this study (Table 6) there is no significant 
relationship between COHb and the presence or absence of mild 
or severe forms of angina in contrast to the previously 
published literature (15,16,95). This negative finding could 
be explained by the variation in smoking habit among smokers 
or inaccuracy and instability of the spectrophotometry method 
used for measuring blood COHb. Study of the relationship 
between COHb and the presence or absence of MI is evident 
from Table 7 which shows that COHb has an inverse 
relationship with the presence or absence of MI and patients 
with MI are m ore likely to have a COHb level within the 
normal reference range - a finding at variance with published 
results (23,79,154). This relationship may then be a chance 
finding.
It has been known for some individuals that smoking can 
relieve tension and stress as a result of the •-psychological 
enhancement produced by nicotine. This enhancement is 
followed by depression later. Study of the problem of stress 
(Table 8) by scoring the answers of questions about stress 
(see Appendix A) and smoking habit before hospital admission 
clarified that there was no significant relationship between 
patient’s smoking habit and stress. The explanation may be 
that stress may not be the factor for maintenance of smoking 
behaviour. It has been mentioned also that the psychosocial 
forces accounting for the initiation of the smoking habit
differ from those that account for its continuation (70). 
However, smokers who suffer from moderate or severe stress 
contributed a 42$ (89/211) of all patients. In each of the 
followed up groups there was no significant relationship 
between stress and myocardial infarction(Tables 32 and 33).
In this respect, life events in the year preceeding 
hospitalisation also show no significant relationship with MI 
(Table 9). Death of a family member was the commonest 
reported event (11$). 14$ of the cases had reported more than 
one event. It is well known that CHD is a multifactorial 
disease, and while stress in the form of life events in the 
year preceding hospitalisation is a factor, it is unlikely 
to have an important effect on its own.
5.2 COMPARISON BETWEEN THE TWO METHODS USED FOR MEASURING 
CARBON MONOXIDE. CHANGES OVER TIME. AND ACCURACY.
A study carried out by Hill et al (6 8)? they clarified 
the high correlation coefficient between plasma cotinine and 
blood COHb (about 0.7), and between both and nicotine (0.73), 
higher than with thiocyanate (0.56). When smokers were 
separated into those smoking cigarettes yielding more or less 
than 1 mg nicotine per cigarette COHb was the better 
indicator of daily exposure and absorption with increasing 
consumption, COHb and plasma nicotine showed a comparable 
progressive increase in men and women in a linear 
relationship.
Expired air carbon monoxide testing can efficiently 
dichotomize smokers and non-smokers (153). It was also found 
that only the number of cigarettes smoked per day and the 
longest period a smoker has quit smoking in the past were 
significantly associated with levels of carbon monoxide. In 
this respect the study of the relationship between breath CO 
and blood COHb concentration for a random subsample of 42 
persons (Table 10) was carried out for comparison between the 
two methods used. The differences between the value obtained 
by the two methods in each patient have been calculated. The 
overall mean of differences (d) is 2.0, variance 0.7 and the 
SD is + 3.3. Comparison between the two means by paired t
test shows that CO is mostly present in a higher 
concentration in blood than in breath (p<0.001) as might be 
expected (81,121,122). Nintetyfive per cent confidence limits 
for the mean of differences between the two methods are 1.2 
to 2.9. In this table although the overall mean difference 
(d) is small (2.0), but some of the individual differences 
are quite large which may indicate a poor agreement between 
the two methods (Table 10).
In a paper published in 1 986 by Bland and Altman (20a), 
it was shown that the use of the correlation coefficient for 
comparison between two methods is misleading. The causes 
mentioned were (1) Correlation coefficient measures the 
strength of a relation between two variables and not the 
agreement between them unless the points are on the line of 
equality with similar scales. (2) Correlation coefficient is 
not affected by the scale of measurements which certainly
affects agreement. (3) Correlation depends on the range of 
the true.quantity in the sample. (4) Data which seems to be 
in poor agreement can still produce quite high correlations.
Figure 1 shows the difference between blood COHb and 
breath CO for each patient. The overall mean difference is 
small, once again some of the individual differences are 
quite large which indicate poor agreement between the two. 
The curves for the coefficient of variation for blood COHb 
(Fig. 2) and breath CO (Fig.3) have an inverted J shape 
which indicates a proportionatly higher variability in small 
CO concentrations and vice versa.
It was interesting to assess the effect of storage on 
blood COHb. Blood samples were analysed immediately and 24 
hours later after they had been kept in a refrigerator (Table 
11). The effect of storage on blood COHb was shown by the use 
of an analysis of variance reliability test (167). 
Reliability of immediately analysed COHb measurements was 
0.99 and reliability for each single measurement in the group 
was 0.99. Analysis 24 hours after the samples were stored 
showed a similar reliability (0.96) for the group and 
slightly lower (0.94) for each single measurement in the 
group. The slightly lower reliability after 24 hours storage 
may be due to interference from pigments produced as a result 
of breakdown of haemoglobin which can affect light absorption 
in spectrophotometery (20). Comparison of the differences 
between the two methods for each patient shows that the 
overall mean of differences (d) is 0.05, SD i  0.55 and
variance 0.3. The overall mean of difference is very small 
and variation between the two measurements is also very 
small. This finding indicates that putting blood samples 
immediately into a refrigerator will not markedly affect CO 
in the sample. Storage for longer time may have an effect.
The relationship between the arithmetic mean and 
coefficient of variation of COHb for a further random 
subsample of 21 venous blood samples (measured by CO-oximeter 
282) was also an inverted J shaped curve (Table 12). This 
relationship indicates a proportionatly higher variability in 
smaller COHb concentrations, as found already. The variation 
was marked between 2.5 to 7.5 ppm COHb. Reliability of each 
single measurement in this samples is 0.94 which, means that 
there is a high intercorrelation between ratings given by the 
two methods.
The effect of 24 hours storage on COHb was also 
studied in another random subsample of 21 venous samples 
(Table 13). Each sample was divided into two halves. The 
part analysed immediately has a mean of 4.4, SD ±  2.4 and 
for the later analysis the mean COHb = 5.6, SD ±  2.1. The 
mean of the differences is 1.2, SD ±  2.0 and variance is 4.0. 
There is no significant increase in COHb concentration after 
storage for 24 hours in the refrigerator (Paired t test 
=1.61; NS) which is similar to the findings from Table 11.
It has been mentioned in the literature that the Gas- 
chromatography method for measuring blood COHb is more
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accurate than spectrophotometry (20). Therefore the two 
methods used for measuring blood COHb were compared, (Table 
14 and Fig.4). The mean of CO measured by CO-oximeter 282 is 
6.1, SD ± 6.6 and by gas-chromatography the mean is 5.6, SD sfc 
2.4. The overall mean of the differences (d) between the two 
methods is small = 0.6, the SD ± 7.2 and variance 52.1 which 
indicate a high variability and poor agreement between the 
two methods. VJithout a standard reference it cannot be 
deduced which is "better”.
In order to see if rapid changes occurred during 
measurement of blood COHb in fresh blood samples, analysis 
was done every 30 minutes. Reliability of COHb measured every 
30 minutes on 3 occasions in 6 subjects was 0.95 for the 
whole group, and for each single measurement was 0.87 (Table 
15). In a second experiment (Table 16) the decay curves for 
breath CO was measured every 15 minutes for about 3 hours for 
6 healthy persons. From the fitted regression lines (Fig.5) 
it is evident that CO concentration decreases over time. The 
amount of CO decreased per unit time (minute), which is the 
mean slope, is equal to -0.0048 ppm. The mean intercepts 
3.7. The calculated half life of breath CO is 182 minutes and 
SD ± 15.3. The outlier was not included in calculations. This 
finding is similar with the published literature that the 
half life for CO is about 4 hours (122).
It is worth noting that CO elimination as well as 
absorption is affected by many variables (30). Factors known 
to be responsible for inter-person variation are :-
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a - Personal variation can account for 20%. 
b - Diffusion of carbon monxide in the lungs, 
c - The pressure gradient of CO in the alveoli, 
d - The presence of lung disease, 
e - Activity of the subject
In this study, only the last of these factors was 
controlled: the subjects were all at rest during the day. The 
other four factors could all have exerted some influence on 
the diffusion of CO in the sample subjects, therefore may 
explain why the calculated half-life is at variance with that 
published in the literature.
5.3 CARBON MONOXIDE IN THE BREATH OF CHILDREN AND ADULTS.
AND CROSS-REACTIVITY BETWEEN BREATH CO AND HYDROGEN 
The previous CO findings were in adults. In order to 
study breath CO changes at younger ages, Glasgow High School 
pupils (n=105) were included in the study. 34* of the pupils 
were smokers. 72* of the smokers smoked only 1 to 4 
cigarettes per day on average, which means that they are not 
heavy smokers and may only be weekend smokers. This agrees 
with published figures (64,133). It was hoped that an 
assessment of the breath test for screening school children 
could be made. The reported cigarette smoking in children was 
compared with the smoking habits of parents. Although the 
data failed to reach statistical significance, the 
probability of a child reporting any smoking experience 
seemed to increased progressively with the number of parents 
who smoke (141,146).
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Study of the relationship between breath CO and the 
self-reported smoking habit of the pupils showed that the 
sensitivity of breath CO is 0.25, specificity is 0.9, 
predictive value of the positive test is 0.6, and 0.7 for the 
negative test using a 9 ppm breath CO cut-off level (Table
17). This low sensitivity and high specificity can be 
explained by the fact that pupils smoke very few cigarettes 
per day on average.
The time interval since the last smoked cigarette (Table
18) was taken into account. 2H% of smokers had a high breath 
CO (10 ppm and more) and they have not smoked for more than 
12 hours before breath CO test. 29^ of smokers had breath CO 
(10 ppm and more) and smoked within 12 hours before breath CO 
test. This finding may be due to the fact that children smoke 
markedly fewer cigarettes per day than adults and that some 
of them are weekend smokers.
In order to see if there is eross-reactivity between 
breath CO and hydrogen (Table 19) a breath hydrogen test was 
also carried out. Breath hydrogen was highly correlated with 
breath CO in school children (r=0.75, significance p<0.001) 
in contrast it is poorly correlated with breath CO in adult 
hospital employees (r=0.19, significance p<0.05). This 
hydrogen interference may make breath CO doubtful as a 
screening test in children compared to adults. At an 
arbitrary cut off point of 20 ppm hydrogen , the predictive
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power of the positive test was 38$ and for the negative test 
was 65$.
The findings among school pupils were similar to those 
in Ruchill Hospital employees. Table 20 shows that the breath 
CO test sensitivity is 0.74, specificity is 0.89, the 
predictive value of the positive test is 0.83 and for the 
negative test 0.84. There is a significant relationship 
between smoking habit and breath CO with higher levels in 
smoking employees (p<0.001). This finding agrees with 
published results (161). The test sensitivity for the 
hospital employees is higher than that for pupils and the 
predictive value of the positive test is higher also. This 
may be due to the difference in smoking habits between High 
School pupils and hospital employees who smoke more than the 
pupils.
The relationship between the time interval from last 
smoking and the measurement of breath CO for Ruchill Hospital 
employees (Table 21) was significant (X^ =16.7; 2df; p<0.001) 
at a cut-off points of one, 1-4 and more than 4 hours. It 
was evident that the longer the time elapsed the lower the 
breath CO, which agrees with published results (122).
At an arbitrary cut off point of 20 ppm breath hydrogen 
for Ruchill Hospital employees (Table 22) the predictive 
power of the postive test was 30$, and for the negative test 
was 84$. Comparing sensitivity and specificity of breath CO 
for the pupils and Ruchill Hospital employees (Table 23) at
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different CO levels shows that sensitivity in each group 
decreases with increasing in breath CO concentration. 
Sensitivity of breath CO for hospital employees is generally 
higher than that for pupils. Change in specificity is 
opposite to the change in sensitivity as expected, ie it 
increases as the cut-off point for breath CO concentrations 
increases, but the hospital employees show a higher 
specificity for the test than do the pupils. The minimum 
error rate was calculated for each group. It was found that 
the error rate was minimum at any CO level between 8-12 ppm 
for hospital employees and at 7 ppm for the pupils.
Apparently there is nothing published on the use of 
Receiver Operating Characterisitics (ROC) curves (Fig.6) in 
assessing tests for smoking. The false positive percentages 
(1- specificity) and true positive percentages (sensitivity) 
for each group were plotted to form (3 8). These curves were 
used to study the effect of varying breath CO levels measured 
by GMI CO-monitor and to evaluate the analytical method 
(breath CO monitor) used in the 'diagnosis' of smokers. The 
ROC curve for the hospital employees is higher than that for 
school pupils. Once again this is due to the different 
smoking habit among employees compared to school pupils.
202
5.4 PREVENTION METHODS USED;HOW EFFECTIVE ARE THESE METHODS.
The approach used in this study to produce a change in 
behaviour was an educational one. Thus accurate and practical 
information was provided to the CCU patients who had made the 
decision to implement changes in their smoking habits or 
diet, hence it was not prescriptive. The education was 
provided primarily as an individualized risk factor strategy. 
This approach has few limitations, since acquistion of 
correct knowledge is only one of the many factors that 
influence behaviour change (142).
The differences in methodology and duration of follow-up 
make comparison between studies difficult. It appears that 
intervention started while patients were still in the 
hospital and at a time when they had already stopped smoking 
because of hospital policies had a higher rate of success 
than when counselling was delayed until after the patients 
had gone home. It appears that nurses and physicians have an 
impact during the early, in hospital, rehabilitative phase 
after MI in encouraging patients to quit or cut down on 
smoking (142).
Assessment of the psychological profile was important to 
know how best to approach the patients for personalised 
health education intervention at follow up. In the MHQ (141 a) 
basic study, the mean scores for normal healthy subjects was
5.1 S.D =3.1 for free floating anxiety, 2.9 S.D =2.2 for 
phobic anxiety, 5.8 S.D =3.1 for obsessive traits, 3.2 S.D 
=2.4 for somatic symptoms, 3.3 S.D =2.3 for depressive 
tendency and 7.5 S.D =3.1 for "hysterical” traits. Using the
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mean .+ 1 S.D as providing the normal range, the distribution 
of the psychological profile was as follows:3 9? of the total 
followed up patients had a normal psychological profile. Out 
of the remaining who had high scores, 6955 of the patients had 
free floating anxiety, 50? had phobic anxiety, 18? had 
obsessive traits, 64? had somatic symptoms, 11? had 
depressive symptoms and "hysterical trait " was noted in 10? 
of males and 23? of females. Health education was directed to 
the patients according to the psychological profile and 
according to the answers to the dietary questionnaire.
The two groups were followed up to compare the 
effectiveness of health education intervention among CCU 
patients. The intensive health education was given by a 
health visitor who had become an ex-smoker a long time before 
the time of the project. The characteristics of the study 
groups were comparable. There was no significant difference 
in structure as regards age, sex (Tables 24 and 25) and 
social class distribution at entry in the study. Patients 
over 55 years of age form an equal percentage in each group 
(54?). Nearly two thirds of the patients in each group were 
males, as in the published literature (41,82,136).
Looking at social class and smoking habit at follow-up 
it is evident that there was no significant relationship 
between these variables (Tables 26 and 27). In the non­
intervention group 50? (6/12) of social class I,II,III NM 
were smokers and 56? (15/27) of HIM, IV and V were smokers. 
Chi-square for the collapsed table, social class I, II,IIINM
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compared to the rest = 0.25; 1df; M.S. From many other 
studies it is evident that smoking is clearly related to 
social class; the lower.income groups contain both more 
smokers and more earlier starters. Occupations normally 
associated with higher education tend to have few smokers 
(75,103). Due to small frequencies in the health education 
group Fisher?s exact probability test was used for the 
collapsed table (social class I, II,IIINM compared to the 
rest P=0.31; N.S). In this study the strength of association 
between social class and smoking habit is less but the trend 
is as expected.
Public knowledge and attitudes about the risks of 
health is steadily increasing, particularly through the 
media, but much ignorance still remains ^30)^ in another 
study although 753 believed that heart attacks were 
preventable, only a few (283) named cigarette smoking as a 
factor. Twenty one per cent named high blood pressure, 133 
named cholesterol, 503 did not name any of these risk factors 
and only 13 named all three. This reflects the widespread 
lack of information about major causes of heart attack (139).
In the present study 443 of the patients mentioned old 
age as a factor for coronary heart disease, 773 mentioned 
cigarette smoking as a factor, 173 mentioned high blood 
pressure, '893 named overweight and eating fats. These figures 
are much higher than those published seven years ago from the 
U.5.A^3 9) f0r cigarette smoking (773 versus 2 83). However 
both studies give a similar percentage (173 and 213) for high
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blood pressure being a risk factor. The differences may be 
due to different populations but could also be the result of 
the health education given to all CCU patients, as the 
questions were asked at follow-up following admission. In 
this study, the intensive health education group have 
significantly higher percentages as regards these three 
factors, than in the non-intervention group; 'namely smoking 
91$ vs 62$, blood pressure 21$ vs 6$ and eating fats 96$ vs 
H5%.
In this study Tables 28 and 29 show the relationship 
between social class and the mean score of patient’s 
knowledge about risk factors forCHD. The maximum possible 
score is 16. Oneway AITOVA in the non-intervention group 
showed no significant relationship between social class and 
patient’s knowledge about CHD (Oneway AITOVA =2.08; 2,60 df;). 
The result was also not significant in the health education 
group (Oneway AIT0VA= 0.56; 2,21 df). This may be due to the 
effect of admission in hospital and the basic health 
education given to all patients.
Life events in the year before hospital admission and 
presence of MI were also studied. Death of a family member , 
financial problems and job loss form the main life events in 
each group. In each group there is no significant 
relationship between none or any life event, and the presence 
or absence of myocardial infarction (Tables 30 and 31). This 
finding may indicate that life events may not be a single 
factor leading to myocardial infarction.
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With regards to the presence of stress before hospital 
admission. There is.no significant relationship between 
myocardial infarction and the presence: or absence of stress 
in each group (Tables 32 and 33). Other findings agree with 
the published literature that the role of physical activity 
in CHD is not completely clear. Physical activity can produce 
psychological improvement which is often noted clinically but 
the effect on morbidity and mortality is unknown 
has been reported in a study in New York city that physically 
inactive men show a higher incidence of first MI than more 
active men among both smokers and non-smokers. The highest 
incidence was in inactive smokers and the lowest by the 
relatively more active non-smokers ^9)^ in a case-control 
study, the results showed no marked difference in the 
physical activity of the job between coronary and non­
coronary groups Stress was the highest of the reported
important cardiovascular risk factors, occuring in 70%
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5.5 COMPARISON BETWEEN THE FOLLOWED UP GROUPS IN RESPECT OF
EFFECTIVENESS OF HEALTH EDUCATION AND CHANGES IN SMOKING 
HABIT AND CO
The characteristics of the study groups were comparable 
as it is also evident from the laboratory findings (Table 
34). Furthermore there is no significant difference between 
the two groups as regards the presence or absence of 
myocardial infarction. There is a significant relationship 
between the presence or absence of myocardial infarction and 
raised cardiac enzymes in each group since it is one of the 
criteria used for diagnosis, but there is no significant 
diffference between the two groups with regard to the 
following variables:- High SGOT (>43 U/L), high triglycerides 
(>1.8 mmol/L), high cholesterol (>7.6 mmol/L), haemoglobin, 
hyperglycaemia.
In other studies it has been found that cholesterol, 
diastolic BP, highest number of cigarettes smoked per day in 
the past, longest period smoking has been stopped in the 
past, and alcohol consumption, are ineffective 
discriminators. That is to say that when intercorrelation is 
taken into account in the analysis, the variables exert no 
independent effect on myocardial infarction (153).
Comparison between carboxyhaemoglobin and the number of 
cigarettes smoked per day at entry examination in each group 
showed that there is no significant relationship between both 
variables in either the non-intervention group or the health
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education group. This unexpected result could (as mentioned) 
be due to the time elapsed between the onset of pain, which 
may stop smoking, and admission when the samples were taken 
(Tables 35 and 36). Giving oxygen during the first few hours 
in emergency and inaccuracy of the spectrophotometric method 
(CO-oximeter 282) could also be other contributing factors.
The normal range of CO varies in different populations, 
being higher in a city with exposure to automobile exhaust 
gases, than in rural areas. The average COHb values in non­
smoking street cleaners in New York was 3$ COHb (56). Hanson 
and Hastings mentioned that 1.5* saturation was the normal 
level in non-smokers not exposed to automobile gases (62).
The normal range of breath CO in the Scottish MONICA 
project was given as 2-8 ppm for non-smokers and 9-^0 ppm for 
smokers (162). Wald et al in Oxford used 2* as a cut off 
level in their study (157). A normal COHb of less than 2$ or 
less than 10 ppm was used as a cut-off level in the study 
reported here.
Comparison between the follow-up COHb and the number of 
cigarettes smoked per day for both groups shows that non- 
smokers who had a high COHb ( >2* saturation) comprised 12$ 
in the non-intervention group and 27$ in the health education 
group. This probably indicates that they were not reporting 
their true smoking history. Smokers who had normal COHb 
levels comprised 22$ in the non-intervention group and 22$ in 
the health education group (Tables 37 and 3 8). Comparison
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between the means of COHb for the smoking groups at the same 
time was done by Oneway ANOVA. There was significant 
relationship between the two variables in the non­
intervention group (Oneway ANOVA; F=13.8; 3,59 df; p<0.001) 
and in the health education group (F=2.9; 2,21df; Just N.S). 
The small overlap in the distribution of COHb levels from 
cigarette smokers and non-smokers was striking and surprising 
in view of the short half life of COHb in blood (170). 
Validation of this findings by assays of blood COHb suggested 
that 27$ of subjects who say that they gave up smoking in the 
health education group may have misreported their smoking 
habit and this percentage was lower (12$) in the non­
intervention group.
Comparison between entry and follow-up COHb levels 
(Tables 39 and *10) in the non-intervention group showed the 
frequencies of patients according to the difference between 
entry and follow up COHb, and the percentages. The mean of 
the differences (d)= 0.83; SD ±  3.56 Paired t test =1.85; 62 
df; N.S. 95$ confidence interval =-0.07 to 1.73. In health 
education group the mean of differences (d) = —1.16; SD jj6.06; 
Paired t test= -0.93; 23df; N.S. 95$ confidence interval -3.7 
to 1.41. These results shows that there is no significant 
change in blood COHb between entry and follow up which may be 
due to unsability and inaccuracy of the spectrophotometry and 
may be due to non significant change in smoking habit in both 
groups over this period.
The type of fuel used for house heating could be a
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possible source of pollution by CO gas. In this study most of 
the houses (60$) were heated by a clean and safe method, free 
from CO wastes (Table 41). About quarter of the patients used 
gas for heating and never complained of gas fire troubles. 
Very few used open fires for house heating. Table 42 shows 
the means^of COHb and SD for group of house heating. There is 
no significant relationship between type of heating and blood 
COHb level. Therefore most of CO is due to tobacco smoking. 
Questions on passive smoking were not included.
A small number of diseases are preventable by risk 
factor modification and in the majority the risk factors of 
interest were alcohol and tobacco (95). The primary aim of 
the North Karelia project was to reduce CHD risk through 
reduction in the risk factors and included smoking as an 
important risk factor, aiming at a reduction of 10$ in the 
smoking rate (107). In the European Multifactorial Preventive 
Trial the primary aim was to reduce risk factors. Changes in 
cigarette consumption after 4 years varied from country to 
country, the lowest was in Belgium -3.9$, the highest was - 
15.6$ in Britain and the average reduction in cigarette 
consumption was - 8.8$ (100). The effect of advice about 
eating and smoking habits in the Oslo study, where 80$ were 
smokers at the begining, was to reduce tobacco consumption by 
45$ in the intervention group over that in controls (69). In 
the Multiple Risk Factor Intervention Trial (MRFIT) the quit 
rate was 47.0$ at the end of the first 4 months which was the 
end of smoking intervention phase (73).
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The success of the intensive health education method was 
assessed by studying the percentage of those giving up 
smoking and those who decreased the number of cigarette 
smoked per day (Tables M3 and MM). The differences between 
the number of cigarettes smoked at entry minus the number 
smoked at follow up was calculated for each patient. The mean 
of differences in the non-intervention group was -1.03 and 
in the health education group was 8.2. There was no 
significant reduction in the number of cigarettes smoked per 
day in the non-intervention group in contrast to the marked 
reduction in cigarettes smoked per day (Paired t test =M.M; 
df=23; p<0.00.1) in the health education group. This marked 
reduction in the reported number of cigarettes smoked per day 
is likely to be due to the effect of intensive health 
education.
Initially all patients in the followed up groups were
smokers. Changes in the smoking habit in the two groups were
studied at follow-up. At entry examination 90$ of patients
smoked only cigarettes and the remaining *10% smoked
cigarettes with either pipe or cigar. Examination of the
self-reported change in smoking habit of the two groups
showed that by the follow-up examination M1* had given up
smoking and 59% remained smokers. In the health education
group, 63% had given up smoking and 31% remained smokers.
Comparison between the two groups showed no significant
2.
increase in quit rate in the intervention group ( X  =3.1M; 1 
df; NS). Although non-smokers did not significantly increase 
in number in the health education group, they decreased the
number of cigarettes smoked per day more than in the non­
intervention group (Tables 43 and 44).
Table 45a shows a comparison between the change in
smoking habit of the two groups using the breath CO test to
detect smokers. There was no significant change in the
smoking habit of the two groups ( X1 = 1.2; 1 df; N.S). The
percentage who "raisreported" their smoking habit was 8% in
the non-intervention compared with 17$ in the health
education group. These are lower than the published figures
for under reporting of smoking which range from 20$ to 46$ 
(76)
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At follow-up the relationship between smoking habit and 
breath CO is significant (p<0.001) in the non-intervention 
and in the Health education group (p<0.01). In the non­
intervention group non-smokers with a high breath CO (>10ppm) 
were 19$ and in the health education group were 27$. Smokers 
with a normal breath CO comprise 22$ in the non-intervention 
group and 11$ in the health education group (Tables 46,47).
Study of the relationship between blood COHb and breath 
CO at follow-up showed that there is highly significant 
difference between blood COHb and breath CO in each group. 
This significant difference show that blood COHb is higher 
than breath CO which is as expected, due to the high pressure 
gradient required for CO elimination from blood.
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Further comparison between other characteristics in the 
followed up groups show no significant difference as regards 
age distribution, sex, weight, height, alcoholic drinks, tea, 
coffee consumption, systolic, diastolic BP and activity in 
work (Table 9^). These findings indicate that the two groups 
were comparable.
It is evident from this study that measuring blood COHb 
is inconvenient due to its expense, time consuming and needs 
a lot of laboratory work experience, in addition to the 
reported inaccuracy and unstability of the spectrophotometric 
method used. The alternative method for measuring blood COHb 
could be gas-chromatography which again requires a lot of 
experience, is time consuming and not practical for field 
studies. It was evident also that there is poor agreement 
between these two methods. This study demonstrated also that 
the hand held breath CO monitor is a simple method for 
measuring alveolar carbon monoxide levels provided 
precautions are taken to use the monitor properly to 
eliminate the possibility of false readings. It is sensitive 
to breath hydrogen therefore diseases producing excess 
hydrogen should be taken into consideration when measuring 
breath CO. However the use of this monitor for screening of 
smokers in children is doubtful. The instrument is not 
sensitive to C02 or water vapour two factors which make it 
suitable for use in breath samples. The method is rapid and 
easy to perform and enables a person's breath CO level to be 
estimated while avoiding the discomfort and inconvenience of 
collecting blood. The CO results measured on breath CO
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monitor can be seen by the subjects, which is likely to make 
it useful as a method of reinforcing health advice to stop 
smoking. It is also likely to be useful when judging the 
reliability of statements made about a smoking habits.
Although there was no statisticall significantly 
difference between the intensive health education and the 
non-intervention methods yet the percentage of those stop 
smoking was about 20$ higher than in the non-intervention 
method. Comparison of these finding with the other published 
data shows a one year success rate of 2$ from a smoking 
cessation kit (34a), 14.5$ from the BBC television series "So 
You Want to Stop Smoking" (111a), 10$ by the use of tobacco 
substitutes (Nicotine chewing gum) and individualised 
counselling (88a), 6$ from accupunture (29a), 6$ from
nicotine chewing gum (39a), 5.1$ from patients given a
leaflet and advised to stop smoking compared to 0.3$ in a 
control group (131a).
The calculated average cost of the intensive personalised 
health education was £ 6 for each home visit including an 
average transport cost and an assuming an average 45 minutes 
consultation. Each patient had on average 5 visits for this 
programme- a total cost of £ 30. From table 45 it appears 
that 5 more people stopped smoking in the health education 
group than expected from the non-intervention figures. The 
cost of helping each of these extra individuals to stop 
smoking is calculated to be about £ 144. This cost is above 
the cost of the standard intervention given in CCU.
CONCLUSIONS
CHAPTER SIX : CONCLUSIONS
6.1-EFFECTS OF HEALTH EDUCATION ON GIVING-UP SMOKING
Anti-smoking health education methods may vary depending 
on the target population, social attitudes, knowledge and 
behaviour.
The intensive personalised antismoking health education 
carried out in this study according to the psychological 
profile of the patient showed no significant additional 
benefit over the conventional anti-smoking advice used for 
changing health behaviour. Both the non-intervention and 
health education groups gave up smoking by similar amounts. 
Self-reports of smoking behaviour indicated that 6355 in 
health education and 41* in non-intervention groups , ceased 
smoking. By use of breath CO measurement, about 17? 
misreported their smoking habit in health education group in 
comparison to 8% in non-intervention group.This intensive 
health education method is expensive in terms of time 
consumed (45 minutes in each home visit and in hospital) and 
it does not show an advantage over the usual methods of 
health care.
6.2 MEASURMENT OF BLOOD AND BREATH CARBON MONOXIDE
In this study three methods were used for measuring 
blood and breath carbon monoxide. There were some 
difficulties encountered during measuring CO and they are
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listed below
1" Gas-chromatographv method. This method is sensitive and 
requires extensive laboratory experience, which is expensive 
and time consuming. Although the method is accurate it is not 
suitable for field studies in populations. The precision of 
this method is good, it has been stated that the technique 
achieves a more accurate and specific measurement than the 
spectrophotometric method (20). In this study there was a 
poor agreement between this method and the spectrophotometric 
method.
2- The Spectrophotometric method for measuring blood COHb is 
easily affected by many intervening factors. For example the 
presence of pigments in haemolytic diseases may interfere 
with light absorption. Therefore blood samples have to be 
analysed immediately and should be kept in air tight 
containers so as to avoid direct oxygenation. Also the C0- 
oximeter 282 needs frequent calibration and cleaning of the 
cuvette which is liable to be clogged by blood clots. 
Handling blood samples may carry a risk unless strict 
precautions are followed. Added to these difficulties is the 
inconvenience of collecting blood samples from the subjects. 
An experienced operator can achieve an accuracy of +- 10$, 
but up to 25$ differences can occur between workers in the 
same laboratory.
3“ Breath CO measurement. In this method the GMI CO monitor, 
which has been used in industry for monitoring ambient CO, is
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tested for measuring breath CO. This method uses a recently 
developed electrochemical cell which at present has to be 
changed every year. Breath CO is highly correlated with 
blood COHb, and therefore can be used for measuring blood 
COHb indirectly. This method is very easy to use, very cheap 
to run and it is practical for field studies particularly 
anti-smoking studies. Repeatability of this method is +- 12. 
However some difficulties were encountered:
a) Cross-sensitivity was found between CO and breath 
hydrogen. Therefore use of breath CO as an objective 
measurement of smoking behaviour is doubtful in children 
with low and sporadic consumption of tobacco. It should be 
taken into account when measuring breath CO in persons 
with sugar malabsorption syndromes.
b) It takes a longer time to settle to zero after use for a 
long time.
c) The electrochemical cell used is valid only for one year.
In this study blood COHb, as measured by 
the spectrophotometric method, was not related to the 
reported smoking habit nor to the number of cigarettes smoked 
per day. This may be due to instability and inaccuracy of the 
method used. By contrast breath CO measured by the GMI CO 
monitor, did show a significant relationship to the number of 
cigarettes smoked in adults. However, use of the CO monitor 
was found to have low sensitivity (25%) when screening for 
smokers in the sample of children. This may be due to the 
sporadic nature of smoking in children.
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RECOMMENDATIONS
CHAPTER SEVEN RECOMMENDATIONS
1. RECOMMENDATIONS AS A RESULT OF THE FINDINGS IN THIS STUDY.
A-Personalised health education.
(i) Although there was no statistically significant advantage 
present in personalised health education over the ordinary 
health education given to all CCU patients, there was an 
indication that it did help smoking cessation in about 20% 
more patients than than those recieving ordinary health 
education. There was a significant decrease in the number of 
cigarettes smoked per day in those who continued to smoke but 
only in the group recieving personalised health education.
(ii) The cost of this intensive personalised health education 
can be reduced by training less expensive health workers to 
do it as a part of their daily work.
(iii) This method could be potentially valuable for reducing 
the number of smokers, thereby the burden of smoking related 
diseases and merits further investigation.
2- Objective CO measurements.
(i) Because it was mentioned in many studies that breath CO 
is highly related to blood COHb breath CO can be used for 
screening of adult smokers particularly in field and 
epidemiological studies.
(ii) The use of the breath CO monitor for measuring breath CO 
in children is of doubtful value due to sporadic and
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infrequent smoking in children.
(iii) The cross-reactivity between breath CO and breath 
hydrogen should be taken into consideration particularly in 
sugar malabsorption syndromes. Due to cross-sensitivity 
between breath CO and breath hydrogen further development of 
the GMI CO monitor is required and a further evaluation study 
of the method should be planned in the future.
2. GENERAL RECOMMENDATIONS.
A TO HEALTH AUTHORITIES
The declining trend in tobacco smoking in Britain seems 
mostly due to the effects of health education, and it is 
worthwhile continuing antismoking campaigns. Restriction and 
prohibition of tobacco smoking in many places in the 
community can help to reduce the number of smokers. The use 
of an objective visible test for breath CO measurement 
combined with health advice can give a convincing 
demonstration of the effect of smoking to an individual which 
may reinforce advice about smoking cessation.
B TO PROFESSIONAL AND MEDICAL PERSONNEL
General practitioners, working in primary health care 
should provide the public with health advice against smoking 
and provide counselling facilities for smokers. General 
practitioners are in an ideal situation to do this as they 
are widely distributed in the country and they are in 
frequent communication with many of their patients.
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C TO RESEARCHERS
Tobacco smoking is a multifactorial problem related to 
attitudes, behaviour and health habits in the population. 
Research workers should study all aspects related to tobacco 
smoking, and be aware that different populations may have 
different influences acting on smoking behaviour. Therefore 
anti-smoking health education methods should be adapted to 
meet these different profiles of influences, to achieve 
success.
Antismoking education will cost little relative to the 
cost of treatment of tobacco- related morbidity. This makes 
health education a necessity in developing and in developed 
countries alike.
In developing countries, smoking is markedly increasing 
every year and it almost certainly will produce an epidemic 
of disease in the future. Research workers in developing 
countries should study the social, economic and personal 
factors involved in smoking in order to plan for a strategy 
to combat the smoking problem.
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TABLES AND DIAGRAMS
TABLES AND DIAGRAMS
DESCRIPTION OF THE TOTAL STUDY POPULATION
TABLE L 1 1
AGE AND SMOKING HABIT FOR ALL CASES.
Smoking
Habit
Age
Never-
smoked
lEx-smokerISmokers
I I 
I I 
_  I_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ I
I Row | 
1 Total I 
1 I 
1 1
<45 6 I 8 1 m 1 28 I■
. (21.4) I (28.6) 1 (50.0) 1 (100.0) |
45-55 8 I 15 1 36 I 59 I
(13.6) I (25.4) 1 (61.0) I (100.0) |
55-65 13 I 3*1 I 59 I 106 |
(12.3) I (32.0) I (55.7) I (100.0) |
>65 5 I 7 I 7 I 19 I
Years (26.3) I (36.8)i
. *
! (36.8) 11 . .
I (100.0) I 
I I
Column 32 1 64 1 116 I 212 I
Total (15.1) 1 (30.2)1
1 - - ■ » n ,
I (5*1.7) 
1
I (100.0) | 
!_ _ _ _ _ _ _ _ _ _  I
( ) = Row percentage shown in brackets.
N.S = not significant.
(Chi-square = 5.52; 6df; N.S)
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TABLE (2)
SEX AND SMOKING HABIT FOR ALL CASES.
Smoking
Habit
Sex
.
Never- 
! smoke
i
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
{Ex-smoker
I
I
. . . l _ _ _ _ _ _ _ _ _ _ _ _ _
Smokers
.
Row | 
Total I
I
. _ _ _ _ _ _ _ _  I
Mai e
-
Female
'
'
18
(11.6)
14
(24.6)
.  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
j 48 
I (31.0) 
I 16 
I (28.1)
89
(57.4) 
27
(47.4)
155 I 
(100.0) !
57 I 
(100.0) j 
j
Column
Total
32
(15.1)
I 64 
I (30.2) 
I_ _ _ _ _ _ _ _ _ _ _ _ _ _ _
, ■ ■ r , 
116 
(54.7)
212 | 
(100.0) | 
j
Row percentage shown in brackets. 
(Chi-square = 5.51; 2 df; N.S )
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TABLE L 3& 1
AGE WHEN SMOKING BEGAN AND NUMBER OF CIGARETTES
SMOKED PER DAY FOB MALE SMOKERS.
Cigarettes 
start.age
<15 ! 15-25 
CIGARETTES PER
>25
DAY
Row ! 
Total !
Years.
<15 4 10 13 27 !
(15.0) (37.0) (48.0) (100.0) i
15-25 18 13 11 42 !
(43.0) (31.0) (26.0) (100.0) !
>25 11 3 5 19 !
(57.9) (15.8 (26.3) (100.0 ) !
Column 33 26 29 88 !
Total (37.5) (29.5) (33.0) (100.0 ) !
Percentage shown in brackets. 
(Chi-square =10.62; 4 df; p. <0.05)
TABLE (3b)
AGE WHEN SMOKING BEGAN AND HUMBER OF CIGARETTES SMOKED 
PER DAY FOR FEMALE SMOKERS
Cigarettes <15 I >15 Row
start, age Cigarettes per day
i
Total
<15 2 ! 8 10
(20.0) j (80.0) (100.0)
>15 11 ! 7 18
Years (61.1) ! (38.9)
i
(100.0)
Column total 13 ! 15 28
(46.4) i (53.6) (100.0)
Percentage shown in brackets. 
(Chi-square =4.37; 1df; p<0.05)
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TABLE 14 1
SMOKING HABIT AND CAKEOXYHAEMOGLOBIN LEVEL FOR ALL CASES.
1---------------
I (COHb) I 
I Smoking habit I
<10 10-20 I >20 
I p p m-;
i
1 Row I 
1 Total j
i
! Non-smokers { 7 19 6 1 32 |
1 1 (21.9) (59.3) (18.8) 1 (100.0)1
I Ex-anokers I 14 40 1 10 1 64 j
1 1 (21.9) (62.5) (15.6) 1 (100.0)1
1 Smokers j 25 63 I 28 1 116 |
! 1 
1 i
I______________|
(21.6) (54.3) I (24.1)
|
I (100.0)1 
1 I
|________j
j Column j 
1 Total I
46
(21.7)
122
(57.5)
44
(20.8)
! 212 j 
I (100.0)!
Row percentage shown in brackets. 
(Chi-square =2.02; 4 df; N.S)
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TABLE 151
NUMBER OF CIGARETTES SMOKED PER DAY AND CARBOXYHAEHQGLQBIU 
MEASUREMENTS FOR SMOKERS.
! COHb | <10 { 10-20 { >20 Row
{Cigarettes I 
}________________________.___
ppm { ppm { ppm Total
I <15 (mild) | 8 I 30 { 8 46
I I (17.4) I (65.2) I (17.4) (100.0)
I 15-25 (moderate)| 8 I 18 { 11 37
! I (21.6) I (48.6) { (29.7) (100.0
{>25 Cigt.(heavy) ! 9 I 15 I 9 33
; i
i___________ .________________
(27.3) I (45.5) I (27.3) (100.0)
{Column { 25 { 63 I 28 116
{Total { (21.6) { (54.3) ! (24.1) (100.0)
Row percentage shown in brackets. 
96 _cases were ex or never smoke. 
(Chi-square = 4.05; 4 df; N.S)
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TABLE ( 6 )
PRESENCE OF ANGINA AND CARBOXYHAEMOGLOBIN LEVEL FOR ALL CASES.
1 (COHb) I <10 I 10- I >20 I Row
iAngina 1 ppm I ppm I ppm j Total
jNo angina I 24 I 79 I 26 129
! 1 (18.6) I (61.2) | (20.2) (100.0)
jGrade I j 13 I 26 | 8 L  47
i i i i (27.7) I (55.3) ! (17.0) (100.0)
j Grade II | 9 I 17 I 10 ! 36
i i i i
j_____________
(25.0) I (47.2) I (27.8) I (100.0)
iColumn I 46 j 122 | 44 212
1 Total I
i
(21.7) I (57.5) j (20.8) I (100.0)
Row percentage shown in brackets.
__ _ _____
(Chi-square = 3 .73; 4 df ; N.S)
- Grade I represents severe form of angina.
- Grade II represents mild form of angina.
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TABLE i 1 1
CARBOXYHAEMOGLQBIM IN PATIENTS WITH OR WITHOUT MYOCARDIAL 
INFARCTION.
COHb i 
M. Infarctionj
<10 ppm I 10-20 
I
ii
>20 
i  ppm
I Row 
! Total
Yes i 29 1 50 19 98
(29.6) i (51.0) (19.4) (100.0)
No | 16 I 66 25 107
(15.0) I (61.7) (23.3) (100.0)
Column i 45 I 116 44 205
Total ! (22.0) I (56.6) (21.4) (100.0)
Row percentage shown in brackets.
7 cases uncertain whether MI present or not.
(Chi-square = 6.4; 2 df; p<0.05 )
There is a significant inverse relationship between 
Ifyocardial Infarction and COHb distribution; patients with MI 
are more likely to have a within normal COHb level.
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TABLE (8)
STRESS AND SMOKING HABIT IN ALL CASES.
j Stress 
S&noking' Habit
i . _
{Moderate 
{& severe
{Mild or 
{no stress
{ Row I 
I Total |
I
i
|Non-smokers
1
1 29
ii
{ 3
I
I 32
ii
ii
1 (90.6) 1 (9.4) I (100,.0) I
IEx-smokers 1 56 1 8 I 64 1
S (87.5) 1 (12.5) I (100 .0) |
{Smokers ! 89 I 26 I 115 1
ii - ..........
1 (77.4) 
1
I (22.6) 
I
I (100 .0) I 
1 1
I
{Column Total
i
{ 174 
{ (82.5) 
I
I 37 
I (17.5) 
I
I 211 
I (100
ii
1
.o) i 
1
Row percentage shown in brackets. 
1 missed case
(Chi-square = 4.64; df = 2; N.S )
TABLE i  2. I
MYOCARDIAL INFARCTION AND LIFE EVENTS IN THE YEAR 
BEFORE HOSPITAL ADMISSION.
I M. Infarction 
i Life events
I Yes No Row I 
Total
! Job loss I 6 7 13 I 
(6.3) I
j Family member death S 12 11 23 I 
(11.2) |
I Financial problems I 11 8 19 I 
(9.3) i
j Residence change I 3 4 7 I 
(3.4) |
I More than one I 8 20 28 I 
(13.6) |
I None I 58 57 115 I 
(56.1) |
j Column Total i 98 107 205 - I
I (47.8) (52.2) (100.0) |
Percentage shown in brackets.
7 cases uncertain whether MI present or not.
(Chi-square r 0.73 between none and presence of any of 
life events; 1 df; N.S).
TAELES AND DIAGRAMS
COMPARISON BETWEEN BREATH CARBON MONOXIDE AND BLOOD 
CARBOXYHAEKOGLOBIN .
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TABLE (10)
COMPARISON BETWEEN BLOOD CAREOXYHAEMOGLOBIN AND BREATH
CAREON MONOXIDE FOR 42 PERSONS.
I Subject ■ Blood COHb Breath CO |
I No. Mean
ppm
I CV . Mean | 
ppm I 
|
CV I
!~ 1 28.1 I 1.9 ‘ 21.0 j" 2.9 I
I 2 3.9 I 24.4 6.1 | 11.5 I
1 3 4.2 I 13.1 8.0 | 5.0 |
1 4 2.5 I 20.0 4.0 | 11.3 I
1 5 5.2 I 10.6 8.2 | 14.6 j
i 6 27.2 I 2.9 24.0 | 3.0 |
i 7 2.5 I 26.0 3.0 | 43.3 I
; 8 4.0 I 40.0 1.2 | 36.7 I
1 9 18.0 I 3.1 11.0 | 6.5 I
j 10 5.5 I 36.4 3.4 | 15.9 I
I 11 14.5 I 3.4 8.6 j 12.8 |
I 12 4.0 I 13.8 3.6 | 15.0 |
I 13 6.5 ! 7.7 6.6 | 8.2 |
I 14 15.0 I 16.7 7.2 | 6.3 I
I 15 4.0 I 37.5 1.2 | 36.7 ' I
i 16 18.0 ! 2.8 11.0 l 6.4 |
I 17 5.5 ! 36.4 3.4 | 15.9 I
I 18 14.5 i 3.4 8.6 | 12.8 j
i 19 4.0 I 12.5 3.6 | 15.0 j
I 20 6.5 i 7.7 6.6 j 8.2 |
I 21 15.0 I 16.7 7.2 | 6.3 I
! 22 6.0 I 10.8 3.8 | 28.7 I
! 23 3.0 I 16.7 5.0 | 14.2 |
I 24 3.0 I 48.3 4.4 } 12.5 I
I 25 4.0 I 20.0 2.2 | 20.5 I
! 26 4.5 I 11.1 4.8 { 27.1 . !
! 27 4.5 I 11.1 3.8 | 10.5 i
I 28 ' : 4.5 I 11.1 1.6 J 33.8 |
I 29 4.0 I 19.5 1.2 j 30.1 |
I 30 18.0 I 2.4 11.0 | 5.7 I
i 31 5.5 I 10.0 3.4 | 16.2 {
! 32 14.5 I 3.1 8.6 j 13.5 I
i 33 4.0 I 25.3 3.6 | 19.3 I
S 34 6.5 I 8.0 6.6 | 9.0 |
i 35 15.0 ! 7.4 7.2 | 8.1 j
i 36 6.0 I 10.2 3.8 | 17.8 !
i 37 3.0 ! 12.3 5.0 { 21.3 !
I 38 3.0 ! 16.3 4.4 | 12.9 I
I 39 4.0 I 11.1 2.2 | 14.4 |
I 40 4.5 ! 13.9 4.8 | 16.1 j
I 41 4.5 I 12.9 3.8 j 12.3 I
I 42 4.5 I 14.7
_ . I________
1.6 |
. ______I.
29.1 I 
_______ I
CV = Coefficient of variation 
Mean 7.98 5.96
SD ±6.59 ±4.62 v "
Paired t test =4.0 (p<0.001).
d = 2.02 SD of differences ±3.3 Variances 10.7 
A 95 % confidence limit for <1 is 1.2 and 2.9
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TABLES AND DIAGRAKS
BLOOD AND BREATH CARBON 1DNOXIDE: CHANGES OVER T B E  
AND ACCURACY.
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TABLE i  12 I
COEFFICIENT OF VARIATION OF ELOOD CARBOXYHAEKOGLOEIN 
FOR 21 PATIENTS MEASURED BY CO-OXIMETER 282.
ISubject 
I No. I
Mean COHb 
ppm
Coefficient j 
of variation!
________  I
i 1 I 4.5 25.0 !
I 2 | 4.5 15.1 !
I 3 I 5.0 20.0 |
I 4 I 11.0 3.0 I
I 5 I 4.5 73.3 I
I 6 S 7.0 13.2 |
I 7 I 3.5 33.3 I
I 8 I 16.0 4.5 I
I 9 I 4.5 36.0 |
I 10 I 5.5 14.5 I
! 11 ! 6.0 7.8 |
I 12 | 8.5 26.8 !
I 13 I 2.0 56.8 j
I 14 i 4.0 33.3 I
! 15 I 5.5 17.9 I
I 16 I 7.0 8.0 |
I 17 I 7.5 8.6 |
I 18 | 5.0 16.0 |
I 19 I 6.5 9.7 I
I 20 J 6.5 9.0 |
I 21 |
I...... . I
23.2 2.4 j 
________  I
Reliability of each measurment is 0.94
table H a l
EFFECT OF TIME AND STORAGE ON CARBOXYHAEMOGLOBIN IN 21 
BLOOD SAMPLES MEASURED BY CO-OXIMETER 282.
ISampie Immediate j After 24 I
i No. analysis I hours |
j______
% saturation I
I 1 2.6 | 2.2 j
1 2 1.7 I 1.7 I
1 3 1.7 I 4.9 I
1 4 2.3 I 6.0 |
1 5 1.8 | 4.8 |
16 1.9 I 5.0 j
1 7 3.8 | 6.8 |
I 8 2.2 | 4.0 |
1 9 5.1 i 3.8 |
110 5.8 j 7.8 |
111 4.1 I 5.7 i
112 3.8 | 3.3 I
113 3.2 | 4.6 |
114 6.0 | 5.9 S
115 5.3 I 5.1 I
116 6.8 | 7.0 |
117 7.8 | 5.7 I
! 18 10.7 I 8.1 I
119 6.8 | 11.4 |
120 4.4 | 6.8 j
121
I____
4.0 | 6.7 I
Mean 4.4 5.6
SD ± 2.4 + 2.1
(Paired t test =1.6; N.S)
(d = 1.2; SD + 2.0; variance = 4.0
TABLE L  li 1
COMPARISON BETWEEN TWO METHODS FOB COHB MEASUREMENT j_ 
GAS-CHROMATOORAPHY AND A SPECTROPHOTOMETRY BY CO­
OXIMETER 282 FOR 31 PATIENTS.
ISample 
! No.
ICO-oximeter
j 282
I PPm
Gas
chromatography
ppm
ISample 
j No.
ICO-oximeter 
I 282
j ppm
i
I Gas ! 
I chrcmato-| 
jgraphy pprni 
|__________}
I 1 I 1.0 6.8 I 17 1 2.0 1 5.6 {
I 2 I 2.5 7.2 i 18 1 10.5 1 5.9 1
I 3 I 3.0 5.5 I 19 I 4.0 1 7.6 j
I 4 I 3.0 7.3 1 20 I 2.5 S 6.1 j
I 5 I 3.5 8.0 I 21 I 16.5 I 2.5 !
I 6 I 2.5 9.8 I 22 I 23.3 i 3.1 I
I 7 I 1.5 4.3 ! 23 I 15.0 . I 3.1 i
! 8 I 2.5 4.5 I 24 I 3.0 i 6.4 j
I 9 I 1.0 5.2 I 25 I 6.5 i 6.7 !
I 10 I 0.0 6.9 I 26 I 11.5 I 7.7 !
I 11 I 3.5 5.0 I 27 I. 16.5 I 5.6 !
I 12 I 6.0 4.4 I 28 I 13.0 I 6.6 |
i 13 I 1.5 0.0 I 29 ! o.o I 7.3 !
i 14 I 0.5 4.3 I 30 i 11.0 I 11.3 S
I 15 I 1.5 0.0 I 31 I 20.5 I 4.3 !
i 16 I 0.5 3.6 i
L
I I
CO-oximeter 282 Gas-chromatography
mean 6.1 5.6
SD +6.6 + 2.4
The mean _of the differences between the two methods (d") =
0.55-f SD (d)+ 7.2 and variance s 52.1.
A 95% confidence limit for the mean of differences = - 1.7 and 
2.8 which means that there is no evidence of bias 
between the two methods but many of the individual 
differences are very large.
v . . .  . .
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T a b l e  L  15. 1
RAPID CHANGES IN BLOOOD CARBOXYHAEKOGLOBIN EVERY 30 MINUTES 
ANALYSED BY CO-OXIKETER 282.
I Time 
{Subject 
I No.
I_____
1
I o 
1
I After 
130 minutes
1 ________
I After 
{60 minutes { Variance {
1 1
j
1 4.2 I 4.4 J 4.1 { 0.02 {
I 2 
!
1 5.2
i
1 9.0 { 7.7 { 3.73 {
I |i
1 3
l
1 7.8 i 8.5 { 7.7 I 0.19 {
| ii
! 4 1 7.8 1 10.5 { 10.0 1 2.06 {
1
! 5 
!
1 6.6 1 7.5 { 5.8 1 0.72 !
; ii
1 6 
1______
1 5.6 1 6.3 } 6.0
i i 
{ 0.12 {
All subjects were smokers.
Reliability of whole group (rk) =0.95 
Reliability of each single measurement (r1) = 0.87
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TABLES AND DIAGRAMS
CARBON M)NOXIDE IN BREATH IN SCHOOL PUPILS AND 
HOSPITAL EMPLOYEES AND CROSS SENSTIVITY BETWEEN 
BREATH CO AND HYDROGEN.
ACCURACY OF CARBON EDNOXIDE FOR IDETIFICATION OF 
SPDKERS.
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table L 11 1
RELATIONSHIP BETWEEN SMOKING HABIT AND BREATH CARBON
MONOXIDE FOR GLASGOW HIGH SCHOOL PUPILS.
Smoking ! 
Breath CO I
Smokers !
ii
Non- I 
Smokers i
Row
Total
ii
10+ ppm !
ii
9 !
ii
7 ! 16
ii ii ii (15.2)
<10ppm ! 27 i 62 ! 89
i ii ii (84.8)
Column 1 36 j 69 ! 105
Total ! (3*1.3) ! (65.7) i (100.0)
Percentage shown in brackets.
(Chi-square = 4.04; df= 1; p<0.05 )
Sensitivity of breath CO test 0.25
Specificity 0.9
Predictive value of a positive test 0.56
Predictive value of a negative test 0.70
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TABLE (18)
TIME BETWEEN LAST SMOKED CIGARETTE AND CARBON MONOXIDE TEST
FOR GLASGOW HIGH SCHOOL PUPILS.
Time
CO ppm
>12 h ! <12 hours
1
Row
Total
10+ ppm 7 i 2
1 9(25.0)
<10 ppm 22 1 5
1
27
(75.0)
Column 29 ! 7 36
Total (80.6) ! 09.4) (100.0)
Percentage shown in brackets. 
Only 36 pupils were smokers
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TABLE (19)
BREATH HYDROGEN FOR GLASGOW HIGH SCHOOL PUPILS.
! Breath 
! Hydrogen
Smokers Non-
Smokers
Row
Total
j >20ppm 5 8 13
(23.2)
I <20ppm 15 28 43
(76.8)
! Column 20 36 56
(35.7) (64.3) (100.0)
Breath hydrogen was done for 56 pupils. 
Percentage shown in brackets. 
(Chi-square = 0.06; df = 1; N.S )
TABLE L 20 I
SMOKING HABIT AND BREATH CARBON MONOXIDE FOB RUCHILL HOSPITAL 
EMPLOYEES MEASURED BY GUI CO-MONITOR.
Smoking 
Breath CO
Smoker Non-
Smoker
Row
Total
10+ppm 43 0s 52
(36.4)
<10ppm 15 76 91
(63.6)
Column 58 85 143
Total (40.6) (59.4) (100.0)
Percentage shown in brackets.
(Chi-square = 60.2; df =1; p<0.001)
Senstivity = 0.74 ; specificity = 0.89
Predictive value of positive test = 0.83 and 
0.83 for negative test.
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TABLE L 21)
TIME BETWEEN LAST SMOKING AND BREATH CARBON MONOXIDE FOR 
RUCHILL HOSPITAL EMPLOYEES.
! Time 
'CO ppm
<1 hour 1-4 h >4 hours Row
Total
! 10+ ppm 30 11 1 42
(72.4)
j <10 ppm 7 2 7 16
(27.6)
I Column 37 13 8 58
I Total (63.8) (22.4) (13.8) (100.0)
Percentage shown in brackets.
(Chi-square = 16.7; 2 df; p< 0.001 )
There is significant relationship between breath CO and 
time since last cigarette. The longer the interval the 
lower the breath CO.
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TABLE (22)
BREATH HYDROGEN FOR RUCHILL HOSPITAL EMPLOYEES.
Smoking
Breath
Hydrogen
Smokers Non-
Smokers
Row
Total
>20ppm 3 7 10
(7)
<20ppm 55 78 133
(93)
Column 58 85 143
Total (40.6) (59.4) (100.0)
Percentage shown in brackets.
(Fisher's exact probability =0.0 9; N.S).
TABLE (23)
SENSITIVITY AND SPECIFICITY OF BREATH CARBON MONOXIDE FOR 
RUCHILL HOSPITAL EMPLOYEES AND GLASGOW HIGH SCHOOL PUPILS AT 
DIFFERENT CO LEVELS. ..
I Breath CO Hospital employees School Children !
I level SensitivityISpecificity Sensitivity{Specificity {
I 6 ppm 0.84 0.64
i i
! 7 ppm 0.81 0.76
i i
0.42 | 0.75 1
1 i
I 8 ppm 0.81 0.82
i i
0.33 I 0.80 {
I ;
I 9 ppm 0.74 0.87
I 1
0.28 I 0.87 1
I 10 ppm 0.74 0.89 .0.25 ! 0.90 {
i 11 ppm 0.72 0.89 0.11 | 0.94 {
1 i
I 12 ppm 0.72 0.91
i i
1 I
I 13 ppm 0.67 0.94
j 14 ppm 0.66 0.95
1 1
I 15 ppm 0.62 0.96
t i
S 16 ppm 0.59 0.96
i i
i i i i
i 17 "ppm 0.55 0.96
i S
i i i i
The minimum total error for breath CO for the employee is 
between 8-12 ppm and that for the school pupils is at 7 ppm. 
Note: School pupils have a narrow range of breath CO.
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TABLES
ASSESSING EFFECTIVENESS OF HEALTH EDUCATION INTERVENTION
- DESCRIPTION OF THE TWO FOLLOWED UP GROUPS AND 
COMPARISON BETWEEN THEM
- CHANGES IN SMOKING HABIT FOR BOTH GROUPS OF PATIENTS.
- CHANGES IN OTHER FACTORS INVOLVED IN HEALTH EDUCATION.
- CHARACTERISTICS OF THE GROUP GIVING UP SMOKING.
TABLE L 24 1
AGE AND SEX DISTRIBUTION OF THE NON-INTERVENTION GROUP.
Sex
Age
Male Female Row ! 
Total !
i
<45 6 2 8 I
(12.7) !
45-55 15 6 21 I 
(33.3) !
>55 years 26 8 34 I
(54.0) I 
1 1
Column 47 16 63 !
Total (74.6) (25.4) doo.o) !
i
. . i
TABLE L 2S. 1
AGE AND SEX DISTRIBUTION OF THE HEALTH EDUCATION GROUP
Sex
Age
Male Female Row ' 
Total i
ii
<45 3 3 6 !
(25.0) !
45-55 5 0 5 !
(20.8) !
>55 years 8 5 13 !
V- (54.2) ji
Column
Total
16
(66.7)
8
(33.3)
24 ! 
doo.o) !
Percentage shown in brackets.
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TABLE 126}_
SOCIAL CLASS AND FOLLOW-UP SMOKING HABIT IN NON-INTERVENTION GROUP.
Smoking habit 
Social class
Non- & 
Ex- 
Smoker
Smoker
Row ! 
Total |
i
i
____  _ . i
Social Class 6 6
ii
12 !
I, II &IIINM (21.8) |
Social Class 12 15 27 !
III M, IV& V (49.0) !
Retired 5 4 9 !
(16.4) !
Unemployed 1 6 7 i
(12.7) !
i
Column 24 31 55 i
Total (43.6) (56.4) (100.0) |
ii
Eight cases missed
(Chi-square for collapsed table social classes I,II, 
IIINM and the others = 0.25; 1 df; N.S).
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TABLE (27)
SOCIAL CLASS AND FOLLOW-UP SMOKING HABIT IN HEALTH EDUCATION GROUP.
S Smoking 
! Social Class
Non- & 
Ex- 
Smokers
Smokers Row !
ii
Total !
i
! Social Class 
! I,II,III NM
4 1 5 i 
( 2 5 . 0 )  I
i Social Class 
! Ill M, IV & V
5 1 6 j 
( 3 0 . 0 )  {
i Retired 2 3 5 ! 
( 2 5 . 0 )  |
! Unemployed 1 3 4 ! 
( 2 0 . 0 )  |
1 Column .12 8 20 |
1 Total ( 6 0 . 0 ) ( 4 0 . 0 ) ( 1 0 0 . 0 )  !
i
4 cases social class could not be ascertained.
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TABLE (28)
SOCIAL CLASS 'AND-KNOWLEDGE ABOUT CHD IN NON-INTERVENTION GROUP.
S.class 
Knowledge
Retired & 
unemployed
Soc.Class 
I,II,IIINM
Soc.class 
HIM, IV, V
Entire
patients
Mean Sore 
Number
Standard
deviation
11.6
22
* 2.3
12.2
12
^1.2
10.5
29
*• 2.3
11.2
63
*2.2
The maximum possible score is 16. 
(Oneway ANOVA = 2.08; 2,60df; N.S)
TABLE (29)
SOCIAL CLASS AND KNOWLEDGE ABOUT CHD IN HEALTH EDUCATION GROUP.
S.Class 
Knowledge
Retired & 
unemployed
Soc.class 
I,II,IIINM
Soc.class 
IIIM,IV,V
Entire
patients
Mean Score 
Number
Standard
deviation
11.8
13
*  2.3
12.0
5
* 2.5
10.8
6
=b1 .5
11.6
24
a - 2.1
The maximum possible score is 16. 
(Oneway ANOVA =0.56; 2,21df; N.S)
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TABLE L 3Q. 1
LIFE EVENTS IN THE YEAR BEFORE HOSPITAL ADMISSION FOB 
BON-INTERVENTION GROUP,
j M. infarction ! Yes I No I Row
i Life events |
t 1
!
I ____ ___j
Total
! 1
{ Job loss I 1
I ! 
i 2 | 3
(1.6) (3.2) ! (4.8)
j Death of family member! 2 ' 6 ! 8
(3.2) j (9.7) 1 (12.9)
I Financial problems I 4 1 2  | 6
(6.5) (3.2) ! (9.7)
I Residence change ! 1 0 | 1
(1.6) (0.0) ! (1.6)
! More than one i 3 6 i 9
(4.8) (9.7) ! (14.5)
! None ! 14 21 | 35
(22.6) (33.9) I
1
(56.5)
! Column total ! 25 37 1 62
j-- ----------------_ _ j
(40.3) (59.7)!
1
(100.0)
1 case could not be ascertained.
(Chi-square test =0.0; 1 df; N.S between none and 
presence of any of the life events).
TABLE (31)
LIFE EVENTS IN THE YEAR BEFORE HOSPITAL ADMISSIN FOR HEALTH 
EDUCATION GROUP.
! M. infarction 
i Life events
Yes ! No 
1 1 
1
I Row !
! Total | 
1 1
j Job loss 3
1t
! 0
1 1 1 1
1 3 1
(12.5) ! (0 .0 ) ! (12.5) !
! Death of family member 1 i 1 ! 2 !
(4.16) I (4.16) I (8.3) I
! Financial problem 3 I 1 ! 4 !
(12.5) ! (4.16) I (16.7) !
! More than one 0 i 2 I 2 i
(0.0) ! (8.3 ) I (8.3) !
! None 9 ! 4 ! 13 I
(37.5) 1(16.7) ! (54.2) |
I Column Total 
!
16
(66.7)
! 8 
! (33.3)
I 24 ! 
! (100.0 ) !
Percentages shown in brackets.
No residential change.
(Chi-square test =0.0 8; 1 df; N.S between none and
presence of any life events).
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TABLE (32)
STRESS AND MYOCARDIAL INFARCTION IN NON-INTERVENTION GROUP.
MI
Moderate 
& Severe
No & mild 
stress
Row
Total
Yes 19 7 26
(43.3)
No 22 12 34
(56.7)
Column
Total
41
(68.3)
19
(31.7)
60
(100.0)
3 cases could not be ascertained. 
(Chi-square test = 0.48; 1 df; N.S )
TABLE L 21 L
STRESS AND MYOCARDIAL INFARCTION IN HEALTH EDUCATION GROUP.
Viiii1 
y
iiii
Moderate
stress
No&mild
stress
Row
Total
Yes 15 1 16
(66.7)
No 6 2 8
(33.3)
Column
Total
21
(87.5)
3
(12.5)
24
(100.0)
There was no severe stress in this group. 
(Fisher's exact probability =0.22 ; N.S)
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TAELE L 24 1
COMPARISON BETWEEN LABORATORY FINDINGS IN BOTH GROUPS.
| GROUP non­ { Health . I !
I Investigation Type intervention { Education {Difference{
t_______________ ______ ___________
group
i
group I 5 
I I. i_ ______ ;_j
} Myocardialinf arction 43.2 % 1 66.7 % I NS !
{Cardiac enzymes for I I
I MI patients I I
I SGOT 043 U/L) 96.0 % 1 - 87.5 & ■/» - I HS |
|CK enzyme (>160 U/L) 96.0 % I 93.9 % I KS |
|LD (> 230 U/L) 92.0 % i 68.8 % I HS |
{High Triglycerides I I
|(> 1.8 mmol/L) 20.6 % { 16.7 % I HS I
j High Cholesterol I I
I (>7.6 mmol/L) 
1
9.5 % 1 8.5 % I HS | 
1 1
I Haemoglobin i
i i 
{ ;
I < 14 56 49.2 % 1 37.5 % J NS }
I between 14-18 % 49.2 % I 53.8 ctfi { NS {
I >18 * 1.6 % 1 4.2 % I NS {
{High Blood sugar
I
12.7 % i 8.3 % { NS { 
{
N.S a not significant.
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t a b l e L151
ENTRY CARBOXYHAEMOGLOBIM AND NUMBER OF CIGARETTES SMOKED PER 
DAY FOR NON-INTERVENTION GROUP.
-----------------------------------------
COHb ! 
Cigarettes No.!
< 2  !
»i
2- 4 >4
% satu.
Row ! 
Total !
<15 !
I
2 i 
1
23 3
.
I 28 } 
(44.4)!
15-25 !
•i
2 !
ii
11 6
. .
1 9 !  
! (30.2)!
>25 Cigt/day !
ii
2 ! 
1 1
10 4 16 ! 
! (25.4)!
Column ! 6 | 44 13 63 !
Total i (9.6) ! (69.8) (20.6) ! d o o . o )  I
(Oneway ANOVA done on raw values gives F=0.98; df=2,60; N.S)
TABLE L 36 1
ENTRY C ARBOX YH AEMO GL OB IN AITD NUMBER OF CIGARETTES SMOKED PER 
DAY FOR HEALTH EDUCATION GROUP.
COHb
Cigarettes No.
! < 2
ii
2- 4 j 
: % Satu. |
Row ! 
Total j
i
<15
ii
! 1
ii
1 1 1 1
! 16 ! 
I I
1
17 ! 
(70. 8)
>15 Cigt/day ! 3
ii
! 4 !
i i i
7 ! 
(29.2) !
Column ! 4 ! 20 { 24 !
Total ! (16.7) 1 (83.3) ! (100.0)!
Percentages shown in brackets.'
(Oneway ANOVA done on raw values gives F=0.16; df=1,22; N.S)
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TABLE (37)
FOLLOW-UP C ARBOX YH AE MO GL OB IN AND NUMBER OF CIGARETTES SMOKED 
PER DAY FOR NON INTERVENTION GROUP.
COHb 
Cigarettes No.
< 2 i 2-4 >4$ sat. Row
Total
Non-smokers 23 2 1 26
(41.3)
< 15 3 3 9 15
(23.8)
15-25 2 3 11 16
(25.4)
>25 Cigt/day 3 1 2 6
(9.5)
Column 31 9 23 63
Total (49.2) (14.3) (36.5) (100.0)
(Oneway ANOVA ; F=13.77; 3,59 df; p<0.001 see page 180)
TABLE L 31 1
FOLLOW-UP CARBOXYHAEMOGLOBIN AND NUMBER OF CIGARETTES SMOKED 
PER DAY FOR HEALTH EDUCATION GROUP.
COHb 
Cigarettes No.
< 2 2- 4 >4$ sat. Row { 
Total !
Non-smokers 11 V 3 15 ! 
(62.5)!
<15 1 1 2 4 j 
(16.7)1
15-25 cigt/day 1 1 3 5 ! 
(20.8) !
Column 13 3 8 24 !
Total (54.2) (12.5) (33.3) (100.0)!
Percentages shown in brackets.
The two groups 15-25 and group >25 cigt/day were combined 
due to small frequencies.
(Oneway ANOVA; F= 2.86; 2,21df; Just N.S see page 181)
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TABLE H i l
COMPARISON BETWEEN ENTRY AND FOLLOW-UP COHb IN 
NON-INTERVENTION GROUP.
-Mean of differences= 
0.83$ sat; SD ± 3.6 
-Paird t test = 1.85;
62 df; N.S.
-95$ confidence intervals 
-0.07 to 1.7
TABLE (40)
COMPARISON BETWEEN ENTRY AND FOLLOW-UP COHb IN HEALTH 
EDUCATION GROUP.
-Mean differences=
-1.16$ sat; SD±.6 .T 
-Paired t test =
-0.93; 23df;N.S.
-95$ confidence interval 
= -3.7 to 1.4
Entry COHb- 
follow upCOHb
Frequencies Percentage
$
-10 to -11.9 2 8
- 8  to -9.9 2 8
-6 to -7.9 1 4
-4 to -5.9 0 0
-2 to -3.9 9 38
0 to -1.9 0 0
0.1 to 1.9 4 17
2 to 3.9 2 ' 8
4 to 5.9 0 0
6 to 7.9 1 4
8 to 9.9 2 8
10 to 10.9 1 4
Total 24 100
! Entry COHb- 
j follow upCOHb
SFrequencies I 
1 1 
1 1
Percentage
$
! -6 to -7.9 ! 2 ! 3
{ - 4 to -5.9 ! 3 ! 5
i - 2 to -3.9 ! 10 ! 16
! 0 to -1.9 I 10 I 16
! 0.1 to 1.9 ! 9 ! 14
! 2 to 3.9 ! 22 ! 35
j 4 to 5.9 ! 5 i 8
j 6 to 7.9 I 0 ! 0
! 8 to 9.9 S 0 S 0
j 10 to 11.9 ! 2 i 3
! Total ! 63 \ 100
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TABLE (41)
TYPE OF HOUSE HEATING AND CARBOXYHAEMOGLOBIN LEVEL FOR
ALL FOLLOWED UP PATIENTS •
COHb
Heating
Electricity
Open fire or 
Gas
Central
Heating
More than one
<2 2 - 4
26
13
15
>4
% sat.
Row
Total
31
(36.4)
21
(24.7)
21
(24.7)
12
(14.1)
Column
Total
9
(10.6)
63
(74.1)
13
(15.3)
85
(100.0)
2 cases missed
TABLE (42)
TYPE OF HOUSE HEATING AND CARBOXYHAEMOGLOBIN LEVEL 
(STATISTICAL FINDINGS)
COHb
Heating
Number Mean COHb 
% satu.
SD
Electricity 31 0.05 5.59
Open fire or gas 21 4.13 11.66
Central Heating 21 1.98 4.33
More than one 12 1.03 5.13
Total patients 85 1.67 7.21
(Oneway ANOVA F= 1.02; 3,81 df; N.S).
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TABLE L 431
THE DIFFERENCES BETWEEN THE NUMBER OF CIGARETTES SMOKED PER DAY 
AT ENTRY MINUS THE NUMBER AT FOLLOW UP.(NON-INTERVENTION GROUP)
iDifference Frequencies I Percentage {
{entry cigt/day I % |
!- follow up i i
{ cigt/ day I I
. |___ .________ J
J - 14 to-15 6 i 9.6 {
I - 12 to-13 4 ! 6.3
{ - 10 to-11 1 I 1.6 {
{ - 8 to - 9 2 ! 3.2 !
I - 6 to -7 1 ! 1.6 {
! - 4 to -5 3 ! 4.8 I
! - 2  to -3 0 ! 0 .0 {
{ o to -1 24 I 38.0 !
! 1 to 2 2 ! 3 .2 {
I 3 to 4 4 I 6.3 !
i 5 to 6 5 ! 7.9 I
! 7 to 8 3 I 4.8 !
{ 9 to 10 8 ! 12.7 I
The mean of differences = 2.1 cigt/ day S.D ± 7.3 
( Paired t test = 1.12; df= 62; N.S)
TABLE (44 )
THE DIFFERENCES BETWEEN THE NUMBER OF CIGARETTES SMOKED PER DAY 
AT ENTRY MINUS THE NUMBER AT FOLLOW UP IN HEALTH EDUCATION GROUP
Differences (Entrey 
minus follow up ) 
cigarettes per day
■
Frequencies
■ ■
.
■■
Percentage
%
- 10 to - 11 1 4.2
- 2 to - 3 1 4.2
0 to - 1 6 25.0
1 to 2 0 0 .0
3 to 4 0 0.0
5 to 6 4 16.0
7 to 8 0 0 .0
9 to 10 1 4.2
11 to 12 0 0 .0
13 to 14 I 2 8.3
15 to 16 I 0 0 .0
17 to 18 I 6 25.0
I 19 to 20 I 3 12.5
The mean of differences =8.2 Cigt per day S.D t 9.1 
(Paired t test = 4.4; df= 23; p<0.001)
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TABLE L 15. 1
COMPARISON BETWEEN SELF-REPORTED SMOKING HABIT OF THE TOO GROUPS 
AT ENTRY AND FOLLOW-UP EXAMINATIONS.
j Follow-up smokingi
! GROUP 
1 _ _ _
{Non-smokers!
i i
Smokers { Row {
{ Total { 
! !ii
I Non-intervention 1 26 { 37
i |
! 63 !
1i I (41.3) I ! !
(58.7) ! doo.o) Ii ii
1 Health education
i i
I 15 ! 9
i i
! 24 {
I group 
1 _
! (62.5) ! (37.5) { (100.0) { 
... 1
j Column ! 41 ! 46 ! 87 !
i Total
i _
I (47.1) ! (52.9) ! (100.0) { 
1_ ^ , 1
Percentage shown in brackets. 
(Chi-square = 3.1*1; 1 df; N.S)
TABLE (45A)
COMPARISON BETWEEN SMOKING HABIT OF THE TWO GROUPS AT ENTRY 
AND FOLLOW-UP EXAMINATION (BREATH CO TEST).
-------- ----------
1Follow-up smoking 
I GROUP 
1______________ _ __
Non-smokers 
up to 9 ppm
Smokers 
10 + ppm
Row { 
Total !
! Non-intervention
! Health education 
! group
21
(33.3)
11
(45.8)
42
(66.7)
13
(54.2)
63 ! 
(100.0) { 
24 { 
(100.0) {
{ Column Total 32
(36.8)
55
(63.2)
87 I 
(100.0) |
Percentage shown in brackets.
(Chi-square = 1.17; 1df; N.S)
For this table the cut-off point of 9 ppm is taken from 
The litrature.
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TABLE (46)
FOLLOW-UP SMOKING HABIT AND BREATH CO FOR NON-INTERVENTION GROUP.
j Breath CO ! 
! Follow-up I 
! smoking habit !
<10
■■
10-20 ! 
I !
i
i i
>20ppm Row ! 
Total !
! 1 i I
j Ex-smokers j
i i i i
21
i
3 ! 
1
2 26 | 
(41.3)1
i Smokers 1
i i i i
8 18 I
i i i
11 37 1 
(58.7) 1
i
i Column ! 29 21 j 13 63 I
i Total j (46.1) ! (33.3) I (20.6) (100.0) i
(Chi-square = 21.5; 2df; p<0.001)
(Two-sample t test on the actual values = 5.87; 62 df; p<0.001)
TABLE (47)
FOLLOW-UP SMOKING HABIT AND BREATH CO FOR HEALTH EDUCATION GROUP.
Breath CO(ppm) j 
Follow-up ! 
smoking habit I
<10
ppm
10 -20 
ppm
>20
ppm
Row
Total
Ex-smokers 11 3 1 15
(62.5)
Smokers 1 5 3 9
(37.5)
Column 12 8 4 24
Total (50.0) (33.3) (16.7) (100.0)
Percentages shown in brackets.
(Chi-square= 8.7; 1df; p<0.01 for collapsed table <10 and 
10 and more ppm).
(t test on the actual values =3.05; 23 df; p<0.01).
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TABLE [ | 8  1
FOLLOW-UP BLOOD COHb MINUS BREATH CO DIFFERENCES FOB ALL 
FOLLOWED UP PATIENTS.
Follow-up Frequencies Percentage j
COHb minus % !
Breath CO
- 20 to - 23.9 7 8.1 !
- 16 to - 19.9 6 6.9 !
- 12 to - 15.9 7 8.1 !
- 8 to - 11.9 15 17.1 !
- 4 to - 7.9 26 29.9 !
- 0 to - 3.9 17 19.5 i
0 to 3.9 7 8.1 j
4 to 7.9 0 0.0 i
8 to 11.9 2 2.3 !
The mean of the differences = - 7.7 ppm S.D * 7.1 
(Paired t test = - 10.1; df= 86; p<0.001)
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TABLE 1
COMPARISON BETWEEN SOME OTHER FACTORS IN THE TWO GROUPS.
! Characteristics Non-intervent­ Health Educ­ Significance
ion ation group Chi-square
! Number (N) 63 24
! Age
i <45 12.72 25.02 NS
1 45 - 55 33.32 20.82 NS
j >55 Years. 54.02 54.22 NS
j Males 74.62 66.72 NS
S Weight
1 < 50 4.82 8.3 2 NS
! 50 - 60 19.02 8.3 2
J 60 - 70 33.32 37.52
! 70 - 80 31.72 33.52
! > 90 Kg 11.12 12.52
! Height NS
I <150 6.32 4.22
! 150 - 160 27.02 20.82
I 160 - 170 30.22 50.02
j > 170 cm 36.52 25.02
iAlcoholic drink NS
! Initial 61.92 50.02 NS
I follow-up 63.52 41.72 NS
!Tea consumption
j Initial 88.92 95.82 NS
i follow-up 90.52 83.32 NS
!Coffee consumption 55.42 60.22 NS
'Activity in work . 66.12 50.02 NS
NS= not significant.
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APPENDICES
DEPARTMENT OF COMMUNITY MEDICINE, UN 1 VERS I TV OK GLASGOW 
CONFIDENTtAL
Q U E S T 1 0 N N A  1 HE. C R 1,
All information which could permit identification of the individual 
will be treated as strictly oonfidential, will be used only by 
persons engaged in and for the purposes of this survey, and will 
not be disclosed for any other purpose.
Ploase answer all the questions in this health record, and bring 
it with you ut the advised time and place. Put a tick In the 
appropriate boxes. If you cannot give un exact answer, give the 
best estimate you can.
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DEPARTMENT OF COMMUNITY MEDICINE, UNIVERSITY OF GIASHOW 
QUESTIONNAIRE. C1I.1.
Surname (Mr./Mrs./Miss)  ............ ....... ....... ..
(BLOCK LETTERS)
First Names:........................... ...............
Address:......................................... ... .
Postcode
Tel. No. (Home):..................................
Family Doctor:  ............ .............. .
Add ress:  ............................ ..........
I a) What is your occupation? (Please describe as fully
as possible)
b) Are you 1 G  a manager?
2 0  a foreman?
3 Q  an employee not 1 or 2
4 0  self-employed without employees?
5 0  self-employed with employees?
c) If you are a full-time housewife, what is your
husband’s occupation?
2a) What Is your date of birth?
Day Month Yea r
b) Where have you 1 (“I in the country? (isolated
____ i.   i. 1 i i i  i 1spent most of 
your life? 
(more than 
half number 
of years)
dwelling, hamlet or small 
community)
2 P] in a village?
3 Q  in a town?
4 pj in a city?
5 elsewhere?
c) Is it industrial? i n Yes 2 Q  No
•5 a) Sex 1 D  Male 2 Female
b) A«re you a twin? l £ |  Yes 2 £ 3  No
If yes, are you 1(3 Like 2 13 Unlike twin?
4 Are you I Q  Married? 2 □  Single? '
3 f) Widowed? 4 pj Separated? 5£1 Divorced?
5 Do you usually have a cough? 1 (Q Yes 2 jq_ No
U Do you usually bring up any phlegm from your chest first 
thing in the morning in the winter?
1 □  Yes 2 p  No (If no, go to question 9)
7 Do you bring up phlegm on most days for as much as three 
months in the winter each year?
1 l3 Yes 2 i j No
For official use only
Ref,
Card No.
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8 J.n the past three years have you had a period of
increased cough and phlegm lasting for three weeks or more?
'■Q Yes - one period 2 1' 1 Yes - 2 or more periods 
3 □  No
9 Do you get short of breath walking with people of your own 
age on level ground?
1. Q  Yes 2 □  No
it) Does your chest sound wheezy or whistling on most days (or 
nights)7
1 □  Yes 2 D  No
11 How much exercise do you get at work?
1 f~~| None 2 [~j A small amount 3 A lot
12 How much exercise do you get on the way to and from work 
each day?
............ Minutes
13 How much physical exercise do you engage in outside work
each day or at the weekend? .. . ...... ....Hours per week
14 What is your usual physical activity at work during the 
past year?
iQ  Severe 2 □  Moderate 3 P  None 4 O Unsure
15 a).Have you experienced in the last year
i Q  loss of job? 2 0  death of a family member?
3 Q  financial problems? 4 □  change of residence?
5 Q] more than one of above? 6 Q  none of the above?
b) If so, when?
1 □  1 month ago 2 p  3 months ago 3 {HZ3 4-6 months ago
4 7-12 months ago
16 How many hours in twenty four do you usually sleep?
.............hours
17 How much of the following drinks do you usually take each 
day?
•0 Milk. *••• Cups Coffee......cups
u) Tea,., cups
18 a) Do you take sugar in tea or coffee? 
i Q  Yes 9 CZjNo 3 Q  Varies
b) Do you take sugar on cereals or pudding?
1 □  Yes . 2 Q N o
-.9 How much of the following are you accustomed to taking
each week?
a) Spirits........ nips b) Beer........pints
i?) Wine...........glasses
for official use only
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/.25T
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I
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20 Do you usually eat salads?
- Most days — .Less than 
I '— J of week ^ *— * once a week
- 3 -
3 IH3 Nevei
21 a) Do you smoke.cigarettes now?
! □  Yes 2 { 1 No (If no, go to question 22)
b) If yes, are they
1 \ |Low tar? 2 | 1 Medium tar?
c) Do you inhale?
1 Q  Yes 2 | 1 No
d.) What kind of cigarettes do you smoke?
1 Q  Manufactured with filters
2 p  Manufactured without filters  ^dj Hand rolled
e) How many manufactured cigarettes do you usually smoke 
oer day? Number per day...........
f) About how many ounces of tobacco do ycu use per weul;
for rolling your own cigarettes? „....... Oz.per week
g) What is the maximum number of cigarettes that you have
smoked per day for as long as a year? (include hand
rolled)........Number per day
h) How old were you when you began to smoke cigarettos
regularly? ^
22 a) If you do not smoke cigarettes now, did you ever smoke 
them regularly?
i □  Yes 2 jd No, never (If no, go to question 23)
b) If you used to smoke regularly, what is the maximum
number of cigarettes you ever smoked per day for as
long as a year? ,
 ....... Number of cigarettes
c) Did you inhale?
1 PI Yes 2 □  No
d) How old were you when you began to smoke cigarettes?
Age....................
e) When did you stop smoking cigarettes? (Give year of
Year. ...... stopping)
For official use only
1* Til
1. fi5i
1.52
1 ..54
TTSiV
1. 56 1. 57
1.58 1. 59
1.60! 1.61
1.62 L 63
rmra
1. G!
1. 67
1. 68
1. 66
1.70
1. 69
1.71
23 a) Have you ever smoked a pipe regularly?
1 No (if No, go to question 24)
2 Used to smoke a pipe but not now (go to d))
3 Now smoke a pipe
b) If you smoke a pipe now, about how many ounces of 
tobacco do you smoke?
......... 0z. per week
c) Do you inhale?
1 □  Yes 2 | I No
d) How old were you when you began to smoke u pipe?
Age..............
Ref. No. 
Card No.
i at 7..CI
^ L . o l 2  „cjW
2 .0 *1
' . r o
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e) 
?.4 a)
b)
c)
2 5 a)
b>
26 a)
b)
c)
d)
e)
f)
If you do not smoke a pipe now, when did you stop?
(Give the year)J Year.............. .
Does any member of your family smoke?
i Q  Father 2 a  Mother 3 a  Sister 4 □  Brother 
5 I f More than one member of family B dj None 
Do they smoke
1 Q  Cigarettes? 2 Q  Cigars? 3 | | Pipe? 4
What is the longest duration of 
smoking? one
Number of years..........
Have you ever smoked cigars (including small cigars)
regularly?
lCU No (If No, go to question 26)
2 d  Used to smoke cigars but not now 
3 0  Now smoke cigars
If you smoke cigars now, about how many do you smoke
per week?
Number per week............
Have you ever had any pain or discomfort in your chest?
1 Yes 2 j iNo (If No, go to question 27)
Do you get this pain or discomfort when you walk 
uphill or hurry7
1 □  Yes 2 Q No
Do you get it when you walk at an ordinary pace on the
level?
I Q  Yes 2 Q No
When you get any pain or discomfort in your chest, 
what do you do?
1 □  Stop 2 | jSlow down 
3 p~| Continue at the same pace
Does it go away when you stand still?
1 Q  Yes 2 □ N o
How soon?
1 { | 10 minutes or less * □  More than 10 minutes
Where do you get this pain or discomfort? (Mark the 
place(s) with an X on the diagram
2.14
2.15
2.16 2.17
"2: in-'
2. 19 2. 20
3 - . -3 .7 -
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17 Have you ever had a severe pain across the front of your 
chest lasting for half an hour or more?
1 □  Yes 2 D No
28 a) Do you get a pain in either leg or foot on walking?
1 Q  Yes 2 Q n o  (If no, go to question 29)
b) Does this pain ever begin when you are standing still or
, -- ' „  M sitting?
1 I | Yes 2 j jNo
c) Do you get the pain in your calf or calves?
1 D Y e s  2 [JNo
d) Do you get it when you walk uphill or hurry?
1 [j Yes 2 [[[J No
e) Do you get it when you walk at an ordinary pace on the
1 □  Yos 2 P  No lBVel7
f) Does the pain ever disappear while you *re still
1 □  Yes 2 Q N o  walking?
g) What do you do if you get it when you are walking?
Stop 2 ( ( Slow down 3 Q  Continue at the same pace
h) What happens to it if you stand still?
i D  Usually continues for more than 10 minutes 
2 D  Usually disappears in 10 minutes or less
29 Do you have diabetes?
i D  Yes 2 £3^° 3 r j Do not know
30 Do you have high blood pressure?
1 1 | Yes 2 Q no 3 Q  Do not know
31 Do you regularly take any medicine? 
i n  Yes 2 □  No
32 a) Have you ever been in hospital?
1 |~ | Yes 2 J~*|No
b) If yes, please give the following information for each
admission:
Year Nature of Jllness or what was wrong
1  . . .      .
2.        .....................
3......................................................
(Attach separate sheet of paper if necessary)
33 a) Are your parents both alive?
Yes 2
If no
b) What caused your father’s death?  ..............
Age at death..............
c) What caused your mother's death?.......,....,..........
lira n t  rioath. . ...............
2.3-.
J-V?
T W
2.31
1 4o
T n n 2.4: ; 243
2.44' 
2.47
2.4: i 2A?
2.4t 23 5"
2-Ao
3'5V
.7'J*
a.sy
4'(>C
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3*1 If you are married, does your wife/husband suffer from
a) Bronchitis? * o  Yes 2 Q  No
b) Heart trouble? 1 Q. Yes 2 { | No
35 a) What was your first regular occupation, excluding temporary 
work? (Please give full description)
b) What was your father's main occupation? (Please give full
description)
36 Please indicate by a tick in the appropriate box in each of the 
following sections which description fits you best.
a) In general I am usually tense or nervous
THIS DESCRIBES ME: 1 □  Exactly
2 J] To some extent
3 0  Not very accurately
4 O  Not at all
b) There is a great amount of nervous strain connected with my 
daily activities
THIS DESCRIBES MY SITUATION: II— | Exactly
2 j | To some extent
3 C D  Not very accurately
4 I j Not at all
c) At the end of the day I am completely exhausted mentally and
physically
THIS DESCRIBES ME: 1 □  Exactly
2 I I To some extent
3 C D  Not very accurately
4 I jNot at all
d) My daily activities are extremely trying and stressful
THIS DESCRIBES MY ACTIVITIES: 1 Q  Exactly
2 3  To some extent
3 CD Not very accurately
4 CD Not at all
37 How do you feel about your present job?
1 CD Completely satisfied
2 CD Neither satisfied nor dissatisfied 3 CD Dissatisfied
38 a) How many brothers were there in your family (excluding
yourself)?
b) How many sisters were there in your family (excluding
yourself)?
c) Were you your mother's first child, second, third etc.?
2'ieJ I
i. U!*<
2.y o *  y/
2’U
i.ru-
.
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3D How many times have you changed your job since leaving school?
40 At what age did you finish full-time education?
• •  ............ years
41 How is your home heated?
1 Electricity 2 Open fire 3 Gas heaters
4 Central heating (any type) 5 gas 8s electricity 6 Other
pfj
PLEASE CHECK THAT YOU HAVE ANSWERED ALL THE QUESTIONS. 
THANK YOU FOR YOUR HELP.
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DEPARTMENT OF COMMUNITY MEDICINE, UNIVERSITY ,OF GLASGOW 
Confidential
Date: Ref. No.
Name: Ser.obaer, & Card No.
1 - Height (without shoes)  ...... ...inches
2 - Weight (indoor clothing) ............... pounds
3a Pulse rate/min  ....  ,/min
b Regularity Regular 2 □  Irregular
4 - Blood pressure (at rest) 
a Systolic BP ...............mmHg.
b Diastolic BP ..............mmHg«
5- Respiratory function tests 
a FEV 1.0..................
fvc
6 - X-ray 
a Cardiac size 
b Lung fields
1 I I normal 
1 normal 
* □  oedema
2 j 1 enlarged
4 } } effusion
5 [ ]^ other.
3 □  vonous congestion
7 - ECG changes 
t t n  Q wave
3 | ~ ]  LV1I
4 CD T inverted 
6 Q  BBB
8 1 | No abnormalities
2 - ST Seg. a I I elevation
b | jdepression - measure 
5 [3] A V Block 
7 { j Arrythmia
8 - Myocardial infarction
l Q  Yes 2 □ no 3 Q Not sure
9 - Cardiac Enzymes
1 SCOT (AST)..................   U/L
2 Total CK............   U/L
3 LD (Lactic dehydrogenase).......  U/L
10 - Blood serum: (Fasting)
a - Cholesterol.  ............ramol/L
b - Triglycerides........    .mmol/L
c - Blood sugar..,.....,,,...,.,...... .mmol/L
• t:: r;j. j_
i i i
5
<u 1 ?
? to i/
73 tu
!U •Y
rr io ~ ZI
3* *4
25' 24 7
ti "51
30 i t i z 33 i i f
3 * J Z
a
M b-2 A3 M -
Ay L'f
W) 50 •jt J X
*“ S3 57f
3'5 y<. *Y
5i Zo\
i
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(2 )
11_ Carboxy HB level  ..................
12- Haemoglobin level.................. .
13- Blood Oxygen   .......................
1 4 - Urine examination
a  Blood 2 □  Glucose 3
a  Normal More than one
P Protein
■o No15~ B. Blocker use 1|
1
16-Previous Myocardial infarction
II I Yes 2| | No /3| | Probablea
f • 17—  Cause of Admission
’ ' ■ -| I-- ”1 75i .7 1 Emergency 21 Non emergency’ f \ 1--- 1 ---
18- Fate 
1 Survived D -Died
fe. 6f
&
67-
T-b
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DEPARTMENT OF COMMUNITY MEDICINE, UNIVERSITY OF GLASGOW 
PREVENTION OF 5M0KING-RE1ATED DISEASE; FOLLOW-UP QUESTIONNAIRE 3
SURNAME:(Mr/Mrs/Miss)
FIRST NAMES
ADDRESS POST CODE
TELEPHONE NO.
CONFIDENTIAL
FOR OFFICIAL USE
t^of q..c
1. What is your occupation? (Please describe as fully as possible)
2. How much of the following drinks do you usually take:-each day?
a. Milk....... cups b. Coffee........cups
c. Tea. . . . . . . . cups
3. Do you take sugar in :tea .or coffee?
a. i Q v e s  z Q  No 3 | | varies
b. Do you take sugar on cereals or pudding?
1 □  V«  2 H  No
4. How much of the following are you accustomed to taking each week
a. Spirits...... .nips b. . Beer..../. . .pints
c. Wine.......... glasses
5. a. Do you smoke cigarettes now?
l j ~ J v e s  2 □  No. If 'No', go to next question
b. If 'Yes1, are they
1 | | Low Tar 2□ Medium tar
c. Do you inhale?
1 | | Yes 2 Q  No
d. What kind of cigarettes do you smoke?
Manufactured with filter..
Manufactured without filter 
Hand rolled
e. How many cigarettes do you usually smoke per day?
Number per day..
f. How many ounces of tobacco do you use per week for.: rolling 
your own cigarettes?
J L
4:0?
4« 0& 4-.01
4-^ 0 Mi
4it 411
4H
‘fZ*
w
4i4- 415
HR
♦'1
424 4?$
QZ6 47=?-
.oz. per week
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10.
11
12.
g. When did you finish your last cigarette? 
since...... hours........minutes---
h . What is your preferred brand name of cigarette?
Do you smoke a pipe now?
1 I I Yes 2 I I No 3 I I Used to smoke a pipe but
»— J  *- -*• I— J not now
If 'No1, go to next question
If you smoke a pipe now, about how many ounces of tobacco do
you smoke?
........oz. per week
Do you inhale?
Yes 2 Q  No
When did you finish your last smoking?
since...... hours.... .minutes
Do you smoke cigars now?
No 2 | | Used to smoke but nob now
Now smoke cigars 
If you smoke now, about how many do you smoke per week?
..... .per week
Have you any pain or discomfort in your chest after discharge 
from the hospital?
1 [” ~j Yes 2 [ ^ ]  No
Is it similar to pain you get before admission to hospital?
I [ [ Yes 2] j No
Do you have a raised blood pressure?
I I | Yes 2 | | No 3 | | Donitt know
Do you have, diabetes?
Yes 2 □  No 3| | Don't know
Have you been admitted to hospital in last 2 months?
1 [ J Yes 2 1 [ No
What is the cause?................ . . . . . . . . . . . . .......
When? Date. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
^2$ 4*1 m o
Y-Jz
tyf tyz.
44;
‘tty
W
ty(,
3lk
Health Education Questionnaire 4 Ref Number...... .......
Please tick the correct answers 
1 • ' '
1~ Have you given a booklet about health education and heart disease 
in the hospital? ,
i n  yes 2 | 1 nb 3 o  not sure 4 j | more than one
2~ Is that booklet similar to this booklet?
e~ small and yellow. □
b- Large blue one. □
3~what the important points do you remember which is applicable to you 
as regards these booklets?
A.. ............ ....... ...................... ......... .......
B..... ............................. ...........................
C-  ............. ..... ....... ...... .......................
4- Please tick the correct answer^ in this section.
A- Liability to get heart diseases is increased
1 1 I If heart disease runs in familye
2 □  The older the age the greater the risk.
3_J__ J women because they are more at risk than men.
4* | | in non smokers.
5-l_J Those who eat to much and not getting enough excercise,
B“ These things might give hi^h blood pressure *
1~|__] Being slim.
2~ j | smoking.
3- 1 | Eating toe much salt. /
4-1 | To much stress.
5 - 1 J Never Alcoholic drinks.
6- j J Regular physical activities.
c- I think the rules for losing weight are
1“ ’ | To cut down the amout of fat in the diet.
2- | | To eat more meat.
3~ ; | increase physical activity and sports.
4- j | use less lard or oil in cooking.
5“ | j not to cut down sugar in diet.
Thank you for your co-operation.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
o n lj
□
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HEALTH EDUCATION QUESTIONNAIRE (INVESTIGATION PART)
5- Height in cm ....
6- Weight in Kg ....
7- COHb % saturation.
8- Breath CO ppm
316
I l l l U ^ j p d l l  I I U c U U  I J J i c t l  I
conducted by the
Glasgow MMR Cardiorespiratory Screening Unit and the 
■ Department of Epidemiology and Preventive 
Medicine of the University of Glasgow ■
MMR Reference Number ; "
Questionnaire
All information which could permit identification •
, of the individual will be treated as strictly
• confidential, will be used only by persons 
engaged in and for the purposes of this survey, 
and w ill not be disclosed for any other purpose.
Please answer all the questions in this health -
f • record, and bring it with you when you
• come to the un it Write a tick in the
1 .. appropriate boxes. If you cannot give an exact . . . .  
answer, give the best estimate you can.
For official use only
1.01 1.02 1.03 1.04 1.0S 1.08 1.07
Surname (Mr.. Mrs.; Miss)
(BLOCK LETTERS).
Christian names . . . . . . . . .
A d d res s  .
Works n o : 
Dept n o : ..  
Check n o :
Family doctor 
Address .........
Dr.
1 a W hat is your occupation ? (Please describe as fully as possible)
b Are you 1 □  a manager?
2 □  a foreman ?
3 □  an employee ?
4 □  self-employed without employees?
5 □  self-employed with employees ?
2  a  W hat is your date of birth ? 
I Day of month Month Year
b Were you born 1 □  in the country? (isolated dwelling, hamlet or 
small community)
2 0  in a village?
. . • . 3 □  in a town?
\ I 4  □  in a city ?
> 5 □  elsewhere? (e.g. at sea)
1.09
uot
1.10 1.11 1.12
1.13
1.14 1.18 1.18 1.17 1.18 1.19
100
3 1 7
c Where have you lived for the most of your life?
'1 □  in the country ? (isolated dwelling, hamlet or 
small community)
• 2 □  in a village ?
3 □  in a town ?
4 □  in a city? ’
5 □  elsewhere ? (e.g. at sea)
3 Are you
1 □  Married? 3 0  Single?
2 □  Widowed? 4 □  Other?
4 Do you usually bring up any phlegm from your chest first thing in the 
morning in the winter ?
1 □  Yes 2 □  No (If "No" go to question 7)
5 Do you bring up phlegm like this on most days for as much as three months 
in the winter each year?
1 □  Yes 2 □  No
6 In the past three years, have you had a period of increased cough and 
phlegm lasting for 3 weeks or more ?
., 1 □  .Yes— 1 period 3 □  No 
2 □  Yes— 2 or more periods
7 Do you get short of breath walking with people of your own age on level 
ground ?
1 □  Yes 2 □  No
8 Does your chest sound wheezy or whistling on most days (or nights) ? 
1 □  Yes 2 □  No
9 Does the weather affect your breathing ? 
1 □  Yes 2 □  No
If "Yes", specify type of weather
10 H o w  much exercise do you get at work ?
1 □  None
2 □  A  moderate amount
3 □  A  lot
11 H o w  much exercise do you get on the way to and from work each day ? 
.. . . . . . . . . . minutes
12 H o w  much physical exercise do you get outside work each day or at the 
weekend ?
  hours per week
13 Do you drive a car regularly?
1 □  Yes . 2 □  No
14 H o w  many hours in twenty-four do you sleep ? 
. . . . . . . . . . . hours
15 H o w  much of the following drinks do you usually take each day?
a Milk ....    pints
b Coffee . . . .   cups
c Tea  ......  cups
For official use only
1.21
1.23
1.24
1.27
1.28
1.32
1.33 1.34
1.3S
1.38 1.37
1.38
1.39 1.40 1.41 1.42
3 1 8
16 a Do you take sugar in tea or coffee ?
1 □  Yes 2 □  No
b Do you take sugar on porridge or pudding ?
1 □  Yes 2 □  No
17 H o w  much of the following do you usually take each week? 
a Spirits .......   nips
b Beer ........  pints
c Wine .. :....  bottles
M.M.R. ref. no.
For official use only
1.51 i.rc 1.59 1.54
i -i. 1 : ' 1.5/ 1.58
1.43
1.44
1.45 1.48
147 1.48
1.49 1.50
18 a Do you smoke cigarettes now ?
1 □  Yes .
2 □  No (If "No", go to question 19)
b Do you inhale?
1 □  Yes - 2 □  No
c What kind of cigarettes do you smoke
1 □  Manufactured, with filters ?
2 □  Manufactured, without filters ?
3 □  Hand-rolled?
d H o w  many manufactured cigarettes do you usually smoke per day ? 
Number per day    .....
e About how many ounces of tobacco do you use per week for rolling your 
own cigarettes ?
0 z. per week .......
f What is the maximum number of cigarettes that you have smoked per 
day for as long as a year? (Include hand-rolled)
Number per day.......
g H o w  old were you when you began to smoke cigarettes regularly? 
A g e .......
1 9a If you do not smoke cigarettes now. did you ever smoke them regularly ? 
1 □  Yes 2 □  No. never
b If you used to smoke regularly, what is the maximum number of cigar­
ettes you ever smoked per day for as long as a year ?
Number of cigarettes.......
c Did you inhale?
1 □  Yes 2 □  No
d H o w  old were you when you began to smoke cigarettes ?
A g e .......
e When did you stop smoking cigarettes? (Give year of stopping) 
Year ....
20 a Have you ever smoked a pipe regularly?
1 □  No (If “No", go to question 21)
2 □  Used to smoke a pipe but not now (go to d)
3 N o w  smoke a pipe
Survey no.
1.75 1.78 1.77
Serial obs. no.
1.78 1.79
Card no.
1.80
1
2 01 202 2.03 2.04 2.05 2.08 2.07.
2.08
2.09
2.10
2.11 7.12
2.13 2.14 2.15
2.18 2.17
2.19
2.20
2.21 2.22
2.23
2.24 2.25
2.28 2.27
2.28
3 1 9
. b If you smoke a pipe now. about how many ounces of tobacco do you 
smoke ?
Oz. per w e e k  .
c Do you inhale?
1 □  Yes 2 □  No
d H o w  old were you when you began to smoke a pipe ?
A g e .......................
e If you do not smoke a pipe now. when did you stop? (Give the year)
Year  ....
21 Have you ever smoked cigars regularly?
a 1 □  No (If "No” go to question 22)
2 □  Used to smoke cigars but not now
3 0  N o w  smoke cigars
b If you smoke cigars now. about how many cigars do you smoke per week ? 
•Number per w e e k  .
22 a Have you ever had any pain or discomfort in your chest ?
1 □  Yes 2 □  No (go to 23)
b Do you get this pain or discomfort when you walk uphill or hurry ?
1 □  Yes 2 □  No
c Do you get it when you walk at an ordinary pace on the level?
1 □  Yes 2 □  No
d When you get any pain or discomfort in your chest what do you do ?
1 □  Stop
2 □  Slow down
3 □  Continue at the same pace.
e Does it go away when you stand still ?
1 □  Yes 2 □  No
f H o w  soon?
1 □  10 minutes or less
2 □  More than 10 minutes
g Where do you get this pain or discomfort ? Mark the place(s) with X on 
the diagram.
23 Have you ever had a severe pain across the front of your chest lasting for 
half an hour or more?
1 □  Yes 2 □  No
24 a Do you get a pain in either leg on walking ?
1 □  Yes 2 □  No (go to 25)
b Does this pain ever begin when you are standing still or sitting ? 
1 □  Yes . 2 □  No
c Do you get the pain in your calf (or calves) ?
1 □  Yes 2 □  No
For official use only
2.29 2.30 2.31
2.32
2.33 2.34
2.35 2.36
2.37
.2.38 2.39
2.47
2.48
2.49
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d Do you get it when you walk uphill or hurry ?
1 □  Yes 2 □  No
e Do you get it when you walk at an ordinary pace on the level ?
1 □  Yes 2 □  No
f Does the pain ever disappear while you are still walking ?
1 □  Yes 2 □  No
g What do you do if you get it when you are walking ?
1 □  Stop
2 □  Slow down
3 □  Continue at the same pace
h What happens to it if you stand still ?
1 □  Usually continues more than ten minutes
2 □  Usually disappears in ten minutes or less
25 Do you have diabetes ?
V □  Yes
2 □  No
3 □  Do not know
26 Over the past year have you noticed a definite increase in :
a Thirst?
1 □  Yes 2 □  No
b The quantity of urine you pass ?
1 □  Yes 2 □  No
c The ease with which you get tired ?
1 □  Yes 2 □  No
27 Over the same time have you noticed: 
a Unexplained weight loss ?
1 □  Yes 2 □  No
b Worsening of your eyesight?
1 □  Yes 2 □  No
c Boils or carbuncles ?
1 □  Yes 2 □  No
d Itching of skin where you pass water?
1 □  Yes 2 □  No
28 a Have you ever been in hospital ?
1 □  Yes 2 □  No
If "Yes" please give the following information for each admission: 
b Year Nature of illness or what was wrong ?
1 ......................................
2  .............
3 ........................................ .......
4 ..........  ..........................................
(Continue on separate sheet of paper if necessary)
2.S2
2.53
•2.54
2.55
2.58
2.67
2.58
2.59
2.80
2.61
2.62
2.63
2.64
2.65
2.66
2.67
2.68
2.75 2.76 2.77
Survey no.
Serial obs. no.
2.78 2.79
Card no.
2.80
2
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29 Are your parents both alive ?
a . 1 □  Yes 2 □  No
If "No"
b What caused your father’s death ?
c What caused your mother's death ?
30 If you are married, does your wife/husband suffer from 
a bronchitis? 1 □  Yes 2 □  No
b heart trouble ?______ 1 □  Yes_____________2 □  No________________
31 a What was your first regular occupation, excluding temporary work? 
(please give full description)
b What was your father's main occupation ? (Please give full description)
32 Please indicate by a tick in the appropriate box in each, of the following 
• sections which description fits you best.
a In general, I am usually tense or nervous
THIS DESCRIBES M E: 1 □  Exactly
2 D  To some extent 
3 D  Not very accurately 
4 D  Not at ail
b There is a great amount of nervous strain connected with my daily 
activities
THIS DESCRIBES M Y SITUATION: 1 D  Exactly
2 D  To some extent
3 O  Not very accurately
4 D  Not at all
c At the end of the day I am completely exhausted mentally and physically 
THIS DESCRIBES M E: 1 D  Exactly
2 D  To some extent
3 D  Not very accurately
4 D  Not at all d M y daily activities are extremely trying and stressful 
THIS DESCRIBES MY ACTIVITIES: 1 a  Exactly
2 D  To some extent 
3 D  Not very accurately 
_____________________________________________ 4 p  Not at all____________
33 How do you feel about your present job ?
1 D  completely satisfied
2 D  well satisfied
3 D  neither satisfied nor dissatisfied
4 D  a little dissatisfied
5 □  very dissatisfied_______________________________________
34a How many brothers were there in your family ? (Excluding yourself)
b How many sisters were there in your family? (Excluding yourself)
c Were you your mother's first child, second, third, etc?
35 How  many times have you changed your job since leaving school ?
36 When did you last change your job ? (Please give year)
37 At what age did you finish whole time education ?
Please check that, you have answered all 
the questions. Thank you for your help.
3.01 3.02 3.03 3.04 3.05 3.06 3.07
3.08 3.09 3.10 3.11
3.12 3.13 3.14
3.15 3.16
•
Survey no. 
Serial obs. no. 
Card no.
3.17 3.18 3.19
3.20 3.21 3.22
3.23
3.29
3.27 3.28
3.29
3.30 3.31
3.32 3.33
3.34 3.35
3.36 3.37
3.38 3.39
3.40 3.41
3.75 3.76 3.77
3.78 3.79
3.80
3
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H E A L T H  ^ U E 3 T I Q N N A I  R E
SUHNAH3...........................     AG3 ..
CHRISTIAN N 'NETS.......... ................. ...........
D iTS. ....................    H03PIT.iL NUMBER.
Instructions
The following questions arc concerned with the way you feel or act. 
answer that applies to you. Do not spend long on any one question,
. 1. Do you often feel upset for no obvious reason?
. 2 .  Do you have an unreasonable fear of being in enclosed 
spaces such as shops, lifts, etc.?
,. 3. Do people ever say you are too conscientious?
i. 4. Are you troubled by dizziness or shortness of breath?
>• 5. Can you think as quickly as you used to?
>. 6. Are your opinions easily influenced?
.. 7» Have you felt as though you night faint?
Please circle the
8. Dc ycu find yourself worrying about getting some 
incurable illness?
9* Do you think that ’cleanliness is next to
godliness’?
10. Do you often feel sick or have indigestion?
11. Do ycu feel that life is too much effort?
12. Have you, at any time in your life, enjoyed acting?
13. Dc ycu feel uneasy and restless?
14*. Do you feel more relaxed indoors?
... 15* Do you find that sill/-or unreasonable thoughts
keep recurring in ycur nind?
... 16. Do ycu sometimes feel tingling or pricking
sensation in your body, arms or legs?
Yes = 2  No = 0
Often = 2 Sometimes = 1 
Never = 0
No = 0 Yes = 2
Never = 0 Often = 2 
Sometimes = 1
Yes = 0 No = 2
Yes = 2 No = 0
Frequently = 2  
Occasionally = 1 
Never = 0
Never = 6 Sonetbes = 1 
Often = 2
No = 0 Yes = 2
Yes = 2 No = 0
At times = 1 0ften=2 
Never = 0
Yes = 2 No 0
Frequently = 2 
Sometimes = 1  Never = 0
Definitely = 2
Sometimes = 1
Not particularly = 0
Frequently = 2  ,
Sometimes =1 Never =0
Rarely = 1 Frequently = 2  
Never = 0
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.... 17* Do you regret much of your past behaviour?
.... 18, Are you normally an excessively emotional person?
.... 19» Do you sometimes feel really pe.nicky?
.... 20. Do you feel uneasy travellinj on buses or the
underground even if they are not crowded?
.... 21. Are you happiest when you arc working?
.... 22. Has your appetite got less recently?
.... 23. Do ycu wake unusually early in the morning?
.... 24. Do you enjoy being the centre of attraction?
.... 25. Would you say ycu were a worrying person?-
.... 26. Do you dislike going out alone?
;... 27. Are you a perfectionist?
.... 28. Dc you feel unduly tired and exhausted?
.... 29. Do you experience long periods of sadness?
.... 30. Do you find that you take advantage of
circumstances for your own ends?
31. Do you feel often 'strung-up' inside?
.... 32. Do ycu worry unduly when relatives are late
coming home?
!!!! 33* Do you have to chock things you do to an
unnecessary extent?
.... 34* Can you get off to sleep alright at the moment?
.... 35* Do you have to make a special effort to face up
to a crisis or difficulty?
.... 36. Do you often spend a lot of money cn clcthcs?
.... 37* Have you ever had the feeling you are 'going to
pieces'?
.... 38. Are you scared of heights?
Yes = 2 No = 0
Yes = 2  No = 0
Yes = 2 No = 0
Very = 2  A little = 1 
Not at all = 0 .
Yes = 2 No = O'
No = 0 Yes = 2
Yes = 2 No = 0
No = 0 Yes = 2
Very = 2 Fairly = 1 
Not at all = 1
Yes = 2 No = 0
No = 0 Yes = 2
Often = 2 Sometimes = 1 
Never = 0
Never = 0 Often = 2  
Sometimes = 1
Never = 0 Sometimes = 1 
Often = 2
Yes = 2 No = 0
No = 0 Yes = 2
Yes = 2 No = 0
No = 2 Yes = 0
Very much so = 2 
Sometimes = 1 
Not more than anyone 
else = 0
Yes = 2 Nc = 0
Yos = 2 No = 0
Very = 2 Fairly = 1 ' * 
Not at all = 0
32h
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39. Does it irritate you if normal routine is disturbed?
40. Do you often suffer from excessive sweating or 
fluttering of the heart?
41. Do you find yourself needing to cry?
42. Do you enjoy dramatic situations?
43* Do you have bad dreams which upset you when you 
wake up?
44. Do you feel panicky in crowds?
45. Dc you find yourself worrying unreasonably about 
things that do not really matter?
46. Has your sexual interest altered?
47* Have you lost your ability to feel sympathy for 
ether people?
48. Do you sometimes find yourself posing or 
pretending?
Greatly = 2 4 little = 1
Not at all = 0
No = 0 Ye 3 = 2
Frequently = 2  
Sometimes = 1  
Never = 0
Yes = 2 He = 0
Never = 0 3 ometimes = 1 
Frequently = 2
Always = 2 Sometimes = 1 
Never = 0
Never = 0 Frequently = 2 
Sometimes = 1
Less = 2
The same or greater = 0 
No = 0 Yes = 2
Yes = 2 No = 0
PLEASE CH5CIC THAT EACH QUESTION HAS 33SN ANSWERED
FOR HOSPITAL US? ONLY
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Work History since last review:
Patient has returned to work: 1=No, 2=Yes, sporadic, 3=Yes, continuous
Average hours per week, at present:
Same work as before: 1=Same employer, 2=0ther employer
Modified work: 1=Same employer, 2=Other employer
If other work, specify:
I.L.0. Code
No. of weeks from infarct till return to work 
Advised to return by Consultant: 1eNo, 2=*Yes 
Did patient return to work as advised: 1=No, 2=Yes
If not, state reason:
Smoking: Rehabilitation measures; changes in habit, since last review;
1=None, 2=General reinforcement, 3=Specific (hypnosis etc)
If 3> specify therapeutic measures:_____________ ___________________
If 3, number of sessions required: at clinic
at home
Exercise Status:
Rest Status:
Present status: 1=Stopped, 2=Continues same, 3=Restarted 4=Rsduced
5=Increased 6=Non-smoker 7=Ex-smoker [ ' j
If smoking: 1= 1-5cigs 2= 6— 10cigs 3= 11-20cigs 4= 20+cigs
5= Pips, light 6= Pipe, heavy Cigar, light
8= Cigar, heavy 9= Variable (specify) | “1
Drugs prescribed at present: No change/Changed to:
Considered fit to return to work: 1=Sec again at next review
2=Yes, now. 3=In specified time £
Referred to: Occupational Therapy; Social Mork Dept; Psychologist/psychiatrist ;
Dietician; E.T.T.; Coronary Angiography.
Other referrals:
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Please answer all questions. .
1. How many eggs do you eat each week? _________________________ _
2. Do you use butter or margarine?_________________ ;________________
Do you spread it thickly? moderately thick? thinly?
If you use margarine which type odo you use? _______ ___________________
3. Do you eat cheese? YES/lIO Which kind?
About how much do you eat a week?
4. How many cups of tea do you drink each d a y ? __________ __________________
How many teaspoons of sugar in a cup? ______ ____________________
5. How many cups of coffee each day? '_______________ ■
How many teaspoons of sugar in each cup?_______________ _________
6. How much milk do you drink each day?
(include all milk consumed in cereal, porridge, pudding, etc.)
7. Do you add sugar to cereal, porridge, puddings, etc?  ________________
8. What do you eat in a typical day? Give a brief history of one day's
eating - t i m e  of meal and what is eaten (also add in 'elevenses').
9. How much squashes, lemondades, etc. do you drink per week?
10. How much alcohol do you drink per week? ________ ;________________ and what
kind of alcohol do you usually drink? ____________ _________________________
11. How much bread and rolls do you eat each day?
12. About how many cakes, biscuits and pastries do you eat each day?
13. Do you eat fried foods? ____________ Which" type of fat is used in cook­
ing that food? ■_________ _______ _
14. How often do you eat fresh fruits? Once a day/a week/a month/Never?
15* Do you often eat jam? How many teaspoons, per day? ____________:
Do you eat marmalade? How many teaspoons per day?  ___________ _
Do you take honey, syrup or treacle? __________ '____________________ _
16. Have you ever been given advice about going on a diet?
What advice were you given? _______________________  ___
Who gave you that a d v i c e ? _________________________
How long did you stay on that diet?
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I.B.a. W.I.G.
Hors are some questions about you and. your illness. Circle cither YES or NO to 
indicate your answer to each question.
1. Do you worry a lot about your health? , YES
2. Do you think there is something seriously wrong with you body? YES
3. Does your illness interfere with your life a great deal? YES
4. Are you easy to got on with when you are ill? YES
5. Does your family have a history of illness? YES
6. Do you think you are more liable to illness than other people? YES
7. If the doctor told you that he could find nothing wrong with you
would you believe him? YES
8. Is it easy for you to forget about yourself and think about all sorts
of other things? YES
9* If you feel ill and someone tolls you that you are looking better, do
you become annoyed? YES
10. Do you find that you arc often aware of various things happening in 
your body? YES
11. Do you ever think of your illness as a punishment for something you
have done wrong in the past? YES
12. Do you have trouble with your nerves? YES
13* If you feel ill or worried, can you bo easily cheered up by the
doctor? YES
14. Do you think that other people realise what its like to be sick? YES
15* Does it upset you to talk to the doctor about your illness? YES
16. Are you bothered by many pains and aches? YES
17. Does your illness affect the way you get on with your-family or 
friends a great deal? YES
18. Do you find that you get anxious easily? YES
19. Do you know anybody who has had the same illness as you? YES
20. Are you more sensitive to pain than other'people? YES
21. Are you afraid of illness? YES
22. Can you express your personal feelings easily to other people? YES
23. Do people feel sorry for you when you are ill? YES
NO
NO
NO
HO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO ,
NO
NO
NO
NO
NO
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24. Do you think that you worry about your health moro than most people? YES NO
25. Do you find that your illness affects your sexual relations? YES NO
26. Do you experience a lot of pain with your illness? YES NO
27. Except for your illness, do you have any problems in your life? YES NO
28. Do you care whether or not people realise you are sick? YES . NO
29. Do you find that you get jealous of other people’s good health? YES NO
30. Do you ever have silly thoughts about your health which you can't
get out of your mind, no matter how hard you try? YES NO
■31. Do you have any financial problems? YES NO
32. Are you upset by the way people take your illness? YES NO
33. Is it hard for you to believe the doctor when he tells you there is
nothing for you to worry about? YES NO
34. Do you often worry about the possibility that you have got a serious
illness? YES NO
35. Are you sleeping well? YES NO
36. When you are angry, do you tend to bottle up your feelings? YES NO
37. Do you often think that you might suddenly fall ill? YES NO
38. If a disease is brought to your attention (through the radio, 
television, newspapers or someone you know) do you worry about
getting it yourself? YES NO
39* Do you get the feeling that people are not taking your illness
seriously enough? YES NO
40. Are you upset by the appearance of your face or body? YES NO
41. Do you find that you are bothered by many different symptoms? YES NO
42. Do you frequently try to explain to others how you are feeling? YES NO
43. Do you have any family problems? YES NO •
44i Do you think there is something the matter with your mind? YES NO
45. Are you eating well? YES HO
46. Is your bad health the biggest difficulty of your life? YES NO
47* Do.you find that you get sad easily? YES NO
48. Do you worry or fuss over small details that seem unimportant to
others? ygg NO
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49. Are you. always a co-operative patient? YES NO
50. Do you often have the symptoms of a very soriou3 di3Gaso? YES NO
51. Do you find that you got angry easily? YES NO
52. Do you have any work problems? fES NO
53. Do you prefer to keep your feelings to yourself? YES ■NO
54. Do you often find that you get depressed? YES NO
55. Would all your worries be over if you were physically, healthy? YES NO
5 6. Are you more irritable towards other people? YES NO
57. Do your think that your symptoms may bo caused by worry? YES NO
58 * Is it easy for you to lot people know when you arc cross with them? YES NO
59. Is it hard for ycu to relax? YES NO
60. Do you have personal worries which are not caused by physical illness?YES NO
61. Do you often find that you lose patienco with other people? YES NO
62. Is it hard for you to show people your personal feelings? YES NO
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- HOME AND EXERCISE ROUTINE
. In order to get you "back to full physical fitness we would advise 
graded exercises.
During the first week at home —
(1) Stay in the house but activities should increase daily 
including use of stairs.
(2) , Exercises for- a few minutes, other than walking, three
times a day, e.g.
(a) deep breathing
(b) knee bending exercises with a straight badk, 
hands resting on a table.
(d) stretching the arms upwards and back down to the 
sides together with trunk twisting.
After the first week, start taking two or three walks a day, very 
short at first (to the first lamp post only) but increasing gradually (maybe 
by a lamp post at a time at first) until by /three to four weeks after leaving 
hospital you are walking 2/3 miles total every day* Those with outside stairs 
and no lift should take one walk per day only at first. Do not walk
immediately after meals or on a very cold or windy day.
If exercise causes repeated chest pairi'or undue breathlessness or 
fatigue contact your doctor, but if pain, breathlessness or fatigue is-slight 
stop for a few minutes and then continue more slowly. Take extra rest that 
night but do the same amount of exercise the next day. Keep at the same 
level of exercise per day until you can do it without stress and then steadily 
increase again. If you have chest pain lasting 15 minutes or longer contact 
your doctor immediately. Light household duties can be substituted for one 
of the daily walks after the first week.
With this regime you can, in time, become fitter than you were 
before your infarction. j
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D epartment of
C o mm un i ty M edicine
R u c h il l  H o s p it a l
G l a s g o w  G 2 0  9 N B
T e l : 041-946 7120
May, 1984
Dear Patient,
I expect you may remember that we met while you were in the Western 
Infirmary. You were kind enough to answer some questions about your health, 
and to provide a blood specimen.
I am now in the process of following up all the patients, and I would 
like to see you again to ask a few more questions and do another simple 
blood test.
A special clinic has been set up for the purpose in the Clydebank
Health Centre between 2.30 and 4.45 p.m.
Please indicate below on which Wednesday you can attent the appointment. 
Funds are available to defray the cost of your travel up to about £3.
I hope that you are now well and look forward to seeing you again.
Yours sincerely
DR. H. EL-GENDAWY
After ticking the suitable date, please detach this portion and 
return in the enclosed envelope to me at the above address.
Name
Ref. No
Wednesday / /84 at
OR Wednesday / /84 at
. p.m.
p.m.
or Wednesday / /84 at .. p.m.
or Wednesday / /84 at p.m.
R l c h i l l  H o s p i t a l
G l a s g o w  G 2 0  9 N B
T e l : 041-946 7120
July 1984.
Dear Patient,
I expect you may remember that I sent a letter to you a short time ago in 
order to explain that I am now in the process of following-up all the patients I 
met in the Western Infirmary and I would like to see you again for about 10 
minutes-to ask a few questions, and to do another simple blood test.
Probably you haven'tenough time but I. am sure you are interested to 
participate in this study concerning health education as regards ischaemic heart 
diseases and smoking. Particularly you may know that Scotland has a higher 
frequency of ischaemic heart diseases.
A special clinic has been set up for the purpose in Clydebank Health Centre 
on Wednesday July between 2.30 and 5.00 p.m. the last day. You can come
at any time between these hours and please indicate below at which time you can 
attend. You can come by taxi and the travel expenses will be paid up to £4.
I hope you are now well and look forward to seeing you again.
Yours sincerely,
/
/
DR. H. EL-GENDAWY
Please detach this portion and return in the.enclosed envelope to me at the 
above address.
Name. ....... ............... .
Ref. No................ .
Wednesday 7/84 at ....... p.m.
D epartment of
Co m m un i ty M edicine
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D epartment of
Co mm un i ty M edicine
R u c h i l l  H o s p i t a l
. G l a s g o w  G 2 0  9 N B
T e l : 041-946 7120
July 1984
Dear Patient,
I expect you may remember that I sent a letter to you a short time ago in 
order to explain that I am now in the process of following-up all the patients I 
met in the Western Infirmary and I would like to see you again for about 10 
minutes to ask a few questions, and to do another simple blood test.
Probably youhaven't enough time but I am sure you are interested to 
participate in this study concerning health education as regards ischaemic heart 
diseases and smoking. Particularly you may know that Scotland has a higher 
frequency of ischaemic heart diseases.
A special clinic has been set up for the purpose in the Western Infirmary 
on Friday July between 2.30 and 5.00 p.m. the last day. You can come
at any time between these hours and please indicate below at which time you can 
attend. You can come by taxi and the travel expenses will be paid up to £4.
I hope you are now well and look forward to seeing you again.
N.B. Enter by Level 3 and the clinic is on Level 4 in the Western Infirmary. 
Ask the receptionist on Level 4 for directions.
Please detach this portion and return in the enclosed envelope to me at the 
above address.
Yours^-sincerely, 
5 ' / / s / l
DR. H. EL-GENDAWY
Name
Ref. No
Friday 7/84 at . p.m
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APPENDIX B
CODING FOR STRESS
Q36 - Please indicate by a tick in the appropriate box in 
each of the following sections which description fits you 
best.
a) In general I am usually tense or nervous.
THIS DESCRIBES ME: 1- Exactly.
2- To some extent.
3- Not very accurately.
4- Not at all.
b) There is a great amount of nervous strain connected with 
my daily activities.
THIS DESCRIBES MY SITUATION : 1- Exactly.
2- To seme extent.
3- Not very accurately.
4- Not at all.
c) At the end of the day I am completely exhausted mentally 
and physically.
THIS DESCRIBES ME : 1- Exactly.
2- To some extent.
3- Not very accurately.
4- Not at all.
d) My daily activities are extremely trying and stressful. 
THIS DESCRIBES MY ACTIVITIES : 1- Exactly.
2- To some extent.
3- Not very accurately.
4- Not at all.
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DEFINITION OF THE SCALED .
The scale runs from "exactly" 1 to 8 where 1 represents a 
response of 1 to all four questions (the highest stress) and 
8 represents "not at all" responses to all four questions.
Coding procedure.
Score
1. 1111 Exactly on all four.
2. 111X or 1122 (not including 1114) "exactly" on any
three," to some extent" or "not very accurately" on the 
fourth or "exactly" on any two and "to some extent on 
the other two".
3. 2222 or 1222 "To some extent" on all four or " to some
extent" on any three and "exactly "on the fourth.
4. All others not specified in 1,2,3,5,6,7 or 8.
5. 44XX or 4XXX (including 1114) "not at all" or any one
or any two, and any other responses on the other three 
or two (except 4433).
6. 4433 "Not at all" or any two "not very accurate on 
the other two.
7. 444X "Not at all" or any three,any other response 
on the fourth.
8. 4444 "Not at all" on all four.
Scale 1,2 form a severe degree of stress.
Scale 3,4 forms moderate degree of stress.
Scale 5,6,7 represents mild forms of stress.
Scale 8 means no stress.
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DEFINITION OF TERMS AND CODING FOR CARDIORESPIRATORY SYMPTOMS
Winter Phlegm
A positive history is a'•Yes' response to "Do you usually 
bring up any phlegm from your chest first thing in the 
morning in winter?"
Persistent winter phlegm
A respondent is considered to have persistent winter 
phlegm if he answered ’Yes' to the question "Do you usually 
bring up any phlegm from your chest first thing in the 
morning in winter? and fYes! to the question "In the past 
three years have you had a period of increased cough and 
phlegm lasting for three weeks or more ?
Dyspnoea
A positive history is a ‘Yes1 response to "Do you get 
short of breath while walking with people of your own age on 
level ground?
Chronic bronchitis
Defined as the presence of persistent phlegm production 
with an exacerbation lasting three weeks or more in the past 
three years, and shortness of breath while walking with 
people of the same age on level (iei an examinee is 
considered to have a history of chronic bronchitis when he 
has persistent winter phlegm and dyspnoea at the same 
-time) (103).
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Angina(103)
(Question numbers refer to Questionnaire - see Appendix A1)
A positive history of angina is based on the pattern of 
positive answers to questions 2.26 parts a,b,c,d,e,f,and g:
a. Have you ever had any pain or discomfort in your chest?
b. Do you get this pain or discomfort when you walk uphill
or hurry?
c. Do you get it when you walk at an ordinary pace on the
level?
The angina assessment also depends on the answers to the 
following questions:
d. When you get any pain or discomfort in your chest, what
do you do? Stop, slow down, or continue at the same 
pace?
e. Does it go away when you stand still?
f. How soon? 10 minutes or less, or more than 10 minutes?
Positive answers: ’’Ten minutes or less”
g. Respondents are asked to mark the place(s) with X on
the diagram.
Then angina is classified into four grades:
Grade 0 : No to part a. Yes to (a)&(b) and to (c) and 
Grade 1: Stop or slow down to (d) and yes to (e) and 10 min. 
or less to (f) and X on sternum or left ant. chest +left arm. 
Grade 2: As grade 1 but yes to'(c)
Grade 3 : Yes to (a) + any other answer.
Grade 1,2 are combined and represent severe form of angina. 
Grade 3 represent mild grade of angina.
Grade 0, means no angina, thus those with positive history of 
angina in fact have either grade I or grade-II angina. 
’’Possible infarction” A respondent was classified as giving 
a history of possible infarction if he answered ’Yes’ to the
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question "Have you ever had a severe pain across the front of 
your chest lasting for half an hour or more?"
Hypertension
Hypertensives are those who have either systolic BP more 
than 150 mm Hg or diastolic blood pressure more than 100 mm 
Hg or both. v-
Criteria for Acute Myocardial InfarctionM)
1. Typical chest pain of more than 30 minutes duration.
2. Serial changes in the elctrocardiogram indicating ST 
segment elevation associated with terminal inversion
of T- waves and the loss of initial QRS potential.
3. Rise in serum SGOT above 60 units and LDH > 500 units.
Myocardial infarction was diagnosed if at least two 
of the following three criteria were present; definite 
clinical picture, ECG changes (development of pathological Q 
waves or S-T, T changes) and a significant rise of Cardiac 
enzymes.
The Body Mass Index:(BMI) is derived by dividing weight by 
height squared (1^2)# It is used because it takes weight into 
greatest account and height to a lesser degree. On the basis 
of weight-height limits the upper limit of normal BMI for men 
was 25 Kg/m2 and for women 24 Kg/m^. Persons whose BMI 
exceeded these limits are considered "overweight”.
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Pffprfr-frtp
(Question numbers refer to Questionnaire, see Appendix A1)
If 1 Yes1 to question 26g and the site of pain is in the (a) 
sternum (upper or middle) or (b) sternum (lower) or (c) left 
anterior chest or (d) left arm or (e) other* j 
If 'No1 to question 26e: grade 1 
If ’Yes* to question 26c: grade 2 
possjb3-g,ipfprp^i9P
If 1 Yes* to question 27: yes 
If •No* to question 27: No 
Intermittent claudication
If 10 minutes or less (question 28/h2) to (Q28/hl): Yes 
If 'No* to question 28/e : grade 1 
If ’Yes’ to question 28/e : grade 2 
If more than 10 minutes (Q28/hl) :No
3b0
RUN NAME 
F AGESIZE 
VARIABLE LIST
INPUT MEDIUM 
INPUT FORMAT
PRINT FORMATS 
N OF CASES 
RECODE
VAR LABELS
I . H . D .
NOEJECT
VAR101 TO VAR152,VAR2G1 TO-VAR255,VAR301 TO VAR337
, VA RA01 TO VARA53
DISK
F I X E D ( F A . O , A F 1 . Q , 3 F 2 . 0 , 1 3 F 1 . 0 , F 3 . 0 , F 2 - . 0 , 3 F 1  . 0 , F 2 . 0 , F 1  . 0 , 2 F 2 . 0 ,  
2F1 . Q, 3F2 . 0 , 5 F 1 . 0 , A F 2 , 0 , F 1 , D , F 2 . 0 , F 1 . Q , 5 F 2 . 0 /
F A . 0 , 2 F 1 . Q , F 2 . 0 , F 1  . 0 , 2F2« 0 , 2F1  , 0 , F 2 . Q , F 1  . 0 , F 2 . 0 , 2 0 F 1 . 0 ,  
3 F 3 . 0 , F 1 . 0 , F 3 . 0 , F 2 . 0 , F 3 . Q , F 2 . 0 , 9 F 1  . 0 , 3 F 2 . 0 , F 1  , 0 , F 2 . 0 , F 1 . 3 /  
F A . C , F 1 . 0 , 3 F 3 . 0 , F 1 . 0 , 2 F 3 . 0 , 2 F 3 . 2 , 1 3 F 1 . 0 , 3 F A . G , F 2 . 1 , 5 F3 . 1 , 5 F1 . 0 /  
■ F A . o , 3 F I . 0 , 2 F 2 . 0 , 2  F I . 0 , 3 F2 . 0 , AF1 . 0 , 2 F2 . C , F 3 , 0 , F 2 . 0 , F1 . 0 , F2 . 0 ,
F 1 . 0 , F 3 . 0 , F 1 , 0 , F 2 . 0 , 5 F1 . 0 , F2 . 0 , 1 8F1 . 0 , F 3 , 0 , 3 F 3 . 1 )
VAR307 TO VAR31C,VAR327 TO VAR332,VARA51 TO VARA53(1)
UNKNOWN
VAR233 TO VAR235,VAR237,VAr2 3 9 ( 1 1 , 2 5 = 1 1 ) ( 1 A , 1 6 = 1 A ) ( 1 5 , 22=15)  
( 1 7 , 1 9 , 2 0 = 1 7 )
VAR1Q1,CASE NO/
VAR102,CARD NO/
VAR1U3,S. CLASS/
VAR10A,EMPLOY/
VAR105,HUSB OCCUP/
VAR106,BIR DAY/
VAR107,BIR MON/
VAR108,E I R YEAR/
VAR109,RESID/
VAR110, INDUST/
VAR111,SEX/
VAR112,TWIN/
VAR113,LIKE TWIN/
VAR11A,MARITAL S/  4
VAR115,COUGH/
VAR116,M0RN PHLE/
VAR117,3M PHLE/
VAR118,3W PHLE/ ■
VAR119,WAK BREATH/
VAR120,WHEEZES/
VAR121,W0RK EX/
VAR 1 2 2 , WAY EX/
VAR123,0UT EX/
VAR12A,W0RK ACT/
VAR125,PAST EXP/
VAR126, TI ME/
VAR127,SLEEP/
VAR 1 2 8 , MILK D/
VAR129,C0F DRIN/
VAR130,TEA D/
VAR131,SUG I NT/
VAR132,CER SUG/
VAR133, SPI RI TS/
VAR13A,BEAR D/
VAR135,WINE/
VAR136,SALAD/
VAR137,CIGT SMO/
VAR13S,TAR/
VAR139, INHA/
VAR1A0,CIGT KIND/
V A R 1A1 ,CIGT NO/
VAR1A2,T0BA 01/
VA R1 A 3 , CIGT M NO/
VAR1AA,SM0 AGE/
VAR1A5,XCIGTSM/
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VAR 146 
VA P147
V A P148 
VAR149
V A R150 
VAR 15 1 
VAR152 
VAR 201
V A P.202
V A P 2 0 3
V A P 2 0 4 
VAR 205 
VAR206 
VAR 207 
VAR208 
VA R 209 
VAR21C 
VAF211 
VAR 212
V A R 213 
VA R 21 4 
VAR215 
VAR216 
VAR217 
VAR21S
V A R 219
V A R 2 2 0 
VAR221 
VAR222 
VAR223 
VAR224 
VAR225
V A R 226 
VAR227 
VAR22? 
VA R 229 
VAR23"
V A ft 23 1 
VAR232 
VAR233
V A R 23 4 
VAR235 
VAR236 
VA R 237
V A R23 P 
VAR239
V A R 2 4 n 
VAP 241 
VAR242 
VA R 243 
VAR 244 
VA c 245
V A f; 2 4 6
V A R 2 4 7 
VAR240 
VAR 24*5 
VAR 25"
V A F. 2 51
V A R 2 5 2
V A R 2 5 3
V A R 2 5 4
V A n 2 5 5
w C l6 NO/
IN H A /
SMO AGE/
Sf*0 STOP/
AD DAy/
AD MON/
AD YEAR/
CASE NO/
CARD NO/
PIPE SMO/
TOPA 02/
INHA/
PIPE SM AGE/ 
STOP YEAR/
PAM SMO/
SMO TYPE/
SMO DURA/ 
CIGAR/
Cl  GAP NO/ ,
CH PAIN/
HURRY PAIN/
° A CE PAI /
PAIN EFF/
PAIN FATE/  
PAIN DURA/ 
PAIN SITE 
SCHEST PAI N/  
LIMB PAIN/  
REST PA I /
CALF P A I /  
HURRY PAI /  
PACE PAI /
WALK PA FATE/  
RESPON/
PAIN FATE/  
DIABETES/
BP/
f-1 E DI USE/
PRE HOSPIT/  
FIR AD/
SE AD/
TH AD/  
PARENTS/
FDEA CAUSE/
F DEA AGE/
M Dr. A CAUSE/
M DEA AGE/ 
SPOU BRONCH/ 
SPOU HEART /  
FI  SO CL/
PATH S CL/
TENSION/
STRAIN/
ZXHAUS/
DAILY ACT/
JOB FEELING/  
P=OTH NO/ 
SIST NO/ 
ORDER/
JOB CHAN/
EDUC F I N /  
HEATING/
VAR 301 
. VAR302
V A R 3 Q 3 
VAR3Q6 
VAR30S
V A R 3 0 6 
VAP307 
VAR3C? 
VAR 30°
V A R 3 1 v
V A R 3 1 1
V A R 3 1 2
V A R 3 1 3
V A R 31 A
VAR315
V A R 316 
VA R 317 
VAR31? 
VAR319
V A P. 3 2 0
V A R 3 21 
VAR322 
VA.R323 
VAR32A 
VA R 325 
VAR326 
VAR327
V A R 3 2 ? 
VA R329 
VAR33Q 
VAR331 
VAR332 
VAP333 
VAR33A 
VAR335 
VAR336 
VA R 337
V AR 601
VAR 602
VAR6;)3
V A R«606 
VAR 60 5
V A R 6 0 6
VAR 607 
VAR 6i'J?.
V A h 6 j 9
V A R 6 1 C 
VAR611 
VAR 612
V A R 6 1 3 
VAR61A
V A R 61 3
V A S 6 1 <5
V A R 61 7
V A ft 6 1 ;
V A 5. 6 1 9
V A R 6 2 r)
V A R 62 1 
VAR622
VAR622 
VA R626
V A (•: 6 2 5
CASE NO/
CARO NO/
h i g h t /
WEIGHT/
°ULS E /
PEGU/
S. EP/
D . BP/
FEV1 /
F VC/
HRT SI ZE/  
LUNGS/
G WAVE/
ST ELEV/
ST 0 £P/
ST DEPTH/
LV H /
T INVER/
AV BLOCK/
56 B /
ARRYTHMIA/
NO ABN/  
f’ INF/
SGOT/
TOT CK/
LDH/
CHOLEST/
TRI G/
SUG/
COMB /
HB/
OXYHB/
URINE/
P.  BLOCK/
OLD NIt 
AD N CASE/  
FATE/
CASE NO/
CARD NO/
S.CLASS/  
" I L K /
COFFEE/
TEA/
DRINK SUGAR/  
C .o.SUGAR/  
SPI RI TS/
BEAR /
VJINE/
CIGT SMOK/ 
TAR /
INHA/
CIGT KIND/  
CIGT N O /
TOR OZ /
LAST CIGT/  
BRAND NAHE/  
PIPE SMO/
TOG OZ PI PE/  
INHA/
LAST PI PE/  
CIGAR SMO/ 
CIGAR NO/
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VAR426,CHEST P/
VAR427, SIMI  P/
VA R428 , H I  gH Bp /
VARA29,  DIABETES/
V A R 4 3 0 ,  H 0 S P ADM/
VAR431,ADM CAUSE/
VAR432/.H ED BOOK/
VARA33,BOOK S I MI /
V A R 43 4 HD L I ABI L I T Y /
V A R 4 3 5 
VAR 436 
VAR 437
V A R 4 3 3
VAR43P HIGH BP/
VAR44Q 
VAft 441 
VAR442 
VAR 443 
VA.R444
VAR445 ,WGHT LOSS/
VA R 446 
VAR447 
VA R 448 
VAR449
VAR450,HEIGHT/
VAR451,WEIGHT/
VAR452/C0HB/
VAR453,E REATH CO/
VAR103, (0)UNEMPL0 ( 1 ) S0  CLASS 1 ( 2 ) S 0  CLASS 2 ( 3 ) S 0  CLASS 3NM 
( A) SO CLASS 3M(5)  SO CL4(6)S0 CL 5 ( 7 ) RETI R( 3 ) NOT A°PL/  
VAR1C'4(1) MANAG(2) FOREMAN( 3 ) EMPLOY( 4 ) S EMPL0Y(5)S EMPO W EMPL/
V A R1 05 ( 0)  UN EMPLO( 1) SO CLASS 1 ( 2 ) S . CL  2 ( 3 ) S  CL 3NM(4)S CL3M 
( 5 ) S 0 C LA( 6 ) SO CL 5 ( 7 ) RETIR /
VAR 109(1 ) COUNT P. Y( 2)  VILLAGE (3)  TO WN( 4) CITY ( 5 )  E WHERE/ 
VAR11D( 1) YES( 2) N0/
VAF.11K1)  MALE (2)  FEMALE/
VAR112(1)YES( 2 ) NO/
VAP113( 1) LI KE( 2) UNLI KE( 8) NOT APp ( 9 ) MISSED /
VAR1 U( 1 )  MARRIED(2)  SING(3)WID0(  4)SEP A(5)  DIVOR /
VAP 11 5 TO VAR117( 1) YES( 2) N0/
VAR11c(1)0NE b E R I 0 D ( 2 ) 2  PERIODS( 3 ) NO /
VAR119 TO VAR12C( 1) YES( 2) N0/
VAR 1 2 1 ( 1 ) NO( 2 ) SMALL( 3 ) LOT/
VAR124(1)SEVER (?)  MOD( 3 ) NON( 4 ) UNSURE/
VAR12S(1)J0B LO SS( 2 ) F MEM DEATH( 3 ) FIN AN PR0B(4)RESID CHANGE 
, (5)M THAN 0 N E ( 6 ) N 0 N E /
VA ft 1 26 ( 1 ) 1 MON AG 0 (2)  3 MON AGO( 4 ) 7 - 1 2  MON AGO/
V A R 1 3 1 ( 1 ) YES(2)NO( 5 ) V A R I /
VAF132( 1 ) YES( 2 ) N0 /
VAR136(1)MOST OF WK(2)0NCE WK(3)NEVER/
VAR137C1)YES(2)N0/
V A R 1 3 ( 1 )  L 0 W ( 2 ) MEDI UM /
VAR 1 5 9 ( 1 ) YES(2)NO/
VAP140( 1 ) FILTEP( 2)  N FILTER( 3 ) ftOLLED/
VAR 1 4 5 ( 1 ) YES( 2) N0/
VAR147(1)  YES(2)  M‘1 /
VAR2C3(1)NO(2)PAST SM0(3)YES/
VAk2 0 5 ( 1 ) YES( 2 ) NO/
VAR205( 1 ) FATH(2)M0TH(3 ) S I S T ( 4 ) BROTH( 5)M0RE(6)M0NE/  
VAR2Q9( 1) CI GTS( ?) CI GAR( 3) PI PE( 4) COMBI NED/
VAR211(1)NO(2)PA CIO SM(3)N0N SMO/
V A ft 21 3 TO VA'R215(1)YES ( 2 ) N 0 /
VAR216( 1 ) S T O P ( 2 ) S L O W ( 3 ) C O N T I N U E /
V A R217 (1)  YES ( 2)  NO /
' VAR2' l g ( 1 ) < i r Mi NC2) > i a  MIN/
V4R219(1)YES(2)NOT MARKED/
VAP220 TO VAR22 6 ( 1 )  YES( 2 ) NO/
VA R 227 (1 ) S TOP( 2)  SLOW(3> CONTIN/
VAR220 C1 ) CONTIN>1C MIM(2)  DISAPPEAR/
VAR220 TO VAR23C ( 1 ) YES( 2 ) N O ( 3)  DONT KNOW/
VAR231 TO VAP232 ( 1)  YES(2)  NO/
VAR 23 3 TO VA°23S,VAR237>VAR239,VAR/ ,21 ( D L U N G  C A M  CER ( 2 ) OTH £ R CANCER 
(3)  IHD(4)CEREB V D ( 5) V A S C (6)0BST LUNG D(7)0TW RESP D ( c ) O L D  AGE 
(9) I NFEC (1ONERV0US D ( 11 )  U R  IN T (1 2) G YN-OBST ( 13)  DI G E  ST S(14)ACCID  
(1 5 ) OTH HRT D(16)WAR IN J ( 17) EN DO CR IN E D( 1 8) P S Y CH ( 19) A UTOIMM 
( 2D) DI A5ETES( 21) ANGIN A( 2 2 ) HRT F A I L ( 2 3 ) EYE( 2 A)HERNIA( 2 5 ) GENITAL S 
C26)ENT( 27 )  BONE D /
VAR236( 1) YES( 2) NO/
VAR2 3 7 ( - 9 8 ) NOT APPLC-99)MISSED/
VAR232(98)NOT APPL(99)MISSED/
VAR2 3 9 ( - 9  8) NOT APPL(-99)BLANK/
V A R 2 A C ( - 9 5 > N O T  - A P P L < - 9 9 ) M I S S E D /
V A  R 241 TO VAR242( 1) YES( 2 ) N0( 8 ) N0T APPL(9 ) MISS ED /
VAR243 TO VAR244(0)UNEMPL(1)S CLK25S CL2(3)S CL3NM(4)S CL3M 
(5 ) S CL4(6)S CL 5 ( 7) R ETI R ( 3) NO T APPL ( 9) M I  SS ED /
V A R 2 4 5  TO V A R 2 4 P ( 1 ) E X A T ( 2 ) SOME E X ( 3 ) N O T  A C C ( 4 ) N O ( 8 ) N  A P P ( 9 ) M I S S D /  
V A R 2 4 9 ( 1 ) S A T I S F I E D ( 2 ) N E I T H E R ( 3 ) D I S S A T S ( P ) N O T  A P P L ( 9 ) M I S S E D /  
V A R 2 5 5 ( 1 ) E L E C T ( 2 ) 0  F I R E ( 3 ) G A S ( 4 ) CENT H ( 5 ) G A S R E L E C ( 6 ) O T H E R ( 7 ) > 1 /  
V A R 3 1 1 ( 1 ) N O R M ( 2 ) E L A R G M E N T ( 0 ) M I S S E D /
VAR312(1)N0RM(2)OEDEMA( 3 ) CONGES(4) EFFUS(5J0THER( 9 ) MISSED/
VAR313 TO VAR315( 1) YES( 2) N0(9) BLANK/
VA R 317 TO VAr322( 1 ) YES( 2) NO( 9) 3LANK/
VAR323(1)YES(2)NO(3)NOT SURE/
VAR333(1)BLOOD(2)GLUCOSE(3)PROT(4)NORM(5)MORE THAN 1 ( 9 ) MISSED/
, VAR334 TO VAR335( 1) YES( 2) N0(3) PR0BABLE( 9) MI SSED/
VAR336(1)  EMERG(2)N0N EM ER C-( 9) M I  S SE D /
VAR337( 1) SURVI VE( 2 ) DIED( 0 ) UNKNOWN/
VAR4C3(0)UNEMPL0(1)S0 CLAA 1 ( 2 ) SO CLASS 2<3)SO CLASS 3NM 
( 4 ) SO CLASS 3NM(5)SO CL4(6)S0 CL 5 ( 7 ) RETIR( 8) NOT APPL/  
VAR4C7( 1) YES( 2) N0( 3) VARI ES/
VAR408( 1 ) YES( 2 ) NO/
VAR412( 1) YES( 2) N0/
VAR4.13(1)L0U (2)  MEDIUM TAR/
VAP414( 1) YES( 2 ) N0/
VAP415(1)MANF+FILT(2)MANF W FI LT(3)HAND ROLLED/
V A R 4 2 0 ( 1 ) Y E S ( 2 ) NO( 3 ) SM I N  P A S T /
VAR422( 1) YES( 2) N0/
VAR424(1) YES(2)NO/
VAR426 (1 ) YE S( 2 ) NO/
VAP427( 1) YES( 2 ) N0/
VAR42S(1)YES(2)F' 0(2)D0NT KNOW/
VAR429(1)YES(2)NO(3)DONT KNOW/
V A R 4 3 C (1)  YE S ( 2) MO /
VAR432( 1) y ES( 2) N0( 3 ) N0T SURE(4)M0RE T ONE/
V AR 433(1 ) S  ^ALL (?)  LARC-E(3) POTH( 4) NONE/
' V A R 4 3 4 TO V A R 44 ? ( 1 ) Y ES ( 2 ) N0 /
KISSING VALUES V A R1 'J3 ( 9)  ,V A R1 C3 ( Z ) VA R 1 "6 TO V AP. 1 CS ( 9 9) ,  VAR 1 09 ( P ) /
VAR1G9(°)  ,VA.R113 TO VAR 1 2 1 ( 9 ) /
VAR1 2 2 ( ° 9 9 ) , VAR1 2 3 ( 9 9 ) , V AR12 4 TO V AR 1 26 ( 9) , V A R 1 2 7 ( 99 ) /
VAR12?(9)  ,V AP.12 = TO VAR13C( 9 9 ) , VAR131 TO VAR13 2< 9 ) , /
V A R 1 3 3 TO VAR135( 99) , VAF136 TO VAR14 C (9) ,VAR1 41 TO VAP 14 4 ( 9 ? , 9 9 ) /  
V AP H 5 ( 9 )  , V A P 1 4 A ( 9 9 ) , V A R U 7 ( 9 ) , V A R H 8  TO VAR 1 49 (99)  ,VA R2Q3 (9 ) ,  /
VAR2CA(98 , 90 )  ,VAR2 . 5 ( 9 )  ,VAR2*J6 TO V AR 207(  99)  , V AP 2G8 TO VAR209 ( 9 ) , /
VAR210(P9 ) , VARZ1 1 ( 9 ) , VAR21 2(93 , 9 9 ) ,VAR213 TO V A R 2 1 8 ( 9 ) , /
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VA R 220 TO VAR232(9) , VAR233 TO VAR235( - 9 9 ) ,VAR 2 3 6 ( 9 ) , /  
V AR2 3 7 ( - 9 9 ) , V AR2 3 8 ( 9 9 ) , VAR2 3 9 ( - 9 9 ) , V AR2 4 6 ( 9 9 )  , /
VAR241 TO VAP.240(9) ,VA925Q(9 9) ,  V AR 2 51 TO VAR252C99) , /
VAR253(° )  , VAR254( 99) , VAR255( 99 )  ,VAR3Q3 TO VAR 3 0 5 ( 9 9 9 ) , /  
VAR3U6(9) ,VAR3U7 TO VAR310( 999 )  , VAR311 TO V A R 3 2 X 9 ) , /
VAR32A TO VAR326 ( - 99 9 ) , VAR2 27 ( - 5 ) , VAR3 2?  TO VAR3 5 2 ( - 9 9 )  , /
V A F 3 3 2 TO V AR33 7 ( 9 )  , /
VAR404(9) , VAR4J5 TO VAR4 0 6 ( 9 9 ) , VAR 407 TO VARA0£( 9) /
V A R A G 9 TO VAR411 ( 9 8 , 9 9 ) ,VAR416 TO VAR417( 9  * , 9 9 )  , /
VARMC ( - 9 8 , - 9 9 )  ,V A RA19( 9 B,99)  ,V AR 42 0(  ?>,?) ,VAR A21 ( 9 3 , 9 9 )  , /  
VARA22(9)  , VAR4 23 ( - 9? , 9 0 )  , VAP. 424(8, 9)  ,VAR 425(  9 8 , 99) ,  /
V A R 4 2 6 TO VAR44o(?, 9) , VAR45C TO VARA53( - 9 8 , - 9 9 ) , /
COMPUTE AGE=(VAR152-VAR108)+(VAR151-VAR1G7) / 12
COMPUTE.. AGEGP=AGE
RECODE ”, AGEGPdO THRU 2 4 . 9  = 1 ) ( 2 5  - THRU 3 4 . 9 = 2 X 3 5  THRU 44 . 9=3)
(45 THRU 5 4 . 9 = 4 X  55 THRU 64 . 9  = 5 X 6 5  THRU H I = 6 )
COMPUTE AGEGP2=AGEGP .
RECODE AGEGP2( 1 , 2 , 3 =1 ) ( 4 = 2 ) ( 5 = 3 ) ( 6 = 4 )
-VALUE'LABLES AGEGP( 1 ) < 2 5 ( 2 ) 2 5 - 3 5 ( 3 ) 3 5 - 4 5 ( 4 ) 4 5 - 5 5 ( 5 ) 5 5 - 6 5 ( 6 ) > 6 5 /
VALUE LABLES AGEGP2 ( 1 ) < 4 5 ( 2 ) 4 5 - 5 5 ( 3 ) 5 5 - 6 5 ( 4 ) > 6 5 /
COMPUTE WAY EX = V AR122
RECODE UA Y EX( 0=0)  ( 1 THRU 1 C= 1) ( 10  THRU 2 0 = 2 X 2 0  THRU 40=3)
(AC THRU H I =4)
VALUE LABLES WAYEX( 0 ) NONE( 1 ) < 1 0 ( 2 ) 1 G- 2G( 3 ) 2 U - 4 0 ( 4 ) > 4 0 /
COMPUTE 0UTEX=VAR123
RECODE OUTEX (1 THRU 5=1) (5  THRU 1 0 = 2 X 1 0  THRU 1 5 = 3 X 1 5  THRU H I = 4 )
VALUE  L A B L E S  OUT E X ( D ) N O ( 1 ) < 5 ( 2 ) 5 - 1 0 ( 3 ) 1 0 - 1 5 ( 4 ) > 1 5 H 0 U R S /
COMPUTE K I LK D = V A R 1 2 R
RECODE MILKD(1 THRU 2 = 1 ) ( 2  THRU HI  = 2)
VALUE LABLES » I L K D ( 0 ) NONE( 1 ) < 2 ( 2 ) > 2  M I L K /
COMPUTE MILK=VAR4CA
RECODE MILK (1 THRU' 2 = 1 X 2  THRU 4 = 2) (4 THRU 6 = 3 X 6  THRU HI  = A)
VALUE LABLES MI LK( C)NONE( 1 ) < 2 ( 2 ) 2- A ( 3 ) 4 - 6 ( 4 ) > 6 /
RECODE VAR129(1 THRU 3=1)  (3 THRU 6 = 2 X 6  THRU HI  = 3)
VALUE LABLES VAR1 2 9 ( C)NO( 1 ) < 3 ( 2 ) 3 - 6 ( 3 ) > 6C0FFCUPS/
RECODE VARA05(1 TH F.U 3 = 1 X 3 THr U 6= 2 X  6 THRU H 1 = 3)
VALUE LABLES VAR4 0 5 ( 0 ) MOME( 1 ) < 3 ( 2 ) 3 - 6 ( 3 )>6 CUPS/
RECODE VAR130O TH FU 3 = 1 X 3  THRU 6= 2) ( 6 THRU H I  = 3)
VALUE LABLES V AR1 3 0 ( C)NO( 1 ) < 3 ( 2 ) 3 - 6 ( 3 ) > 6 /
RECODE VARAG6(1 THRU 3 = 1 ) ( 3  THRU 6=2)(6  T H R ^ H I = 3 )
VALUE LABLES VfiR4C6( 0 ) NONE( 1 ) < 3 ( 2 ) 3 - 6 ( 3 ) > 6 /
COMPUTE ALCOHOL=0.0
COMPUTE ALC0H0L=VAR133+(2*VAR134)+(6*VAR135) .
RECODE ALCOHOL(0 = 1 ) (1 THRU 5 = 2) (6 THRU 1 0 = 3 X 1 1 . 0  THRU 20=4)
( 2 1 . 0  THRU HI =5)
VALUE LABLES AL COHOL ( 1 )  NONE ( 2) 1 -5  ( 3) 6-1 0( 4) 1 1 -2IJ ( 5 )>2 1 /
COMPUTE '' , ALC0H0L2=G.G
COMPUTE ALC0HCL2 = VAR409 + ( 2 * V A R 4 1 i ] ) + ( 6 * v A R 4 1 1  )
RECODE ALC0H0L2(0.G=0)  (1 THRU 5 = 1) (6 THRU 1 0 = 2 X 1 1  THRU 20=3)
(21 THRU HI=A)
VALUE LABLES ALCOHOL’ ( 0 ) NONE( 1 ) 1 - 5 ( 2 ) 6 - 1 0 ( 3 )  11-2Q(  4) >21 /
COMMENT ANGINA PECTORIS
COMPUTE AMGINA=:
IF (VAR213 EG 2)ANGINA=j
IF (VAR215 EG 1 AND VAR214 £Q 1 OR VAR215 EG 1 AN-D ( (VAP216 ER 1)
OR ( VA9216 EG 2) )  AND VAR217 EG 1 AND 
VAR21? EG 1 AND VAR219 EQ 1)ANC-INA = 1 
IF ( V A R 213 EG 1 AND VAR214 EG 1 AND VAR215 EQ 1 AND ( (VAR216 EG 1)
OR (VAR216 EO 2 ) )  AND VAR217 EG 1 AND
V A F 2 1 7 EG 1 -AND VAR219 EG 1)AflGINA = 2 
VALUE LABLES ANPINA(Q)NO ANG IN A( 1 ) ANGINA1(2)  ANGIN A 2/
COMMENT SMOKING SECTION
COMPUTE
IF
SMO K = C
( (VAR127 EQ 2) OR (VAR137 EQ 0) AN D V AR145 EQ 2 AND VAR2G3 EQ 1 
AND VAP2.11 EQ 1)SMOK=1
IF (VAR 137 EO 2 AND VAR145 EQ 1) SM0K=2
IF ( V A R 2 0 3 EG 2)SMOK=3
IF (VAP.211 EQ 2)SM0K=4
IF ( VAR137 EG 1 ) SM0K=5
IF ( V A R 2 0 3 EQ 3 ) SMCK=t.
IF (VAR211 E G 3 ) SM0K=7
IF ( V A R 1 37 EQ 1 AND VAR203 EQ 3 ) S M G K = 8
IF ( VAR1 37 EQ 1 AND V A R 211 EQ 3) SM0K=9
IF ( V A R1 3 7 EQ 1 AND VAR203 EQ 3 AND VAR210 EQ 3)SM0K=10
IF (VAR2C3 EQ 3 AND VAP211 EQ 3 ) SM0K=11
VALUE LABLES SM0K(1)N0N SMOK( 2 ) EX CIGT SMOEX ( 3 ) PIP SMO( 4 ) EX C1G SMO
( 5 ) CUR CIGT ■ SM0C6) PIP SMOK(7)  Cl G AR SMO(8 ) CIGTRPIP SMO 
( 9 ) CIGTRCIGAR SMOK(1G)3 TYPE SMOK(1 1 ) PIPE+CIGAR SMOK/
COMPUTE SMOK2=SMCK
RECODE S M C K 2 ( : i , 1 = 1 X 2 , 3 , 4 ,  = 2 ) ( 5 = 3 ) ( 6 ,  7 ,  8 ,  9 , 1 0 , 1 1  = 0
VALUE LTfELES SM0K2(1)N0N SM0*ER(2)EX SMOK ER< 3) CIGT SMOK( 4 )  CIGT + OTH SM/
COMPUTE SMO =0
IF ( ( VAR412 EQ 2) AND (VAR420 EQ 2)  AND ( V A R A 2 4 EQ 1) )SM0=1
IF (VAR412 EQ 1 ) SM0=2
IF CVAR420 EQ 1) SM0=3
IF (VAR424 EQ 3 ) SM0=4
IF ( (VAR420 EQ 3) OR (VAR424 EQ 2 ) )SM0=5
VALUE LABLES SM0(1)N0N SM0(2)CIGT SM0K(3)PIP SMOK( 4 ) CIGAR SM0(5)N0N SMO/
COMPUTE SMO 2 = SM0
RECODE S M 0 2 ( 0 , 1 , 5 = 1 ) ( 2 , 3 , 4 = 2 )
VALUE LABLES SM02(1)N0N SMOKERS( 2 ) SMOKERS/
COMMENT CIGARETTE NUMBER
RECODE VAR 1 4 1 ( 9 8 , 9 9 = 0 ) /V AR14 2 ( 9 8 , 9 9  = 0 ) /VAR2Q4( 9 8 , 9 9  = 0 ) / VAR212 ( 9 8 , 9 9 = 0 )
COMPUTE NCIGS1=VARl41 + ( V AR H2 * 3 C / 7 ) + ( V AR 2 C 4 * 3 0 / 7 )  + ( VAR212 / 7 )
RECODE NCI G5K1 THRU S . 5 = 1 X 5 . 5  THRU 1 4 . 9 9 = 2 X 1 5  THRU 24 . 99  = 3)
(25 THRU 3 4 . 9 9 = 4 ) ( 3 5  THRU 97=5)
VALUE LABLES ■ NCIGS1 (C>NON SMOK( 1 ) < 5 . 5 ( 2 ) 5 . 5 - 1 5 ( 3 ) 1 5 - 2 5 ( 4 ) 2 5 - 3 5 ( 5 ) > 3 5 /
RECODE VA rA16 ( 9 8 , 9 9 = 0 )  /  V A R41 7(9?. , 99=0)  /V A R 42 1 ( 93 , 99= 0) /VAR 42 5 ( 9 8 , 9 9  = 0)
COMPUTE NCI G2=VAR416+( VAR417* 30 / 7 ) +( VAR421* 30 / 7 ) +( VAR425 / 7 )
RECODE NC IG2 ( U=0) ( 1 THRU 5. 5 = 1 X 5 . 5  TH RU- 14 . 9=2)  ( 1 5 THPU 2 4 . 9 = 3 )
(25 THRU 3 4 . 9 = 4 ) ( 3 5 .C THRU 97=5)
VALUE LABLES NCIG2(0)N0N SMO( 1 ) < 5 . 5 t 2 ) 5 . 5 - 1 5 ( 3 ) 1 5 - 2 5 ( 4 ) 2 5 - 3 5 ( 5 ) > 3 5 /
COMMENT LAST SMOKING
RECODE V A R 41 P. ( 1 THRU 6 " ' = 1 X 6 0  THRU 1 2 0  = 2 X 1 2 0  THRU 1 8  0 = 2 X 1 2 0  THRU 2 4 0  = 4
) ( 2  4q  THRU 3 C 3 =  5 )  ( 3 C0  THRU 5 6 0  = 6 X 3 6 0 .  THRU 7 2 0 = 7 X 7 2 0  THRU H I  = 8 )  
VAL UE  L A B L E S  V A R41 S ( 0 )  NO NE ( 1  ) 1 H ( 2 )  2H ( 3 ) 3H ( 4 )  4H (.5,) 5 H (  6 ) 6H ( 7 )  6 - 1 2H ( 3  ) >1 2H oU RS /
RECODE V A R 4 2 3  ( 1 THRU 6 0 = 1 ) ( 6  D THRU 1 2 0 = 2 ) ( 1 2 0  THRU 1 S C = 3 X 1 8 G  THRU 2 4 0  = 4
) ( £ 4 J  THRU 3 C G = 5 ) ( 3 0 0  THRU 3 6 0 = 6 X 3 6 0  THRU 7 2 0 = 7 ) ( 7 2 D  THRU H I = 3 )  
VALUE L ABL E S  VA R ^ 2 3  ( ~ ) NO N E ( 1  ) 1 H ( 2 )  2H ( 3 )  3H ( 4 )  4H ( 5 )  5H ( 6 )  6H ( 7) 6 - 1  2H ( 8  ) > 1 2H OU RS /
COMPUTE S M A G E = V A R 1 4 4  '
RECODE SM A GE ( LO THPU 15 = 1 X 1 5  THRU 25 = 2)  (25 THRU 35=3)  (35
Thru /o = 4) ( L j  thru  5 5=5)  ( 55 THRU 65 = 6 X 6 5  THRU MI=7)
VALUE LABLES S'*AGE C1) < 15 (2)  1 5- 25 (3 ) 2 5- 35 (4)  5 5- 45 ( 5 )4 3- 55 (6 ) 5 5-6 5 ( 7 )  >65/
COMPUTE PSAGE = VARKP
RECODE PSAGE(L9 THRU 1 5 =1 ) ( 1 5  THRU 25 = 2 ) ( 2 5  THRU 35 = 3) (35
THRU 45=4) (A? TH F U 5 5= 5) ( 5 5 TH R U 6 5= 6) ( 6 5 TH R U HI =7 )
VALUE LABLES PSAGE ( 1 ) <15  (2)  1 5-25 ( 3 ) 2 5 - 3 5 ( 4 )  3 5 - 4 5 (  5 ) 4 5 - 5 5 ( 6 )  55- 65 ( 7 ) > 6 5 YEARS/
COMPUTE SAGEP=VAR206
RECODE S AC EP ( LO THRU 1 5= 1 ) (1 5 THRU 25 = 2 X  25 THRU 35 = 3 X 3 5
THRU 45 = 4) (45 THRU 5 5= 5) ( 55 THRU 6 5 = 6 X 6 5  THRU HI =7)
VALUE LABLES SAGEP ( 1 ) <  1 5 ( 2 ) 1 5 - ( 3 ) 2 5 - ( 4 )  3 5 - ( 5 )  4 5 - ( 6 )  5 5 - (  7 ) > 6 5YEARS/
COMMENT INT CLAUDICATION
COMPUTE CLAUDI=2
IF (VAR221 c0 2 ) C L flU D1 = 0
3^7
IF
VALUE LABLES
COMPUTE
RECODE
VALUE LABLES
COMPUTE
RECODE
VALUE LABLES
COMPUTE
RECODE
VALUE LABLES
COMPUTE
RECODE
VALUE LABLES 
COMMENT 
COMPUTE 
1F
IF
!  F
IF
IF
IF
IF
IF
VALUE LABLES
COMPUTE
RECODE
VALUE LABLES
COMMENT '
COMPUTE
COMPUTE
COMPUTE
IF
COMPUTE
RECODE
VALUE LABLES 
RECODE
VALUE LABLES
COMPUTE
RECODE
VALUE LABLES 
COMMENT 
COMPUTE 
RE CODE
( V A R 221 EQ 1 AND VAR222 EQ 2 AND VAR223 EQ 1 AND VAR224 EG ,1 AND 
VAF.225 EQ 2 AND VAR226 EQ 2 AND ((VAR227 EQ 1) OR (VAR227EQ 2 ) )  AND 
AND VAR223 EQ 2)CLAUDI=1 
CLAUDKOJNO ( 1 X I L D  ( 2 )  SEVER/
FDTHAGE=VAR238
FDTHAGE(LO THRU 4 5 = 1 ) ( 4 5 . THRU 55 = 2 ) (  5 5 THRU 6 5 = 3 X 6 5  THRU H I = 4 )  
FDTHAGE ( 1 X ^ 5 ( 2 ) 4 5 - 5 5 ( 3 )  5 5 - 6 5 ( 4 )  >6 5v EARS/
MDTHAGE=VAR24Q'
MDT H A GE ( LO THRU 45 = 1) (45 THRU 5 5 = 2) ( 5 5 THRU 65 = 3 X 6 5  THRU HI = D  
MDTHAGEd ><45( 2 ) 45 -5 5 (  3) 55 -65 (  4)  >65YEAPS/
FDTHCAUSE=VAR237
FDTHCAUSE (1 , 2 = 1 X 4 , 1 0 = 2 )  ( 3 , 1 5 , 2 1 = 3 )
FDTHCAUSE ( 1 ) CANCERS( 2 ) NERVOUS S( 3 ) HEART D/
MDTHCAUSE=VAR239
MDTHCAUSEd , 2 = 1 X 4 , 1 0 = 2 )  ( 3 , 1 5 , 2 1 = 3 )
MDTHCAUSE ( 1 ) CANCERS(2)NERVOUS S( 3 ) HEART D/
PHYSICO-MENTAL STATUS 
PHY SMENT= 4
(VAP245 EQ Q AND VAR246 EQ 9 AND VAR247 EQ 9 AND VAR 248 EQ 9)
p h y s m e n t= g
(VAR245 EQ 1 AND VAR246 EQ 1 AND VAR247 EQ 1 AND VAR24S EQ 1)
P H Y S M E N T = 1
(VAR245 EQ 1 AND VAR246 EG 1 AND ( (VAR247 EQ 1) OR (VAR247 EQ 2 ) )
AND ( ( V A R2 4g EQ 2)  OR (VAR248 EQ 3 ) ) )PHY SMENT = 2
( ( (VAR245 EQ 2) OR (VAR245 EQ 1 ) )  AND VAR246 EQ 2 AND VAR247 EQ 
2 AND VAR248 EQ 2)PHYSMENT=3 
(VAR245 EQ 4 AND ((VAR246 EG 1) OR (VAR246 EQ 2)  OR (VAR246 EQ 
3) OR (VAR246 EG 4 ) )  AND ((VAR247 EQ 1) OR (VAR247 EQ 2)  OR 
(VAR247 EQ 3) OR (VAR247 EQ 4 ) )  AND ((VAR248 EQ 1) OR 
(VAR245 EQ 2) OR (VAR248 EG 3) OR (VAR248 EQ 4 ) ) ) PHYSMENT=5
(VAR245 EQ 4 AND VAR246 EQ 4 AND VAR247 EQ 3 AND VAR248 EQ 3)
PHYSMEMT=6
(VAR245 EQ 4 AND VAR246 EQ 4 AND VAR247 EQ 4 AND ( (VAR243 EQ 1)
OR (VAR248 EQ 2) OR (VAR243 EQ 3) OR (VAR248 EQ 4)))PHYSMENT=7  
( VAR245 EQ 4 AND VAR246 EQ 4 AND VAR247 EQ 4 AND VAR243 EQ 4)  
PHYSMENT=*
PHYSMENT(C) NO RESP0NSE(1 ) HIGHEST STRESSC2) S TAG £2 (3 )  STAGE3 (4 ) 
STAC-E4(5) ST AGE5(6) STA GE6 ( 7) LOW E ST STRESS(8)N0 STRESS/ 
PHYS»ENT2=PHYSMENT
PHYSMEMT2 ( 1 , 2 = 1 ) ( 3 , 4 = 2 X 5 , 6 , 7 = 3 ) (8 = 4)
PHYSHENT2( 0 ) NO RESPONSE(1 ) SEVER STRAI N( 2 )M0DERATE( 3 )M I  LD 
STRAIN( 4 ) NO STRAIN/
HIGHT8WEIGHT 
HIGHT=(VAR3C3)/ . 3 9 4  
WEIGHT=(VAR3G4)/2 .2
.ai=c.c-
(MIGHT GT 0 . '  AND WEIGHT GT C . j )
QI=WEIGHT*1C0, j / (HIGHT+HIGHT)
3 1 = 1 0 0 . 0*GI
VAR450(lo thru  15 0 = 1 ) ( 1 5 0  THrU - 1 6 0 = 2 ) ( 1 6 G THRu 170=3)
(170 TMCU 180 = 4) (1-'‘ 0 THRU HI=5)
V A R 45 0 (1 ) < 1 5 0( 2) 1 5 C-—160( 3) 160-1 7 !j( 4) > 17 i"CM /
VAR45KLC THRU 50 . C= 1) (5C .G  THRU 6 i . ?=2) (6  , .  0 THRU 7 j . \ j = 3)
( 7 0 . u THRU c0 . 0  = 4 ) ( 8 0 . G  THRU 97, . j= 5) ( 9 0 . 'j THRU HI = o)
VAR451( 1 ) <5CKG(2)5 0 - 6 0 ( 3 ) 6 C -7 0 (4 )7 Q -3 0 (5 )> 90 K G M/
PUL SE = VAR3 D5
PU LS E ( LO THRU 6 ~ = 1 X 6 0  THRU 8 0 = 2 X 0 0  THRU 1 0 0 = 3 X 1 0 0  THRU 12C=4)
(12 3 THRU H1=5)
P U L S E ( 1 X 6 j ( 2 ) 6  ‘ -5  .5 (3)  £ 0-1 00 (4)  1 OC-1 2 Q( 5) >12 T. /
SYSTOLIC ELCOD PRESSURE
SB D G° = V A R 7'.i7
SEPGP( LC THRU 1 1 9 = 1 ) ( 1 2 .  THRU 1 2 3 = 2 X 1 3 0  THRU 1 3 9 = 3 ) ( 1 4 0  THRU 149
3^8
= A X 1 5 u  THRU 15?= 5 X 1 6 0  THRU Hl = 6)
VALUE LABLES SBPGP< 1) < 11 ?<2) 12 0 - 1 2 9 ( 3 )  130-1 39<4)1 A0 - 1 49<5) 1 5C-1 5?<6) > 160/
COMMENT DIASTOLIC BP<VAR303)
COMPUTE DE P GP = V A R 33 2
RECODE DEP GP ( LO THRU 7?=1)CS0 THPU 8.9 = 2 X 9 0  THRU 1 0 9 = 3 X 1 1 0  THRU 129
(130 THRU H1=5)
VALUE LAELES DBPGP (1)  < 79 ( 2) 5 R 9 (3)  9 Li-1 09 ( A ) 11 0-1 2 9 ( 5 ) > 1 3 0 /
COMMENT EESPIRATOPY FUNCTIONS
C0 MPJUT-E F E VOL1 -  V A R3 i'9
RECODE FEVOLKLO THRU 1 . ' 0= 1 )  ( 1 .CO THRU 2 .0 0= 2 )
<2.03 THRU 3 .0 0= 3 )  ( 3 . CO THRU HI  = A)
VALUE LAELES FEVOL 1 ( 1 ) < 1 < 2 ) 1 - 2 ( 3 ) 2 - 3 ( A) >3 L I T /
COMPUTE FVCAP=VAR310
RECODE FVC AP ( LO THRU 2 . C = 1 ) ( 2 . 0  THRU 3 . 0 = 2 X 3 . 0  THRU HI = 3)
VALUE LAeLES FVCAP ( 1 ) < 2 ( 2 ) 2 - 5 ( 3 ) > 3  L I T /
COMMENT CARDIAC ENZYMES
COMPUTE SGOTE=VAR32A
RECODE SGOTE ( LO THRU UPA2 = 1) (00A3 THRU 0 1 0 0 = 2 X 0 1 0 0  THRU HI = 3)
VALUE LABLES SGOTE( 1 ) 1 2-A2 NORMAL<2 ) A 3 - 1 C0<5)>1 CO UL/
COMPUTE ' TOTALCK = VAR325
RECODE TOT ALCK ( LO THRU 16C=1) (16C THRU 1 9 9 9 = 2 X 2 0 0 0  THRU H1 = 3 )
VALUE LABLES TOTALCK(1 )< 16 0  NORMAL( 2 ) 1 6C-19 9 9 ( 3 ) >2C0u/
COMPUTE LDENZYME=VAR326
RECODE L D E N Z Y M E ( LO THRU 22 9=1) (230  THRU 5 25 = 2) <526 THRU 99<> = 3)
(1000 THRU H1 = A)
VALUE LABLES LDENZYME( 1 ) < 2 2 9 ( 2 ) 230-525N0RMAL( 3 ) 5 2 6 - 9 9 9 ( 4 ) > 1 0 0 0  UL/
COMPUTE CHO LES T = V A R3 27
RECODE CHOLEST (LO THRU 3 = 1 X 3 . 1  THPU 7 . 5  = 2 X 7 . 6  THRU H I=3)
VALUE LABLES CHO LE ST ( 1 ) <3 ( 2) 3 . 1 - 7 .  5 NOP.MAL< 3) >7 . 6 /
COMPUTE TRIGLY = VA R3 28
RECODE TR IGLY ( LO THRU' 0 .5  = 1) ( 0 . 6  THRU 1 .8  = 2 X 1 . 9  THRU 2 .9  = 3)
(3 THRU 3 . 9  = A X A  THRU HI = 5)
VALUE LABLES TR IGL Y ( 1) <0 . 5 ( 2 ) 0 . 6 -1  .6 NORM AL ( 3) 1 . 9 - 2  .<>< 4) 3 - 3  . 9  (5 ) >4 MMOLL/
COMPUTE 5LSUGAR=VAR329
RECODE SLS UG A R( L 0 THRU 2 . 7 = 0 ) ( 2 . 7  THRU'9 . 9  = 1 ) ( 1 0  THRU HI = 2)
VALUE LABLES 5LSUG A P. ( O X  2 .7 ( 1) 2 . 7 - °  .9 NORMAL (2 )>10 -H IGH MMOL L/
COMMENT CAREOXYHAEMOGLOFIN
COMPUTE C0HE=VAR3 3G
RECODE COHB ( LO THRU 1 . 9 = 1 X 2  THRU 3 .9  = 2 ) ( A  THRU 5 . 9 = 3 ) < 6  THRU HI = u)
VALUE LAeLES COH?( 1 )<1  . 9 ( 2 ) 2 - 3 . 9 ( 3 ) 4 - 5 . 9<4 ) > 6 % S AT/
COMPUTE COHB2=VARA5i
RECODE C0H92 ( LO THRU 1 . 9 = 1 X 2 . ' :  THRU 3 . 9= 2) ( 4 . Q THRU 5 .9  = 3)
( 6 . 0  THRU HI = A)
VALUE LAELES COH= 2 ( 1 ) < 1 . 9 ( 2 ) 2 - 3 . 9 ( 3 ) 4 - 5 . 9 ( A)>6%SAT/ -
RECODE VAR 453(L0 THRU *5.5=1) (1C THRU 1 9 . 9 = 2 X 2 0  THRU H I=3)
VALUE LABLES VAr 4 5 3 ( 1 ) < 1 G( 2 ) 1 0 - 20 C3 ) > 20P°M/
COMPUTE HR=VAR331
RECODE HE ( LO THRU 1 1 . 9 = 1 X 1 2  THRU 13 .9  = 2 X 1 4  THRU 1 5 . 9  = 3)
(16 THRU 1 7 , 9 = A ) <16 THRU HI=5)
VALUE LABLES HB( 1)< 11 . 9 ( 2 ) 1 2 - 1 3  . 9 ( 3 ) 1 4 - 1 5 . 9 ( 4 ) 1 6 - 1 7 . 9 ( 5 ) > 1 8 /
COMPUTE 0XYHS=VAR332
RECODE OX Y H3 ( LO THRU 4 °= 1 ) ( 5 •.'THE U 70=2)  (7 ‘ THRU 9 5= 3) C 90 THRU HI=A)
VALUE LABLES CXY HE( 1)< 5; : (2)  5 ' - 6 9 ( 3
COMPUTE HD = 0
IF (VAR 4?4 EG 1)HD=HD+1
IF (VARA35 EG 1)HD=HD+1
IF ( VARA36 EG 2 ) HD=HD+1
IF (VA P437 EG 2)HD=HD+1
IF ( V A R 4 : l> EG 1 ) H D = H D +‘1
IF ( VAR 43? EG 2)HD=HD+1
IF ( v a r a a  ^ EG 1)HD=HD+1
IF ( V A P 4 A 1 EG 1 )HD = HC + 1
IF
IF
IF
IF
IF
IF
IF
IF
RECCDE
VALUE LAELES 
CROSSTABS
( V A R A A. 2 EQ 
( V A R LLl EQ 
( V A R A A L  £Q 
( V A R A A ; EG 
( V A R A A 6  EQ 
( V A R A A 7 EQ 
(V A R A A 2 EQ 
( V A P A A 9 EQ 
H D ( 1 T H R U  
H D ( 1 ) °  0 0 R
1 ) H D = H D + 1
2 ) H D = H D + 1  
1 ) H D = H 0 + 1  
1 ) H D = H D + 1  
1 ) H D = H D + 1  
1 ) h d  = HD-M  
1 ) H C = H D + 1  
; ) H D = H D + 1
7 = 1) ( - THRU 1 : = 2 ) ( 1  A THRU HI  
K h W ( 2 ) G O O D  K N W ( 3 ) E X  K N W /
TAHLES=MCIG2 BY C0H3/ 
TRIGLY BY VAP.323/ 
SLSUGAR BY VAR323/
HE BY VAR323/
V A R A 5 7 EY C OHB2/ 
VARA53 PY sr*02/
NCIG2 BY COHB2/
SMOK2 EY S6FGP/
Sf*OK2 BY DBPGP/
S^OK2 BY CCHR/
SNOK2 BY OX Y HP/
NCIGS1 PY C 0 H B/
V A R 3 23 BY COHP.A 
ANGINA EY C 0H8/
Sf*0 K 2 BY PHYSMENT /  
VAR323 BY PHYSMENT/
AG E GP 2 PY VAR323/
VAR 255 BY C OHB/
0XYH3 BY CO H P/
CLAUDI BY COHR/
V A R 3 23 BY VAR237/  
VAP.323 BY V A R23 3/
VA R 252 BY V AR23 2/  
ANC-INA BY VAR323/
VA R 25 2 BY ANGINA /  
VAR323 BY VAP312/
VAR323 EY VA R3 U/  
VAR323 BY V A R313/
VA R 3 2 3 RY VAR317/  
VAR323 BY VAR315/  
VAR323 BY V A R 31 Q/ 
VAP323 BY V A P 3 2 " / 
VAR323 PY V A R3 21 /  
VAR323 PY VAP.32 2/  
VAR323 PY SGOTE/ 
VAR32! BY TOTALCK/ 
VAP.323 EY LDEMZYME/
V A R 3 2 3 BY BLSUGAR/
V A R 3 2 3 BY V A ft 3 3 5 /
BY NCIGS1/
B Y  S N O K  2 /
BY S r OK 2 /
PY V A B 1 •; Q /
S 0 K 7 /
VA P 1 1 6 /
VA F 1 17 /
V A F 1 1 2 / 
VAF12-:/
VAR 111/
V A R  H i
v a p 1:3
V A P 1 1 1
V A f: 1 :J 3 
AGE OP EV 
S v C K 2 B v 
S.M O K 2  BY 
S M C K 2  PY 
S m 0 K 2 BY 
AG E  GP 7 BY 
VA R  121 p Y V A P2 2 ~ / 
U A Y F X  BY VA G 3 2 3  / 
O U T E X  EY VAP.323 /
350
V A R 1 2 A R Y V A R 3  2 3 / '
VAR 125 RY V A R 3 2 3 /
VA R 1 26 PY VA.R323/.
•v ILKO BY VAR323 /  ' " '
VPR125 P Y  V A R 3 2 3/
. V A R1 3 C. BYVAP323 /
ALCOHOL EY VAR323/
ALCOHOL RY A NO, IRA/
Sf’*OK-Z BY ANGINA/
V AR3 2? r5 Y S M 0 K 2 /
S C  K 2 BY V A R 2 j .: /
S N0 K 2 BY VAR2 29 /
VAF.2U5 BY VAR327/
SWOK2 BY FEVOL1/
SNOK2 BY FVCAP/
NCIC-S1 BY F EVOL 1 /
N C I G S 1 BY FVCAP/
SMOK2 EY CHOLEST/
XILKO BY r-’ ILK /
VAR 1 29 PY VARA05 /
V A R13 3 BY V A R A 3 6/
ALCOHOL BY ALCOHOL2/
SNOK2 F Y  S M 0 2/
NCIGS1 BY NCIG2/
VAR323 BY VARA26 /
VAR323 BY VARA27/
S F P G P  BY VAF.23Q /
VA R 23‘~ BY V A R A 2 £ /
VA P.229 BY V AR329/
V A R A 3 3 b Y Sr*02/
COHB BY COHB2/
V A R A 53 by C OHB 2 /
SM02 EY C0HE2/
SM02 BY V AR A53 /
HD BY VA R10 3 /
HD PY VA R 323/
STATISTICS ALL
OPTIONS 3 , £ , 5 , 7 , 9
READ INPUT DATA 
FINISH
END OF LISTING OF FILE : GO I Vr 3 .S U lU 3 , * , 1) FOR USER :GOIVH3 AT 1 OR 6 /02 / 2 1 _ _ 1 6 : 3  A : 29
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INSTRUCTIONS FOR PORTABLE CARBON MONOXIDE MONITOR
APPLICATION
The monitor is designed for the measurement of ambient levels of 
carbon monoxide in the atmosphere and acts as a personal safety 
indicator sounding an audible alarm when the carbon monoxide level 
rises above the pre-determined alarm level.
The actual alarm level can be displayed to the user by depressing the 
alarm level momentary action switch.
When the switch is released, the instrument reverts to displaying the 
actual ambient carbon monoxide concentration.
ppm
CO 71
000
L
- O N
O F F
ALARM
LEVEL
I
C A R B O N
M O N O X I D E
M O N I T O R
F i g .  1
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Normal operation is by means of:-
(a) Allowing the ambient gas concentration to diffuse into the 
sensing element via the gas inlet aperture on the top of the 
instrument case.
(b) By connecting the calibration mask accessory to the inlet 
aperture, and a piece of gas sampling line and aspirator bulb to 
the inlet and outlet nozzles on the calibration mask and 
aspirating the gas sample from either a calibration bottle to 
allow instrument calibration, or from a remote location in order 
to measure the,gas concentration at that location.
The above components are connected together as shown in Fig. 3.
T ’rsL a  n rt
LEVEL
\x
F i g .  2
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OPERATION
The operation and function of the top cover controls and 
indicators is as follows:
(1) Carbon monoxide concentration of gas sample in ppm CO.
(2) Battery Level Indicator - Display indicates approximately 1 hour
of operating time left.
3 .  P O W E R  
O N / O F F
A .  A L A R M  
L E V E L  
I N D I C A T I O N
2 . B A T T E R Y  L E V E L  
I N D I C A T O R
000
ALARM
LEVEL
V M I
C A R B O N
M O N O X I D E
M O N I T O R
1 . C A R B O N  
M O N O X I D E  
C O N C E N T R A 1
5 .  G A S  
I N L E T
F i g . A
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(3) Power On/Off - Off switches off all instrument functions while
leaving sensor in the standby condition.
(A 20 sec. delay can be required for stabilising 
the sensor after switching from the standby 
condition to the on condition).
- All instrument functions on.
(4) Alarm - Depressing this switch allows the alarm level to
be displayed instead of the carbon monoxide 
concentration.
Releasing the switch reverts the display back to 
the measured carbon monoxide concentration.
(5) Gas Inlet - Aperture to allow gas sample to be measured by
the sensor. Do not restrict the gas diffusing 
through this aperture, unless instrument 
calibration or remote sampling is being 
performed while utilizing the calibration mask.
COMon
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The operation and function of the end panel controls is as follows:-
(1) Charging Sock'et - inserting mains charger jack plug and
applying mains power allows recharging 
of the instrument internal battery when the 
ON/OFF switch is in the OFF position.
(2) Charging Indicator - indicator is illuminated when the battery is
being recharged.
(3) Zero Adjust - used during calibration procedure to
set the zero level of the instrument.
1. C H A R G I N G  
S O C K E T
 2 .  C H A R G I N G
r  I N D I C A T O R
G A  N
V.MAX25V-J
C O V E R P L A T E
T H R E A D E D
I N S E R T S
S E N S I T I V I T Y
A D J U S T M E N T
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SPECIFICATION
Input Voltage:- 
Input Current
Operating Temperature 
Rel. Humidity
Dimensions:-
Battery Charger 
Input Voltage 
Operating Temperature 
Output Voltage 
Output Current
12v to 25v dc 
20mA
(Available from accompanying mains 
battery charger.)
- 5°C to 40°C
90% RR non-condensing
Width 80mm
Depth 35mm
Length 150mm
Weight 290gm
240v 50Hz 
0°C to 40°C 
12v to 25v dc. 
50mA
COMon
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TYPICAL PERFORMANCE CHARACTERISTICS:-
Measurement range 0 to 200 ppm CO
Transient response (to reach 90% of final value) (diffusion mode)
Air —  — Air + carbon monoxide 40 secs
Air + carbon monoxide ----- Air 40 secs
In the aspirated mode both responses 40 secs.
Accuracy 200 ppm + 5% of Reading
(+2 ppm for Readings <40 pp 
Linearity (in the range 0 to 200 ppm) + 2% of Scale
Temperature coeff of zero + 0.4 ppm/°C
Temperature coeff of span +0.4% of Reading/ C
Repeatability:- + 2% of Full Scale
Accuracy of alarm set point:- + 2  ppm
Hysterises:- 10 ppm
Audible Alarm Output (70 dBA typical)
Variation of alarm set point:- 5 ppm to 200 ppm (factory set to 50 ]
Sensor operating life 1 to 2 years
Continuous operation on fully charged batteries:- 15 hours
(without alarm activated)
Time to recharge batteries 12 hours
Operating time left at 'Lo BAT' indication 1 hour
/
COMon 8.
359
m i i a
6.2.84 PORTABLE CARBON MONOXIDE MONITOR ISSUE 1
CALIBRATION
CAUTION: Calibration should only be carried out in a designated
non hazardous area and using known gas concentrations.
The instrument is fitted with an internal span control and external 
zero control. To calibrate aspirate the zero gas (Air with 0 ppm CO) 
and when the display has stabilized to its lowest point, ad just the 
zero control to give a reading of 0 ppm.
When this has been completed, aspirate calibration gas into the cell, 
and again when it has stabilized to its highest reading adjust the 
sensitivity control to give the reading as indicated on the 
calibration cylinder.
To preset the alarm set point, depress the alarm level pushbutton on 
the top of the case. This will display the present value of the alarm 
set point. To adjust, vary the alarm adjustment potentiometer. While 
the-pushbutton is depressed the level can be monitored.
As soon as the button is released, the readout will revert to the 
actual gas concentration present.
NOTE 1 Access to the gain control and the alarm level setting 
control is only possible by unscrewing the special case 
fasteners, and removing the instrument top cover.
S E N S I T I V I T Y
A D J U S T
Z E R O
A D J U S T
B A T
A L A R M
L E V E L
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BATTERY RECHARGING
The instrument internal battery is recharged by inserting the charging 
jack plug into the instrument jack socket, and connecting the charger 
mains plug to a mains outlet.
When the instrument is in the charging mode, the charging L.E.D. will 
be illuminated. -
B A T T E R Y
C H A R G E R
J A C K
P L U G
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DESCRIPTION
The instrument is based on the measurement of parts per million (ppm) 
carbon monoxide using a sensitive, selective electrochemica1 fuel cell 
and is portable and capable of operating for up to 15 hours when 
completely re-charged.
a. The instrument is powered from a rechargeable Nickel Cadmium 
battery, which is accessed externally by means of a jack socket 
allowing for the use of a mains "Bat tery charger. A charging 
L.E.D. adjacent to the jack socket is illuminated when the 
battery is being recharged. The battery can only be recharged 
when the On/Off switch is in the Off position.
b. The sensor itself is housed in the main compartment of the case,
and is configured in such a way as to allow satisfactory
operation both in the natural diffusion mode, and the aspirated 
mode with only the addition of an external, push fit, calibration 
mask. The sensor is a three electrode sensor and as such can not 
be connected in circuit at all times. When not in circuit the 
working and reference electrodes are connected together, 
maintaining the bias potential at OV. Thus when the instrument is 
switched on again, the concentration reading is available after a 
short period of time (20 s) has been allowed for the sensor to 
stabilize.
c. The control electronics accept a voltage output across the cell
load resistor which is dependant on the carbon monoxide 
concentration, and amplifies this signal to a suitable level 
to interface with the DVM module which gives a digital 
readout of the signal level at its input. Compensation for 
variations of cell output with temperature is also included.
d. The adjustable alarm set point allows the user to preset his
desired alarm level, and when the concentration of carbon 
monoxide exceeds the limit the audible alarm is triggered. When 
the concentration falls to a desired level below the alarm level 
the alarm ceases.
COMon 11.
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SENSOR
The Carbon Monoxide sensor is of the three electrode fuel cell typ 
designed to be maintenance free and stable over long periods of time 
There are no user replaceable parts other than the complete senso: 
module.
The sensors use the capillary diffusion barrier technology which ha: 
been proven over many years, and this results in low temperature 
coefficient, a direct .response to concentration (Z volume), anc 
relatively unaffected by pressure. The use of electrodes based or 
fuel cell technology gives a high reserve of activity which makes fo: 
long term stability.
Carbon monoxide diffusing to the sensing electrode (anode) react: 
according to the equation
CO + H20 + 2e = C02 + 2H+
At the counter electrode (cathode) the reaction is
\02 + 2H+ = H20 + 2e
the oxygen requirement being automatically supplied from the ambien 
air by controlled diffusion.
Figures 8 and 9 respectively show the electrical and mechanica 
details of the sensor.
COMon
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INSTRUCTIONS FOR EXHALED HYDROGEN MONITOR 
APPLICATION
The monitor is designed for the measurement and recording of exhaled 
hydrogen in the diagnosis of malabsorption of carbohydrates which can 
assist in identifying such conditions as:-
1. Lactose intolerance -
2. Assessment of gut transit time
3. Excessive bacterial growth in the small intestine.
The Monitor provides a range of hydrogen measurement of 0 to 250 ppm - 
which can be read out directly on the digital display and if required 
can be permanently recorded using the GMI recorder unit CR001.
/
/
/
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Fig. 1
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TYPICAL PERFORMANCE CHARACTERISTICS ... 
Range :
Transient Response (to reach 90% of final
Air Air 4- Hydrogen
Air 4- Hydrogen --—  Air
Sensitivity 
Accuracy -
Temperature coeff of zero (1)- 
Teraperature coeff. of sensitivity (1) 
Repeatability 
Cross sensitivity : -
Oxygen
Carbon Dioxide
Carbon Monoxide
Methane
Sensor operating life 
Battery back-up
0 - 250 ppm Hydrogen 
value)
7 - 10 secs.
12 - 18 secs.
2ppm •
•/.+/- 2% (+/- 1 ppm for readings 
less than .50 ppm)
  2ppm/°C.
.0.5 ppm/°C 
4-/- 1 ppm
Step change by 5% by 
volume = approx 2 ppm 
Step change by 5% by 
volume = approx 2 ppm 
Step change by 50 ppm 
.=* approx 7 ppm 
Step change by 1% by 
volume = approx lppm 
12 months 
20 hours
Note 1: The instrument should ideally be operated under constant
ambient temperature conditions, and does not respond to rapid 
temperature changes. Any temperature changes should be kept to a 
minimum in both magnitude and rate of change.
EXHYMINS
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Combines with other IL instrumentation 
for comprehensive oxygen availability 
and consumption analyses.
The new IL282 CO-Oximeter can be inter- tory function and oxygen statuses. Another
faced with our IL813, 713 or 513 Blood Gas natural application of this system would be
Analyzer and IL318 Printer to form a com- use in conjunction with the IL601 Cardiac
plete blood gas laboratory. This prints out a Output System for oxygen consumption
15-parameter profile of acid/base, respira- studies.
Phone toll-free for a demonstration of the IL282:800-225-1481.
Instrumentation 
Laboratory Inc.
Biomedical Diulsion
113 Hartwell Avenue 
Lexington, MA 02173
367
An IL advance, 
to advance your 
patient care.
The IL2S2 CO-Oximeter is a dedicated spectrophoto­
meter that analyzes whole blood specimens for 
4 hemoglobin parameters, olus oxygen content. Total 
hemoglobin (THb). % C ;Hb. % C O H b  and % MetHb 
are determined utilizing 4 wavelengths of light and 
16 extinction coefficients locked in memory. O? con­
tent is calculated from THb and measured % 0?Hb.
A built-in mtcrccrocessor helcs control the numerous 
automated functions.
Easy operation.
To make an analysis, you simoly: present the sample, 
pusn the SAMPLE burton, and watcn for THbi'g/cl) 
to ccme uo on the LED display. Cther values are then 
displayed at a push of their buttons. Presentaticn-to- 
disclay time is only 62 seconds. Data remains avail­
able for! 2 hour or until the next sample is run.
Zeroing, aspiration, hemolyzing. measurement, cal­
culation and cleaning are all automatic. If the IL318 
Printer or hospital computer is connected to the 
IL282. it receives all data automatically.
Routine sample volume is 350 ul. Micrcsamcles of 
175 ul may be presented from Natelscn capillary 
tubes. A  syringe-loading ootion is available.
More useful, accurcte data 
This new IL instrument provides the comprehensive 
hemoglcDin analysis that— ccmomed with bleed gas 
analysts— is increasingly being stressed for complete 
patient care, to improve assessment of oxygen satur­
ation and transport. It is much easier and faster than 
manual methods.
Determines 4 hemoglobin parameters not just 
one or two.
The inclusion of C O H b  and MetHb optimizes accur­
acy in spectrophotometrically determining 0 2Hb.
And these additional "knowns" are valuable by them­
selves. For example. C O H b  is a key factor in diag­
nosing fire victims, smokers or workers exposed to 
carbon monoxide (pollution). MetHb may be signifi­
cant in hemoglobinopathies and drug-related 
conditions.
The IL282's calculated oxygen content is highly 
accurate and correlates closely with Van Slyke 
values. It is based on the total hemoglobin and the 
actual percent oxyhemoglobin.
a!
:■: ISsi JV SftVri*1.
Automated stcbility and other features upgrade 
precision.
Ahollow-cathode lamp in the IL282 emits unchanging 
wavelengths. Dual-beam optics compensate for'lamp 
intensity variations.
The instrument cleans itself and updates its blank 
absorbance values after each sample, and every 
Vi hour when in Standby mode. It is compatible with 
routine blood quality control procedures. THb values 
correlate with those of cyanmethemoglobin refer­
ence methodology.
Audible/visual warning systems alert the operator 
to faults. Corrective action normally involves a simple 
cuvette maintenance procedure.
368
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4 I used to be able to walk miles 
but now I only have to go down 
to the local shops and back and 
I'm out of breath. And if I'm 
going to do anything energetic -  
even if it’s just the washing -1 
have to put a tablet under my 
tongue to stop the pain coming 
on. But usually I’m alright. I just 
have to be careful not to overdo 
i t .  9
:
4  I thought I’d be the last person to have any heart trouble. I’ve 
always loved sport. I was a champion cross country runner when I 
was younger and since then I’ve kept myself fit playing football fo 
local teams. But when I started running a busy pub I began to put 
on a lot of weight. I was up to 16 stone when I had my heart attack
i It was so sudden. I was just getting a meal ready and my 
lusband went out to the garden to pick some vegetables. The 
lext thing I knew he had collapsed and died. Nobody expected i t -  
ie always seemed so fit and healthy. 9
It could mean a heart 
attack out of the blue. Or years of 
suffering from angina. It might even 
mean a cardiac arrest and sudden 
death.
It’s easy to think it couldn’t happen to 
you. But heart disease is the biggest 
single killer in Britain today. It is 
estimated that four out of every ten men 
will suffer from some form of heart 
disease by the time they are 65 years old. 
And in the last twenty years there has 
been an increase of heart disease in 
younger women.
But you can do something to reduce 
the risk. And you’ll not only be fighting 
heart disease. You’ll soon start to feel 
fitter than ever before.
Take a look at this booklet and find out 
what you can do. It will tell you:
□ w hat heart disease is
□ w h y  some people get it
□ h ow  to help yourself avoid it
□w hat to do for someone who’s got it 
(including advice on emergency first aid).
Don’t wait until it’s too late. Do 
something now. Take some good advice 
and help yourself to a healthier heart.
1
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There are many different 
types of heart disease. This booklet is 
about the type that is most common and 
most tragic. The type that causes heart 
attacks. It’s called Coronary Heart 
Disease (CHD).
How the heart 
works
The heart is a blood-filled bag of muscle 
about the size of a fist. The muscle 
contracts about 70 times a minute to 
pump blood around the body. Like any 
other active tissue, the heart muscle 
needs a good supply of oxygen. It gets 
this from the bloodstream. Its supply is 
taken not from the blood which is being 
pumped through the heart but from 
separate little arteries, the coronary 
arteries. These arteries branch off from 
the main artery (the aorta) and then 
divide into smaller branches which fan 
out all over the surface of the heart.
aorta  
left coronary a rte ry
right co ronary arte ry
W hat goes 
wrong?
Over a period of many years, starting in 
early adult life, the walls of these arteries 
can gradually become ‘furred up’ with a 
fatty deposit called atheroma. If the 
atheroma gets too thick and the arteries 
too narrow, the blood supply to the heart 
muscle can be restricted or even blocked. 
This is coronary heart disease. It has two 
main forms: angina and heart attack.
(  Since I found out I had angina about 3 years ago, I’ve had to 
make a lot of changes in my life. For instance, we’ve had to move 
our bedroom and bathroom downstairs so I don’t have to go 
upstairs so much. And I’m on a very strict diet. But by taking 
angina tablets and by following my doctor's advice I find I can cop 
with a fairly demanding job. You just have to be sensible about it. 
Nowadays if I feel tired at work I stop for a while or go home earl' 
instead of pushing myself to the limit like I used to. In fact, these 
days I’m more relaxed than I’ve ever been! y
norm al a rte ry a rte ry  w ith  build 
up o f atherom a
W hat is angina?
If the narrowing of the coronary arteries 
is very gradual then the first signs of 
trouble may only be noticed when the 
heart is having to work harder than 
usual. Because the blood flow through 
the arteries is restricted, anything whicl 
makes the heart pump a little faster thar 
usual -  even if it is only walking up step: 
-  starves the heart of blood. The classic 
situation is when a person is exerting hii 
or herself, or getting excited or angry. 
This brings on a heavy cramp-like pain
icross the chest, like a huge weight. 
Sometimes the pain spreads to the neck, 
houlder, arm or jaw. It usually fades 
iway after a few minutes rest.
This kind of pain is known as angina, 
t is not the same as a heart attack 
>ecause it is usually relieved by a short 
>eriod of rest or relaxation. Somebody 
vho suffers from angina does have a 
ligher than average risk of having a heart 
ittack. But angina itself can be relieved 
>r controlled by drugs and, in severe 
:ases, surgery.
What is a heart 
attack?
\  heart attack happens when there is a 
>udden and severe blockage in one of the 
:oronary arteries so that the blood 
supply to part of the heart muscle is cut 
aff. The blockage is usually caused by a 
blood clot forming in an artery already 
damaged by fatty atheroma. This is 
called a coronary thrombosis (or 
sometimes a coronary).
The part of the heart muscle affected 
is severely damaged causing the pain that 
is the most common symptom of a heart 
attack. This pain is usually, but not 
always, a crushing vice-like ache felt in 
the chest. It can spread to the neck, jaw 
or arm. It does not usually ease off for 
several hours. As well as being in pain 
the person usually feels faint, giddy or 
sick.
In some cases the effects of the 
blockage can be so severe that the heart 
stops beating altogether. This is called a 
cardiac arrest. Unless the heart starts 
beating within a few minutes the person 
will die. Unfortunately about 50% of all 
fatal heart attack victims die within half 
an hour, often before medical help 
arrives. Some of these people could be 
saved by prompt emergency first aid.
Far too many of us. As you 
can see from this diagram, heart disease 
causes more than a quarter of all deaths 
in this country.
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Causes of death in the U.K. (as a percentage of all deaths)
Based on government figures
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Death rates from coronary heart disease in different 
countries (35-74 year olds)
Based on figures from the World Health Organisation
You can see from this chart how people 
from some parts of the world are more 
likely to suffer from heart disease than 
others. Notice how England, Scotland, 
Wales and Northern Ireland are near the 
top of the league for deaths from heart 
disease. Now compare us with Japan.
And even within Britain there are 
some areas where heart disease is more
common. In general, Scotland, Wales 
and Northern Ireland are worse off than 
England.
The experts are trying to find the 
reasons why the death rate from heart 
disease varies so much from place to 
place. There is no simple answer. As we 
will see later it is likely to be the result of 
many different factors.
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And things aren’t getting any better. 
Have a look at how heart disease death 
rates have been changing around the 
world over the past few years. As you can 
see, we are way behind the improvement 
shown in other countries, for example, 
the United States.
Researchers have studied more than 20 cigarettes a day is four
1968
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o
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B
LJmen 
I I women
United States
Australia
England and Wales
N.Ireland
Scotland
Death rates from coronary 
heart disease in men and 
women aged between 40 and 
69 years
Based on W o r ld  Health Organisation figures
entire populations to try to discover what 
it is in our everyday lives that increases 
the risk of heart attack and angina. Their 
results show that there is no single cause 
of heart disease. Instead, there seem to 
be several different factors which 
together may tip the balance against 
your heart.
Of course, some people are more likely 
to suffer from heart disease than others. 
For example, the tendency to die young 
from heart disease can run in the family. 
And certainly the older you are, the 
greater the risk of having a heart attack. 
The narrowing of the arteries which can 
lead to angina and heart attacks tends to 
get worse as you get older, although it 
may start quite young.
In general, men are more at risk from 
heart disease than women. A man in his 
late forties is five times more likely to die 
of heart disease than a woman of the 
same age. But after the menopause, a 
woman loses the protective effect of her 
hormones and her chances of suffering 
from heart disease are almost equal to a 
man’s. And in the last twenty years there 
has been an increase of heart disease in 
women in their 30s and 40s.
Even though your age, your sex and 
your family history are all beyond your 
control, you can still do a lot to keep your 
risk of heart disease as low as possible.
Risky living
Start by looking at the way you live your 
life. When people think of taking risks 
they think of going hang-gliding, or 
driving too fast, or even crossing a busy 
road. But you might be taking a 
life-and-death risk every day without 
even realising it. By smoking, eating too 
much of the wrong food and not getting 
enough exercise and relaxation you could 
be gambling with the health of your 
heart.
Smoking
Cigarette smoking can double your risk 
of dying from a heart attack. And if you 
smoke heavily you are even more likely 
to die young from heart disease. For 
example, a man aged 50 who smokes
times more likely to suffer from heart 
disease than a non-smoker of the same 
age. And women are just as much at risk 
as men. The risk for a woman who 
smokes is especially high if she is over 35 
and is on the pill.
How does smoking affect the heart? 
The nicotine in tobacco smoke increases 
the pulse rate and raises the blood 
pressure. The carbon monoxide content 
of cigarette smoke cuts down the amount 
of oxygen in the blood. So your heart is 
having to work harder but getting less 
oxygen. Smoking also accelerates the 
‘furring up’ of the coronary arteries.
W hat you can do
The answer is to give up smoking. As 
soon as you stop smoking you will start to 
reduce your risk of a heart attack. You 
could be almost back to a non-smoker’s 
risk level within a few years.
Don’t think that by cutting down or 
switching to a low-tar brand of cigarette 
you will be protecting yourself against 
heart disease. You might actually be 
inhaling even more carbon monoxide by 
taking longer and more frequent puffs. 
And smoking cigars or a pipe will only be 
safer than cigarettes if you don’t inhale. 
Giving up smoking altogether isn’t easy. 
But it’s certainly worth it. To help you 
make your decision, think about what 
you gain by stopping. It’s not just that 
you improve your chances of avoiding 
heart trouble. You gain in other ways 
too:
□  You’ll be healthier and breathe more 
easily -  for example, when you climb 
stairs or run for a bus. And you’ll help 
that smoker’s cough
□  You’ll suffer fewer colds and 
infections
□ Y ou’ll smell fresher. No more bad 
breath, stained fingers or teeth
□Y ou’ll save money.
If you’re not sure you can do it, think of 
this: there are eight million people in this 
country who have stopped smoking. So 
you can do it too.
Deciding to stop smoking, and really 
wanting to do it, is half the battle. If 
you’ve made up your mind you’re going
stop, the chances are you’ll manage it. 
ut because it’s not an easy thing to do, 
s worth working out just how you’re 
>ing to do it.
[First of all, decide on the day when 
rn’re going to stop and then stick to it. 
Lake it a big day. Do something special, 
[an a treat at the end of the day as a 
ward.
jFrom now on, try to change your 
iutine so you can avoid the situations in 
hich you know you’ll want to smoke.
3u won’t have to avoid these danger 
tuations for ever, just for the first few 
eeks.
jD on’t think about tomorrow. Take 
ich day as it comes. If you do feel a 
rong urge to smoke, then do something 
se instead. Don’t just sit there wanting 
cigarette and worrying about it, 
ecause you’ll probably end up smoking, 
ind activities to replace smoking -  
lings to distract yourself, things to do 
ith your hands, things to help you 
:lax. Do something active. Play some 
)ort. Go for walks or for a run. Get 
thers to join you so you can share the 
leasure.
1 After your first enthusiasm has worn 
ff, keep at it. Remind yourself of your 
iasons for giving up and what you’re 
aining now you’ve done it. Don’t be 
:mpted to smoke ‘just the odd cigarette.’ 
>ne odd one easily leads to two, or three 
,. You really have to work at breaking 
le habit for good if you want to give 
aur heart a chance.
F you would like a step-by-step guide to 
iving up smoking you can obtain a copy 
f So you want to stop smoking from your 
>cal health education unit or by writing
So you want to stop smoking’
O Box 410 
.ondon SE99 6YE
r, if you live in Scotland, write to:
cottish Health Education Group 
(bodburn House 
lanaan Lane 
Edinburgh EH10 4SG.
6 1 started smoking when I was 19. A friend offered me a cigarette 
and I really enjoyed it. After that I was hooked and I was soon 
getting through about 30 a day. I did try to give up because I knew 
it wasn’t good for me. But it was impossible -1  liked smoking too 
much to stop. Then a couple of years ago I had to run an urgent 
errand at work. It meant I literally had to run about half a mile 
and back. By the time I got back to the office I could hardly 
breathe. It really brought home to me the damage smoking must 
be doing to me. If I felt like that at 23 what was I going to feel like 
at 40? I decided to give up smoking there and then. Of course, it 
was difficult to break the habit at first but I’m glad I kept at it this 
time. I have had the occasional cigarette when it’s been offered to 
me but I don’t enjoy it anymore. In fact, I feel sick if I smoke. It ’s a 
relief to have kicked the habit. And it’s not just my health that’s 
improved -  my bank balance feels a lot better too! It ’s nice to have 
the ‘cigarette money’ to spend on other things. J
M n
Diet
Another way to beat heart disease is to 
watch what you eat. Your everyday 
choice of food can be a key factor in the 
health of your heart. And if you are 
choosing food for the family, you’ve got 
their hearts in your hands too. So beware 
of eating the wrong foods and putting on 
too much weight.
Look at the chart to see what you 
should weigh. Find your height (without 
shoes) and run your finger in a straight 
line across the chart. Find your weight 
(without clothes) and run your finger up 
the chart. Where the two lines cross tells 
you how your size rates.
The more overweight you are, the 
more likely you are to get high blood 
pressure or diabetes, both of which can 
lead to heart attacks and angina. So take 
the experts’ advice and make an effort to 
keep your weight down.
For most people it’s all too easy to put 
on weight. This might be because it runs 
in the family -  whatever you eat seems to 
turn straight to fat. Or perhaps you 
aren’t taking enough exercise to burn up 
the calories in your food.
But the most likely reason is that you 
are simply eating far too much of the 
wrong sorts of food. In other words, too 
many fatty and sugary foods. These are 
loaded with calories. Did you know that 
just one ounce of butter or margarine 
contains more calories than half a pound 
of potatoes? And two teaspoons of sugar 
contain nearly as many calories as a 
quarter pound of peas.
So the best way to keep your weight 
down is to cut down on the amount of fat 
and sugar in your daily diet.
W hat you can do
Eat less fat
The fat in your food is not only 
responsible for those extra inches on 
your waistline. It can also push up your 
blood cholesterol level. Cholesterol is 
one of the natural substances in the 
blood. It is mostly made from the fat in 
the food we eat. If there’s a lot of fat in 
your diet you may have a high level of 
cholesterol in your blood. This can 
accelerate the build up of atheroma that
t  Three years ago my husband was told his blood pressure was 
too high. Since then we’ve completely changed our diet. We eat 
more fresh fruit and vegetables, home-baked wholemeal bread 
and very little fat. And we’ve managed to cut out sugar and salt 
altogether. There are so many delicious things you can make 
without eating the wrong food. We honestly feel a lot fitter than 
when we were eighteen! y
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Your weight in stones From G A R R O W  J.S. ( 19 8 1)
Treat Obesity Seriously. Edinburg! 
Churchill Livingstone.
Underweight. Are you eating enough?
OK. This is the desirable weight range for health.
Overweight. Not likely to have much effect on your health but don't get 
any fatter!
Fat. Your health could suffer if you don't lose weight.
Very fat. This is severe and treatment is urgently required.
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Meat Percentage fat
iventually leads to heart disease. So the 
ligher the level of cholesterol in your 
>lood, the greater the risk of heart 
rouble.
The best thing to do is to cut down on 
he total amount of fat you eat by up to a 
[uarter. You can see from the blue table 
i o w  much fat there is in different foods. 
Jse the table to help you decide where 
ou can cut down on the fat in your diet.
]  Eat less meat. Try fish or vegetable 
lishes. When you do eat meat, choose a 
:aner cut if you can -  it’s worth the extra 
ost. Or eat chicken, which has less fat 
han other meats and is usually cheaper, 
dways cut the fatty bits off meat.
3 Grill, don’t fry.
DBuy skimmed or semi-skimmed milk 
istead of full-fat milk. And try yoghurt 
istead of cream.
0 You can see from the table that some 
heeses are nearly half fat. Try a lower fat 
heese.
USpread less butter or margarine.
3Use less lard or oil in cooking.
ou may have heard of saturated fats and 
nsaturated fats. The difference 
etween them is their chemical 
take-up. They are all made up of basic 
abstances called fatty acids. Some of 
lese are saturated fatty acids (or 
aturates). The rest are unsaturated and 
lclude a special group called 
olyunsaturated fatty acids (or 
olyunsaturates). All the different fats 
re eat are made up of different 
ambinations of different fatty acids, 
lost are high in saturates, but some are 
igh in polyunsaturates.
Dietary experts believe that saturates 
re the main enemy so far as the heart is 
mcerned. Too much fatty food high in 
lturates can push up your blood 
tiolesterol. And that pushes up your 
tiances of getting heart disease.
About half the fat that most people eat 
rich in saturates. Experts believe that 
e should cut the amount of saturated 
its we eat by up to a half. Take a look at 
le yellow table. It shows how high 
irtain foods are in saturated fats. Use 
le table to work out how you can cut 
Dur intake.
Fried streaky bacon 45% r..........  ■ i
Grilled streaky bacon 36% 1 1
Grilled lamb chops ?9%r...........: . n
Pork pie ?7%i :i
Luncheon meat 27% 1 ........ 1
Liver sausage 27% f............... 1
Roast lamb (shoulder) 26% r ..... ... n
Fried pork sausages 2.5% 1 .........Z]
Roast leg of pork 20% i ' ..  □
Fried beefburgers 17% 1 ...... . 1
Grilled rump steak 12% 1 .1
Casseroled pigs liver 8 % r ............. i
Stewed steak /%[._._......‘ "i
Casseroled chicken 7%L................. 3
Fried lambs kidneys 6%f ""...........J
Tinned ham 5%l .......... J
Fish
Smoked mackerel 16% 1 J
Fried fish fingers 13% 1 ..... .... .. ...1
Grilled kippers 12% 1 J
Cod fried in batter io% L.: i z : .:::j
Steamed plaice 2%l .............. 1
Steamed haddock l% ! .............. "I
Cheese
Cream cheeses 50% 1 1
Stilton 40% 1 ........1
Cheddar 34% I ................ 1
Parmesan 30% 1 1
Processed cheese 25% 1 J
Camembert 23% 1 .. J
Edam 23% 1 ............ 1
Cheese spread 23% 1................. 1
Cottage cheese 4% 1 1
M ilk, butter, oils
Oil (all kinds) 100% f _ ..."
1 ard 99% 1 1
Butter 82% 1 J
Margarine (all kinds) 80% 1____ ____ □
Double cream 50% 1 1
Dairy ice-cream 7%r . .... .........i
Gold-top milk 5% 1 1
Silver-top milk 4% 1 ......... 1
"ibghurt l% l....... 1
Skimmed milk Less than 1%
The saturated fat in fatty food
These figures show the percentage of 
saturated fat in the total fat content of the 
food we eat, for example full cream milk 
(gold-top) is 5% fat. Two thirds (60%) of 
that fat is saturated.
All dairy products
Milk about 60%
Butter
Cheese
Cream
Margarines
hard (in packets) about 40%
soft (in tubs)
typical blends about 30%
'high in polyunsaturates' about 20%
Fats and oils
Coconut oil about 75%
Lard about 45%
Blended cooking fat about 40%
Corn oil about 20%
Groundnut (peanut) oil
Olive oil
Soya oil
Sunflower oil less than 15%
Safflower oil
Meats
Lamb fat about 50%
Beef fat about 45%
Pork fat about 40%
Chicken fat about 35%
Fish
Mackerel about 25%
Cod
Plaice
Herring about 20%
Remember, whenever you can, choose 
food low in saturates (sometimes 
labelled high in polyunsaturates). Look 
for margarines and cooking oils labelled 
‘high in polyunsaturates’. And think 
twice about choosing products labelled 
‘blended vegetable oils’. These contain 
mostly palm or coconut oil which are 
both rich in saturates, as you can see 
from the table.
Eat more fibre
Fibre is the name given to a whole range 
of complex plant substances. They pass
right through the intestines without 
being absorbed into the body. By 
providing roughage, fibre not only aids 
digestion and helps prevent 
constipation. It also seems to stop too 
much fat and sugar getting into the 
bloodstream too quickly. And some 
scientists believe that a high-fibre diet 
can help keep the blood cholesterol 
down. What’s more, fibre can give 
satisfying bulk to a meal without adding 
too many calories.
Fibre comes mainly from bread, 
cereals, potatoes, peas, leafy vegetables 
and fruit. All in all, it is the single most
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Foods high in fibre
important form of food likely to be 
lacking in your everyday diet. Look at 
the table below for some of the best 
sources of fibre.
Remember there is no fibre at all in 
any food which comes from animals, like 
meat, eggs and dairy products.
It’s not difficult to put fibre in your 
diet. You simply need to eat more bread, 
including some wholemeal bread, and 
potatoes; choose a high-fibre breakfast 
cereal containing wholegrain or bran; 
and eat plenty of fruit and vegetables.
Fibre Content of Food
High Fibre Content
Peas
Bran cereal 
Stewed prunes 
Beans, like baked beans 
Sweetcorn 
Bananas
Wholemeal bread 
Brown rice 
Rye crisp bread 
Dried fruit
Leafy vegetables, like spinach 
Potatoes, baked
Medium Fibre Content
Muesli 
Most nuts
Most green vegetables
Apples
Oranges
Celery
Brown bread
Cornflakes
Low Fibre Content
T omatoes 
Potatoes, boiled 
Grapefruit 
Porridge 
White rice 
Lettuce 
Cucumber 
White bread
No Fibre Content
Sugar
Eggs
Butter
Cheese
Milk
Meat
Fish
Eat less sugar
N ot because sugar is especially harmful 
to the heart but because it is so tempting 
that it is difficult not to eat too many 
calories. Too many calories mean you get 
fat -  and that can be bad for your heart.
Nobody needs sugar. It has no 
nutritional value other than its energy 
content. And we can get all the energy 
(calories) we need from the other food we 
eat. So try to reduce the amount of sugar 
you eat by at least a half.
Start by cutting down on sweets, 
chocolates, soft drinks, jams and other 
preserves and cakes or pastries. Just have 
them as an occasional treat. Try drinking 
your tea and coffee without sugar. Cut 
down gradually by about half a teaspoon 
a month. You’ll soon get used to not 
using it. But if you really can’t do 
without the taste, saccharin is sweeter 
than sugar and contains no calories at all.
It’s surprising how easily you can
adjust to less sugar. And you will 
probably start to notice all the other 
more subtle flavours in your food.
Eat less salt
Most of us eat far more salt than we need 
First of all, we buy food that already 
contains a lot of salt -  meat, bacon, 
sausages, butter, cheese, tinned 
vegetables, bread and cereals. Then we 
add more salt when we cook it. And 
finally we sprinkle more salt onto it whei 
we eat it.
Some experts believe that this high 
intake of salt may be putting up the 
nation’s blood pressure. You can reduce 
this risk by simply cutting down on the 
amount of salt you eat. You will be 
surprised how quickly you can get 
used to eating much less salt in and 
on your food.
in
(  So much heart disease could be prevented if every patient over 
the age of 35 had their blood pressure checked once a year during 
a visit to their GP. f
High blood 
pressure
Blood pressure is the pressure which the 
heart and arteries apply in order to 
squeeze the blood around the body. 
When you are sitting or lying quietly 
your blood pressure stays at a steady 
resting level. In moments of exercise, 
excitement, anger or anxiety the level of 
blood pressure is raised to increase the 
blood flow to the brain and muscles. 
When the moment has passed the blood 
pressure drops again to its steady level. 
The sudden rise in blood pressure is 
brought about by the release of stress 
hormones like adrenaline.
What is high blood pressure?
High blood pressure (hypertension) 
means that the resting blood pressure is 
higher than normal. Very few young 
people have high blood pressure but after 
the age of 35 it becomes much more 
common, mainly because of the way we 
live our lives. These are some of the 
things that might give you high blood 
pressure:
□ b ein g  overweight 
□  smoking
□drinking too much alcohol
□ lack  of regular exercise 
□eating too much salt 
□  too much stress.
The trouble is that you may not even 
realise that your blood pressure is too 
high. By itself, high blood pressure 
doesn’t feel any different. But high blood 
pressure makes the heart work harder 
and speeds up the ‘furring up’ of the 
arteries. So people whose resting blood 
pressure is too high are more likely to 
suffer from angina or a heart attack.
They may also be in danger of having a 
stroke, when the blood supply to the 
brain is cut off by a blood clot or 
haemorrhage.
at you can do
There’s a lot you can do to help keep your 
blood pressure at a normal level.
□  Watch your weight. Keeping your 
weight at its correct level can help to keep 
your blood pressure down.
□ D o n ’t drink too much alcohol. Try not 
to drink more than two or three pints (or 
the equivalent), two or three times a 
week. Half a pint of beer is equivalent to 
one glass of table wine or a single whisky 
or other spirit.
□ S to p  smoking.
□Take some exercise.
□ E a t less salt.
□ R e la x .
O  Have your blood pressure checked.
You may not know your blood pressure is 
high if you haven’t had it checked 
recently by a doctor or nurse. This is 
especially important if you are over 35 
years old. If your blood pressure is too 
high it can be kept at a normal level by 
medical treatment if necessary. There is 
good evidence that the control of blood 
pressure can prevent heart disease.
Is stress bad for the heart?
Most people would put stress at the top 
of their list of things that are bad for the 
heart. It seems obvious that worry and 
anxiety, or frequent crises and rows, can 
make your blood pressure go up and lead 
to a heart attack. But this is still difficult 
to prove, partly because stress is almost 
impossible to measure and define.
However, people who have a certain 
kind of personality -  striving, ambitious, 
competitive, impatient, always pressed 
for time -  seem to be more in danger of 
having a heart attack than more relaxed, 
easy-going types. We call the first 
heart-risk type Type A.
It seems that people who are more 
Type A are likely to have higher blood 
pressure and blood cholesterol levels 
than the calmer Type B. There is some 
evidence that this is because Type As 
have more stress hormones circulating in 
the bloodstream. This can lead, through 
high blood pressure and high blood 
cholesterol, to an increased risk of heart 
disease. It has also been suggested that 
someone who is normally calm but is 
frequently forced into stressful 
situations might eventually suffer the 
same effects as Type A.
How you can cope with stress
A certain amount of stress is an essential 
part of ordinary everyday life. It helps 
keep you on your toes and out of danger. 
Every time you cross a busy road or have 
an argument or watch an exciting 
programme on television your stress 
level goes up for a while. But if anxiety or
II
4  After my heart attack I realised I had to do something about th< 
state of my health. I was overweight and pretty unfit. It ’s not easy 
to change your routine but I knew that unless I got some more 
exercise and kept myself slim I’d be digging my own grave. So I 
took up running and joined the swimming club at work. I really 
enjoy it. J
pressure of work continue for many 
months or years your heart may suffer. 
This kind o f chronic stress can be 
difficult to recognise and sometimes 
impossible to avoid. Family problems, 
money worries, difficulties at work may 
not be easy to solve.
But you can help yourself by learning 
how to relax and trying to take things 
easy. When you have some free time, try 
to take up an activity, hobby or interest 
which helps keep your mind off your 
worries. It’s difficult to worry about your 
problems when you are totally absorbed 
in doing some gardening, reading a book 
or watching a football match. And there 
are several simple ways of helping your 
mind and body relax during the day. Try 
one of them next time you feel tense 
about something.
Deep breathing
Sit or lie quietly, in as peaceful a place as 
you can find. Close your eyes. Picture a 
scene of tranquillity, like waves lapping 
on a sandy shore, or leaves rustling in a 
gentle breeze. Breathe slowly and deeply, 
through your nose. Make each out- 
breath long and soft and steady.
Clench-and-let-go exercises
Sit or lie quietly, in as peaceful a place as 
possible, and close your eyes. Clench 
both your fists for about 15 seconds. 
Then relax them and feel the tension 
draining away from your arm muscles. 
Repeat this twice. Then hunch your 
shoulders for 15 seconds, and relax, 
feeling the tension drain away. Repeat 
twice. Continue the same routine with 
jaw-clenching and relaxing. And finally, 
screw your eyes up tightly and relax 
them, feeling the tension disappear.
Meditation
Sit or lie quietly in as peaceful a place as 
possible and close your eyes. Repeat over 
and over to yourself a simple sound, 
word or phrase. Anything, so long as it’s 
simple and easy to repeat. Just 
concentrate on the repetition so that it 
fills your mind and banishes anxious 
thoughts. Let yourself relax into this 
steady rhythm for 5 or 10 minutes.
Exercise
Any activity which gives you some 
exercise is especially good for your heart. 
Exercise helps relieve the tensions that 
have been building up inside you. And 
your body gets a chance to let off steam. 
All kinds of exercise from the gently 
stretching postures of yoga to the 
vigorous leaps and bounds of badminton 
will help you to combat stress.
Exercise not only helps to reduce stress. 
There is good evidence that regular 
vigorous exercise can have a protective 
effect on the heart. And exercise can 
certainly help to make you feel and 
look better.
Your heart will benefit most from the 
kind of exercise that builds up stamina. 
Stamina means staying power or the 
ability to keep going without gasping for 
breath. It depends on the efficiency of 
your muscles and circulation. And the 
most important ‘muscle’ o f all is the 
heart itself.
To build up your stamina you need to 
choose a form of exercise that gives your 
body plenty of movement, and is just 
energetic enough to make you fairly 
breathless (but not gasping for breath). 
This is called dynamic exercise. The 
vigorous effort of moving your muscles 
rhythmically creates a greater demand 
for oxygen in the blood, and more work
12
Stamina Rating
Badminton
Canoeing * * *
Climbing stairs
Cricket •
Cycling (hard)
Dancing (ballroom) *
Dancing (disco) * * *
Digging (garden) * * *
Football A A AW W W
Golf ■■■Hi
Gymnastics ■■■HI
Hill walking IF
Housework (moderate) •
Jogging
Judo w w
Mowing lawn by hand * *
Rowing
Sailing •
Squash * * *
Swimming (hard)
Tennis * *
Walking (briskly) * *
Weightlifting •
Yoga *
^  n o t much effect 
* *  beneficial effect 
very good effect 
excellent effect
for the heart and lungs. Regular exercise 
of this kind improves the balance of fatty 
substances in the bloodstream, lowers 
the resting blood pressure level and 
strengthens the heart muscle.
At the simplest level, brisk walking is 
an excellent stamina-building exercise. 
But you could also try running up stairs, 
jogging, skipping, disco-dancing, 
cycling or swimming.
Have a look at the chart above to help 
you choose the form of stamina-building 
exercise which suits you best. Whatever 
you choose make sure it’s something you 
enjoy or you will never keep at it. Of 
course you can change from one activity 
to another; it’s the level of exertion that’s 
important.
Once you have found a form of exercise 
which you enjoy, try to do it:
□ O ften  enough -  2 or 3 times a week for 
20 or 30 minutes at a time
□ H ard enough -  to make you fairly 
breathless but not gasping for breath
□ L o n g  enough -  it must become a part 
of your life. For good.
Remember, whatever you choose to do, 
always go easy to start with and build up 
gradually. Don’t attempt vigorous 
competitive games -  like squash -  until 
you’ve reached a good level of fitness. If 
you’re recovering from an illness or 
operation or are worried that exercise 
may affect any other aspect of your 
health, consult your doctor first.
(  I wouldn’t say I was a fanatical 
jogger but I do enjoy going for a 
half hour run once or twice a 
week. I usually go early in the 
morning and it really sets me up 
for the day. I think a bit of 
regular exercise is especially 
important for someone like me 
who’s approaching 40 and sits 
at a desk most of the day. 9
attack
A heart attack can be very 
painful and frightening so the first thing 
most people need is rest and reassurance. 
But for some people there is a danger that 
the heart might stop beating properly, or 
even stop altogether. If this happens the 
person will lose consciousness and die 
unless emergency first aid is given. So 
the critical time is the first few minutes 
before medical help arrives.
If you’re not sure whether it is a heart 
attack look for these signs:
•  Sudden, crushing vice-like pain in the 
centre of the chest which may spread 
to the arms, throat, jaw or back
•A sh e n  (waxy-white) skin and blueish 
lips and nailbeds
•  Feeling cold, clammy, faint, giddy or 
sick
•B reath ing and heart may stop.
If you think it might be a heart attack, 
send for a doctor or an ambulance (dial 
999) as soon as you can. Stay with the 
victim and reassure him until help 
arrives.
You may have to give emergency first 
aid before medical help arrives. Turn to 
the next page for a basic guide to first aid 
for a heart attack.
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Is he conscious?
yes
I
I . Gently put him in a half sitting (semi-recumbent) 
position with head and shoulders raised and knees 
bent. This is the most economical position for the 
heart.
2. Loosen clothing at the neck, chest and waist.
3. If he is cold, cover him with a blanket but do not 
apply a hot water bottle -  this draws the blood to 
the skin surface and away from the vital organs, like 
the heart.
4. Do not give him anything by mouth -  not even 
aspirin or brandy.
5. Do not move him unless it is essential for safety 
reasons.
6 . Stay with him and reassure him until the doctor 
arrives.
Learning about first aid
You'll be able to cope much better in an emergency if 
you have learnt how to do first aid properly Heart 
resuscitation can only be properly learned with expert 
guidance.
The British Red Cross Society and the St. John 
Ambulance (or the St. Andrew's Ambulance 
Association in Scotland) run first aid courses. For 
information about courses in your area, contact either 
your local Red Cross branch (address and phone 
number in your telephone directory under either 
British Red Cross Society or Red Cross); or your local 
St.John Ambulance branch, or if you live in Scotland, 
your local branch of the St. Andrew's Ambulance 
Association (address and phone number in your . 
telephone directory). The Royal Life Saving Society 
also runs first aid courses. See back for details.
Quickly check to see if he is breathing.
H ow  to  check:
Can you hear or feel the breaths? Put your ear 
against his nose and lips.
Can you see or feel the chest or abdomen 
moving?
Does his face look ashen or purple? ( If  you 
can’t  tell because his skin is coloured, check 
whether the inside of the lower lip or the 
nailbeds are blue.)
I
Is he breathing?
yes
I . Loosen his clothing at the neck, chest and waist.
2. Put him in the recovery position:
This keeps the tongue forward and the mouth low
so that the airway is kept clear and he can breathe.
3. Stay with him, watching all the time in case the 
breathing or heart stop.
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Kiss of Life) immediately.
Take your mouth away and watch the chest fall.
After 4 full breaths, check his pulse to see if his heart 
is beating.
How to check:
Can you feel the carotid pulse? Put two  
fingers in the groove at the side of his A dam ’s 
apple and press firmly.
If you can’t feel a pulse, and his face is ashen or 
purple, then his heart has stopped beating.
1
Is his heart 
beating?
yes
1
Continue mouth-to-mouth resuscitation giving 16 
to 18 breaths per minute (one every 3-4 seconds) 
until breathing starts again.
Press about 80 times a minute. To help you keep 
time, count out a rhythm of “one and ... two and ... 
three and ...” as you do it.
3. He will not start breathing again until the heart has 
started beating. So after pressing 15 times, stop the 
heart resuscitation and give 2 quick breaths by 
mouth-to-mouth resuscitation as described.
Continue to give 15 presses and 2 breaths in this way.
If there is another person with you, get them to do 
the heart resuscitation. Give 5 presses, I breath, 5 
presses, I breath, without pausing. Press about 60 
times a minute. To help you keep time, count out a 
rhythm of “ one thousand and one... one thousand 
and tw o ... one thousand and three...” as you do it.
4. After one minute, check the carotid pulse to see if 
the heart has restarted. Then keep checking every 
three minutes, or until the colour of the face begins 
to improve.
Continue heart resuscitation until the heart starts 
beating.
5. Once the heart has started beating keep on with 
mouth-to-mouth resuscitation until breathing starts 
again.
6. Once the breathing has started, put the person into 
the recovery position and wait for medical help to 
arrive.
7. Stay with the person, watching all the time in case 
the breathing or heart stop again.
To avoid awkward repetition o f he/she h im /her the  heart attack 
victim  has been re ferred  to  th roughout this chart as he.
Quickly clear the mouth of any dirt or vomit etc.
3end the head backwards with one hand and push 
:he jaw upwards with the other hand. This lifts the 
:ongue off the back of the throat. This action alone 
nay allow breathing to start.
>• Start heart resuscitation.
(Never attempt heart resuscitation if the heart 
is beating).
I . Lie the patient on his back on the floor or other firm 
surface, and kneel alongside.
quickly give him 4 full breaths: 
the nostrils together then take a deep breath 
in, seal your lips around his mouth and blow into it. 
See that the chest rises as you blow in.
2 . Put the heel of one hand on the lower half of the 
patient’s breast bone, and cover it with the heel of 
the other hand. Press down hard on the lower half of 
the breast bone to a depth of about 13 inches.
The main thing is to allow 
the patient to rest while the heart 
recovers. Immediate treatment after a 
heart attack is usually:
□  Complete rest in bed (this is usually 
but not always in hospital)
□  A painkiller (if necessary)
□  Treatment to correct the heart beat (if
necessary)
□Careful observation (keeping a close 
eye on the patient’s condition).
In hospital
Most patients will stay in hospital for 
several days for observation. Some 
patients will be admitted to a special 
ward called the coronary care unit. This 
unit has special staff and equipment to 
cope with the complications of a heart 
attack. The patient may be connected to 
a monitor called an electrocardiogram 
(ECG) which can detect any fault in the 
heart beat. If anything is wrong, 
treatment can be started immediately.
After a few days complete rest, the 
patient can usually start to get moving 
again, and may be allowed home to be 
looked after by his own doctor.
The heart has a remarkable 
capacity for healing its damaged tissue 
and most people who recover from a 
heart attack have every chance of leadin 
an active life afterwards.
It’s natural to feel a bit shaky and 
insecure when you’ve just left hospital 
after a heart attack. Without the ECG 
and the watchful eye of trained staff it’s 
easy to feel frightened to do anything. 
But it’s a mistake to feel over cautious.
Getting back to normal
Most people can expect to be more or le: 
back to normal within a few months aft< 
a heart attack. But of course this depenc 
on how bad the attack was.
Your doctor can help you to work out 
carefully planned programme of activity 
This will enable you to gradually and 
steadily build up your physical strength 
and self-confidence.
At first you may only be up and abou 
for part of the day. Then you’ll start 
doing a little more -  going for a gentle 
walk everyday perhaps. Soon you will 
probably be able to build up to more 
strenuous exercise like brisk walking, 
swimming or cycling. Ask your doctor 
for advice.
Of course, everyone’s progress after a 
heart attack is different. It all depends c 
how much you feel you can do and how 
much your doctor thinks you can 
manage.
Back to work?
You can usually expect to return to your 
job within several weeks. Again, this wi 
depend on how bad your heart attack 
was. It is obviously unwise to do really 
hard physical work immediately after a 
heart attack. In some cases your doctor 
or occupational health services may be 
able to help negotiate with your 
employer a return to lighter work or 
part-time hours, before you go back to 
your full-time job.
Healthy eating
If you’ve already had a heart attack it’s 
just as important to make an effort to ea 
less fatty food and keep your weight 
down. By eating sensibly you could helf
t  This was not my first heart 
ittack so I'm taking things 
slowly, trying to build up my 
strength gradually. I usually go 
ror a gentle walk each day to 
:he shops or the park so that I 
:an get a bit of exercise and 
some fresh air. And every day I 
try to walk just a bit further 
than the day before, y
11 used to play a lot of squash before my heart attack, but for the 
moment I'm happy with cycling and swimming until I feel fit 
enough for something more strenuous. You soon find out your 
limitations and do as much as is good for you. y
reduce the risk of another attack. Look 
at page 8 for a guide to healthy eating.
Smoking
If you haven’t already stopped smoking 
now is the time to give it up for good. As 
soon as you stop smoking you will start to 
reduce the risk of having another heart 
attack. Have a look at the section on page 
7 for advice on giving up or get a copy of 
So you want to stop smoking from your 
local health education unit or by writing 
to:
‘So you want to stop smoking’
PO Box 410 
London SE99 6YE
or, if you live in Scotland:
Scottish Health Education Group 
Woodburn House 
Canaan Lane 
Edinburgh EH10 4SG.
Sex
This depends on how long it takes you to 
recover your physical strength. It is 
usually better to wait until you can 
manage brisk walking without 
discomfort or breathlessness before you 
start having sex again. Again, your 
doctor will be able to give you advice.
Driving
Because driving is a stressful activity it 
can push your blood pressure and pulse 
rate up to quite high levels. So you 
shouldn’t start driving again until your 
heart has recovered enough. For most 
people this means a few months after 
their attack. But it may be necessary to 
give up heavy driving (for example, 
heavy goods vehicles and public 
transport). In all cases check with your 
doctor before you start to drive again.
Staying fit and 
healthy after a 
heart attack
If nothing else, a heart attack at least 
gives you the chance to stop and think 
about the way you have been living your 
life. Many people who have recovered 
from a heart attack say their outlook and 
way of life have changed so much that 
they never felt better!
This booklet has shown how the risk 
of heart disease can be reduced. If you 
have already had a heart attack it makes 
sense to think about what you can do to 
help avoid another. It’s never too late to 
change. Stop smoking, eat sensibly, take 
some exercise and learn to relax. You’ll 
not only feel fitter than you’ve felt for 
years. You’ll be giving yourself and your 
heart a new lease of life.
4  When I had my heart attack I was only a year off retirement. I 
was a mechanical engineer but the company let me go back to a 
desk job until I retired. Now I can enjoy myself at home doing the 
things I never really had time for before. We go walking a lot and 
I’ve built my own workshop at the bottom of the garden so that I 
can get on with my woodwork, y
drenaline One of the so called ‘stress 
ormones’. Speeds up the pulse rate, 
tits up the blood pressure, increases 
lood flow to brain, heart and muscles, 
repares the mind and body for quick 
lought and action.
ngina Constricting feeling, usually a 
2avy crushing pain in the chest and 
>metimes the neck, shoulders and 
•ms. Comes on after exertion or 
notion and is relieved by rest. Caused 
y  poor blood supply to the heart 
mscle.
orta Main artery taking oxygen-laden 
lood from the heart to the other arteries 
ipplying the body.
rrhythmia Any variation from the 
ormal regular heartbeat.
rtery Vessel carrying blood away from 
le heart to supply the tissues. Has a 
lick muscular wall to withstand the 
lood pressure.
theroma Fatty deposit containing 
lolesterol which gradually builds up on 
le inner lining of arteries over a period 
f many years. Can cause the blockages 
hich lead to heart attacks and strokes.
lood pressure Pressure o f blood in the 
lain arteries needed to push it through 
le smaller vessels o f the circulation, 
leasured using a sphygmomanometer, 
bnormally high blood pressure is called 
ypertension.
lalorie Unit o f energy. A calorie is the 
ciergy needed to raise the temperature 
f a kilogramme o f water by 1 °C. The 
rerage person at rest burns about 1 
ilorie a minute to supply the body’s 
asic energy needs.
lapillaries Microscopic vessels that 
arry blood through the substance o f the 
ssues, between the arteries and veins, 
lood pressure is needed to force the 
lood through.
larbon Monoxide Poisonous gas in 
igarette smoke which interferes with 
le oxygen carrying capacity o f the 
lood.
lardiac Relating to the heart.
Cardiovascular system The heart and 
lood vessels.
Carotid arteries Pair o f large arteries 
ipplying the brain. Can be felt on each
side of the Adam’s Apple.
Cerebral Relating to the brain, eg. 
cerebral artery, cerebral thrombosis.
Cholesterol Fatty substance needed by 
the body as a building block for tissues 
and chemical processes. Some 
cholesterol is present in our food. But 
most is made in the body from other 
substances derived from food, 
particularly fats. Blood carries 
cholesterol around the body.
Coronary arteries Small arteries which 
encircle the heart and supply blood to the 
heart muscle itself. They branch off the 
aorta as it leaves the heart. Atheroma in 
the coronary arteries is the main cause of 
heart disease.
Coronary heart disease (CHD) Disease, 
such as angina or heart attack, caused by 
atheroma silting up the coronary 
arteries.
Coronary thrombosis Blood clot in a 
coronary artery blocking the blood 
supply to part of the heart muscle, and 
causing a heart attack (also called a 
coronary).
Electrocardiogram (ECG) Picture o f the 
electrical impulses made by the beating 
heart.
Haemoglobin Red substance in blood 
which carries oxygen from the lungs to 
the tissue. Its action can be blocked by 
the poisonous gas carbon monoxide.
Heart attack Non-medical term for a 
sudden serious disorder o f the heart. 
Usually refers to a coronary thrombosis.
Hypertension Abnormally high blood 
pressure which, if uncontrolled, can 
increase the risk of heart disease or a 
stroke.
Infarct Part of an organ which has died 
because its blood supply is cut off. 
Usually refers to the dead part of the 
heart muscle after a coronary 
thrombosis.
Ischaemia Poor blood supply usually 
due to narrowing or blockage of an 
artery.
Myocardial infarction Commonest type 
of heart attack in which part of the heart 
muscle dies because its blood supply is 
cut off due to a coronary thrombosis.
May cause sudden death.
Nicotine Poisonous substance in 
tobacco. Strongly addictive. Increases 
pulse rate and blood pressure, and 
disturbs the balance of fatty substances 
in the bloodstream.
Obesity Condition of being grossly 
overweight, at least 20% heavier than the 
heaviest weight in the ‘ideal’ range for 
that person’s height.
Palpitations Sensation o f ‘fluttering’ in 
the chest, usually caused by a faster or 
stronger or perhaps an irregular 
heartbeat.
Polyunsaturated fats Fats which contain 
a high proportion of polyunsaturates. 
Thought to be less harmful to the heart 
and arteries than saturated fats, and may 
even be beneficial. Examples are fish oils 
and certain vegetable oils like sunflower, 
safflower and soya oil.
Pulse Wave of pressure in the arteries 
which follows each heart beat. Can be 
felt through the skin over some arteries. 
Examples are radial pulse (wrist) and 
carotid pulse (neck).
Saturated fats Fats which contain a high 
proportion of saturates. Thought to be 
potentially harmful to the heart and 
arteries if  eaten in too great a quantity 
over a period of years. Examples are the 
fats in dairy products like butter, cream 
and cheese, in meat and meat products; 
in lard, and in some vegetable oils like 
coconut and palm oil.
Stamina Physical fitness that gives a 
person heart and muscle endurance or 
‘staying power’; the ability to keep up 
vigorous exercise without gasping for 
breath. Stamina fitness is thought to help 
protect the heart against heart attacks.
Sternum Breast bone.
Stress General term that covers a variety 
of everyday psychological pressures that 
might have ill-effects on the heart and 
arteries.
Stroke Paralysis or malfunction due to a 
sudden lack of blood supply to part of the 
brain, usually caused by a thrombosis or 
rupture of a cerebral artery.
Thrombosis Blockage due to a blood 
clot in a vessel. See coronary thrombosis.
Veins Vessels draining blood from the 
tissues and back to the heart, ready to be 
pumped round the lungs and re-charged 
with oxygen.
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Books
Avoiding heart attacks (DH SS, 1981) 
Available from HMSO bookshops
Avoiding heart trouble (Consumers 
Association, 1980)
Available from leading booksellers
Heart attacks: prevention and 
treatment (BMA, 1979)
Available by post from:
Family Doctor Publications 
BMA House 
Tavistock Square 
London, WC1H9JP.
First aid
You can get details of first aid courses 
from:
The British Red Cross Society 
9 Grosvenor Crescent 
London SW1X7EJ
St John Ambulance 
1 Grosvenor Crescent 
London SW 1X7EF
St Andrew’s Ambulance Association 
St Andrew’s House 
Milton Street 
Glasgow G4 OHR
The Royal Life Saving Society 
Mountbatten House 
Studley
Warwickshire B80 7N N .
First Aid Manual: ( Dorling 
Kindersley L td ., 1982)
The authorised manual o f St. John 
Ambulance, St. Andrew’s Ambulance 
Association and the British Red Cross 
Society. Available from leading 
booksellers.
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Advice 
for those 
recovering 
from a 
heart attack.
The aim of this advice is to guide you concerning your 
activities after leaving hospital and to get you back to a norm al active 
life. Some answers are given to questions that might have bothered 
you about your illness.
Prepared by Prof. M. F. Oliver, M.D., F.R.C.P. 
and Dr. A. L. Muir, M.D., F.R.C.P.E.
W hat is a heart attack?
Figure 1
Right
coronary
artery
Left
coronary
artery
The heart, like any other muscle, needs to be 
supplied with blood to keep it working. The 
main arteries, called the coronary arteries, bring 
blood to the heart (see fig. 1).
1
Left
coronary
arteryRight
coronary
artery
Figure 2
A heart attack occurs when there is a 
temporary block of one of these arteries, reducing 
the blood supply to part of the muscle of the heart. 
This causes injury to the portion of the heart muscle 
supplied by that small artery; the injury is similar 
to a bruise of the muscles in the arm or leg, occuring 
after a sharp blow, and like such bruising it takes 
two or three weeks to heal (see fig. 2). During the 
acute stage of injury the heart has been rested.
The convalescent stage which you are now entering 
is based on rebuilding your heart’s efficiency for a 
full return to fitness. •>
Physical Activity
Physical activity should be graduated and 
increased as the weeks go past.
During the first week at home you should 
follow much the same routine as in hospital, but 
don’t be frightened to walk upstairs or out of your 
home. During the second week at home increase 
your activities so that by the third or fourth week 
after leaving hospital you should be undertaking 
most household and light gardening activities. 
Before you return to work you should be physically 
active again.
If you were unfit before your heart attack and 
found little time or interest in sport or leisure 
activities you should make a decision to do more 
and take up some activity such as hill walking, 
swimming, playing golf, etc. This can improve the 
blood supply to the heart.
You may find that you are not able to do 
much at first but you should concentrate on 
becoming more and more active, although 
strenuous activity should be avoided. Carrying 
heavy loads such as suitcases should also be 
avoided.
Remember you could walk to and from work, 
and climb stairs instead of taking the lift, but no 
sprinting up the stairs to see if you can beat the lift!
Return to Work
If progress is good you should be back at work 
within two months after leaving hospital, unless 
your doctor advises you otherwise. Normally you 
can return to your old job unless a lot of heavy 
manual work is involved. If your doctor says your 
job is not suitable, you should contact your local 
Job Centre or Employment Office and ask for an 
interview with the Disablement Resettlement 
Officer.
Do not be discouraged if your progress seems 
slow. Some people recover from a heart attack 
more quickly than others.
4
bleep and Kest
It is common to feel tired when recovering 
from a heart attack and there is no reason for you 
to think that you are not progressing when 
unexpectedly you get tired. Just give in to it and 
have a rest—even if it is socially inconvenient.
Make sure you have seven or eight hours sleep each 
night. Sleeping tablets are not usually necessary but 
your own doctor will advise you about this. A short 
sleep in the afternoon is good for you during the 
first few weeks after leaving hospital, and also later 
if you can manage it.
5
K e s p o n s iD in t ie s
While you are at home recovering, you have a 
marvellous opportunity to take an extended 
holiday and to examine the way you lived before 
your illness. Did you work long hours of overtime? 
Did you let the housework get on top of you?
Did you worry unnecessarily about your job, or 
family, or your home life? Did you get into 
arguments or get upset easily? There are many 
ways to cut down on all this stress and strain in 
your life. For example, cut out the overtime, let 
other people help you with the work in the house 
or in your job, keep out of arguments, stop rushing 
about as if everything had to be done at breakneck 
speed. If you can calm down and lead a less hectic 
life, you will probably find yourself feeling 
mentally and physically healthier than you have 
done for years.
u  l e i
The chart below shows average weightsTor 
different heights. Check your weight against that 
shown on the chart. If you are overweight a low 
calorie weight reducing diet is advised (see page 13). 
If you are not, then no particular dietary advice is 
necessary.
MEN WOMEN
Height Weight Height Weight
5 ’3 ” 9 st 81b 4 ’ 11” 8 st 3 lb
5 ’4 ” 9 st 101b 5 ’ 8 st 5 lb
5 ’5 ” 10 st 1 lb 5 ’ 1” 8 st 71b
5 ’6 ” 10 st 4 lb 5 ’2 ” 8 st 9 lb
5 ’7” 10 st 8 lb 5 ’3 ” 8 st 121b
5’8 ” 10 st 11 lb 5 ’4 ” 9 st 1 lb
5 ’9 ” 11 st 2 lb 5 ’5 ” 9 st 5 lb
5 ’ 10” 1 1 st 6 lb 5 ’6 ” 9 st 8 lb
5' 11” 1 1 st 1 1 lb 5 ’7” 9 st 121b
6 ’ 12 st 21b 5 ’8 ” 10 st 21b
6 ’ 1” 12 st 71b 5 ’9 ” 10 st 6 lb
6 ’2 ” 12 st 11 lb 5 ’ 10” 10 st 101b
6 ’3 ” 13 st l ib 5 ’ 11” 1 1 st 0 lb
6 ’ 11 st 4 lb
However if you are under 50 years of age with 
high blood fat levels, specific dietary instructions 
may be given by your own doctor. These are 
outlined on page 14.
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o m o K in g
Stop smoking cigarettes! There is clear 
evidence that the risk of a subsequent heart attack 
is substantially reduced in those who give up 
smoking. You should therefore stop cigarette 
smoking completely, and for good. Although pipe 
smokers are less at risk, cigarette smokers who take 
to a pipe may find it difficult not to inhale and 
inhaling pipe tobacco smoke is also harmful. If you 
find it difficult at first leaflets are available from the 
Scottish Health Education Group, Freepost, 
Edinburgh EH12 OPQ, giving practical hints on 
“How to stop Smoking”.
8
^exuai intercourse
Intercourse is probably best avoided during 
the first month after discharge from hospital. 
Thereafter, as you return to physical health, no 
restrictions are necessary.
Car Driving
You should wait two months after your heart 
attack before driving your car, and when you do, 
try to cut down the strain involved by avoiding 
city traffic and congestion, by allowing plenty of 
time for a journey and by travelling at a more 
leisurely pace.
You will not be allowed to drive heavy goods 
or public services vehicles.
9
A i r  i r a v e i
You can still travel safely by aeroplane, 
although it is wise to avoid long and tiring flights 
for the first two months after your attack.
Angina
You may have chest pain on exercise. Not all 
chest pains come from the heart. Unless it is 
frequent and interfering with your activities, it can 
be ignored, although there are drugs available for 
its control. If it is causing distress, consult your 
doctor. Car driving, cold and winds can 
occasionally produce angina; if so, such factors 
should be avoided.
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Special Advice tor Women
Women often find themselves in a position of 
considerable responsibility on returning home after 
a heart attack. You may feel, for example, that the 
house has been rather neglected while you have 
been away, that you are responsible for the running 
of the household, the provision and cooking of 
food, and the care of your close relations. It is 
important during the first month or so after 
returning home that you do not take on your full 
domestic activities and that you continue to allow 
yourself to convalesce. If things are not just as you 
want in your own home, then be patient and put 
them right when you are completely recovered.
Try to find a relative or a neighbour who will help 
with the shopping.
You should not take oral contraceptives.
While “The Pill” is harmless in young healthy 
women, there is an increased risk of a heart attack 
in those who already have heart disease. You 
should consult your doctor about other methods of 
Family Planning.
You should not take oestrogens as hormone 
replacement treatment following the menopause.
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Treatment
Some people require drug treatment of various 
kinds. Your own doctor will advise you.
Do not be discouraged because you have had 
a heart attack. M ost people return to a full active 
life and some indeed become fitter than ever before.
Show this booklet to your family and friends 
so that they understand the advice given and can 
help make your recovery all the more enjoyable.
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Diet for those who are overweight
SOME GENERAL RULES FOR LOSING WEIGHT
1. Eat as much as you like of:-
Fresh green vegetables and salads, fresh fruit, 
and clear soup.
2. Take average portions of:-
Meat, poultry, cheese CAlb/week), eggs (3/week) 
and fish.
3. Cut down the amount of starchy foods you eat. 
For example reduce the size of each portion of:- 
Potato, bread, butter, milk, peas and sweetcom, 
thick soups and sauces. Remember alcohol is 
fattening too, so try to reduce your drinking.
4. Cut out altogether sugary foods such as:- 
Cakes, sweets, biscuits, tinned fruit and 
sweetened fruit juices, and sugar in tea or 
coffee.
5. Avoid fried food and sauces or soups thickened 
with flour.
Diet for those with high blood fat levels
1. Eat less meat, and cut off visible fat. You can 
however eat poultry and fish.
2. Avoid fats such as butter, hard margarine, 
beef dripping and white lard both for spreading 
and for cooking. This means you will have to 
avoid most manufactured cakes, chocolates 
and biscuits because they also contain the 
wrong fats. Instead use com oil or sunflower 
oil for cooking. Do not use lard or oils labelled 
simply Vegetable oil’.
3. Use skimmed milk and avoid ordinary milk 
and cream.
4. Allow yourself no more than 3 eggs a week.
5. Reduce the amount of hard cheese eaten.
Try cottage cheeses instead.
6. Eat plenty of fresh fruit and vegetables.
If you are also overweight you should cut down on
starchy and sugary foods as well (see page 13).
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